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Inhalt  
Enantioinversion in der Gold(I)-katalysierten Hydroalkoxylierung von Allenen 
Chirale Phosphoramidit-Liganden mit TADDOL-basiertem Rückgrat haben sich in der asymmetrischen 
Goldkatalyse als äußerst erfolgreich erwiesen. Im Rahmen ihrer Anwendung in der intramolekularen 
Hydroalkoxylierung von Allenen wurde eine bemerkenswerte Entdeckung gemacht: die 
Enantioselektivität der Zyklisierung von Allenol 1 zu Tetrahydrofuran 2 konnte allein durch Variation 
von Lösungsmittel, Temperatur oder Gegenion unter Verwendung ein und desselben chiralen Gold-
Komplexes C3 von (S) nach (R) umgekehrt werden.  
 
Das Phänomen der Enantioinversion, bei dem eine einzige chirale Quelle selektiv beide Enantiomere 
eines Produkts erzeugen kann, ist nicht unbekannt. Allerdings ist dessen Ursprung auf molekularer 
Ebene kaum verstanden. Der hier vorliegende Fall ist besonders eindrucksvoll, da es sich um das 
erste Beispiel handelt, bei dem drei verschiedene Parameter eine signifikante Inversion auslösen. Um 
Einblicke in den zugrunde liegenden Mechanismus zu erhalten, wurden detaillierte mechanistische 
Studien durchgeführt.  
Präparative Untersuchungen, welche die ausführliche Analyse der Reaktionsparameter, Eyring-
Studien sowie NMR-Experimente beinhalteten, konnten mithilfe von DFT-Rechnungen ein plausibles 
mechanistisches Szenario liefern. Der Hauptgrund für die Enantioinversion wurde im Vorliegen 
zweier kompetitiver Reaktionspfade gefunden: Im einen Fall ist die Protodeaurierung geschwindig-
keitsbestimmend und das (S)-Produkt wird favorisiert, während im anderen Fall ein alternativer Pfad 
zugänglich ist, der durch assistierte Protodeaurierung bevorzugt das (R)-Produkt generiert. Eine 
solche Unterstützung kann entweder durch ein protisches Lösungsmittel, ein koordinierendes 
Gegenion oder ein zweites Substratmolekül erfolgen. Das Energieprofil erhält dadurch einen 
beachtlichen entropischen Beitrag, der den stereochemischen Verlauf maßgeblich bestimmt.  
Diese Studie erklärt den ungewöhnlichen Effekt der Enantioinversion erstmals auf molekularer 
Ebene. Die Ergebnisse unterstreichen die Bedeutung der Entropie, die bei der Analyse von 
mehrstufigen Reaktionsmechanismen beachtet werden muss.  
   
Studien zur Totalsynthese von Chagosensine 
Die selektive und konsekutive Funktionalisierung von Alkinen wurde im Kontext eines 
anspruchsvollen Totalsynthese-Projekts erforscht. Die Anwendung einer Sequenz aus ring-
schließender Alkin-Metathese (RCAM), trans-Hydrostannylierung und Zinn/Chlor-Austausch sollte 
den Aufbau eines einzigartigen (Z,Z)-Chlorodiens im vielfältig substituierten Makrozyklus des marinen 
Polyketids Chagosensine ermöglichen.  
Nach erfolgreicher Darstellung der benötigten Fragmente, wurde die geplante Reaktionsfolge 
untersucht. Die ringschließende Alkin-Metathese ließ sich jedoch nicht realisieren, vermutlich 
aufgrund erheblicher Ringspannung der konzipierten Enin-Makrozyklen und der außergewöhnlich 
hohen Dichte an koordinierenden funktionellen Gruppen. Der Versuch, diese gespannten 
Intermediate mittels ringschließender Dien-En-Metathese zu umgehen, schlug ebenfalls fehl. Auch 
der alternative Zugang über ein nicht-zyklisches Enin wurde durch ineffiziente Sonogashira 
Kreuzkupplung und erfolglose Hydrometallierung verwehrt.  
 
Trotz enormer Bemühungen und der Weiterentwicklung von Katalysatorsystemen versagten 
etablierte Methoden wie RCAM, RCM und Sonogashira Kreuzkupplungen im komplexen, hoch-
oxygenierten Umfeld des Naturstoffs. Die Lösung wurde schlussendlich in der Funktionalisierung des 
Alkins vor der Fragmentkupplung gefunden: Bis-Metallierung des Nordsegments und anschließende 
selektive Stille Kreuzkupplung mit dem Südfragment gefolgt von Makrolaktonisierung lieferte in der 
vierten Strategie den Makrozyklus als Schlüsselintermediat. Damit ist die Fertigstellung der ersten 
Totalsynthese von Chagosensine in Reichweite gerückt. 
  
Abstract 
Enantioinversion in the Gold(I)-catalyzed Hydroalkoxylation of Allenes 
Previously developed chiral phosphoramidite ligands comprising a TADDOL-related acyclic backbone 
have proven successful in asymmetric gold catalysis. While extending their applicability to the 
intramolecular hydroalkoxylation, a striking case of enantioinversion was observed: the sense of 
induction in the cyclization of allenol 1 to tetrahydrofuran 2 can be swapped from (S) to (R) solely by 
changing either the solvent or the temperature or the escorting counterion, while using the very 
same chiral gold complex C3.  
 
The perplexing phenomenon of enantioinversion, in which a single chiral source delivers either 
enantiomer of a given product, is not uncommon. However, the understanding of its origins at the 
molecular level is quite limited. Moreover, the present case seemed particularly remarkable, since it 
represents the first reported example in which three different parameters are able to trigger a 
significant switch. Thus, a combined experimental and computational approach was conducted to 
gain insight into the underlying mechanism. 
Preparative studies including thorough screenings, Eyring plots and NMR experiments in combination 
with DFT calculations provided a plausible mechanistic scenario. The major reason for the 
enantioinversion was found in the existence of two competing pathways: a pathway where proto-
deauration is rate-determining favors the (S)-product, whereas an alternative outlet involving 
assisted proto-deauration preferably produces the (R)-product; such assistance can be provided 
either by a protic solvent, a coordinating counterion or a second substrate molecule. Consequently, 
the reaction free energy profile gains a significant entropic component that can ultimately dictate the 
stereochemical course.  
This case study represents the first example, which explains the unusual effect of enantioinversion at 
the molecular level. The results highlight the importance of considering the entropy in the analysis of 
a multi-step reaction mechanism. 
   
Studies Toward the Total Synthesis of Chagosensine 
The selective and consecutive functionalization of alkynes was investigated in the context of a 
challenging total synthesis program. The marine polyketide chagosensine, isolated in 2003 from the 
Red Sea calcareous sponge Leucetta chagosensis in Israel, was deemed an ideal target for the 
application of a sequence of ring closing alkyne metathesis (RCAM), trans-hydrostannylation and 
tin/chloride exchange to install the unique (Z,Z)-chlorodiene motif within a highly decorated 
macrocycle. An additional obstacle to this endeavor was posed by the unsecured structure 
assignment of the natural product, whose synthesis had not been tackled before.  
After the successful preparation of the required building blocks, the original endgame strategy was 
studied. However, RCAM could not be achieved, presumably due to the highly strained enyne 
macrocycle. Attempted ring closing diene-ene metathesis to circumvent such macrocyclic enynes did 
not succeed either. An alternative strategy based on the construction of an acyclic enyne was 
hampered by inefficient Sonogashira cross coupling and unfeasible hydrometalations.   
 
Despite enormous efforts and catalyst development, conventional approaches such as RCAM, RCM 
and cross coupling strategies failed in this complex environment with an exceptionally high density of 
potentially coordinating functional groups. A remedy was found in the functionalization of the alkyne 
prior to fragment assembly: the intricate chlorodiene-containing macrolactone was finally accessed 
by bis-metalation of the northern domain followed by selective Stille coupling with the southern 
sector and subsequent macrolactonization. Thus, the synthesis of the sophisticated intermediate by 
this forth route sets the stage for the completion of the first total synthesis of chagosensine.   
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1 Enantioinversion in the Gold(I)-catalyzed Hydroalkoxylation of Allenes 
1.1 Introduction 
1.1.1 Homogeneous Gold Catalysis 
Over the past decade, the activation of an unsaturated carbon–carbon bond by a π-acidic noble-
metal catalyst has been exploited for a wide range of new transformations of alkynes, allenes and 
alkenes.[1] The discovery of this novel reactivity allowed the construction of diverse carbocyclic and 
heterocyclic scaffolds with increased molecular complexity from readily available substrates with 
high atom economy and functional group tolerance.[2] Thus, numerous applications to target-
oriented synthesis have been reported soon after.[3] Efficient asymmetric variants of such 
transformations, however, proved challenging due to the favored linear-dicoordination of gold.[4] 
This geometrical constraint forces the substrate to approach the reactive gold center trans to the 
chiral ancillary ligand L*, i.e. at maximum distance from the chiral information (Figure 1.1). With only 
single coordination sites, the rotation about the L*–Au bond and the Au–substrate bond remains per 
se unrestricted. Additionally, gold-catalyzed reactions are believed to proceed through outer-sphere 
pathways. Hence, the nucleophile does not enter the first coordination sphere of the Au+ center and 
therefore attacks the π-system from the opposite side.  
  
 
Figure 1.1. Top: intrinsic geometrical constraints to gold catalysis. Bottom: concepts for asymmetric gold catalysis:  
a) chiral counterion strategy; b) chiral dinuclear gold-phosphine complex; c) chiral phosphoramidite-gold complex. 
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Three major concepts to tackle the intricate transfer of chiral information from ligand to substrate 
have been established in homogeneous gold catalysis during the last few years: the use of chiral 
counterions,[5] chiral dinuclear gold-phosphine complexes[6] and the development of chiral one-point 
binding ligands (Figure 1.1).[7] 
1.1.2 TADDOL-Phosphoramidites as One-point Binding Ligands for Asymmetric Gold Catalysis 
In this context, Fürstner and coworkers developed monodentate phosphoramidites featuring a 
TADDOL-related, yet acyclic backbone as chiral ligands for homogeneous gold catalysis.[7b,7c,8] A 
general feature of these ligands is their short and flexible synthesis, providing a fast access to a 
library of catalysts; a selection is depicted in Figure 1.2.  
 
Figure 1.2. Selection of phosphoramidite-gold complexes of either enantiomeric series developed by Fürstner et al.
[7b,7c,8]
 
In contrast to their preceding BINOL-derived congeners (see Figure 1.1 c)),[9] the TADDOL-based 
phosphoramidites are easily prepared on large scale from cheap starting materials and amenable to 
structural editing. As the corresponding gold complexes are air- and moisture-tolerant, they 
represent a user-friendly tool for organic synthesis. These complexes proved valuable for a broad 
variety of mechanistically distinct gold-catalyzed enantioselective transformations. One-point binding 
ligands – if appropriately designed – are beneficial, as the chiral information is closer to the metal 
center, therefore improving the chirality transfer onto the substrate. In this regard, [2+2]- and [4+2]-
cycloadditions, enyne cycloisomerizations and indoline formations were accomplished with good to 
excellent enantioselectivities (Scheme 1.1).  
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Scheme 1.1. Variety of transformations successfully catalyzed by TADDOL-based phosphoramidite-gold complexes. 
The origin of enantioselection was de-convoluted with the aid of computational studies conducted 
on the enyne cycloisomerization catalyzed by gold complex (S,S,S,S)-C3.[7c] The crystal structure of 
this precatalyst, which served as a starting point for the calculations, revealed that two of the aryl 
groups at the TADDOL-moiety and one phenyl group of the amine part form a cavity around the 
metal center (Scheme 1.2, red). This pseudo-C3 symmetrical pocket extends well beyond the gold 
atom only for substituted phenyl rings or larger aromatic systems. Thus, the substrate bound to the 
gold center will be buried in the chiral environment and enantioselectivity should be improved as 
compared to analogs bearing smaller substituents at the ligand. DFT calculations suggest that this 
pseudo-C3 symmetry converts into C1 symmetry upon substrate binding, which translates to the 
absolute stereochemistry of the product by a unidirectional rotation of the substrate in the cavity 
(Scheme 1.2).  
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Scheme 1.2. Probable origin of enantioselection in enyne cycloisomerizations. X-ray structure of (S,S,S,S)-C3 (left), 
schematic illustration with pseudo-C3 symmetric cavity highlighted in red (middle) and repeal of symmetry upon 
substrate binding (right).
[7c]
 
As a result, the architecture of the catalyst and thus the size of the chiral cavity are crucial for the 
formation of the desired products with high enantioselectivities. In order to ultimately challenge the 
novel catalytic system, the reaction scope was further expanded. 
1.1.3 Intramolecular Hydrofunctionalizations of Allenes 
Intramolecular hydrofunctionalizations of allenes as highly atom economical processes affording 
heterocylces[10] were envisioned to showcase the power of the new single-point binding ligands in 
asymmetric gold catalysis. These transformations comprising both endo- and exo-cyclizations of 
carbon-, sulfur-, nitrogen- or oxygen-nucleophiles onto allenes had been investigated in great detail 
by different research groups.[11] Initially, the reaction mechanism was subject to intense debate: 
Widenhoefer proposed an outer-sphere mechanism[6d] while Yamamoto suggested coordination of 
the nucleophile to the gold and an inner-sphere addition to the allene.[12] Only after the subsequent 
isolation of a first vinyl gold species during the cyclization of an allenoate,[13] and other gold 
intermediates characterized thereafter,[14] could the former proposals be re-evaluated. Hence, 
hydrofunctionalizations of allenes are commonly believed to proceed through outer-sphere 
pathways with the proposed mechanism depicted in Scheme 1.3. After ionization of the precatalyst I, 
the cationic gold species II activates the allenic π-system of starting material III forming a π-complex 
IV. Nucleophilic attack at the activated carbon leads to the vinyl gold intermediate V, which 
undergoes proto-deauration to give the π-complex VI. Decomplexation liberates the product VII 
concomitant with the regeneration of the cationic gold catalyst II.  
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Scheme 1.3. Mechanistic proposal for the intramolecular hydrofunctionalization of allenes. 
Despite the advanced studies on this transformation, it was not until 2007 that Widenhoefer et al. 
reported the first enantioselective gold-catalyzed hydroalkoxylation.[6d] Since then, asymmetric exo-
hydroaminations and -alkoxylations of allenes have been subject of intense investigations.[5a,15] As a 
result, such reactions represent a stringent test for the competence of novel catalysts. Thus, Fürstner 
and coworkers applied the newly designed TADDOL-related phosphoramidite-gold complexes to 
aminoallenes, which were cyclized to the corresponding pyrrolidines with 90 to 95% ee 
(Scheme 1.4).[7c]  
 
Scheme 1.4. Intramolecular hydroamination of allenes. Reagents and conditions: (a) (R,R,R,R)-C2 (5.5 mol%), AgBF4 
(5.0 mol%), toluene/EtOAc, 0 °C.[7c] 
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This chemistry was further extended to the related hydroalkoxylation reactions.[16] Since the 
enantioselectivities for the former transformation could be enhanced to over 90% ee using 
precatalyst (R,R,R,R)-C2 in toluene/EtOAc mixtures (1:1), the hydroalkoxylation was conducted under 
similar conditions. However, the 6-exo cyclization of δ-allenol 3 in toluene at ambient temperature 
gave the corresponding tetrahydropyran 4 in only 19% ee. The ee could not be improved by 
screening various solvents typically used for this transformation (CH2Cl2, THF, Et2O, EtOAc, etc.). 
Somewhat surprisingly, ethanol provided the best result with 85% ee at ambient temperature that 
could be increased to 98% ee at low temperature (Scheme 1.6), without the detection of 
intermolecular addition of ethanol. Variation in the substitution pattern was tolerated at the allene 
terminus as well as at the alkyl chain as demonstrated by the tetrahydropyrans 5 and 6. Next, the 
chain length was modified and different γ-allenols were subjected to the optimized reaction 
conditions. Interestingly, precatalyst (R,R,R,R)-C2 gave only poor enantioselectivities for the 5-exo-
cyclizations. Therefore, the naphthyl variant (S,S,S,S)-C3 that had proven more effective in previous 
cycloisomerization reactions was employed. A striking observation was made when this catalyst was 
first utilized for the hydroalkoxylation of 1 at room temperature: it provided (S)-(–)-2 in 38% ee in 
toluene, but gave the opposite enantiomer (R)-(+)-2 in 78% ee when tested in ethanol (Scheme 1.5).  
 
Scheme 1.5. Solvent-dependent enantioinversion. Reagents and conditions: (a) (S,S,S,S)-C3 (5.5 mol%), AgBF4 (5.0 mol%), 
toluene, (S)-(–)-2 87%, (–)-38% ee; (b) (S,S,S,S)-C3 (5.5 mol%), AgBF4 (5.0 mol%), ethanol, (R)-(+)-2 93%, (+)-78% ee. 
The enantiomeric excess for (R)-(+)-2 could be improved to 95% by cooling the reaction in ethanol to 
–78 °C (Scheme 1.6). After adopting the same conditions for differently substituted γ-allenols, the 
corresponding tetrahydrofurans 7 and 8 could be obtained in excellent ees. However, submitting the 
terminal allene 9 to the optimized reaction conditions (at ambient temperature) afforded the desired 
product 10 in only 33% ee. Enantiodiscrimination dropped even more drastically when the geminal 
disubstitution of the alkyl chain was removed (11, 7% ee).[16] Substitution at both the allene and the 
tether seemed indispensable for high levels of enantioselectivity.  
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Scheme 1.6. Hydroalkoxylation of allenols. Reagents and conditions: (a) (R,R,R,R)-C2 (5.5 mol%), AgBF4 (5.0 mol%),  
EtOH (0.1 M), –78 °C; (b) (S,S,S,S)-C3 (5.5 mol%), AgBF4 (5.0 mol%), EtOH (0.1 M), –78 °C; 
a) experiment conducted at 
ambient temperature.
[16]
 
As outlined above, the enantioselection in this particular catalytic system is believed to originate 
from a unidirectional rotation of the substrate in the catalyst’s cavity (see Scheme 1.2). 
Unsurprisingly, the substrate scope is therefore highly dependent on steric factors. More intriguing, 
however, is the strong solvent dependence of the enantioselectivity observed for the 5-exo-
cyclization using (S,S,S,S)-C3 (Scheme 1.5), which was therefore subject to further investigations.  
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1.2 Objectives 
The previously developed TADDOL-based phosphoramidites proved successful as single-point binding 
ligands in a wide variety of gold-catalyzed transformations. However, the fascinating discovery of a 
solvent-induced enantioinversion in intramolecular hydroalkoxylations of allenes raised questions on 
the underlying mechanism for enantioselection. In order to shed light on the stereodiscrimination 
process and further improve substrate scope and enantioselectivity, a more detailed investigation of 
this impressive dual stereoselection was planned.  
First, the scope of enantioinversion should be determined for the intramolecular hydroalkoxylation 
of allenes by revisiting previously employed ligands and substrates. Moreover, it was envisaged to 
correlate and rationalize a link between reaction conditions and stereochemical outcome. Once this 
has been established, NMR spectroscopy and characterization of possible reaction intermediates 
could provide further insights. DFT calculations could help to propose a plausible mechanistic 
scenario accounting for the experimental observations. Thus, a comprehensive mechanistic study 
was conducted with the results presented below.  
1.3 A Striking Case of Enantioinversion 
Remark: this project was initiated by former postdoctoral researcher Dr. Luca Mantilli, who observed 
the solvent-dependent enantioinversion in the hydroalkoxylation reaction. The phenomenon was 
studied in detail within this PhD research. A collaboration with postdoctoral researcher Dr. Larry M. 
Wolf at the department of theoretical chemistry and Dr. Christophe Farès, head of the department of 
NMR-spectroscopy, led to joint publication.
[17]
 
1.3.1 The Phenomenon of Enantioinversion 
Enantioinversion is a process in which both enantiomers of a product are obtained using a single 
chiral source by solely changing the reaction conditions (Figure 1.3).[18] In the case of chiral ligands 
stemming from chiral pool precursors, the antipode of a given catalyst might be inaccessible or 
expensive, thus enantioinversion can provide an alternative entry to a desired product. Along the 
same line, the use of only one chiral ligand is beneficial to avoid a second multi-step catalyst 
synthesis to access the enantiomeric product.  
 
Figure 1.3. Principle of enantioinversion. 
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The greater concept is not restricted to enantioselectivity but has also been described for regio- and 
diastereoselective processes using organo- as well as transition metal catalysts in a broad range of 
transformations.[18]  
Although this phenomenon is not uncommon, it has been rarely used as a result of rational design, 
due to the difficulties in predicting, manipulating and optimizing a particular reaction. Examples of 
enantioinversion in homogeneous gold catalysis have only been mentioned on two occasions and the 
understanding of the origin of this effect at a molecular level is almost non-existent.[19] Thus, it 
seemed pertinent to investigate this phenomenon in more detail.  
1.3.2 The Scope of Enantioinversion in the Gold(I)-catalyzed Hydroalkoxylation of Allenes 
An initial series of experiments was performed in order to evaluate the impact of the solvent-induced 
enantioinversion in gold-catalyzed hydroalkoxylations. Steric properties of both the ligand and the 
substrate seemed to play a crucial role. Thus, a first screening taking these factors into account was 
conducted. Three different catalysts with sterically distinct aryl periphery and amine substitution 
were investigated (Figure 1.4). 
 
Figure 1.4. Catalysts screened in hydroalkoxylation reactions. 
Complex C2 bears an acyclic amine backbone and 4-t-butyl-phenyl groups on the TADDOL-moiety, 
which is substituted with 2-naphtyl groups in complex C3. The cyclic amine scaffold in complex C4 is 
expected to reduce the flexibility of the system. These three catalysts were employed in the 
formation of 2, 7, 8 and 4; the most important results are summarized in Table 1.1. 
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Table 1.1. Screening of gold complexes carrying different phosphoramidites in the cyclization of different allenols.a) 
 
Entry Product Precatalyst Solvent T [°C] (+) [ee, %] (–) [ee, %] 
1  
 
 
C3 CH2Cl2 22  (–)-59 
2 C3 CH2Cl2 –60 (+)-29  
3 C3 EtOAc 22  (–)-68 
4 C3 EtOAc –60 (+)-77  
5 C3 EtOH –60 (+)-97  
6 C2 CH2Cl2 22 (+)-26  
7 C2 CH2Cl2 –60 (+)-51  
8 C4 CH2Cl2 22  (–)-50 
9 C4 CH2Cl2 –60  (–)-12 
       
10 
 
C3 CH2Cl2 22 (+)-1  
11 C3 CH2Cl2 –60 (+)-55  
12 C3 EtOH –60 (+)-92  
13 C3 EtOH –78 (+)-95  
       
14 
 
C3 CH2Cl2 22  (–)-25 
15 C3 CH2Cl2 –60 (+)-26  
16 C3 EtOAc 22  (–)-35 
17 C3 EtOAc –60 (+)-86  
18 C3 EtOH –60 (+)-94 
 
 
19  
 
C3 CH2Cl2 22 (+)-23  
20 C3 CH2Cl2 –60  (–)-35 
21 C3 EtOH –60  (–)-72 
22 C3 CH2Cl2 22 (+)-9  
23 C2 CH2Cl2 –60 (+)-77  
24 C2 EtOH –60 (+)-96  
25 C2 EtOH –78 (+)-98  
a) Precatalyst (5.5 mol%), AgBF4 (5.0 mol%), indicated solvent (0.1 M), indicated temperature.  
A solvent- or temperature-dependent switch in enantioselectivity was observed employing catalyst 
C3 in CH2Cl2 or EtOAc with the exception of the cyclohexyl-substituted tetrahydrofuran 7 (Entries 10-
13). In contrast, no inversion was observed for reactions conducted in ethanol, while the ee 
increased with decreasing temperature. Catalyst C2, which had shown conventional behavior in the 
6-exo cyclizations before (see Scheme 1.6), also provided 2 with higher ees at lower temperatures 
without a change in enantioselectivity in CH2Cl2 (Entries 6 and 7). Enantioinversion, which seemed 
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unique to the 2-naphthyl substituted ligand, was no longer observed when the rigidity of the system 
was increased, as evident from the reaction employing complex C4 (Entries 8 and 9). However, 
decreasing the temperature to –60 °C led to an erosion of ee, hinting toward a possible flip to the 
opposite enantiomer at even lower temperatures. Along the same lines, it cannot be excluded that 
substrate 7 might undergo enantioinversion at a higher temperature. Attempts to evaluate this 
hypothesis were hampered by decomposition of the catalyst upon heating.  
In summary, the enantioinversion seemed to be fairly dependent on the ligand design. The highly 
symmetrical precatalyst C2 performed as expected, while inversion of enantioselectivity was only 
observed for the less symmetrical 2-naphthyl variant C3. The phenomenon was also found to be 
substrate-dependent, especially with respect to the temperature range, in which the switch takes 
place. Thus, in the studied temperature range, cyclization of allenol 1 to tetrahydrofuran 2 
represented the most impressive enantioinversion when the reaction was performed in EtOAc 
(Entries 3 and 4). At this stage, it was abstained from optimizing the conditions for each substrate; 
rather, allenol 1 was used as a model in the following mechanistic studies in order to rationalize the 
outcomes to this unusual phenomenon. 
1.3.3 Control Experiments 
At the outset of this study, a series of control experiments was performed to scrutinize the role of 
each reaction component under the previously identified standard conditions (vide supra). In 
homogeneous gold catalysis, the catalytically active cationic complex is prepared by a halide 
abstraction reaction from a precatalyst L*-AuCl with an appropriate silver salt. The catalyst solution is 
then typically filtered in order to remove silver chloride, before being added to the reaction mixture. 
Since silver salts alone or in combination with gold catalysts also exhibit catalytic activity,[20] the 
cyclization of allenol 1 to tetrahydrofuran 2 was repeated without filtering the catalyst solution 
consisting of (S,S,S,S)-C3 and AgBF4. No difference in enantioselectivity was observed as compared to 
the standard conditions (Table 1.2, Entries 1 and 2). The reaction was also conducted in the presence 
of silver chloride and the absence of the chiral gold catalyst. Insoluble silver chloride was unable to 
catalyze the reaction as almost no conversion of starting material was observed within five days 
(Entry 3). The use of silver tetrafluoroborate led to the formation of the racemic product in less than 
10% yield after 24 hours (Entry 4). Thus compared to the fast gold catalysis, silver-catalyzed racemic 
background reactions seemed to be too slow to influence the enantiomeric excess of the product. 
The reaction rate was also reduced when the precatalyst was not ionized by a suitable silver salt 
(Entry 5). Additionally, enantioselectivity was independent of the concentration of the reaction and 
the catalyst loading (Entries 6-8).  
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Table 1.2. Basic control experiments.   
 
 
Entry Catalyst (mol %) Co-catalyst (mol%) Concentration [M] Conversion [%] (R) [ee, %] 
1 (S,S,S,S)-C3  (5.5) AgBF4 (5.0) 0.1 > 99 (+)-78 
2a) (S,S,S,S)-C3  (5.5) AgBF4 (5.0) 0.1 > 99 (+)-77
 
3 – AgCl (5.0) 0.1 < 5b) n.d. 
4 – AgBF4 (5.0) 0.1 10
c) rac 
5 (S,S,S,S)-C3  (5.5) – 0.1 25c) (+)-65 
6 (S,S,S,S)-C3  (5.5) AgBF4 (5.0) 0.2 > 99 (+)-78 
7 (S,S,S,S)-C3  (5.5) AgBF4 (5.0) 0.01 > 99 (+)-77 
8 (S,S,S,S)-C3  (16) AgBF4 (15) 0.1 > 99 (+)-78 
a) no filtration of catalyst solution; b) after 5 d reaction time; c) after 24 h reaction time. 
In order to rule out an alteration of the catalyst by reaction products, further control experiments 
were performed. First, the dependence of enantioselectivity on conversion was surveyed. To this 
end, the ee of the product was determined at various time intervals while the reaction was in 
progress. Since the conversion was very fast in ethanol at ambient temperature (vide supra), the 
solvent was exchanged for CH2Cl2 and the mixture cooled to –60 °C. These conditions allowed 
extracting numerous aliquots before the reaction was completed and further data points were 
collected beyond full conversion after approx. 16 hours. The enantiomeric excess was found to be 
constant over the entire timeframe (Table 1.3). In an additional experiment, the stability of the 
catalyst was verified by NMR spectroscopy, indicating no change within eight hours at ambient 
temperature. 
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Table 1.3. Continuous sampling and ee determination.   
 
Entry Time  (R) [ee, %] 
1 30 min (+)-27 
2 60 min (+)-26 
3 90 min (+)-27 
4 120 min (+)-27 
5 180 min (+)-27 
6 17.5 h (+)-25 
7 24 h (+)-26 
8 48 h (+)-26 
 
Likewise, even the prolonged exposure of product (S)-2 (54% ee) to freshly prepared catalyst of 
either absolute configuration under the standard reaction conditions in CH2Cl2 did not lead to an 
erosion of enantioselectivity (Table 1.4). Thus, product formation is irreversible.  
Table 1.4. Investigation of possible product influence.   
 
Entry Time [h] C3 (S) [ee, %] Entry Time [h] C3 (S) [ee, %] 
1 12  (S,S,S,S) (–)-53 7 12  (R,R,R,R) (–)-50 
2 24    (–)-54 8 24    (–)-51 
3 36   (–)-50 9 36   (–)-51 
4 48   (–)-51 10 48   (–)-54 
5 60   (–)-53 11 60   (–)-54 
6 72   (–)-53 12 72   (–)-52 
 
The gold-catalyzed hydroalkoxylation of allene 1 to tetrahydrofuran 2 was also carried out in the 
presence of a different hydroalkoxylation product (+)-8 (94% ee). No significant erosion of ee was 
observed for tetrahydrofuran 2 and the ee of the added tetrahydrofuran (+)-8 remained unchanged 
(Scheme 1.7). Auto-induction through a change of the catalyst by reaction products can therefore be 
excluded.[18c,21] 
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Scheme 1.7. No product influence on enantioselectivity. 
Ideally, stereoselection in asymmetric catalysis should be described by a linear correlation between 
the ee of the product and the ee of the precatalyst.[22] This relationship was studied next in search for 
deviations from linearity – so-called non-linear effects – that could explain the observed 
enantioinversion. For this purpose, a series of reactions was set up in CH2Cl2 at both 22 °C and  
–60 °C. Accurately defined mixtures of (S,S,S,S)-C3 and (R,R,R,R)-C3 were activated with AgBF4 at 
ambient temperature before being added to the substrate solutions at the respective temperatures. 
The resulting mixtures were stirred at ambient temperature for 45 minutes or at –60 °C for 16 hours. 
The ee of the product was determined by HPLC (Table 1.5) and plotted against the ee of the 
precatalyst, resulting in a linear correlation at either temperature (Figure 1.5). 
Table 1.5. Correlation between ee of precatalyst C3 and ee of product 2. 
Entry T [°C] C3 [ee,%] 2 [ee, %]   Entry T [°C] C3 [ee, %]  2  [ee, %]  
1 22 > (+)-99 (–)-58 10 –60 > (+)-99 (+)-29 
2  (+)-60 (–)-28 11   (+)-60 (+)-23 
3  (+)-50 (–)-21 12   (+)-50 (+)-17 
4  (+)-20 (–)-5 13  (+)-20 (+)-8 
5  0 0 14  0 (+)-1 
6  (–)-20 (+)-13 15  (–)-20 (–)-8 
7  (–)-50 (+)-18 16  (–)-50 (–)-16 
8  (–)-60 (+)-27 17  (–)-60 (–)-17 
9  > (–)-99 (+)-59 18  > (–)-99 (–)-27 
 
Figure 1.5. Left: correlation between ee precatalyst and ee product at 22 °C. Right: correlation between ee precatalyst 
and ee product at –60 °C. 
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Since a linear correlation was observed in both temperature regimes, the formation of aggregates[23] 
and even more importantly gem-diaurated complexes, previously identified as possible 
intermediates,[24] could be excluded. Thus, the enantiodiscrimination process is not controlled by 
dimeric or oligomeric forms of the catalyst and an in situ kinetic resolution can be ruled out.[25]  
In order to exclude the possibility that moisture was condensed in the reaction mixture during the 
filtration of the catalyst suspension after ionization, an additional control experiment was performed. 
In contrast to chloride abstraction using AgBF4, the cationic complexes resulting from ionization with 
AgOTs or AgNTf2 could be isolated. Thus, the reaction was repeated in CH2Cl2 at both ambient and 
low temperature using the in situ ionization protocol and the results were compared to those 
employing the pre-isolated cationic complexes (S,S,S,S)-C5 or (S,S,S,S)-C6 (Table 1.6).  
Table 1.6. Comparison of catalyst (S,S,S,S)-C3 ionized in situ with AgOTs or AgNTf2 with catalyst (S,S,S,S)-C5 and (S,S,S,S)-C6 
prepared ex situ.a) 
 
Entry Catalyst AgX Temperature [°C] (R) [ee, %] 
1 (S,S,S,S)-C3 OTs 22 (+)-70 
2 (S,S,S,S)-C5  – 22 (+)-73 
3 (S,S,S,S)-C3 OTs –60 (+)-92 
4 (S,S,S,S)-C5 – –60 (+)-94 
5 (S,S,S,S)-C3 NTf2 22 (–)-36 
6 (S,S,S,S)-C6  – 22 (–)-32 
7 (S,S,S,S)-C3 NTf2 –60 (+)-51 
8 (S,S,S,S)-C6  – –60 (+)-59 
a) All reactions were performed in 0.1 M solutions. 
At both temperature regimes, comparable enantioselectivities were obtained regardless of the 
ionization method. Thus, adventitious moisture affecting the enantioselectivity outcome in aprotic 
solvents could be ruled out. In summary, the observed enantioinversion could not be explained by an 
irregular behavior of the catalytic system and the underlying mechanism seemed to be a more 
involved process.  
16  ENANTIOINVERSION IN THE GOLD-CATALYZED HYDROALKOXYLATION OF ALLENES 
   
 
1.3.4 Reaction Parameters  
With the insights gained from the first set of control experiments, a combined experimental and 
computational study to de-convolute the intriguing enantioinversion seemed worthwhile. For a start, 
thorough screenings of the reaction parameters were conducted.  
1.3.4.1 Solvent  
During the optimization of the reaction conditions different solvents had been evaluated and the 
selection was now broadened. When the reaction was carried out at ambient temperature in 
solvents of low polarity, such as different chlorohydrocarbons, trifluorotoluene and toluene or in 
acetone, the (–)-product was formed in 21-59% ee (Table 1.7, Entries 1-7). More polar solvents like 
acetonitrile and nitromethane afforded only 7% ee (Entries 8 and 9), while the best ee for (S)-(–)-2 
was obtained in EtOAc (Entry 10). However, protic co-solvents had a massive influence: conducting 
the reaction in EtOAc/H2O mixtures (9:1) afforded the (+)-product in 59% ee (Entry 11). Protic 
solvents, such as methanol and ethanol, favored the formation of (R)-(+)-2 (Entries 12 and 13). 
Interestingly, also the aprotic but coordinating solvents THF and DMA provided (R)-(+)-2 (Entries 14 
and 15). Unfortunately, more extreme polarities could not be assessed as catalyst and substrate 
were insoluble in nonpolar hexane, pentane and HMDSO as well as in the most polar solvent water, 
preventing the reaction from occurring (Entries 16-19).  
The inherent virtue of the TADDOL-based phosphoramidite ligands of low symmetry to provide 
either antipode of a given product solely by changing the solvent had thus far only been recognized 
on one occasion.[26] The authors suggested a modification of the structure of the catalyst through 
coordination of the solvent. Beyond its role to dissolve substrate and reactant, the solvent is known 
to influence reactivity and selectivity of a reaction,[18d,27] which also applied to the present case study. 
The results summarized above show that either enantiomer of 2 can be obtained with respectable 
optical purity by solely changing the reaction solvent while using a single enantiomer of catalyst 3. By 
this means, (R)-(+)-2 was obtained in 83% ee in DMA while (S)-(–)-2 was produced in no less than 
68% ee in EtOAc. Overall, the reversal of enantioselectivity seemed to be governed by solvent 
properties and the following trend might be deduced from the screening: protic and coordinating 
solvents favor the formation of (R)-(+)-2 as opposed to aprotic and non-coordinating solvents 
favoring (S)-(–)-2.  
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Table 1.7. Enantioinversion induced by the solvent at ambient temperature (22 °C).a) 
 
Entry Solvent (R) [ee, %] (S) [ee, %] Yield [%] 
1 CH2Cl2  (–)-59 95 
2 CHCl3  (–)-50 89 
3 CCl4  (–)-28 73 
4 (CH2Cl)2  (–)-53 85 
5 toluene  (–)-38 87 
6 PhCF3  (–)-47 74 
7 acetone  (–)-21 86 
8 MeCN  (–)-7 72 
9 MeNO2  (–)-7 81 
10 EtOAc  (–)-68 77 
11 EtOAc/H2O (9:1) (+)-59  70 
12 MeOH (+)-72  86 
13 EtOH (+)-78  93 
14 THF (+)-23  86 
15 DMA (+)-83  76 
16 hexane – – 0b) 
17 pentane – – 0b) 
18 HMDSO – – 0b) 
19 H2O – – 0
b) 
a) All reactions were performed in 0.1 M solutions; b) insolubility of substrate and gold complex prevents the reaction from 
occurring. 
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An equally pronounced enantioinversion triggered by a switch from toluene to methanol had 
recently been observed in the case of hydroaminations of alkenes using dinuclear gold complexes.[19b] 
In this case, the authors suggest that the change in reaction mechanism arises from the ability of 
methanol to act as a proton transfer agent.[28] To evaluate such a proposal for the present example, 
further alcoholic solvents were examined. Methanol, ethanol and i-propanol gave similar 
enantioselectivities (71-78% ee) at equal reaction rates (99% conversion in 45 minutes), while the 
rate was significantly diminished (10% conversion in 45 minutes) in t-butanol and the 
enantioselectivity decreased to 44% ee. A similar behavior had been reported by Haddad and 
coworkers in catalytic asymmetric hydrogenations[29] and by Tang et al. in the alkylation of indoles.[30] 
The findings suggest that a combination of proton transfer ability and steric congestion in the chiral 
cavity is responsible for the disparity in enantioselectivity and reaction rate. Less bulky alcohols could 
be incorporated in the chiral cavity of the catalyst described above (see Section 1.1.2), altering its 
conformation and thereby increasing the enantioselectivity. The transformation is accelerated by a 
possible assistance in the proton transfer step. In contrast, sterically more demanding t-butanol 
might not be included in the chiral pocket, thus proton transfer is not facilitated. Furthermore, if the 
reaction rate was diffusion controlled, the high viscosity of t-butanol could also play an important 
role. Additionally, rotation of the substrate (vide supra) in the more open cavity might be less 
restricted as reflected in lower enantiomeric excess. 
Although EtOAc and DMA gave the highest ees, CH2Cl2 and ethanol were the solvents of choice for 
further screenings, since they are more readily dried. As traces of water had shown a massive 
influence on enantioselectivity, strictly anhydrous conditions were mandatory in all experiments.  
1.3.4.2 Counterion 
Next, the escorting counterion as a second reaction parameter was studied in more detail. The 
nature of the counterion has been identified to play a crucial role in the reactivity and 
stereoselectivity of cationic metal catalysts in previous asymmetric transformations.[18d,31] While the 
use of chiral counterions has attracted increased attention over the past years,[32] the exploitation of 
achiral counterions in efficient chirality switching remained rare.[1b,33] For gold(I)-catalyzed reactions, 
Bandini et al. have previously disclosed an inversion of stereoinduction when applying tosylate or 
BArF anions in their hydroamination-SN2’-cascade reactions.
[19a] The counterion appeared to be 
directly involved in the stereodiscriminating step in the SN2’ reaction, as shown by the same group.
[34] 
The counterion was also found to affect the regioselectivity in gold-catalyzed pyrrole-synthesis as 
demonstrated by Davies and coworkers.[35] It has been proposed that ligation of the counterion to 
the catalytic metal center can alter the initial catalyst structure or that of a transition state.[18d] 
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Additionally, the ability of the counterion to participate in the proton migration event has been 
recognized before in cycloadditions and hydroaminations.[28b,36]  
It was speculated that the coordination strength of the counteranion was the pivotal characteristic. 
Therefore, a screening of different counterions in CH2Cl2 as well as in ethanol at ambient 
temperature was performed. Importantly, an alteration of the asymmetric induction was only 
observed when dichloromethane was used as solvent (Table 1.8, Entries 1-7). Weakly coordinating 
counterions favored the production of (S)-2 in this solvent, while the more strongly coordinating 
trifluoroacetate and tosylate led to the preferred formation of (R)-2. In contrast, the effect of the 
counterion on the stereochemical course completely vanished in ethanol (Entries 8-12).  
Table 1.8. Enantioinversion induced by the counterion at ambient temperature (22 °C).a) 
 
Entry Solvent X (R) [ee, %] (S) [ee, %] Yield [%] 
1 CH2Cl2 BF4  (–)-59 95 
2  SbF6  (–)-32 96 
3  ClO4  (–)-43 68 
4  NTf2  (–)-36 79 
5  OTf  (–)-14 82 
6  CF3COO (+)-66  87 
7  TsO (+)-70  96 
8 EtOH BF4 (+)-78  93 
9  SbF6 (+)-78  92 
10  NTf2 (+)-78  90 
11  TsO (+)-77  91 
12  CF3COO (+)-77  95 
a) All reactions were performed in 0.1 M solutions. 
In conclusion, coordinating solvents and coordinating counterions in non-coordinating solvents share 
the same behavior. However, neither the size of the anion and thus steric interactions nor the 
coordination strength alone seemed to be responsible for the inversion phenomenon, suggesting 
that the situation is more complicated. The ability of the counterion to participate in hydrogen 
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bonding to the substrate and/or the ligand should also be considered, as suggested by Fan and 
coworkers for a similar finding.[37] All three factors together – size, coordination strength and 
hydrogen bonding ability – could play an important role in the underlying mechanism.  
1.3.4.3 Temperature  
Temperature is known to be an ideal parameter for improving the diastereo- and enantioselectivity 
of a given transformation. However, only a few examples of dual enantioselectivity controlled by 
altering the temperature alone have been reported to date.[18d,21,27,38] Based on the preliminary 
screenings (see Section 1.3.2), temperature studies were conducted in numerous protic and aprotic 
solvents (Table 1.9).  
Table 1.9. Enantioinversion by changing the reaction temperature.a) 
 
Entry Solvent T [°C] (R) [ee, %] (S) [ee, %] Yield [%] 
1 EtOAc 22  (–)-68 77 
2  –60 (+)-77  80 
3 CH2Cl2 22  (–)-59 95 
4  –60 (+)-29  89 
5 toluene 22  (–)-38 71 
6  –60 (+)-33  71 
7 EtOH 22 (+)-78  93 
8  –30 (+)-92  90 
9  –60 (+)-97  93 
10 MeOH 22 (+)-72  86 
11  –60 (+)-96  96 
12 Et2O 22 (+)-6  78 
13  –60 (+)-74  80 
14 THF 22 (+)-23  78 
15  –60 (+)-86  88 
16 DMA 22 (+)-83  76 
17  –20 (+)-91  63 
a) All reactions were performed in 0.1 M solutions. 
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A reversal of enantioselectivity by altering the temperature was observed exclusively for aprotic 
solvents. In contrast, protic and coordinating solvents predominantly gave (R)-2 in the temperature 
range studied (Table 1.9, Entries 7-17). Nevertheless, the temperature dependence of the ee for 
these solvents cannot be approximated by the Arrhenius equation. In THF, for instance, the ee at 
22 °C is (+)-23%. If the Arrhenius activation energy Ea were constant, the equation 
 = RT · ln
(
)
(
)
      (1)[39] 
predicts an ee of (+)-31% at –60 °C, but (+)-86% was detected. This massive deviation implies that the 
activation energy must change with temperature, in that it renders the disfavored pathway at room 
temperature the preferred pathway in the low temperature regime.  
The remarkable temperature dependence was further investigated by Eyring studies, which allowed 
the enthalpic (∆∆H‡) and entropic contributions (∆∆S‡) to be derived. Moreover, a switch in 
mechanism can be detected by a deviation from linearity in modified Eyring plots as these 
parameters change. 
In transition state theory, the temperature-dependent variance of the rate of a chemical reaction is 
described by the Eyring equation (2):  
k =


e
∆‡
       (2) 
The ee of an asymmetric reaction can be expressed as the natural logarithm of the relative rate 
constant for the formation of two enantiomers (R) and (S) as follows: 
	ln


= ln	

		%	

	–	%	
     (3) 
An alternative representation is provided by the differential Eyring equation (4):[40] 
ln


=	–	
∆∆ ‡
!



	+ 	
∆∆#‡
!
    (4) 
Eyring studies were performed in both ethanol and CH2Cl2 using the gold precatalyst (S,S,S,S)-C3 and 
AgBF4. Every data point was independently determined three times (Tables 1.10 and 1.11). According 
to equation (3), the enantioselectivity was expressed as the natural logarithm of the relative rate 
constants for the formation of (R)-2 and (S)-2 (Table 1.10 and 1.11, data used for Eyring plot 
highlighted in blue for ethanol and green for CH2Cl2). These values were plotted against the 
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reciprocal temperature and the differential Eyring equation (4) was applied, using at least four data 
points for each linear regression whilst minimizing the R2 value (Figure 1.6).   
Table 1.10. Data for ethanol. 
Entry T [°C] T–1 [103·K–1] ee [%] ee [%] ee [%] Ø ee [%] ln(kR/kS) 
1 –85 5.3191 (+)-91 (+)-90 (+)-92 (+)-91 3.0550 
2 –78 5.2182 (+)-95 (+)-92 (+)-92 (+)-93 3.3168 
3 –70 4.9261 (+)-95 (+)-93 (+)-95 (+)-94 3.4761 
4 –60 4.6948 (+)-96 (+)-95 (+)-97 (+)-96 3.8918 
5 –50 4.4843 (+)-95 (+)-96 (+)-96 (+)-96 3.8918 
6 –40 4.2918 (+)-95 (+)-95 (+)-94 (+)-95 3.6636 
7 –21 3.9683 (+)-92 (+)-93 (+)-93 (+)-93 3.3168 
8 0 3.6630 (+)-87 (+)-87 (+)-87 (+)-87 2.6662 
9 10 3.5336 (+)-85 (+)-85 (+)-84 (+)-85 2.5123 
10 22 3.3898 (+)-78 (+)-77 (+)-78 (+)-78 2.0907 
11 38 3.2154 (+)-72 (+)-71 (+)-72 (+)-72 1.8153 
 
Table 1.11. Data for CH2Cl2. 
Entry T [°C] 103 T–1 [K–1] ee [%] ee [%] ee [%] Ø ee [%] ln(kR/kS) 
1 –60 4.6948 (+)-29 (+)-28 (+)-29 (+)-29 0.5971 
2 –50 4.4843 (+)-26 (+)-27 (+)-24 (+)-26 0.5322 
3 –40 4.2918 (+)-24 (+)-26 (+)-22 (+)-24 0.4895 
4 –21 3.9683 (+)-14 (+)-21 (+)-25 (+)-20 0.4055 
5 –10 3.8023 (–)-14 (–)-26 (–)-17 (–)-19 –0.3847 
6 0 3.6630 (–)-31 (–)-29 (–)-32 (–)-31 –0.6411 
7 10 3.5336 (–)-41 (–)-41 (–)-43 (–)-42 –0.8954 
8 22 3.3898 (–)-57 (–)-59 (–)-57 (–)-58 –1.3249 
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Figure 1.6. Eyring plot for the gold-catalyzed hydroalkoxylation in EtOH (blue squares) and CH2Cl2 (green triangles). 
Additionally, the thermodynamic parameters were obtained from the linear equations (Table 1.12). 
The findings point toward a remarkable entropic component. 
Table 1.12. Linear regression equations and thermodynamic parameters deduced from the differential Eyring equation (4). 
Solvent Sector ln(kR/kS) ∆∆H
‡ [kcal·mol–1] ∆∆S‡ [cal·mol–1·K–1] 
EtOH left  1.66 T–1 – 3.45 –3.3 –6.8 
 right –1.29 T–1 + 9.92 2.6 19.7 
CH2Cl2 left 2.25 T
–1 – 8.92 –4.5 –17.7 
 right 0.26 T–1 – 0.63 –0.5 –1.2 
 
Due to the presence of two linear regions for each solvent in the Eyring plot, two sets of 
thermodynamic parameters can be derived. Subtraction of the appropriate parameters provide 
δ∆∆H‡ = ∆∆H‡(right) – ∆∆H
‡
(left)
 and δ∆∆S‡ = ∆∆S‡(right) – ∆∆S
‡
(left), which represent the change in 
dominance of enthalpy and entropy in the partial steps.[41] Thus, δ∆∆H‡(EtOH) = 5.9 kcal⋅mol−1 and 
δ∆∆S‡(EtOH) = 26.5 cal·mol–1·K–1 for ethanol as well as δ∆∆H‡(CH2Cl2)
 = 4.0 kcal⋅mol−1 and  
δ∆∆S‡(CH2Cl2)
 = 16.5 cal·mol–1·K–1 for dichloromethane are obtained and plotted on an 
enthalpy/entropy diagram (Figure 1.7). Linear regression through the two data points and the 
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zeropoint – known as the isoinversion relationship – allows the isoinversion temperature Ti to be 
determined from the slope. For the present case, Ti is 229 K (–44 °C), at which temperature the 
optimal selectivity is to be expected. In theory, selectivity phenomena can be interpreted, assessed 
and optimized with the isoinversion principle.[41] However, this needs a large amount of data and the 
underlying mechanism cannot be deduced from merely thermodynamic parameters. 
 
Figure 1.7. Isoinversion diagram. 
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1.3.5 DFT Calculations[42] 
At this stage it could only be speculated, whether a proton shuttle mechanism was operative or 
conformational changes of the organogold intermediates triggered the reversal of enantioselectivity. 
Thus, attempts to improve the understanding of the phenomenon were made with the aid of DFT 
calculations[43] at the PBE0-D3//TPSS-D3 level of theory. To this end, the situation at ambient 
temperature in EtOAc was analyzed first. The resulting energy profile is depicted in Figure 1.8 and the 
corresponding catalytic cycle illustrated in Scheme 1.8.  
 
Figure 1.8. Computed Gibbs free energy profile at 298 K in EtOAc (enthalpies are enclosed in brackets); diastereomeric 
channels for the (S)-product (red) and the (R)-product (black); possible shortcut (thick arrow). 
The cationic complex cat-A was used as starting point, representing catalyst (S,S,S,S)-C3 after 
ionization and formal exchange of chloride by EtOAc. The bulky amino group of this lowest-energy 
complex must undergo a rotation (indicated by the blue arrow in Scheme 1.8) forming cat-B to 
expose the gold atom and allow substrate binding. Initially, complexation of the substrate 1 occurs 
preferably at the dimethyl substituted double bond providing π-complex INT1. Nonetheless, slippage 
of gold to the adjacent double bond forming π-complex INT2 has only a small barrier (TS1). The chiral 
ligand L* splits the pathway at this stage into two diastereomeric channels with INT2-R being 
favored. A twist of the gold-associated double bond by 90° leads to two diastereomeric allyl cations 
INT3 thermodynamically favoring INT3-S. It has to be mentioned, that only a series of facile single 
bond rotations is necessary to interconvert INT3-S into INT3-R, representing a possible shortcut 
between the two diastereomeric channels (Figure 1.8, thick arrow). Direct access from INT1 to INT3 
has also been investigated, but no stable product could be located. INT3 needs to overcome only a 
small barrier (TS3) to evolve into the cyclized vinyl gold species INT4. The subsequent proto-
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deauration via 1,3-proton shift exhibits a significant barrier (TS4), while the final release of the 
product 2 with concurrent complexation of a new substrate molecule is almost barrierless.  
 
Scheme 1.8. Plausible catalytic cycle for the hydroalkoxylation in aprotic solvents. 
Overall, the energy profile obtained above is consistent with the experimental findings as formation 
of the (S)-product is favored, but interconversion between the two channels is possible accounting 
for the measured moderate ees of approx. 60%.  
Next, the pathway in the protic solvent methanol was computed with an explicit molecule of 
methanol included for each stationary point on the pathway (Figure 1.9). Methanol is coordinated to 
the gold center in the ionized catalyst cat-A, which undergoes the above mentioned conformational 
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change to cat-B to make space for the incoming substrate. Methanol will most likely be associated to 
the substrate via hydrogen bonding prior to complexation. Since the concentration of the associating 
methanol is large and constant, entropy for the association essentially plays no influential role and 
complexation to the dimethyl substituted double bond is again preferred (INT1-p). The barrier  
(TS1-p) for the catalyst to glide to the adjacent double bond forming π-complex INT2-p is low and the 
pathway is likewise split into two diastereomeric channels at this stage. Due to hydrogen bonding, 
the pendant hydroxy group becomes more nucleophilic and cyclization to INT3-p occurs directly, 
bypassing a discrete allyl cation intermediate. Assistance from methanol in the 1,3-proton migration 
step via the six-membered transition state TS3-p significantly lowers the barrier for proto-
deauration. Thus, the one-step twisting/cyclization event becomes rate-limiting in protic media. An 
inversion of the selectivity similar to the aprotic case is improbable, since a free allyl cation 
intermediate is never generated and the pathways cross only after the rate-determining step in  
INT3-p.   
 
 
   
Figure 1.9. Computed Gibbs free energy profile at 298 K in MeOH (enthalpies are enclosed in brackets); diastereomeric 
channels for the (S)-product (red) and the (R)-product (black). 
The protic solvent was found to act as a proton shuttle facilitating the 1,3-proton shift via the six-
membered transition state TS3-p. Therefore, the formation of the (R)-product is always favored in a 
protic solvent; the overall barrier is reduced by more than 7 kcal·mol–1.  
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This proposed mechanism conforms reasonably well to the results obtained from the experiments. 
The calculated activation parameters ∆∆H‡calc = –4.5 kcal·mol
–1 and ∆∆S‡calc = –9.6 cal·mol
–1·K–1 are 
relatively close to the experimentally observed parameters ∆∆H‡exp = –3.3 kcal·mol
–1 and  
∆∆S‡exp = –6.8 cal·mol
–1·K–1 obtained in ethanol (see Table 1.12). It has to be noted that not only 
coordinating and especially protic solvents, but also coordinating counterions residing in close 
proximity to the gold cation (TsO– or CF3COO
–) may be able to assist proto-deauration and therefore 
intrinsically favor the formation of (R)-2. 
As proto-deauration represents the rate-determining step in aprotic media at ambient temperature 
as depicted above, a more accessible alternative pathway was projected comprising an assisted 
proto-deauration process resembling the scenario in protic media. First, it was assumed, that a 
second substrate molecule could be involved in the 1,3-proton shift. The resulting energy profile with 
neopentyl alcohol mimicking the second substrate is depicted in Figure 1.10 and compared with the 
previous scenario in aprotic solvent. 
The association of a second substrate molecule to INT2 via hydrogen bonding again increases the 
nucleophilicity of the pendant hydroxy group. Thus, the allyl cation intermediate is bypassed and the 
formerly two-step process becomes a one-step twisting/cyclization process to form the cyclized vinyl 
gold species INT4-a. The initial association providing INT2-a is uphill in energy, yet the activation for 
the one-step cyclization event (TS3-a) is similar to that of the two-step sequence. Most importantly, 
the assisted proto-deauration via a six-membered transition state TS4-a is significantly facilitated. In 
summary, the rate-limiting step is shifted from TS4 to TS3-a, while the overall barrier is reduced by 
more than 5 kcal·mol–1. For this mechanistic scenario, the formation of the (R)-product is again 
favored.  
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Figure 1.10. Comparison of energy profiles at 298 K in EtOAc (enthalpies are enclosed in brackets) for unassisted  
proto-deauration (left, excerpt of Figure 1.8) and assisted proto-deauration (right).  
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Scheme 1.9. Excerpt of the catalytic cycle for the hydroalkoxylation assisted by a second substrate molecule  
(modelled as neopentyl alcohol for the sake of CPU-time). 
The inversion in selectivity with temperature in aprotic media was also studied by means of DFT 
calculations. For this purpose, the situation was compared with the assisted pathway in EtOAc at 
298 K (Figure 1.11, a)). At low temperature, substrate association is less uphill in energy as the 
entropic cost is reduced. Substrate-assisted cyclization as well as proto-deauration becomes more 
facile compared to ambient temperature. Furthermore, assisted cyclization is favored over 
unassisted cyclization and the substrate-assisted pathway always prevails at 213 K (Figure 1.11,  
b) faded). Once again, no facile possibility for the (R)- and (S)-pathways to cross is given, since the 
allyl cation intermediate is bypassed. The formation of (R)-(+)-2 is kinetically preferred in the rate-
limiting cyclization step and conforms well to the results observed experimentally.  
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Figure 1.11. Computed Gibbs free energy profiles for the assisted pathways in EtOAc at 298 K (left) and 213 K (right, TS2 
for the unassisted pathway for comparison faded). 
Nonetheless, one possibility for interconversion between the two pathways by transformation of 
INT4-a into INT3 and vice versa through a barrierless association/dissociation of a second substrate 
molecule has to be considered (Figure 1.12). The differential Gibbs free energy (∆∆G) of TS4-R-a and 
INT3-R is rather small at ambient temperature so that formation of (R)-(+)-2 via TS4-R-a and 
interchannel crossing through single-bond rotations in INT3-R to INT3-S are competitive. In turn, 
INT3-S can coordinate an assisting substrate molecule and form (S)-(−)-2 via TS4-S-a (Figure 1.12 
left). At ambient temperature, both pathways are therefore accessible with the lower-energy 
pathway producing the (S)-product. Under cryogenic conditions, the temperature-dependent 
entropic penalty for the association is reduced, thus the associative pathway becomes favored by 
about 4 to 5 kcal⋅mol−1 at 213 K. Since access to allyl cation INT3 is suppressed, (R)-(+)-2 is the 
preferentially formed product in this scenario (Figure 1.12, right).   
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Figure 1.12. Gibbs free energy profiles highlighting the temperature-dependent pathways available to INT4-a  
in EtOAc at 298 K (left) and 213 K (right). 
 
1.3.5 NMR Studies[44] 
The computational results were also scrutinized against detailed NMR studies, which proved 
extremely challenging due to the large and conformationally flexible system with numerous 
overlapping aromatic signals and independent chemical exchange processes. Furthermore, the 
reaction of substrate 1 was too fast to study initial complexation of the allenol to the gold center. 
Thus, an unreactive methoxy-allene derivative 1-OMe was prepared (Scheme 1.10).   
 
Scheme 1.10. Preparation of substrate 1-OMe for NMR studies. Reagents and conditions: (a) NaH, MeI, THF, 0 °C, 70%. 
The ionized catalyst (S,S,S,S)-C3 was mixed with 1-OMe in stoichiometric ratio in anhydrous CD2Cl2 
and analyzed over a temperature range of –80 to +50 °C. Although the model substrate 1-OMe could 
not undergo hydroalkoxylation, it slowly underwent isomerization to a mixture of 1,3-dienes after 
several days. Nevertheless, important information could be deduced from the spectral data. 
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Upon complexation, only the central allene C-atom is significantly shifted upfield by –23 ppm and 
exhibits a JCP coupling of 14 Hz, indicating either an η
1 coordination mode (INT3) or a fast slippage 
process of the gold center from one double-bond π-face to the other (INT1↔INT2, Scheme 1.11). 
The latter is in line with the observation that the exchange is still fast at –50 °C but becomes slower 
at –80 °C, causing broadening of the resonances corresponding to the two terminal allene C-atoms. 
This interpretation is consistent with the literature[45] as well as with the computed Gibbs free energy 
profiles, in which INT1 and INT2 are separated by only a small energetic barrier and are both lower in 
energy than the allyl cation INT3 (see Figure 1.8). Additionally, Boltzmann averaging of the computed 
chemical shifts for each C-atom of the allene moiety is in better agreement with the experimental 
values than the computed shifts of any individual isomer (Scheme 1.11).  
 
 
Δδ [ppm] 
C(1) C(2) C(3) 
INT1-OMe 19.0 –26.0 7.8 
INT2-OMe 4.3 –21.2 16.4 
INT3-OMe 84.1 –5.0 42.0 
Boltzmann averaging 14.8 –24.6 10.2 
Experimental data 12.0 –20.0 8.0 
 
Scheme 1.11. DFT model of the loaded complex using 1-OMe which matches onto the experimentally  
observed NOE contacts; experimental and computed 13C NMR shift changes (Δδ) upon complexation. 
Moreover, NOE contacts between the bound 1-OMe and the ligand unambiguously revealed that 
only two out of four possible modes for the coordination of the allene substrate to the gold center 
are sterically accessible. With the allenic proton showing no NOE contact to the catalyst, the 
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assumed orientation corresponds to the computed structures of the gold π-complexes INT1 and 
INT2. Complexation to the other two π-faces has also been calculated but could safely be disregarded 
as they are much higher in energy. In summary, the experimental results from the NMR study 
corroborate the conclusions drawn from the DFT calculations. 
Another distinctive NMR feature of the π-complex was the presence of two slowly exchanging 
conformations. The conformer ratio of approx. 3:2 was fairly constant over a wide temperature 
range. Scrupulous analysis of the spectra indicated a 180° flip of the naphthyl group that is closest to 
the dimethyl substituted allene terminus. Based on NOE analysis, the position and orientation of the 
model substrate within the catalyst binding site was found to remain unaffected by this rotatory 
movement (Figure 1.13).  
 
Figure 1.13. Key NOE contacts (green) between model substrate 1-OMe and catalyst; naphthyl ring flip 
indicated by the blue arrow. 
An additional rotameric process independent of the naphthyl flip was observed. Rotation of the 
symmetric amine moiety of the phosphoramidite about the P–N bond occurs on a much faster time 
scale both for the minor and the major conformer (millisecond time scale at –20 °C). Consequently, 
this rotation is relatively unhindered by the bound substrate or the naphthyl groups. 
These observations suggest that the amine rotation as well as the naphthyl ring flip have little 
bearing on the enantioselectivity. Thus, it is not the conformational behavior of the ligand that is 
primarily responsible for the enantioinversion as proposed on other occasions.[46] Instead, a more 
involved mechanism with a strong entropic component as described above is operative.  
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1.3.6 Conclusion  
In summary, the TADDOL-related phosphoramidite-gold complexes previously designed in the 
Fürstner group can serve as efficient catalysts in hydroalkoxylations of allenes achieving high levels of 
asymmetric induction. The outstanding character of the reaction studied herein is that either 
antipode of a given product can be made using a single chiral source but modifying reaction 
conditions such as solvent, counterion and temperature. The autonomous action of each parameter 
suffices for switching the stereochemistry, yet these factors can also act in synergy to further 
increase the selectivities. The effect was observed for the naphthyl substituted one-point binding 
ligand with different allenols; however, the magnitude of the enantioinversion was dependent on the 
substitution pattern of the substrate. Nevertheless, the phenomenon of enantioinversion cannot be 
explained solely by steric interactions. A combination of DFT calculations and experimental 
investigations including NMR studies allowed to unravel the underlying mechansim in quite some 
detail.  
The major reason for the enantioinversion was found in the existence of two competing pathways: a 
pathway where proto-deauration is rate-limiting favors the (S)-product, whereas an alternative 
outlet involving assisted proto-deauration preferably produces the (R)-product. A plausible 
mechanistic scenario allowing to rationalize the experimental observations is depicted in 
Scheme 1.12 on the basis of DFT calculations. The outer catalytic cycle represents the mechanistic 
scenario in the absence of an efficient proton shuttle, while the inner cycle illustrates the assisted 
process. In the unassisted pathway, an interconversion between the diastereomeric channels 
accounting for the (S)- and the (R)-product is possible at the allyl cation stage INT3. In the assisted 
pathway, this intermediate is bypassed and facile interconversion essentially impossible. A channel 
crossing between the unassisted and assisted pathway is however feasible, since association of a 
second substrate molecule at the allyl cation stage INT3 is energetically accessible, which explains a 
transition to the assisted pathway at low temperature.  
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Scheme 1.12. Plausible mechanistic scenario: outer cycle unassisted pathway (grey); inner cycle assisted pathway (white); 
possible interchannel crossing at the allyl cation intermediate (red). 
For the unassisted case interconversions between the two diastereomeric channels as well as to the 
mechanistically different assisted pathway are possible at the allyl cation intermediate. Thus, high 
enantiomeric excess for the (S)-product is difficult to achieve. In contrast, the assisted pathway is the 
preferred channel at low temperature and in the presence of proton shuttles (provided by solvent or 
counterion) delivering the (R)-product in excellent ee. For this scenario, the entropic component to 
the reaction free energy profile is significantly increased and can ultimately dictate the 
stereochemical course. In any event, the analysis of this case study highlights that entropic changes 
along the reaction coordinate should not be underestimated in asymmetric catalysis.[47] 
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2 Studies Toward the Total Synthesis of Chagosensine 
2.1 Introduction 
2.1.1 Natural Product Total Synthesis 
Living organisms produce a wide variety of secondary metabolites, which are not involved in the 
essential maintenance of the organism.[48] However, such compounds often contribute to growth, 
reproduction or defense through interaction with a specific molecular target.[49] The structures of 
secondary metabolites have been optimized in the evolutionary process in order to improve the 
biological activity. As a result, natural products display fascinating architectures and versatile 
biological profiles.[50] Sometimes, they show high levels of activity even in completely remote 
contexts and are therefore a valuable source for drug discovery processes in pharmaceutical and 
agricultural chemistry – not only by providing novel bioactive compounds, but also by inspiring the 
design of new structures.[51]  
Polyketides represent a large and structurally diverse class of natural products with a broad spectrum 
of biological activities. They are constructed by multifunctional protein complexes called polyketide 
synthases and usually exhibit highly oxygenated and stereochemically enriched scaffolds.[52] 
Frequently, only minute amounts of the secondary metabolite are available and the natural supply of 
the producing organism is typically limited. Semisynthesis or chemical synthesis can overcome this 
issue, bearing the great advantage of providing access to non-natural derivatives, whose biological 
activity can also be evaluated.[53] A striking example is found in the macrocyclic polyketide 
halichondrin B, which was synthesized in almost 90 steps six years after its isolation from a marine 
sponge in 1986.[54] During a drug development program at Eisai Co., Ltd., the simplified synthetic 
analog eribulin was obtained in 62 steps and showed even increased inhibition of tubulin 
polymerization compared to the natural product (Figure 2.1).[55] The highly potent natural product 
derivative was approved as an anticancer drug in 2010.[56] 
 
Figure 2.1. Natural product halichondrin B; approved natural product derived drug eribulin. 
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A huge number of polyketides are found in marine sponges and soft corals.[57] Among these, 
macrocyclic lactones (macrolides) such as the above mentioned halichondrin B are the most 
widespread subclass produced by marine organisms. More than 350 marine macrolides have been 
characterized since the first report in 1974 of aplysiatoxin, a brominated tumor-promoting natural 
product (Figure 2.2).[58] Despite the availability of chloride and bromide ions in seawater, only a 
limited number of halogenated macrolides have been identified to date.[59] Interestingly, bromide is 
more frequently incorporated, although chloride occurs in higher concentrations in seawater.[60] 
Nonetheless, chlorinated natural products show important biological activities as exemplified by 
spongistatin, a highly potent macrolactone currently in preclinical studies as an anticancer drug 
candidate (Figure 2.2).[61]  
 
Figure 2.2. Selected halogenated marine macrolides. 
More marine polyketides are expected to be discovered and their complex structures will continue to 
inspire synthetic chemists to develop new methodologies and innovative technologies to access 
larger quantities for structure–activity relationship studies and eventually medical use.[61b] Their total 
synthesis represents an ultimate challenge for established synthetic methods, which must provide 
high yields and selectivities in the challenging environment of a natural product with a complex 
architecture and numerous polar functional groups.[62] Furthermore, total synthesis serves as the 
ultimate tool to either confirm or reassign a proposed structure.[63]  
2.1.2 Ring Closing Alkyne Metathesis and Postmetathetic Transformations 
Over the past decades, different methodologies have been developed to access such macrocyclic 
natural products, the most prominent representatives being macrolactonization, intramolecular 
cross coupling and ring closing olefin metathesis. An alternative approach is found in ring closing 
alkyne metathesis (RCAM), which was first accomplished in 1998[64] and has experienced significant 
advancement ever since.[65] The initially employed tungsten alkylidyne C7 was soon replaced by 
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molybdenum complex C8,[66] which had to be activated in situ by dichloromethane[67] or  
1,1-dichloropropane[68] (Figure 2.3). Although the lower Lewis acidity of molybdenum compared to 
tungsten led to an improved functional group tolerance, the catalytic system suffered from moisture 
sensitivity and its ability to cleave molecular oxygen as well as nitrogen, which further complicated its 
use. With the advent of a new generation of molybdenum catalysts, such as C19 and C10 endowed 
with silanolate ligands (Figure 2.3), user-friendliness was combined with high activity and exceptional 
functional group tolerance.[69] Consequently, RCAM can now be used to construct highly 
functionalized cycloalkynes under very mild conditions.[70] 
 
Figure 2.3. Established catalysts for RCAM. 
This development has promoted RCAM as a viable C–C bond forming tool for total synthesis, 
especially since the cycloalkyne constitutes a handle for further postmetathetic derivatizations as 
depicted in Scheme 2.1. Selective access to (Z)- and (E)-olefins is provided by semi-reduction[71] and 
thus represents an alternative to olefin metathesis, where stereoselectivity often presents a 
challenge.[72] Furthermore, π-acid catalysis opens up a route for inter- as well as intramolecular attack 
of a nucleophile to the activated cyclic alkyne, eventually comprising multiple ring closing events.[73]   
More recently, Fürstner and coworkers have reported on the ruthenium-catalyzed transformation of 
internal alkynes into trans-hydrogenated[74] or trans-hydrometalated olefins.[75] Among these, trans-
hydrostannylation has proven outstanding for its high levels of selectivity combined with the 
possibility to further functionalize the products. Excellent trans-selectivity is achieved by employing 
the bulky and neutral ruthenium catalyst [Cp*RuCl]4. Regioselectivity is determined by the substrate 
bias: a protic functional group in proximity to the alkyne leads to stannylated products in the 
proximal position to the functional group.[76] The alkenylstannanes can subsequently be converted 
into the corresponding disubstituted (E)-alkenes by proto-destannylation or trisubstituted alkenes by 
Stille cross coupling.[77] Alternatively, palladium-catalyzed carbonylation gives rise to the respective 
acrylates[78] and vinyl chlorides or vinyl fluorides can be obtained by tin/halogen exchange.[77,79] 
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Scheme 2.1. RCAM and postmetathetic functionalizations. 
This new methodology of RCAM and postmetathetic functionalization not only provides access to 
new structural motifs within a macrocyclic framework, but also allows for new retrosynthetic 
analyses of architecturally challenging target molecules. The application of a sequence of ring closing 
alkyne metathesis, hydrostannylation and tin/chloride exchange to access the (Z,Z)-chlorodiene 
containing macrolide chagosensine will be described in the following chapters.  
2.2 Isolation and Structural Discussion of Chagosensine 
Chagosensine (15) was isolated in 2003 from the widely abundant Red Sea calcareous sponge 
Leucetta chagosensis collected in the Gulf of Aqaba (Eilat, Isreal).[80] The very same sponge, as well as 
other members of the genus Leucetta have previously been identified as sources of imidazole 
alkaloids with cytotoxic[81] or antifungal[82] properties, as well as antimicrobial lipids.[83] The biological 
activity of the novel polyketide chagosensine, however, has not yet been evaluated.  
The structure of chagosensine was elucidated primarily based on NMR spectroscopic data. The 
connectivity and relative configuration was assigned by 1H-1H coupling constants and two-
dimensional NMR techniques, including COSY, HMBC and NOESY correlations. Thus, chagosensine 
was characterized as a highly decorated 16-membered macrolactone containing two trans-
configured tetrahydrofuran moieties and an unprecedented (Z,Z)-chlorodiene (Figure 2.4). Additional 
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unsaturation is found in the sidechain, featuring an allylic alcohol and a carboxylic acid. The 
polyoxygenated macrolide bears a total of nine secondary and two tertiary stereogenic centers.  
 
Figure 2.4. Structure of chagosensine (15) and its synthetic derivatives 16 and 17.[80] 
The absolute stereochemistry was evaluated by derivatization of the natural product and 
degradation studies. Reduction of the macrolactone followed by oxidative cleavage of the C6–C7-diol 
provided the southern THF-moiety. Upon further degradation and comparison with commercially 
available material, the C3 stereogenic center was assigned as (R), which in turn allowed assignment 
of the C2 and C5 stereochemistry. The absolute configuration at C6 and C7 was determined by 
derivatization of the natural product. To this end, the carboxylic acid, the C12- and C17-alcohol were 
methylated prior to esterification of the diol with p-methoxycinnamoyl chloride giving derivative 16. 
Both C6 and C7 were found to possess (R)-configuration based on the Cotton effect observed during 
CD spectroscopy.[84] The configuration at C12 and C17 could be determined via modified Mosher 
analysis[85] of derivative 17, which was obtained after acetalization of the southern diol and 
methylation of the carboxylic acid. The tertiary stereogenic center in the sidechain was elucidated as 
having (S)-configuration by chemical degradation. Ozonolysis of the C18–C19 double bond followed 
by oxidative work-up and methylation gave rise to the corresponding diester, which was compared 
with commercially available material. The absolute configuration of the northern THF-ring was not 
confirmed experimentally and remains therefore in question.  
While the conjugated (Z,Z)-chlorodiene is unprecedented in the literature, some structural motifs of 
chagosensine can be found in other polyketides of marine origin (Figure 2.5). For example, the  
2,5-trans-THF-ring with an adjacent anti-diol found in the southern domain is also present in the 
cytotoxic macrolide amphidinolide F.[86] While, the 2,5-trans-THF-ring in the northern domain 
resembles the originally proposed structure of the haterumalide family members,[87] this particular 
subunit was reassigned after total synthesis[88] prior to submission of the chagosensine isolation 
report, which does not cite this critical publication. In fact, Řezanka et al. have only determined the 
relative configuration of this moiety, thus a misassignment at C13, C15 and C16 is possible. 
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Nevertheless, the stereochemical proposal for the northern segment of chagosensine does appear in 
the antiproliferative natural product isolaulimalide,[89] which has been confirmed after total 
synthesis.[90]   
 
Figure 2.5. Structural relatives of chagosensine in nature. 
This comparison with related marine macrolides highlights the unique structural features of 
chagosensine and points toward potentially promising biological activity. The need for material 
supply to ultimately assign its configuration and evaluate its pharmacological profile in combination 
with the apparent lack of synthetic efforts renders this natural product a valuable target for total 
synthesis.  
2.3 Objectives 
Chagosensine was chosen as a target for total synthesis in order to unambiguously determine its 
structure. Therefore, a highly convergent synthetic strategy with late stage fragment assembly was 
desirable. The stereochemistry should be set as flexible as possible to account for a potential 
misassignment and hence to allow correction of single stereogenic centers. This is best achieved by 
relying on asymmetric catalysis and avoiding chiral pool starting materials.  
From a synthetic viewpoint, the primary challenge posed by chagosensine is the construction of the 
unprecedented chlorodiene motif embedded in the macrocyclic framework. With the recently 
developed postmetathetic functionalization of cycloalkynes at hand, this motif was planned to be 
accessed via a sequence of RCAM, ruthenium-catalyzed trans-hydrostannylation and tin/chloride 
exchange (Scheme 2.2).  
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Scheme 2.2. Envisaged key sequence for the total synthesis of chagosensine. 
The work reported in this thesis thus aims to further increase the structural scope of RCAM by 
application to a highly substituted enyne-yne precursor with exceptionally high density of potentially 
coordinating groups. Moreover, the novel hydrometalation was thought to be established as 
synthetically viable postmetathetic transformation, since chagosensine undoubtedly represents the 
most complex substrate for this methodology so far.  
Once a robust synthesis for the true natural product is established, sufficient material for preliminary 
biological testing should be provided. 
2.4 The Metathesis Approach 
2.4.1 Retrosynthetic Analysis 
As outlined above, the unique (Z,Z)-chlorodiene within the macrocyclic scaffold of chagosensine (15) 
was planned to be accessed through a sequence of ring closing alkyne metathesis (RCAM), trans-
hydrostannylation and tin/chloride exchange. Consequently, a highly convergent synthesis was 
designed (Scheme 2.3). The sidechain was thought to be installed at a late stage by 
diastereoselective alkynylation of a macrocyclic aldehyde with alkyne 18 followed by trans-
hydrostannylation/destannylation. The macrocyclic chlorodiene found in the natural product can be 
traced back to enyne A via tin/chloride exchange and trans-hydrostannylation. Fragment assembly 
prior to ring closure hinged upon a Mitsunobu esterification. Hence, macrocycle A was 
retrosynthetically disassembled into alkyne B and carboxylic acid C as the key building blocks. 
 
Scheme 2.3. Retrosynthetic analysis of chagosensine; PG = protecting group. 
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Since modern transition metal catalyzed transformations were thought to be implemented late in the 
synthesis of a complex target, it seemed advisable to challenge the key sequence first on model 
systems.  
2.4.2 Model Studies on the Key Sequence 
Despite the intriguing examples of ring closing alkyne metathesis (RCAM) in macrolide total 
synthesis,[71a,71b,73b,73d,91] it was unclear at the outset of this project whether the ring closure between 
a propargylic alcohol and a (Z)-enyne with an allylic alcohol would be feasible. Alkynes bearing 
potential leaving groups in the propargylic position are known to be problematic in alkyne 
metathesis, since basically all well-defined catalysts for this transformation are Schrock alkylidynes, 
which are characterized by high-valence metals and electron-donating ligands.[65] The inherent Lewis 
acidity of these complexes endangers fragile substituents, such as propargylic alcohols, due to the 
resonance stabilization of the resulting carbocations (Figure 2.6, VIII). The Lewis acidity, however, 
can be modulated by the electron-donating ligand set and a productive [2+2]-cycloaddition/ 
-cycloreversion sequence to form an alkylidyne of type IX is feasible. The latter, however, is again 
prone to decomposition by elimination of the propargylic alcohol generating a vinylidene species that 
is unable to undergo alkyne metathesis.[92]  
 
Figure 2.6. Effects of metal alkylidynes on propargylic substituents. 
With the development of Mo-complex C9 (see Figure 2.7) Fürstner et al. succeeded in modulating the 
metal’s Lewis acidity and therefore significantly increasing the functional group tolerance.[69,93] Key to 
the success was the catalyst design comprising triarylsilanolate ligands. The aryl groups are not too 
bulky to impede substrate binding, yet bulky enough to disfavor polymerization through an 
associative mechanism. The stereoelectronic properties of the silanolates are highly beneficial as 
bending of the Mo–O–Si hinge reduces electron donation of the ligand to the metal. The resulting 
increased Lewis acidity at the molybdenum center favors substrate binding. In contrast, stretching of 
the Mo–O–Si bonds leads to increased electron donation downregulating the molybdenum’s Lewis 
acidity and hence facilitating product release.[65] Due to constant thermal motion, the catalyst is thus 
expected to meet the opposing electronic requirements within the catalytic cycle and was found to 
tolerate substrates with protic functional groups in the propargylic position.[70e,77,91b] Nevertheless, 
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only substrates comprising one propargylic substitution and one unfunctionalized alkyne had so far 
been studied in metathesis reactions. Therefore, the merger of two propargylic alcohols represented 
the next challenge and a series of suitable model substrates was designed. 
Starting from 1,12-dodecandiol (19), a set of nine differently protected bis-propargylic diols was 
synthesized. After the copper-catalyzed aerobic oxidation developed by Stahl and coworkers[94] 
provided 1,12-dodecandial (20), addition of propynyl-Grignard reagent furnished diol 21 as a mixture 
of spectroscopically and chromatographically indistinguishable syn/anti-diastereomers (Scheme 2.4). 
Since only a limited number of protic functional groups had thus far been tolerated by alkyne 
metathesis catalysts,[91b,95] diol 21 was mono-protected as TES-ether 22, MOM-acetal 24, acetate 26 
and benzoate 28 in moderate yields. The bis-protected alcohols 23, 25, 27 and 29 were 
simultaneously formed and isolated from the reaction mixtures.  
 
Scheme 2.4. Synthesis of diyne model substrates. Reagents and conditions: (a) Cu(MeCN)4(PF)6 (5 mol%), bipyridine 
(5 mol%), TEMPO (5 mol%), NMI (10 mol%), air, MeCN, 86%; (b) CH3CCMgBr, THF, 90%; (c) TESCl, imidazole, DMAP 
(cat.), CH2Cl2, 22 43%, 23 21%; (d) MOMCl, i-Pr2NEt, DMAP (cat.), CH2Cl2, 24 41%, 25 14%; (e) Ac2O, Et3N, DMAP (cat.), 
CH2Cl2, 26 72%, 27 21%; (f) BzCl, Et3N, DMAP (cat.), CH2Cl2, 28 30%, 29 48%. 
With this set of diynes in hand, the RCAM was first tested under standard conditions. All reactions 
employing the latest generation of aryl-alkylidyne molybdenum catalysts comprising silanolate 
ligands, introduced as either the neutral species C9 or the potassium ate-complex C10 (Figure 2.7), 
largely failed to produce the corresponding macrocycles. Solely the bis-MOM-protected derivative 25 
could be cyclized in 54% yield (Table 2.1, Entry 3). This result epitomizes that RCAM between bis-
propargylic substrates is in general possible and that the problem arises from an incompetence of 
the chosen catalyst.  
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Figure 2.7. Molybdenum catalysts C9, C10, C11 and C12, as well as recently developed multidentate silanolate  
ligands L1 and L2. 
Parallel to this work, further catalyst development was undertaken in the Fürstner group.[96] As 
speculated in the past,[97] the silanolate ligands of C9 seem to suffer from partial or even complete 
ligand exchange by protic functional groups. Therefore, a new generation of catalysts was designed 
based on multidentate ligands, inspired by the work of Zhang and coworkers, who utilized podand 
ligands to obtain chelate complexes of the general type C11 (Figure 2.7).[98] In order to maintain the 
above mentioned advantages of the silanol ligands, chelating siloxides were synthesized. Upon 
complexation of the chelating ligand L1 or L2 to the precatalyst C12, a mixture of products was 
formed and the isolation of a defined catalyst species has thus far proven impossible.[92b] Instead of 
chelating a single metal center, the trisilanols act as cross-linking agents between multiple metal 
centers. Nevertheless, application of this new generation of catalysts to the RCAM of the challenging 
bis-propargylic test substrates seemed worthwhile.  
For the absence of a well-defined solid-state structure, an in situ protocol for RCAM was developed: 
a freshly prepared solution of precatalyst C12 and ligand L1 or L2 was stirred prior to its addition to 
the respective substrate solution. Indeed, this two-component catalyst system C12/L2 was capable of 
metathesizing the bis- and mono-MOM substrates as well as the bis- and mono-TES substrates 
(Table 2.1, Entries 1-4). Also, two protic groups were tolerated as demonstrated by diol 21 (Entry 5). 
In general, less protic substrates, i.e. protected alcohols, gave better results than their more protic 
analogs. Only mono- and bis-esters 26-29 completely failed to react (Entries 6-9), presumably due to 
their enhanced leaving group ability increasing the risk of catalyst decomposition via formation of a 
metal-vinylidene species (vide supra). In summary, the scope of RCAM has been expanded to bis-
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propargylic substrates, provided that the propargylic substituents are only moderate leaving groups. 
This represents an important progress given the prevalence of bis-functionalized unsaturated 
systems in macrocyclic natural products. 
Table 2.1. RCAM of bis-propargylic substrates.[96] 
 
Entry Substrate R1 R2 
Yield [%] 
 C9          C12/L2 
1 23 TES TES 0 71 
2 22 TES H 0 64 
3 25 MOM MOM 54 70 
4 24 MOM H 0 67 
5 21 H H 0 53 
6 27 Ac Ac 0 0 
7 26 Ac H 0 0 
8 29 Bz Bz 0 0 
9 28 Bz H 0 0 
 
These findings ultimately led to the successful completion of the total synthesis of ivorenolide A (30), 
a diyne containing natural product.[92b] Previous attempts to achieve ring closure to the cyclic diyne 
flanked by two propargylic alcohols had met with failure, whereas the doubly MOM-protected 
precursor 31 in combination with the new catalytic system provided macrocycle 32 (Scheme 2.5).  
 
Scheme 2.5. Synthesis of ivorenolide A. Reagents and conditions: (a) C12 (20 mol%), L2 (20 mol%), 5 Å MS,  
toluene, 60 °C, 78%.
[92b]
 
Next, the attention was paid to further conjugated substitutions. Thus far, substrates with 
propargylic and conjugated substitution on either side of the newly formed triple bond had only been 
investigated once. A (Z)-enyne displaying a methyl group in the allylic position had been successfully 
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metathesized with a propargylic alcohol.[70e,71a] The envisioned chagosensine RCAM precursor, 
however, possesses an additional alcohol adjacent to the unsaturated system (vide supra, 
Scheme 2.3). Once again, a leaving group in conjugation to the alkyne X or alkylidyne XI poses the 
risk of elimination, since stabilization of the resulting cation over the π-system is similarly effective 
(Figure 2.8). 
 
Figure 2.8. Effects of metal alkylidynes on allylic substituents in conjugation to the triple bond. 
In order to evaluate the enhanced properties of the newly developed catalytic system, a second set 
of model substrates was synthesized, comprising an enyne flanked by alcoholic groups (Scheme 2.6). 
The previously obtained dial 20 (vide supra, Scheme 2.4) served as starting material and was mono-
protected as dimethoxy acetal, which allowed mono-addition of vinyl-Grignard reagent to the 
remaining aldehyde. The resulting alcohol was protected as TBS-ether 33. Ozonolysis followed by 
Wittig olefination provided enyne 34 as an inseparable 1.7:1 mixture of E/Z diastereomers. 
Subsequent acetal cleavage with PPTS and alkynylation afforded a mixture of four diastereomers, yet 
the syn/anti-diastereomers were once again indistinguishable by NMR spectroscopy and column 
chromatography. The E/Z-isomers were finally separated by preparative HPLC. The (Z)-enyne 35 
matching the chagosensine pattern was obviously the more relevant model substrate, but the (E)-
enyne also represents an interesting compound for comparison. In addition, the TBS-ether of the 
major (E)-diastereomer 36 was cleaved to obtain a third substrate 37 for further RCAM trials.  
 
Scheme 2.6. Synthesis of enyne-yne model substrates. Reagents and conditions: (a) p-TsOH, MeOH, toluene, 0 °C, 54%; 
(b) H2CCHMgBr, THF, 66%; (c) TBSCl, imidazole, DMAP (cat.), CH2Cl2, 92%; (d) O3, CH2Cl2, –78 °C; PPh3, –78 °C to rt, 89%; 
(e) but-2-yn-1-yltriphenylphosphonium bromide, n-BuLi, THF, –78 °C to rt, 60% (E/Z 1.7:1); (f) PPTS, acetone/H2O, 60 °C; 
(g) CH3CCMgBr, THF, 35 23% over two steps, 36 38% over two steps; (h) TBAF, THF, 0 °C, 88%. 
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In accordance with the previous observations and the challenges depicted in Figure 2.8, catalysts C9 
and C10 were unable to metathesize any of the enyne-ynes (Table 2.2). Most of the starting material 
could be recovered, while only traces of anisol transfer from the catalyst to either alkyne were 
observed. Using these catalyst, both alkynes can be accessed only in an unproductive fashion. 
Fortunately, C12/L2 gave the corresponding macrocyclic enynes 38 and 39 in excellent and good 
yield (Entries 1 and 2). Subtle differences in reactivity could arise from ring strain, which is assumed 
to be slightly higher for the (E)- than for the (Z)-enyne. In addition, 40 could only be obtained in 
moderate yield (Entry 3), corroborating the trend that multiple protic functional groups harm the 
catalyst. 
Table 2.2. RCAM of enyne-yne substrates. 
 
Entry Substrate R Double Bond Geometry Product 
Yield [%] 
    C9         C12/L2 
1 35 TBS (Z)  38 0 90 
2 36 TBS (E) 39 0 76 
3 37 H (E) 40 0 40 
 
These studies nicely demonstrate that total synthesis can drive methodology development: only after 
the advent of a new catalytic system was the metathesis of bis-propargylic or allylic-propargylic 
alcohols possible. With the results obtained from this survey, the first step of the projected key 
sequence in the envisioned total synthesis of chagosensine seemed feasible. Thus, the second key 
transformation, i.e. the ruthenium-catalyzed trans-hydrostannylation of an enyne, had to be 
investigated.  
The trans-selective hydroelementation of alkynes to trisubstituted alkenes is attractive for its 
excellent regioselectivity, provided that the alkyne is endowed with protic functional groups on only 
one side.[76] In these cases the α-substituted trans-olefins are obtained. Based on single crystal x-ray 
analysis, the protic group was found to form a hydrogen bond to the chloride ligand of the ruthenium 
complex C13 and thus pre-organizes catalyst, substrate and hydroelementation reagent 
(Figure 2.9).[76] For alkynes missing protic functional groups, regioselectivity is drastically diminished 
although electronic and steric properties are operative. 
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Figure 2.9. a) [Cp*RuCl]4 as efficient catalyst for hydroelementations; b) schematic pre-organization of catalyst, 
substrate and hydride species (top view model). • = CMe. 
Moreover, the absence of a directing group can completely shut down the reactivity in case of 
competitive binding modes. The latter is true for conjugated systems, e.g. enyne substrates where 
the ruthenium can be trapped by both triple and double bond.[99] These substrates can only be 
converted to the corresponding dienes in the presence of a neighboring protic group. Acyclic enyne 
substrates had been studied in hydrostannylations before and had shown excellent regioselectivity 
for the proximal position (Figure 2.10, 41 and 42).[76] In contrast to isolated propargylic alcohols, the 
reaction was significantly slower. Therefore, the tin hydride had to be added via syringe pump over 
the course of 1.5 to 2 hours to prevent catalyst decomposition.[100] Hydrostannylations can also be 
directed by a 1,2-diol adjacent to the alkyne as demonstrated by compound 43. Limitations were 
found for alkynes flanked with oxygen substitution on either side of the triple bond, causing a 
significant loss of regioselectivity even if only one is a hydrogen bond donor (see 44). In this case of 
electronic equality of both Csp-centers, steric bulk seems to dictate the reaction outcome and hydride 
delivery from the sterically less hindered side is slightly preferred.  
 
Figure 2.10. Literature-known alkenylstannanes obtained via trans-hydrostannylation of the corresponding alkynes;  
r.r. given as ratio of depicted isomer to opposite regioisomer.[76] 
These observations had to be considered for the projected application of this methodology to the 
total synthesis of chagosensine. The respective substrate en route to the target molecule 
(Scheme 2.3, A) resembles a combination of the species mentioned above: it possesses a concealed 
1,2-diol adjacent to the triple bond and a protected allylic alcohol on the other side. However, since 
the free propargylic alcohol was believed to direct the metal to the adjacent alkyne,[76] the protected 
allylic alcohol should not affect reactivity or regioselectivity. To test this expectation, the previously 
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obtained cyclic enynes were submitted to the standard reaction conditions.[75b] (Z)-Enyne 38 could be 
transformed into the corresponding α/trans-hydrostannylated diene 45 in good yield and excellent 
selectivity (Scheme 2.7). The obtained dienylstannane was elaborated into (Z,Z)-chlorodiene 46 by 
means of copper-mediated tin/chloride exchange.[101] The only byproduct observed was the proto-
demetalated diene 47. Dienylstannane 45 had to be isolated, as a one-pot procedure by introduction 
of CuCl2 after complete addition of tributyltin hydride gave a complex mixture of products. 
 
Scheme 2.7. Construction of the chlorodiene motif. Reagents and conditions: (a) [Cp*RuCl]4 (20 mol%), Bu3SnH, 
CH2Cl2, 90 min, 79%, Z/E > 20:1, α/β > 95:5; (b) CuCl2, THF, 46 67%, 47 6%. 
As expected, the double bond geometry of the neighboring olefin within this relatively unstrained 
macrocycle had no influence on the ruthenium-catalyzed transformation, since the corresponding 
(E)-enyne 39 behaved equally well (see Section 4.3.1).  
The successful investigation of the key sequence on suitable model systems encouraged us to 
embark on the total synthesis of chagosensine pursuing the strategy outlined above (Section 2.4.1).  
2.4.3 Synthesis of the Northern Alcohol Fragments 48 and 49[102] 
Remark: A first entry to these northern alcohol fragments was developed in close collaboration with 
postdoctoral researcher Dr. Jakub Flasz.
[103]
  
The northern fragment possesses four stereogenic centers and a methyl-capped alkyne. The hidden 
symmetry in this fragment inspired the construction of the THF-moiety prior to asymmetric 
alkynylation of aldehyde D (Scheme 2.8). The synthesis of D would comprise an ozonolysis of the 
corresponding olefin and a cobalt-catalyzed oxidative cyclization, thereby leading back to the 
literature-known C2-symmetric diol 50.
[104] The latter can be prepared from acetyl acetone (51) in 
three steps including chlorination, double Noyori reduction and double olefination.  
 
Scheme 2.8. Retrosynthetic analysis of the northern alcohol fragment B; PG = protecting group.  
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The synthetic efforts toward chagosensine commenced with the synthesis of two differently 
protected northern fragments to provide flexibility for the key sequence. At first,  
1,5-dichloropentane-2,4-dione (52) was obtained via dichlorination of acetyl acetone (51) in the 
presence of excess aluminum trichloride. This reaction was first described by Nojiri et al. and later 
modified by Rychnovsky and coworkers (Scheme 2.9).[105] The poor but reproducible yield of approx. 
22% (literature: approx. 25%) is attributed to the unavoidable formation of structural isomers and 
partial decomposition. Next, diketone 52 was reduced to the corresponding anti-diol 53 by 
asymmetric hydrogenation, taking advantage of the highly efficient Noyori catalyst.[105c,106] The anti-
diol was obtained in consistently high enantio- and diastereoselectivity as evident from initial double 
Mosher esterification and subsequent NMR analysis thereof (see Section 4.3.2; for further batches, 
optical rotation values were compared). Dichloride 53 was converted to the diene 50 following a 
procedure by Hanson and coworkers, which has only been applied on one other occasion.[104,107] To 
this end, alkylchloride 53 was attacked by a sulfur ylide generated from trimethyl sulfonium iodide 
and n-BuLi as typically used in Corey-Chaykovsky reactions.[108] However, the reported results could 
not be reproduced in our laboratories: formation of 5-(chloromethyl)tetrahydrofuran-3-ol (54) 
resulting from intramolecular SN2 reaction of 53 could not be prevented and the two products were 
difficult to separate; therefore a maximum of 65% of pure 50 was obtained. The byproduct had only 
been mentioned by Rychnovsky and coworkers, who detected its formation during the Noyori 
hydrogenation, if the temperature exceeded 100 °C.[105c] Traces of this byproduct were also detected 
during the hydrogenation even at lower temperatures in our laboratories.  
 
Scheme 2.9. Reagents and conditions: (a) (i) AlCl3, ClCH2COCl, PhNO2, (CH2Cl)2, 65 °C, 8 h; (ii) sat. aq. Cu(OAc)2; (iii) 
H2SO4 (10%), Et2O, 22%; (b) [RuCl2((S)-BINAP)]2·Et3N (0.1 mol%), H2 (62 bar), 70 °C, 53/54 (crude 
1H NMR) 6:1, 53 39%, 
97% ee, d.r. > 20:1; (c) Me3SI, n-BuLi, THF, –40 °C to rt, 50/54 (crude 
1H NMR) 9:1 50 65%. 
The trans-tetrahydrofuran was generated via a cobalt-catalyzed aerobic oxidative cyclization, initially 
reported by Mukaiyama and coworkers.[109] Conditions described by Pagenkopf et al., who had 
recently developed a more effective water-soluble cobalt catalyst, furnished diol 55 with excellent 
trans-selectivity (Scheme 2.10).[110] However, the reaction did not always go to completion and 
addition of a second portion of catalyst to the reaction mixture proved ineffective. When the crude 
mixture was directly bis-silylated to provide 56, low and inconsistent yields were observed. One 
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byproduct was the bis-silylated diol 57, which arose from unreacted starting material. It could be 
recovered by cleaving the silyl ethers with TBAF. Traces of the chlorinated byproduct 54 from the 
previous step mentioned above were found to poison the cobalt catalyst, which caused inefficient 
cyclization. In contrast to the cyclization precursor 50, the THF-containing diol 55 turned out to be 
water soluble, accounting for a further decrease in yield. Hence, scrupulous re-purification of the 
starting material 50 in combination with a slightly modified non-aqueous work-up led to significant 
improvement ensuring a reproducible yield of 78%.[111] Notably, the reaction proved exquisitely 
selective: although the cyclization precursor 50 bears two π-systems, only oxidative 5-exo cyclization 
to the desired product 55 was detected, leaving the second unsaturation untouched. 
After bis-silylation of diol 55 under standard conditions,[112] ozonolysis of the double bond of 56 was 
investigated to furnish aldehyde 58. Initial experiments followed a method employing  
N-methylmorpholine-N-oxide (NMO), which is thought to trap the carbonyl oxide after decay of the 
primary ozonide, thereby avoiding the formation of the secondary ozonide.[113] Since reproducibility 
was not assured for this transformation, classical conditions using excess triphenylphosphine to 
quench the secondary ozonide were applied, which afforded the desired aldehyde in 75% yield 
(Scheme 2.10).[114] 
 
Scheme 2.10. Reagents and conditions: (a) Co(nmp)2 (10 mol%), t-BuOOH (10 mol%), i-PrOH, O2, 55 °C, 78%;  (b) TESCl, 
imidazole, DMAP (cat.), DMF, 81%; (c) O3, CH2Cl2, –78 °C; PPh3, –78 °C to rt, 75%; (d) propyne, (–)-NME, Et3N, Zn(OTf)2, 
toluene, –78 °C to rt, 75%, d.r. > 12:1; (e) TBAF, THF, –50 °C, 80%. Key NOE contacts (blue) for trans-THF 55. 
Next, a Carreira alkynylation introducing the chiral propargylic alcohol for the conceived 
macrocyclization was envisioned.[115] In two recent total syntheses by Fürstner and coworkers this 
methodology had successfully been employed with propyne gas,[77,116] which had rarely been used 
before.[117] The present example represents the only α-oxygenated aldehyde substrate, which was 
selectively propynylated in good yields using a slightly larger excess of all reagents and prolonged 
reaction times (Scheme 2.10). After Mosher ester analysis[118] of the newly formed stereogenic center 
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at C12 (see Section 4.3.2), the reaction sequence was repeated on large scale providing more than 
one gram of propargylic alcohol 59 as a preferred storage point.  
Protecting group manipulations were necessary to liberate the secondary alcohol in the THF-ring for 
fragment assembly. Initially, two different protecting groups were chosen: a TBS-ether to permit 
global deprotection after cyclization and a MOM-acetal to ensure orthogonality to the other 
protecting groups. After preparation of both compounds, TES-cleavage under adequate conditions 
followed by mono-TBS-protection of the primary alcohol provided the two alcohols 48 and 49 in 10 
linear steps each (Scheme 2.11). 
 
Scheme 2.11. Reagents and conditions: (a) TBSCl, imidazole, DMF, 82%; (b) p-TsOH, MeOH, –50 °C, 73%; (c) TBSCl, 
imidazole, DMF, 48 54%, 49 76%; (d) MOMCl, i-Pr2NEt, CH2Cl2, 91%; (e) TBAF, THF, 0 °C, 88%. 
 
2.4.4 Synthesis of the Southern Acid Fragment 60 
The southern acid segment 60, which contains five of the eleven stereogenic centers of 
chagosensine, is structurally unique for its anti/syn-triol motif adjacent to a (Z)-enyne. Furthermore, 
the stereogenic center at C2 forms a major obstacle, as its position α to the carboxyl functionality 
renders it prone to epimerization. In the retrosynthetic analysis, the acid unit was therefore planned 
to be installed last (Scheme 2.12). Further disconnections centered on a (Z)-selective olefination and 
a Sharpless asymmetric dihydroxylation, simplifying 60 to α,β-unsaturated ester E. The latter was 
thought to be installed via Still-Gennari olefination after oxidative Mukaiyama cyclization and 
oxidation. Thus, scission of the C5–O bond revealed alcohol F, which in turn can be obtained by 
regioselective opening of literature-known epoxide 61.[119]   
 
Scheme 2.12. Retrosynthetic analysis of southern acid fragment 60; PG = protecting group. 
Since 61 is accessed by Sharpless asymmetric epoxidation (SAE) of (Z)-crotyl alcohol (62),[120] the 
synthesis of the southern fragment 60 commenced with a semi-hydrogenation of 2-butyn-1-ol 
(63).[121] The well-precedented reaction worked best using the Rosenmund catalyst with quinoline as 
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poison for the palladium surface in methanol (Scheme 2.13).[122] Next, (Z)-2-buten-1-ol (62) was 
transformed into epoxide 61 following a standard SAE procedure using (+)-diethyl tartrate as the 
chiral ligand.[111] The reaction was highly reproducible and scalable; however, the enantiomeric 
excess of 89-91% could not be increased. In order to overcome this limit, an in situ derivatization of 
epoxy alcohol 61 to the corresponding 4-nitrobenzoate 64 was investigated.[123] After two 
recrystallizations from diethyl ether, the ee of the product could be increased to a maximum of 94%. 
Since this derivatization showed no significant improvement in enantioselectivity but led to an 
inevitable loss of material, the idea was abandoned. Instead, the slightly volatile epoxide 61 was 
protected as a triethyl silyl ether 65 in a separate step. The TES-ether was chosen as a protecting 
group, because of the possibility of direct oxidation to the corresponding aldehyde under Swern 
conditions,[124] which would save one step in the longest linear sequence later in the synthesis.  
 
Scheme 2.13. Reagents and conditions: (a) 10 wt% Pd/BaSO4 (5 mol%), quinoline, MeOH, H2 (atmospheric pressure), 
65%; (b) Ti(Oi-Pr)4 (5 mol%), (+)-DET (6 mol%), t-BuOOH, 4 Å MS, CH2Cl2, –20 °C; P(OMe)3, Et3N, 4-nitrobenzoyl  
chloride, 0 °C, 58%, 94% ee; (c) NaOMe, MeOH, 0 °C, 78%; (d) Ti(Oi-Pr)4 (5 mol%), (+)-DET (6 mol%), t-BuOOH,  
4 Å MS, CH2Cl2, –20 °C, 74%, 90% ee; (e) TESCl, pyridine, DMAP (cat.), CH2Cl2, 98%. 
Selective epoxide opening was accomplished with allyl-magnesium chloride in the presence of 
catalytic amounts of copper iodide (Scheme 2.14). The best results were obtained by slow addition of 
epoxy ether 65 to a chilled suspension of the Grignard-reagent and 20 mol% of CuI in THF, providing 
the desired bis-homoallylic alcohol 66 in a 10:1 regioisomeric ratio.[125] In analogy to the northern 
fragment, an aerobic oxidative Mukaiyama cyclization was envisioned as reliable entry to the 
southern 2,5-trans-THF-moiety. The cobalt catalyst described above[110] smoothly cyclized the 
precursor 66 to the desired THF-ring 67, while formation of the cis-diastereomer was not detectable. 
On small scale, the TES-ether subsisted under the slightly acidic work-up conditions, yet on scale-up 
desilylation led to a water-soluble diol. Hence, only a half-saturated ammonium chloride solution 
could be applied without damaging the product, which led to substantial amounts of the nmp-ligand 
in the organic extracts and complicated chromatographic purification.  
A derivative was synthesized to verify the absolute stereochemistry by single crystal x-ray analysis. To 
this end, the primary alcohol was esterified with 4-nitrobenzoyl chloride and the resulting benzoate 
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desilylated by treatment with acid. The resulting alcohol 68 was crystallized from dichloromethane 
by slow evaporation. As just the racemate (approx. 10%) crystallized – a phenomenon described 
quite well in the literature[126] – only the relative stereochemistry could be confirmed (see 
Section 7.1). Attempts to crystallize the enantiomerically pure mother liquor were hampered by slow 
degradation of the material. 
 
Scheme 2.14. Reagents and conditions: (a) allyl-MgCl, CuI (20 mol%), THF, –25 °C, 67%, r.r. 10:1; (b) Co(nmp)2 
(10 mol%), t-BuOOH (20 mol%), i-PrOH, O2, 55 °C, 78%;  (c) 4-nitrobenzoyl chloride, pyridine, DMAP (cat.), CH2Cl2;  
(d) AcOH/H2O/THF (6:3:1), 68% over two steps; (e) DMP, NaHCO3, CH2Cl2/H2O, 0 °C to rt; (f) R1, KHMDS,  
18-crown-6, THF, –78 °C; 69 28% over two steps, Z/E = 8:1. 
In parallel, the route toward the southern acid fragment was continued, focusing on the oxidation of 
the primary alcohol to the corresponding aldehyde using Dess-Martin periodinane.[127] Although 
reaction monitoring indicated full conversion of the starting material, the crude yield never exceeded 
50%. This outcome could be improved by the sequential addition of one equivalent of water, which 
helped to enhance the reaction rate and avoid the formation of alkoxyperiodinanes.[128] Equally 
beneficial and more convenient is the addition of excess t-butanol.[129] Nevertheless, this mild 
oxidation method suffered from partial C5-epimerization (approx. 10%) visible in the NMR spectrum 
of the crude mixture. The reaction was therefore buffered with NaHCO3 to trap excessive acetic acid. 
The exact same protocol had been used successfully in Kobayashi’s synthesis of the southern 
fragment of amphidinolide C, which closely resembles the present aldehyde, and the obtained 
product was even found to be stable on silica gel.[130] Unfortunately, this modification could not 
entirely suppress C5-epimerization – depending on the batch of DMP and the amount of residual acid 
– and the resulting diastereomeric mixture was not stable on silica gel. The crude aldehyde was 
subjected to the Still-Gennari olefination[131]  to scrutinize the remaining steps toward the enyne 
motif. Following the standard protocol,[111,132] the desired α/β-unsaturated ester 69 was isolated as a 
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8:1 Z/E mixture, albeit in low yield (Scheme 2.14). The remaining material was identified as the 
primary alcohol resulting from TES-cleavage, which could not be separated from the phosphonate.  
At this stage, the labile primary TES-ether, which had complicated purification of the Mukaiyama 
cyclization product and proven unstable in the Still-Gennari olefination, was replaced by a more 
robust TBS-group. Uneventful protection of epoxy alcohol 61 followed by epoxide opening with 
15 mol% copper iodide provided the desired regioisomer 71 as the major product (10:1). After 
chromatographic separation, the Mukaiyama cyclization gave the 2,5-trans-THF product 73 in 
reproducibly good yields on a multi-gram scale (Scheme 2.15).  
With ample material in hand the cumbersome oxidation was revisited, initially repeating the Dess-
Martin conditions. Since no improvement could be asserted compared to the TES-version, a fully 
catalytic methodology recently introduced by Stahl et al. was applied.[94] Simple filtration to remove 
the reagents seemed appealing, since purification of this aldehyde by chromatography led to loss of 
material (30% yield after flash chromatography). In the present case, however, the reaction showed 
only low conversion of starting material after 24 h (< 10%), which might be attributed to the good 
chelation ability of the substrate to the copper catalyst. Likewise, an alternative TEMPO oxidation, 
i.e. the Anelli oxidation[133], as well as the TPAP/NMO oxidation[134] met with failure: the conversion 
was incomplete after 24 hours at ambient temperature and NMR spectra of the crude material 
revealed partial decomposition. Classical Swern conditions were investigated next, providing an 
epimeric mixture of the product and degraded material. Thus, the Parikh-Doering modification of the 
Swern oxidation as a milder alternative was studied.[135] The standard conditions using triethylamine 
as base at ambient temperature showed partial epimerization (approx. 10%) too. Finally, replacing 
triethylamine by the more bulky Hünig’s base and performing the reaction at –25 °C completely 
suppressed epimerization. Aldehyde 74 was isolated in excellent yield and purity after work-up with 
pH 7 phosphate buffer and drying under high vacuum. The crude material was used in the 
subsequent olefination step, which proceeded without complication (Scheme 2.15). The 12:1 mixture 
of (Z)- and (E)-75 could be separated by flash chromatography on fine silica gel,  affording (Z)-75 in 
63% over two steps. 
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Scheme 2.15. Reagents and conditions: (a) TBSCl, imidazole, DMAP (cat.), CH2Cl2, 96%; (b) allyl-MgCl, CuI (15 mol%), THF, 
–25 °C, r.r. 10:1, 71 67%, 72 4%; (c) Co(nmp)2 (10 mol%), t-BuOOH (10 mol%), i-PrOH, O2, 55 °C, 79%;  (d) SO3·pyridine, 
DMSO, i-Pr2NEt, CH2Cl2, –25 °C; (e) R1, KHMDS, 18-crown-6, THF, –78 °C, (Z)-75 63% over two steps, (E)-75 5% over two 
steps. Key NOE contacts (blue) for the trans-THF compound 73. 
Next, the Sharpless asymmetric dihydroxylation of the (Z)-double bond was addressed in order to 
install the required anti-diol.[136] Only a few aliphatic cis-olefins as substrates for this transformation 
were reported in the literature with diastereoselectivities ranging between 4:1 and 8:1.[137] 
Nonetheless, the pyrimidine-based ligand (DHQD)2PYR
[138] was successfully utilized in a closely 
related amphidinolide C fragment synthesis to access the anti-diol.[111] This result prompted the 
application of the reported conditions for the dihydroxylation of olefin (Z)-75, which could be 
obtained with a workable diastereomeric ratio of 5:1 (Scheme 2.16). The diastereomers were 
separated by flash chromatography on fine silica gel providing more than one gram of the diol in a 
single operation. The vicinal alcohols were then masked as TBS-ethers using a large excess of TBS-
triflate.  
A selective reduction of methyl ester 78 to aldehyde 80 met with failure, although the feasibility for 
similarly oxygenated compounds had been reported.[137c] Treatment with one equivalent of the 
reducing agent (titration of i-Bu2AlH prior to use)
[139] in aprotic solvent at low temperature ultimately 
led to a mixture of aldehyde, alcohol and remaining starting material. Presumably, the neighboring 
coordinating groups instigate the breakdown of the otherwise stable hemiacetal allowing for a 
second hydride to be delivered. Consequently, an excess of i-Bu2AlH was used affording the 
alcohol 79 in excellent yield. At this stage, the absolute configuration at C6 and C7 was determined 
by NMR analysis and comparison with the available data of the fragments of amphidinolides C and F 
(see Section 4.3.3).[73b,111,140] Subsequent re-oxidation of the alcohol to the aldehyde 80 was 
accomplished under the previously established Parikh-Doering conditions (Scheme 2.16).  
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Scheme 2.16. Reagents and conditions: (a) K2OsO4 (6 mol%), (DHQD)2PYR (3 mol%), K3Fe(CN)6, K2CO3, MeSO2NH2,  
t-BuOH/H2O, 0 °C, 76 67%, 77 11%; (b)  TBSOTf, 2,6-lutidine, DMAP (cat.), CH2Cl2, 86%; (c) i-Bu2AlH, toluene, –78 °C, 
98%; (d) SO3·pyridine, DMSO, i-Pr2NEt, CH2Cl2, –25 °C, 94%. 
Since selective reduction of ester 78 to the aldehyde oxidation state was not feasible and the 
installation of the anti-diol–aldehyde motif via olefination/dihydroxylation appeared lengthy and 
included two laborious separations of diastereomers, a shortcut was investigated. Specifically, a 
direct cross aldol reaction between aldehyde 74 and protected α-hydroxy aldehyde 81 could give rise 
to aldehyde 82, which after protection of the remaining alcohol as a TBS-ether would deliver 
aldehyde 80. This alternative route might save three steps in the longest linear sequence 
(Scheme 2.17).  
 
Scheme 2.17. Envisioned Aldol shortcut to aldehyde 80. Reagents and conditions: (a) TBSCl, imidazole, DMAP (cat.), 
CH2Cl2, quant.; (b) O3, CH2Cl2, –78 °C; PPh3, –78 °C to rt, 94%. 
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Although this type of aldol reaction suffers from possible self-condensation, polyaldolization and 
other side reactions,[141] literature evidence for proline-catalyzed enantioselective aldehyde cross 
aldol reactions legitimated a short screening of conditions using either L-proline or proline-derived 
catalysts.[142] After the straightforward preparation of aldehyde 81,[143] the aldol reaction was studied 
using L-proline (C14) in various solvents with slow addition of donor aldehyde 81.[144] Neither 
extending the addition time of 81 nor increasing the loading of L-proline (C14) to stoichiometric 
amounts led to the desired C–C bond formation. Diphenylprolinol (C15) as well as the Hayashi-
Jørgensen catalyst (C16) were likewise incapable of inducing the reaction. In summary, all efforts 
resulted in side reactions with no traces of the desired product detectable. Cross aldol reactions 
relying on chiral auxiliaries[145] are expected to provide the required anti-diol, yet they were not 
attractive in the present case due to an increase in step count. Thus, the original route to 
aldehyde 80 was maintained in spite of its length, as it was manageable on multi-gram scale.  
Next, the crucial (Z)-selective olefination to furnish the enyne moiety was addressed. (Z)-enynes had 
been successfully installed in two previous total syntheses in the Fürstner group utilizing a Julia-
Kocienski reaction.[70a,71a,146] Yet, the very same conditions led to a strong preference for the  
(E)-isomer when aldehyde 80 was employed (Table 2.3, Entry 1). Reported reactions with propargylic 
sulfones have predominantly led to (Z)-configured double bonds, since the faster Smiles 
rearrangement of the syn-alkoxide intermediate dictates the stereoselectivity.[147] However, the 
present case is exceptional, probably due to the sterically demanding α,β-dihydroxylated 
aldehyde 80. The initial attack of the nucleophile to the aldehyde is expected to be reversible, yet an 
irreversible Smiles rearrangement would favor the cis double bond. The puzzling result can therefore 
not be explained according to the general understanding of the olefination mechanism. Instead, 
either collapse of the syn-alkoxides shifts the equilibrium to the unfavored anti-alkoxides which 
undergo Smiles rearrangement, or alternative pathways to form the (E) double bond starting from a 
syn-alkoxide become energetically accessible.[147] To investigate the role of the counterion, which is 
usually thought to dictate the formation of syn-alkoxides via closed transition states or anti-alkoxides 
via open transition states, 18-crown-6 was added to sequester the potassium cation. In this case, the 
reactivity was shut down and significant amounts of dimerized sulfone[148] were detected along with 
remaining starting material (Entry 2). The influence of the counterion was further tested by replacing 
potassium with the smaller lithium ion (Entry 3). The preference for the (E)-configuration was 
significantly reduced, which is comparable to the many examples of regular sulfones described in the 
literature.[147] Keeping the lithium ion but switching from the polar solvent (THF) to toluene as a less 
polar solvent again favored the (E) double bond, which contradicts the general understanding of the 
reaction (Entry 4). The latter might be explained by the presence of one equivalent of THF in the 
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substrate which might act as an internal ligand. Neither replacement of lithium by sodium nor 
addition of LiCl could invert the selectivity (Entries 5 and 6). Slight improvements were realized by 
addition of HMPA, which presumably influences the chelation mode (Entry 7). Utilizing the 1-phenyl-
1H-tetrazol-5-yl sulfone (PT)[149] instead of the benzothiazol-2-yl sulfone (BT) also favored the  
(E) geometry, although this preference was less profound than in the BT-series. This observation is 
also opposing the common understanding of the reaction, since the PT is usually known to give 
better (E)-selectivity due to the sterically demanding phenyl substituent, which hints toward an 
abnormal coordination mode. 
Table 2.3. Attempted (Z)-selective olefinations. 
 
Entry Conditions Solvent T [°C] Z/E 
1 BT, KHMDS THF –55 1:11 
2 BT, KHMDS, 18-crown-6 THF –55 – a) 
3 BT, LiHMDS THF –55 1:1 
4 BT, LiHMDS toluene –55 1:2 
5 BT, NaHMDS toluene –55 1:3.4 
6 BT, LiHMDS, LiCl THF –55 1:1 
7 BT, LiHMDS, HMPA THF –55 2:1 
8 PT, KHMDS THF –55 1:7 
9 Ph3PCH2CCCH3, BuLi THF –78 1.4:1 
10 Me3PCH2CCCH3, t-BuOK THF 23 1:1 
11 Me3PCH2CCCH3, LiHMDS THF –78 2:1 
BT = benzothiazol-2-yl sulfone, PT = 1-phenyl-1H-tetrazol-5-yl sulfone. a) s.m., dimerized sulfone 
 
Collectively, the stereochemical outcome of this operationally simple olefination technology is 
difficult to predict and the results reported herein are rather exceptional.[150] A rationale for the 
findings is given in Scheme 2.18, where possible influences of the sterically demanding and highly 
oxygenated neighboring groups prohibit a defined pre-organization of sulfone and aldehyde.  
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Scheme 2.18. Rationale for diastereoselectivity in Julia-Kocienski olefinations: a) commonly accepted mechanistic 
manifold for (Z)-olefination, b) complementary (E)-olefination, c) several possible pre-orientations leading to the 
(E)-olefin under variable conditions. 
After having studied the Julia-Kocienski method in detail, an alternative Wittig olefination was 
investigated (Entries 9-11). Upon variation of the phosphonium salt and the alkali metal base, the 
best result was again obtained using LiHMDS in THF, providing a Z/E ratio of 2:1 (Entry 11).  
Based on these findings, further methods such as Peterson or Still-Gennari olefinations were not 
explored due to the necessity of preparing the reagents combined with the presumably little chance 
of success. Instead, the focus shifted to a two-step sequence via the vinyl-iodide (Scheme 2.19). 
Surprisingly, the well-established Stork-Zhao reaction[151] was not affected by the surrounding steric 
bulk and exclusively provided the (Z)-vinyl iodide 84 in high yield. Unfortunately, neither DMPU nor 
DMSO was able to replace the highly carcinogenic HMPA. A good compromise was found by reducing 
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the equivalents of HMPA to five, which led to full conversion while only slightly diminishing the 
reaction rate. In a second step, the vinyl iodide was subjected to a modified Suzuki propynylation 
protocol reported by Fürstner et al.[152] furnishing the enyne (Z)-83 in 83% over two steps as a single 
isomer and in more than 400 mg in one batch. 
 
Scheme 2.19. Installation of the (Z)-enyne. Reagents and conditions: (a) PPh3CH2I2, NaHMDS, THF/HMPA (19:1), –78 °C, 
97%, Z/E > 20:1; (b) 1-propynyllithium, B(OMe)3, [Pd(dppf)Cl2]·CH2Cl2 (15 mol%), THF, 65 °C, 86%.  
To complete the synthesis of the southern domain, the primary TBS-ether was selectively cleaved in 
the presence of the allylic and homoallylic secondary TBS-ethers using a large excess of HF·pyridine 
buffered with additional pyridine by following a procedure by Curran et al. (Scheme 2.20).[153]  
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Scheme 2.20. Completion of the synthesis of acid 60. Reagents and conditions: (a) HF·pyridine, pyridine, THF, rt, 85%; 
(b) TPAP (10 mol%), NMO·H2O, MeCN, rt, 83%.  
The primary alcohol 85 was then oxidized to the carboxylic acid 60 using TPAP in combination with 
NMO monohydrate in acetonitrile.[154] Attempts to isolate the carboxylic acid by means of acid/base 
extraction or by column chromatography with small amounts of acetic acid (1-5%) met with failure: 
significant epimerization at the α-stereogenic center was observed. The latter could be circumvented 
by a work-up with pH 5 phosphate buffer and subsequent purification by flash chromatography with 
hexanes/ethyl acetate. With all transformations optimized, the southern fragment 60 was obtained 
in 15 linear steps, the preferable storage point being the more stable protected alcohol 83. 
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2.4.5 Synthesis of the Sidechain 18 
Remark: All experiments in this section were carried out in collaboration with Dr. Jakub Flasz and 
M. Sc. Marc Heinrich; details can be found elsewhere.
[103,155]
 
The synthesis of the sidechain 18 was accomplished in three steps comprising an alkyne–alkyne 
coupling and an asymmetric 1,4-reduction followed by desilylation. Methyl-2-butynoate (86) was 
regioselectively coupled with TIPS-acetylene (87) under palladium catalysis[156] to yield the known 
enyne 88 (Scheme 2.21).[157] The tertiary stereogenic center was set by asymmetric 1,4-reduction 
using conditions described by Trost et al.[158] The enantiomeric excess, which was determined via 
derivatization of the product 89 to the corresponding benzoate 90 and chiral HPLC analysis thereof, 
was only moderate when using Josiphos as chiral ligand. Fortunately, the ee could be enhanced to 
98% by switching to (S,SFC)-WalPhos. As the sidechain 18 proved highly volatile, the TIPS-protecting 
group was removed using a freshly prepared solution of TBAF in diethyl ether.  
 
Scheme 2.21. Synthesis of the sidechain 18. Reagents and conditions: (a) Pd(OAc)2 (3 mol%), TDMPP (3 mol%), toluene, 
91%; (b) Cu(OAc)2 (5 mol%), (S,SFC)-WalPhos (5 mol%), Me(EtO)2SiH,  toluene/t-BuOH, 4 °C, 79%, 98% ee; (c) TBAF, Et2O, 
81%; (d) LiAlH4, THF, 0 °C, 82%; (e) pyridine, BzCl, CH2Cl2, 0 °C, 80%. 
Since 18 was planned to be deployed later in the synthesis, the material was stored at the protected 
stage 89 and the synthesis of the macrocycle from the northern alcohol and the southern acid 
fragments studied first.  
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2.4.6 Fragment Assembly and Attempted Ring Closure 
With the southern acid fragment 60 and the northern alcohol segment 48 in hand, the stage was set 
for their assembly. Since the stereogenic center at C15 had to be inverted, a Mitsunobu esterification 
was envisioned. Initially, low yields (35-38%) were obtained for the desired product 91 when the 
reaction was carried out in THF.[71c,159] The result could be improved by changing the solvent to 
toluene, providing the requisite RCAM precursor 91 in 79% yield (Scheme 2.22).[160] These conditions 
were also used for the MOM-protected northern fragment 49 affording 93% of ester 92.  
 
Scheme 2.22. Fragment assembly. Reagents and conditions: (a) PPh3, DIAD, toluene, 0 °C, 91 79%, 92 93%. 
Next, the crucial ring closure via RCAM was tackled. Although the molybdenum alkylidyne 
complex C9 endowed with bulky triphenylsilanolate ligands had failed in the model series (see 
Section 2.4.2), this standard catalyst was tested on the real substrates, which carried protecting 
groups on the propargylic alcohol. When ester 91 was subjected to RCAM-conditions, no conversion 
was observed (Table 2.4). Increasing the catalyst loading to 50 mol% and warming the reaction 
mixture to 80 °C or 120 °C resulted in anisol transfer and traces of an acyclic dimer, while no peak 
corresponding to the desired product could be detected by HPLC-MS.  
 
Figure 2.11. Molybdenum catalysts C9, C10, precatalysts C8 and C12, as well as recently developed  
multidentate silanolate ligands L2 and L1. 
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The outcome was independent of whether the neutral catalyst C9 or the ate-complex C10 
(Figure 2.11) was employed. In a previous total synthesis of the similarly complex natural product 
leiodermatolide, the Cummins’ precatalyst C8[66a,66c,67] in combination with CH2Cl2 for in situ 
activation had been identified as the only effective catalyst.[71a] Therefore, 91 was reacted with the 
activated complex at 100 and 130 °C, but only traces of product could be detected with slightly 
increased amounts of open dimer, while the majority of starting material was still unconsumed. 
While these results were in line with the experience gathered from the model studies, the novel two-
component catalyst system also failed to convert enyne-yne 91 to the corresponding cyclic enyne. 
Since the bulky TBS-group on the propargylic alcohol creates severe steric hindrance about the 
reacting site, the less bulky MOM-variant 92 was investigated next. At first sight, the new catalytic 
system seemed to work well, as more than 80% of starting material was consumed within 30 min at 
110 °C and HPLC-MS indicated approx. 55% of the desired macrocycle. Upon isolation however, only 
15% of 93b could be obtained along with 5-10% of the ethyl capped open enyne-yne, while dimer 
formation was hardly observed. 
Table 2.4. Attempted RCAM of 91 and 92.a) 
 
Entry Substrate Cat. (mol%) Conditions 91 93 94 95 
1 91 C9 (50) 5 Å MS, toluene (0.002 M), rt > 90 0 0 traces 
2 91 C9 (50) 5 Å MS, toluene (0.002 M), 120 °C > 90 0 4 traces 
3 91 C10 (50) 5 Å MS, toluene (0.002 M), 120 °C > 90 0 2 traces 
4 91 C8 (50) CH2Cl2, toluene (0.002 M), 130 °C > 90 traces 1 – 
5 91 C12/L2 (20) 5 Å MS, toluene (0.002 M), 110 °C > 80 traces 0 traces 
6 92 C9 (50) 5 Å MS, toluene (0.002 M), 120 °C > 80 0 traces 13 
7 92 C8 (50) CH2Cl2, toluene (0.001 M), 100 °C > 90 3 0 – 
8 92 C12/L2 (40) 5 Å MS, toluene (0.002 M), 110 °C 20 45 0 25 
9 92 C12/L2 (20) 5 Å MS, toluene (0.001 M), 110 °C 25 55 0 10 
10 92 C12/L1 (20) 5 Å MS, toluene (0.001 M), 110 °C 30 45 0 15 
a) Product distribution given as relative conversion monitored by LCMS. 
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This result showed that careful calibration of the HPLC-MS was mandatory to properly monitor the 
reaction and account for polymerization causing weight loss upon filtration (see Section 7.2). 
Conducting the reaction at a fairly large scale allowed taking aliquots every three minutes and 
plotting the product distribution as conversion versus time (Figure 2.12). As it turned out, most of the 
material was polymerizing within minutes, while only trace amounts of product were formed. 
Altering temperature, dilution and catalyst loadings could not prevent the unwanted side reaction 
from occurring.  
 
Figure 2.12. Absolute conversion studied by HPLC-MS after calibration with starting material 92 and product 93b. 
The ratio of cyclic monomer to polymer was found to be 1:5. In order to decrease the extent of 
polymerization, different modifications to the reaction conditions were made. Unfortunately, sealed 
tube experiments to enforce depolymerization as well as employing additives, such as Lewis acids or 
coordinating co-solvents, did not improve the reaction outcome. Increasing the loading of the 
ligand L2 while maintaining the loading of the catalyst C12 shifted the ratio only marginally toward 
product formation (1:4).  
To better understand the mechanism of polymerization, a few control experiments were performed. 
Interestingly, the closed and fairly strained enyne 93b was not opened by the catalyst and seemed to 
be rather stable when re-subjected to the reaction conditions. Furthermore, the activity of the 
catalyst was studied by addition of the benchmark substrate 96 to the mixture after six hours 
reaction time (Scheme 2.23).[92b] The cyclic diester 97 was formed quantitatively, thus the new 
catalytic system seemed to possess improved stability and was not deactivated by substrate or 
products.  
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Scheme 2.23. Catalyst activity study. Reagents and conditions: (a) C12 (20 mol%), L2 (25 mol%), 5 Å MS, toluene 
(0.001 M), 110 °C, 6 h; then 96. Results: 97 quant, 93b 15%, 92 10%, ethyl transfer products and polymer. 
Since all attempts with a MOM-acetal or TBS-ether in the propargylic position basically failed to 
productively close the macrocycle, deprotection of the propargylic alcohol prior to the metathesis 
was anticipated. As recent total syntheses by Fürstner and coworkers had demonstrated, a free 
propargylic alcohol could – in the case of otherwise sterically hindered substrates – even be 
beneficial for the ring closure using catalyst C9 or C12/L2.[70e,77,91b,92b] The MOM-acetal 92 served as a 
starting point to liberate the propargylic alcohol. Since Brønsted acids would endanger the integrity 
of the silyl ethers, a variety of boron based Lewis acids was screened; all the products detected by 
NMR and/or ESI-MS of the crude mixtures are depicted in Scheme 2.24.  
 
Scheme 2.24. Attempted MOM-deprotection. 
Treatment with catecholchloroborane[161] at low temperature led to a complex mixture of products, 
whereas triphenylcarbenium tetrafluoroborate[162] and lithium tetrafluoroborate at ambient 
temperature were unable to convert the starting material. Increasing the temperature to 70 °C 
afforded cleavage of all TBS-ethers leaving the MOM-acetal untouched (99), as lithium 
tetrafluoroborate dissociates to lithium fluoride and boron trifluoride.[163] Freshly prepared 
Me2BBr
[164] at low temperature could not evoke any reaction; adding up to four equivalents of 
reagent led to the cleavage of the primary and the allylic TBS-ether without harming the MOM-
acetal (100). Sequentially adding more equivalents of Me2BBr (10 equiv.) finally triggered MOM-
cleavage, setting free a very polar triol D. These findings point toward complexation of the slim but 
highly Lewis acidic Me2BBr to multiple coordination sites in the molecule. Thus, selective cleavage via 
preferred complexation to the MOM-acetal was impossible. Nevertheless, the isolated triol 101 was 
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subjected to the metathesis conditions using the C12/L2 catalyst system (Scheme 2.25). No 
consumption of starting material was observed, most likely due to the multiple protic sites in this 
particular substrate.  
 
Scheme 2.25. Attempted RCAM of triol 101. Reagents and conditions: (a) C12 (20 mol%), L2 (25 mol%), 5 Å MS, 
toluene (0.001 M), 110 °C. 
As selective MOM-deprotection was to no avail for diyne 92 and cleavage of the MOM-acetal after 
cyclization to 93b was expected to be likewise challenging, the ruthenium-catalyzed trans-
hydrostannylation was tested at this stage. Upon subjecting a small amount of macrocyclic enyne 
93b to the standard conditions with a high ruthenium loading of 200 mol%, no product formation 
was observed (Scheme 2.26). Presumably, the ruthenium engages in unproductive complexation with 
the double and the triple bond, preventing the hydrostannylation reaction from occurring. This result 
highlights the necessity for a free hydroxy group in proximity to the enyne to direct the metal center 
to the triple bond.  
 
Scheme 2.26. Attempted key sequence with MOM-acetal 92. Reagents and conditions: (a) C12 (20 mol%),  
L2 (25 mol%), 5 Å MS, toluene (0.001 M), 110 °C, 15%; (b) C13 (200 mol%), Bu3SnH, CH2Cl2, rt, 2 h. 
An alternative route to the free propargylic alcohol 98 was therefore investigated. Esterification of 59 
was achieved using dichloroacetic anhydride in dichloromethane. The subsequent TES-cleavage using 
TBAF had to be buffered with dichloroacetic acid to avoid saponification or transesterification of the 
dichloroacetate. Silylation and Mitsunobu esterification with carboxylic acid 60 delivered the desired 
ester 105 in acceptable yield. As anticipated, selective saponification of the dichloroacetate in 
presence of the ester could be achieved with one equivalent of lithium hydroxide in  
1,4-dioxane/water at 4 °C, furnishing propargylic alcohol 98 in readiness for RCAM (Scheme 2.27).  
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Scheme 2.27. Synthesis of propargylic alcohol 98. Reagents and conditions: (a) (CHCl2CO)2O, pyridine, CH2Cl2, 0 °C, 79%; 
(b) TBAF, CHCl2CO2H, THF, –30 °C, 97%; (c) TBSCl, imidazole, DMAP (cat.), DMF, 59%; (d) 60, PPh3, DIAD, toluene, 0 °C, 
65%; (e) LiOH, 1,4-dioxane/H2O, 4 °C, 87%. 
Unfortunately, this precursor also failed to cyclize under the metathesis conditions: only traces of 
product could be observed by HPLC while the vast majority of the starting material must have 
formed oligo- and polymers as assumed by the loss of material. The free alcohol seemed to even 
favor these polymerization events, since half of the starting material was consumed within ten 
minutes without formation of meaningful amounts of product. After two hours, less than 10% of 
starting material could be recovered (Scheme 2.28). Although silanolate catalyst C9 had already 
failed in model substrates bearing a free propargylic alcohol (vide supra), compound 98 was also 
exposed to this catalyst. The reaction was repeated at ambient as well as at elevated temperature. In 
both cases, starting material could be recovered almost quantitatively. As a last resort, the 
dichloroacetate 105 was submitted to the C12/L2 catalyst system using the standard conditions. 
After two hours at 110 °C no product formation was observed; mostly starting material could be 
recovered and the free propargylic alcohol 98 was the only other product detected in the reaction 
mixture. This finding is consistent with the diyne model substrates bearing esters in propargylic 
positions, which were likewise destroying the catalyst with the remaining material staying integer. 
 
Scheme 2.28. Attempted RCAM of 105 and 98. Reagents and conditions: (a) LiOH, 1,4-dioxane/H2O, 4 °C, 87%; (b) C12 
(20 mol%), L2 (25 mol%), 5 Å MS, toluene (0.001 M), 110 °C; (c) C9 (20 mol%), 5 Å MS, toluene (0.001 M), 110 °C. 
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After the investigation of four different substrates (91, 92, 105 and 98) using four different catalytic 
systems and various conditions, doubts arose as to whether this substrate type was tolerated at all. 
One might argue that the propargylic alcohol adjacent to a THF-ring as part of a concealed 1,2-diol 
functionality could pose a challenge to the transition metal catalyst. Such a motif could act as a 
chelating ligand and propargylic-homopropargylic diols had not been employed in RCAM reactions so 
far. The RCAM precursors of mandelalide A 109 and amphidinolide F 110 represent the only two 
substrates bearing α-oxygenated THF-subunits in their skeletons; notwithstanding, the respective 
ethers/esters were located on the opposite side of the THF-ring, retaining an unsubstituted 
methylene unit in the propargylic position (Figure 2.13).[71b,73b]  
 
Figure 2.13. RCAM precursors of chagosensine 108, mandelalide A 109 and amphidinolide F 110. 
To test this issue, an additional model system was synthesized. Thus, northern alcohol 49 was 
esterified with 9-undecynoic acid (111) under Mitsunobu conditions, affording diyne 112 in 
unoptimized yield. This time, under the standard RCAM conditions, the expected monocycle 113 was 
isolated in 87% yield after three hours at 110 °C, ruling out that the hidden diol motif was recalcitrant 
(Scheme 2.29).  
 
Scheme 2.29. Synthesis of THF-containing macrocycle 113. Reagents and conditions: (a) 9-undecynoic acid (111), PPh3, 
DIAD, toluene, 0 °C, 54%; (b) C12 (20 mol%), L2 (25 mol%), 5 Å MS, toluene (0.001 M), 110 °C, 87%.  
Combining this observation with the previous results, where modifications were performed centering 
on the propargylic alcohol unit, steric congestion was thought to be the major hurdle. Hence, the 
vicinal bulky TBS-ethers at C6 and C7 were replaced by an acetonide protection. Despite the 
formation of a third five-membered ring in the system, steric bulk in close proximity to the (Z)-enyne 
would be decreased. The synthesis of the southern domain was therefore adjusted as depicted in 
STUDIES TOWARD THE TOTAL SYNTHESIS OF CHAGOSENSINE 71 
   
Scheme 2.30. Acid-catalyzed acetalization was accompanied by TBS-cleavage, which could be 
reduced to 4% by using 5 mol% of p-TsOH.* Subsequent reduction of methyl ester 114 was more 
efficient when LiAlH4 was employed instead of i-Bu2AlH and the Parikh-Doering oxidation translated 
well to the acetonide system giving constantly high yields. The two-step protocol to install the enyne 
moiety was maintained, although the (Z)-selective olefination of the less hindered aldehyde was 
expected to show better selectivity. Finishing the sequence in analogy to the previous route, 
carboxylic acid 118 was delivered uneventfully.  
 
Scheme 2.30. Synthesis of southern acid 118. Reagents and conditions: (a) 2,2-dimethoxypropane, p-TsOH·H2O (5 mol%), 
114 88%, 115 4%; (b) LiAlH4, THF, 0 °C to rt, 95%; (c) SO3·pyridine, DMSO, i-Pr2NEt, CH2Cl2, –25 °C; (d) PPh3CH2I2, NaHMDS, 
HMPA, THF, 67% over two steps, Z/E > 20:1; (e) 1-propynyllithium, B(OMe)3, [Pd(dppf)Cl2]·CH2Cl2 (10 mol%), THF, 65 °C, 
82%; (f) HF·pyridine, pyridine, THF, rt, 90%; (g) TPAP (10 mol%), NMO·H2O, MeCN, rt, 75%.  
In order to provide a compatible northern fragment, diol 119 was mono-protected as a trityl-
ether 120. Mitsunobu esterification preceded TBS-deprotection that furnished ester 121 in readiness 
for ring closure. Once again, all suitable RCAM-catalysts (Figure 2.11) were screened providing similar 
results. C9 and C10 were unable to convert the starting material, whereas C12/L2 led to rapid 
polymerization. The latter was occurring even faster than for propargylic alcohol 98, since for this 
particular substrate 85% of starting material was consumed within ten minutes while only traces of 
product were detected (Scheme 2.31). The free propargylic alcohol presumably forms a hydrogen 
bond to the neighboring THF rendering the propargylic oxygen more Lewis basic. It was thus 
speculated, that stronger binding to the Lewis acidic molybdenum center favors polymerization via 
an associative mechanism[68] with the molybdenum residing at this chelating position. In contrast to 
the slim aliphatic alkylidine catalyst C12, the more bulky aryl-alkylidine catalysts C9 and C10 disfavor 
                                                          
*
NOE studies of the cyclic acetal 114 allowed to draw a more definite conclusion on the stereochemical assignment of the 
anti-diol. Presence and absence of NOE contacts in combination with the indicative coupling constants (Karplus relation)  
J5,6 = 6.7 Hz and J6,7 = 6.8 Hz provide evidence for the depicted configuration (Scheme 2.30).   
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substrate association. Ring strain however, seems to play only an inferior role as no formation of 
closed dimer was observed on any occasion. 
 
Scheme 2.31. Synthesis of RCAM precursor 121. Reagents and conditions: (a) Ph3CCl, Et3N, CH2Cl2, 0 °C to rt, 95%; (b) 118, 
PPh3, DIAD, toluene, 0 °C, 79%; (c) TBAF, THF, –30 °C to rt, 67%; (d) C12 (20 mol%), L2 (25 mol%), 5 Å MS, toluene 
(0.001 M), 110 °C.   
Although inspection of hand-held models suggested that RCAM could be feasible, all attempts had 
basically met with failure. The electronic properties of the triple bonds and their highly oxygenated 
surroundings in combination with the steric demand hampered a productive ring closure. Since the 
oxygenation pattern and high density of functional groups are characteristic traits of the target 
molecule that cannot be omitted, the synthetic strategy had to be re-evaluated. It was clearly 
desirable to relieve potential strain by avoiding enyne intermediates. One possibility to do so would 
be ring closing alkene metathesis (RCM). This approach, which posed the challenge of constructing 
the signature (Z,Z)-chlorodiene moiety prior to fragment assembly and ring closure, was 
comprehensively investigated by M. Sc. Marc Heinrich and will not be discussed within this work.[155] 
The acyclic (Z,Z)-chlorodiene motif could be synthesized, but ring closure via diene-ene metathesis 
was not feasible although numerous catalysts were studied under a variety of reaction conditions.  
2.5 The First Macrolactonization Approach: Hydrostannylation 
2.5.1 Retrosynthetic Analysis 
An alternative strategy with inverted order of events was conceived to avoid highly strained enyne 
macrocycles. Installation of the (Z,Z)-chlorodiene via the hydrostannylation strategy should precede 
ring closure. As a consequence, the latter had to be realized by means of macrolactonization. 
Mapping this strategy onto a more complete retrosynthesis of chagosensine, where the sidechain 18 
was still thought to be installed last, revealed the acyclic enyne G as the key intermediate. Scission of 
the C9–C10 bond in G divided the molecule into a terminal alkyne H and a vinyl iodide I 
(Scheme 2.32). Since fragment assembly was sought to occur via cross coupling, both building blocks 
synthesized for the RCAM approach needed to be modified accordingly.  
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Scheme 2.32. Retrosynthetic analysis of chagosensine; PG = protecting group. 
 
2.5.2 Modification of the Northern Alcohol Fragments 
Remark: The syntheses of the modified alcohol fragments 122 and 123 were established in 
collaboration with postdoctoral researcher Dr. Aurélien Letort.
[165]
  
Two major modifications of the northern sector had to be made: a terminal alkyne was required for 
the cross coupling and the secondary alcohol within the THF-ring needed to be protected 
orthogonally to all other protecting groups to allow selective deprotection prior to 
macrolactonization. To this end, it was planned to perform an asymmetric Carreira alkynylation of 
aldehyde 58 with TMS-acetylene instead of propyne (Scheme 2.33, (a)). Surprisingly, the conditions 
could not be translated onto the TMS-capped alkyne 124, which was obtained in very poor yield 
(< 10%). The titanium-mediated alternative described by Pu and coworkers[166] lacked selectivity, yet 
the mixture of diastereomers was chromatographically separable providing 31% of the desired  
(12R)-alcohol and 29% of the undesired (12S)-alcohol. Interestingly, when switching the chiral ligand 
from (R)- to (S)-BINOL, the desired diastereomer was only slightly disfavored, suggesting that the 
enantiomeric ligand was unable to override the substrate bias. Sole substrate control over the 
addition of lithium TMS-acetylide at low temperature gave a 1:1 mixture of diastereomers, 
highlighting the need for an asymmetric methodology. The best result was obtained with the Trost 
alkynylation[167] using (R,R)-ProPhenol and a threefold excess of dimethyl zinc and TMS-acetylene: 
the desired (12R)-alcohol was favored by 5:1 and isolated in moderate yield.  
 
Scheme 2.33. Asymmetric alkynylation. Reagents and Conditions: (a) TMS-acetylene, Me2Zn, (R,R)-ProPhenol (20 mol%), 
TPPO (40 mol%), toluene, 4 °C, 41%, d.r. 5:1; (b) TMS-propyne, C12 (20 mol%), L2 (25 mol%), toluene (0.01 M), 110 °C, 39%. 
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As an alternative entry to alcohol 124, a cross metathesis between TMS-propyne and methyl-capped 
alkyne 59 was envisioned (Scheme 2.33, (b)). The latter had been obtained in good yield and 
diastereoselectivity before (see Section 2.4.3). Both, the well-defined catalyst C9 and the two-
component catalytic system C12/L2 were capable to deliver 124, however, the yield did not exceed 
40% using a fivefold excess of TMS-propyne.  
As alcohol 124 was difficult to access and multi-step protecting group management would be 
required afterwards, a new protecting group strategy was pursued starting from diol 55. The primary 
alcohol was selectively protected as a trityl-ether prior to Mitsunobu esterification of the remaining 
secondary alcohol with acetic acid (Scheme 2.34).[168] The artifice of directly inverting the stereogenic 
center while protecting the secondary alcohol would later broaden the opportunities for 
macrolactonization. Olefin 125 was dihydroxylated and the resulting glycol immediately cleaved to 
the corresponding aldehyde 126.[165]  
 
Scheme 2.34. New protecting group strategy. Reagents and conditions: (a) Ph3CCl, Et3N, CH2Cl2, 88%;  
(b) AcOH, PPh3, DIAD, toluene, 95%; (c) K2OsO4 (2 mol%), NaIO4, 2,6-lutidine, dioxane/H2O, 92%. 
Next, asymmetric alkynylations of aldehyde 126 were studied in detail with the most meaningful 
results discussed herein. The standard Carreira alkynylation was investigated first, since there was 
literature precedence for acetates remaining untouched under these conditions.[169] In this specific 
case, however, only 10% of a 5:1 diastereomeric mixture was obtained, along with degradation of 
the starting material (Table 2.5, Entry 1). An indium-catalyzed Shibasaki alkynylation[170] led to 
immediate trityl deprotection (Entry 2). The Trost alkynylation conditions afforded a 6:1 mixture of 
isomers in 16% yield (Entry 3). In addition to poor yields, the diastereomers could not be separated 
by column chromatography. Thus, the TMS-acetylene was replaced by the more bulky TIPS-
acetylene. Under the same conditions, the Trost alkynylation gave only up to 30% of a separable 
mixture of diastereomers, accompanied by decomposition of the starting material (Entry 4). The 
absolute stereochemistry at C12 was determined via Mosher ester analysis of the minor 
diastereomer (see Section 4.3.6).[118] Lowering the temperature to –10 °C to ensure a more selective 
addition into the aldehyde over the acetate led to even more degradation. Since decomposition 
products lacking the trityl group were also detected in the Carreira alkynylation (Entry 6), it was 
speculated that the zinc species were damaging the starting material.[165] 
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Table 2.5. Alkynylations of 126. 
 
Entry Alkyne Conditions d.r. (12R)/(12S) a) Yield [%]b) 
1 TMSCCH (–)-NME, Zn(OTf)2, Et3N, toluene, rt 5:1 10 
2 TMSCCH InBr3, (S)-BINOL, Cy2NMe, CH2Cl2, rt – decomposition 
3 TMSCCH (R,R)-ProPhenol, Me2Zn, TPPO, toluene, 4 °C 6:1 16 
4 TIPSCCH (R,R)-ProPhenol, Me2Zn, TPPO, toluene, 4 °C 3:1 30 
5 TIPSCCH (R,R)-ProPhenol, Me2Zn, TPPO, toluene, –10 °C        3:1 6 
6 TIPSCCH (–)-NME, Zn(OTf)2, Et3N, toluene, rt 20:1 11 
7 TIPSCCH i-PrMgCl·LiCl, THF, –78 °C – deacetylation 
8 TIPSCCH n-BuLi, THF, –78 °C 1:2 67 
9 TIPSCCH n-BuLi, Et2O, –78 °C 1.5:1 42 
10 TIPSCCH n-BuLi, Et2O, ClTi(Oi-Pr)3, –78 °C 1:6 34 
11 TIPSCCH n-BuLi, Et2O, CeCl3, –78 °C 1.2:1 53 
12 TIPSCCH n-BuLi, Et2O, LiI, –40 °C 3:1 65 
a) determined by 1H NMR of crude mixture; b) yield of diastereomeric mixture. 
In order to retain the protecting group strategy, a substrate controlled addition into the aldehyde 
was investigated. Initial experiments using the corresponding Grignard species led to deacetylation, 
while Li-alkynylides at low temperature in THF and Et2O gave rise to opposite diastereomers (Entries 
7-9). This phenomenon is frequently observed in reactions involving organometallic compounds, due 
to the stronger coordination of THF as compared to Et2O.
[171] In the present example, THF seems to 
prevent the formation of the 1,2-Cram chelate XII,[172] which would favor the required propargylic 
alcohol (12R)-128 as illustrated in Scheme 2.35. The attack of the acetylide rather goes through a 
Felkin-Anh model of type XIII.[173] Therefore, reactions in Et2O and metal salt additives should 
preferably deliver the desired product. However, addition of ClTi(Oi-Pr)3 or Ti(Oi-Pr)4 was beneficial 
for the formation of (12S)-128 as well (Entry 10), whereas cerium slightly shifted the ratio toward the 
desired isomer (12R)-128 (Entry 11). Based on these findings, it was speculated that the highly 
oxygenated substrate might align in a different fashion, allowing for example the formation of a  
1,6-chelate XIV, which again favors the undesired product. Clearly, other chelates (e.g. involving the 
primary alcohol or even multiple chelations that possibly trigger a ring flip) might also be feasible, 
rendering the situation fairly complicated. As a consequence, lithium salts were added to block the 
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numerous coordination sites. Indeed, the best result was obtained with a fivefold excess of lithium 
iodide shown in Entry 12.[165]  
 
Scheme 2.35. Rationale for the observed diastereoselectivity: XII 1,2-Cram-chelate accounting for (12R)-128; XIII Felkin-
Anh model and XIV 1,6-chelate, both accounting for (12S)-128; nucleophilic attack along a Bürgi-Dunitz trajectory (grey). 
After separation, the undesired alcohol could be converted into the desired isomer by a two-step 
sequence comprised of an oxidation to the ynone followed by a highly selective Noyori transfer 
hydrogenation (Scheme 2.36).[174] Desilylation using TBAF afforded the terminal alkyne 122 in 90% 
yield.[165]  
 
Scheme 2.36. Completion of the northern fragment 122. Reagents and conditions: (a) DMP, NaHCO3, CH2Cl2; (b) (S,S)-
Teth-TsDpen-RuCl (10 mol%), HCO2H·Et3N, CH2Cl2, 80% over two steps, d.r. 12:1; (c) TBAF, AcOH, TBAF, 90%. 
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To provide flexibility for the endgame studies, a second northern alcohol fragment was synthesized 
with a different protecting group on the primary alcohol. Since this protecting group needed to 
survive the majority of steps in the synthesis, yet had to be orthogonal to the protecting groups in 
the southern fragment, two major mutations were made. As it was known from the southern 
fragment that selective deprotection of a primary TBS-ether in the presence of allylic and homoallylic 
TBS-ethers is feasible, the trityl-group in the northern fragment was replaced by a TBS-group. The 
southern domain had to be adjusted to this new strategy to maintain orthogonality between the two 
fragments as will be described in the next section. Diol 55 was mono TBS-protected[175] in 81% yield 
(Scheme 2.37). Subsequent Mitsunobu esterification throve as expected and ozonolysis under 
classical conditions provided aldehyde 130 in 87% yield.[165]  
 
Scheme 2.37. Alternative protecting group strategy. Reagents and conditions: (a) TBSCl, Et3N, DMAP (cat.), CH2Cl2, 81%; 
(b) AcOH, PPh3, DIAD, toluene, 84%; (c) O3, CH2Cl2, –78 °C; PPh3, –78 °C to rt, 87%. 
The use of the more labile TMS-alkyne was clearly advisable for this particular compound, since 
cleavage of the silyl cap in the presence of a primary TBS-ether and an acetate was expected to be 
challenging. Alkynylation under the previously optimized conditions showed basically no selectivity 
and gave low yield. This outcome was remedied by the oxidation/reduction sequence described 
above, providing the desired propargylic alcohol 131 in 19% over three steps (Scheme 2.38). All 
compounds were rather unstable and the ynone intermediate suffered from epimerization at C13, 
with the resulting syn-THF-moiety rapidly decomposing. Subsequent TMS-cleavage turned out to be 
cumbersome, leading to decomposition when silver fluoride was used or partial TBS-cleavage 
accompanied by acetate migration to give 132 when using TBAF at low temperature. 
 
Scheme 2.38. Efforts toward the northern fragment 123. Reagents and conditions: (a) TMSCCH, n-BuLi, Et2O, LiI, –40 °C, 
37%, d.r. 1:1; (b) DMP, NaHCO3, CH2Cl2, 61%; (c) (S,S)-Teth-TsDpen-RuCl (7 mol%), HCO2H·Et3N, CH2Cl2, 83%, d.r. > 20:1. 
An alternative and shorter entry to 123 avoiding the rather difficult desilylation was found in the 
direct alkynylation using acetylene. In analogy to the former results, addition of Grignard-reagent 
mostly led to deacetylation. Attempts to oxidize the alcohol and diastereoselectively reduce the 
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obtained ketone via CBS reduction[176] gave a 1:1 isomeric mixture in poor yield (Scheme 2.39). The 
ynone itself was again unstable and decomposed during column chromatography or upon storage 
and thus prohibited further attempts for selective reduction.  
In order to circumvent these additional steps, a diastereoselective alkynylation with acetylene gas 
was pursued following a procedure by Carreira and coworkers.[177] Under these conditions, 
enolization of the aldehyde proved problematic: along with a small amount of a 2.3:1 diastereomeric 
mixture of the alcohol, which could only be separated by preparative HPLC, significant decomposition 
was observed. The major component of the complex mixture was the dimerized aldehyde 134 
(Scheme 2.39). Overall, this route to the terminal alkyne 123 was inefficient and therefore 
abandoned without further analysis. 
 
Scheme 2.39. Alternative routes toward the northern fragment 123. Reagents and conditions: (a) HCCMgBr, Et2O,  
–20 °C, 18%, d.r. 1:1; (b) (i) DMP, NaHCO3, t-BuOH, CH2Cl2, rt; (ii) (S)-(–)-2-Me-CBS, BH3·THF, THF, EtOH, –40°C,  
123 24% over two steps, d.r. 1:1; (c) acetylene, (–)-NME, Zn(OTf)2, i-Pr2NEt, toluene, –40 °C to rt, 123 19%, 
d.r. 2.3:1; 134 verified by ESI-MS. 
Instead, the bulkier TIPS-variant was investigated (Scheme 2.40). Alkynylation using the lithium 
acetylide translated well onto the primary TBS-ether providing an even higher d.r. than in the case of 
the primary trityl-ether. Nonetheless, the diastereomeric mixture was oxidized to the corresponding 
ynone 135, which was relatively stable in contrast to the TMS-derivative. Reduction to the alcohol 
was achieved with excellent yield and diastereoselectivity. Selective cleavage of the TIPS-group with 
TBAF was difficult, yet the terminal alkyne could finally be obtained in yields ranging between 45% 
and 65%.[165]  
 
Scheme 2.40. Completion of the synthesis of alcohol 123. Reagents and conditions: (a) TIPSCCH, n-BuLi, Et2O, LiI, –40 °C, 
67%, d.r. 5:1; (b) DMP, NaHCO3, t-BuOH, CH2Cl2, 65%; (c) (S,S)-Teth-TsDpen-RuCl (7 mol%), HCO2H·Et3N, CH2Cl2, 96%, 
d.r. > 20:1; (d) TBAF, THF, –35 °C, 61%. 
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Overall, access to the northern fragments 122 and 123 was established with 11 steps in the longest 
linear sequence. The low overall yield of 1-2% pinpoints a severe bottleneck for material supply. A 
more efficient alternative to the required fragment is therefore desirable once the stereochemical 
assignment of chagosensine has been confirmed or corrected. 
2.5.3 Modification of the Southern Sector 
The vinyl iodide intermediate of the previous synthesis of the southern fragment (Section 2.4.4) 
represented a valuable cross coupling partner. Both, the bis-TBS-ether 84 as well as the acetonide 
version 116 could be directly engaged in Sonogashira cross couplings. As a supplement, the primary 
TBS-ether was transformed into the corresponding methyl ester 137 providing a suitable coupling 
partner for alcohol 123. As (Z)-vinyl iodides tend to isomerize and decompose when exposed to light 
or heat the subsequent reactions were performed in the dark.  
Selective cleavage of the primary TBS-ether 84 was again achieved using the HF·pyridine protocol 
(Scheme 2.41). The primary alcohol 136 was obtained in excellent yield and further oxidized to the 
carboxylic acid using TPAP/NMO. TMS-diazomethane effected methylation of the crude carboxylic 
acid,[178] but initially low yields were observed. These findings were attributed to impurities in the 
crude mixture arising from the TPAP/NMO oxidation. Thus, the PIDA/TEMPO oxidation was 
considered due to a more convenient work-up protocol.[179] An acetonitrile/hexanes extraction 
allowed iodobenzene impurities stemming from PIDA to be removed and provided a 
spectroscopically pure carboxylic acid. The respective methyl ester 137 could be obtained in 66% 
yield over two steps. The same sequence was applied to the acetonide-protected vinyl iodide 116 
giving rise to the methyl ester 139 in similarly good yields.  
 
Scheme 2.41. Synthesis of southern iodides 137 and 139. Reagents and conditions: (a) HF·pyridine, pyridine, THF, 136 91%, 
138 98%; (b) PIDA, TEMPO (20 mol%), NaHCO3, MeCN/H2O; (c) TMSCHN2, THF, 0 °C, 137 66%, 139 72% over two steps.   
Overall, the efficient and scalable route to the vinyl iodides 84 and 116 in twelve linear steps was 
extended by a sequence of three steps to provide methyl esters 137 and 139 to increase flexibility in 
the endgame studies discussed in the following section. 
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2.5.4 Fragment Assembly 
The critical assembly phase of the new building blocks commenced with a Sonogashira cross 
coupling.[180] As it turned out, the ostensibly routine cross coupling reaction between trityl-ether 122 
and vinyl iodide 84 suffered from low conversions, thus a screening was necessary. Under standard 
conditions using copper iodide and triethylamine in acetonitrile, Pd(PPh3)4 failed to convert the 
starting materials (Table 2.6, Entry 1),[181] while Pd(PPh3)2Cl2 provided 7% of the desired enyne 140 
along with 31% of the Glaser coupling product 141 (Entry 2).[182] The vinyl iodide 84 could be 
recovered from the reaction mixture in 86%, whereas the northern fragment had mainly 
decomposed. Only a slight improvement was observed by reducing the amount of copper while 
increasing the palladium loading (Entry 3). Replacing acetonitrile with THF as solvent shut the 
reactivity down; both starting materials were recovered (Entry 4). The best results were obtained 
when the reaction was performed in triethylamine as solvent under gentle warming (Entry 5).[183] 
Other Pd(II)-sources, e.g. [Pd(dppf)Cl2]·CH2Cl2, brought no improvement (Entry 6). The yield of the 
desired enyne 140 could be increased to 34% by slow addition of a solution of the rather fragile 
alkyne to the reaction mixture via syringe pump (Entry 7). These conditions were originally used by 
Clark et al. to install a structurally very similar enyne motif in the C18-C34 fragment of 
amphidinolide C in respectable 82% yield.[184] In the present case, however, the northern alkyne was 
still decomposing, preventing an efficient cross coupling. Furthermore, traces of the diyne formed via 
Glaser coupling were detected in all instances, although the solvents were carefully degassed prior to 
use. These observations led to the assumption that degradation products of highly oxygenated 123 
could oxidize the copper(I) species and thus trigger homocoupling of any remaining alkyne. It was 
therefore advisable to investigate a copper-free cross coupling by employing (allylPdCl)2 and  
tri-t-butylphosphine in acetonitrile with DABCO as base.[185] Unfortunately, no improvement was 
recorded as the desired product was isolated in only 19% yield (Entry 8).  
Since Suzuki coupling had been successful for the construction of the methyl-capped enyne in the 
previous synthetic strategy (see Section 2.4.4), fragment assembly was attempted with slightly 
modified conditions. The terminal alkyne 122 was treated with excess n-BuLi and the lithiated species 
transmetalated to boron before it was subjected to the palladium-catalyzed coupling event with 84 
(Entry 9). However, no product was detected and once again the southern fragment was recovered 
while the northern sector had mainly decomposed. The latter is probably due to the borate ester 
formed at the propargylic alcohol. Therefore, the corresponding TMS-ether was prepared and the 
Suzuki coupling repeated with equimolar amounts of lithium base and borate. The desired product 
was still not formed and the northern alcohol was decomposed, despite protection.  
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Table 2.6. Cross coupling reactions.  
 
Entry Conditions Solvent Result Yield [%] 
1 Pd(PPh3)4 (5 mol%), CuI (20 mol%), Et3N MeCN no reaction – 
2 Pd(PPh3)2Cl2 (5 mol%), CuI (20 mol%), Et3N MeCN 31% 141 7 
3 Pd(PPh3)2Cl2 (10 mol%), CuI (10 mol%), Et3N MeCN 19% 141 10 
4 Pd(PPh3)2Cl2 (10 mol%), CuI (10 mol%), Et3N THF no reaction – 
5 Pd(PPh3)2Cl2 (10 mol%), CuI (15 mol%), 55 °C Et3N traces of 141 28 
6 [Pd(dppf)Cl2]·CH2Cl2 (10 mol%), CuI (15 mol%), 55 °C Et3N traces of 141 25 
7 Pd(PPh3)2Cl2 (10 mol%), CuI (15 mol%), 55 °C, 2.5 h Et3N traces of 141 34 
8 (allylPdCl)2 (5 mol%), P(t-Bu)3HBF4 (20 mol%), DABCO DMF 84 recovered 19 
9 n-BuLi, B(OMe)3; [Pd(dppf)Cl2]·CH2Cl2 (10 mol%), 65 °C THF 84 recovered – 
 
A second acyclic enyne was synthesized from 123 and 137 to provide an alternative substrate for the 
crucial endgame studies. Using the best reaction conditions found for 140 (see Table 2.6, Entry 7), 
the TBS-analog 142 was also obtained in a maximum yield of 33%. The use of an excess of alkyne did 
not alter the result. Therefore, a highly reactive copper-free catalytic system was envisioned that has 
found application in chemical biology employing 2-amino-4,6-dihydroxypyrimidine L5 or its sodium 
salt as a ligand for palladium.[186] The reaction was performed at 0 °C in DMF without reaching 
completion providing 142 in moderate, but reproducible yield, while the remaining starting materials 
could be partially recovered (Scheme 2.42). An increase in temperature enhanced the conversion but 
did not improve the yield of 142. 
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Scheme 2.42. Synthesis of enyne 142. Reagents and conditions: (a) Pd(OAc)2 (10 mol%), L5 (20 mol%), Cs2CO3, DMF, 
0 °C, 36% (51% b.r.s.m.).   
An opportunity to overcome the low reactivity might be found by recourse to Stille cross coupling, 
which mandated ‘umpolung’ of the coupling partners. To this end, the terminal alkyne of 123 was 
transformed into iodoalkyne 143 without incident by a silver-catalyzed iodination (Scheme 2.43).[187] 
Next, the southern coupling partner had to be metalated to tin. The more readily available primary 
TBS-ether 84 was the substrate of choice, despite the compatibility issues that one would have to 
face later. A palladium-catalyzed stannylation with Pd2(dba)3 and hexamethylditin in NMP
[188] failed 
to proceed. In contrast, lithium/halogen exchange of 84 with t-BuLi at –78 °C followed by addition of 
tributyltin chloride and warming to ambient temperature[189] afforded a single product. Evaluation of 
the analytical data indicated rearrangement of the C6-OTBS-group, providing the (E)-configured vinyl 
silane 145. Although the desired product had not been formed, the mono-protected diol was isolated 
to verify the absolute configuration of the C6-alcohol by Mosher ester analysis (see Section 4.3.7).[118] 
The decisive factor is that steric bulk seems to be a major drawback in the design of the southern 
domain. However, the acetonide-containing southern fragment was not contemplated as an 
alternative at this stage, since consecutive hydroelementations of the respective enyne would most 
likely lack regioselectivity (see Section 2.4.2).  
 
Scheme 2.43. Anticipated ‘inverted’ cross coupling. Reagents and conditions: (a) AgNO3, NCS, DMF, rt, 83%; (b) t-BuLi, 
Bu3SnCl, THF, –78 °C to rt, 145 61%.   
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In parallel, an alternative entry to the (Z)-enyne bypassing the cross coupling was investigated. An 
alkynylation strategy was deemed little promising, taking into account that all previous additions of 
metal acetylides into aldehydes had been rather unsuccessful. Nonetheless, a few experiments were 
sampled with the bis-TES-protected northern fragment 58. At first, construction of the terminal 
enyne starting from vinyl iodide 84 had to be mastered. Adopting the conditions of the previously 
successful Suzuki coupling utilizing sodium acetylide furnished 147 (Scheme 2.44, a)). Opting for a 
Carreira alkynylation,[190] which had shown the best diastereoselectivities in all alkynylations so far, 
led to a complex mixture. After re-isolation of enyne 147, a substrate-controlled addition of the 
derived lithium acetylide was pursued delivering the product as a 3:1 mixture of C12-epimers. 
Determination of the absolute configuration at C12 was postponed. Nevertheless, the epimeric 
mixture of 148 served well as an additional substrate for hydroelementation reactions.  
  
Scheme 2.44. Different approaches to enyne 148. Reagents and conditions: (a) 1-ethynylsodium, B(OMe)3, 
[Pd(dppf)Cl2]·CH2Cl2 (15 mol%), 65 °C, 62%; (b) n-BuLi, 58, THF, –78 °C, 42% (3:1 C12-epimeric mixture);  
(c) 5 Å MS, C12 (20 mol%), L2 (22 mol%), toluene (0.01 M), 110 °C. 
Last but not least, cross alkyne metathesis between (Z)-83 and 59 represented one more opportunity 
to construct the same acyclic enyne 148 in a stereochemically defined manner by recycling formerly 
synthesized fragments (Scheme 2.44, b)). Despite the known hassles for cross metathesis as 
fragment coupling between two equally valuable alkynes, 83 and 59 were exposed to C12/L2. 
Unfortunately, neither forcing conditions nor excess of the propargylic alcohol 59 could induce 
product formation.  
In summary, construction of the acyclic (Z)-enyne motif by cross coupling or alkynylation has proven 
unexpectedly challenging. Nevertheless, three different substrates 140, 142 and 148 were obtained 
in sufficient quantities to test the subsequent trans-hydroelementation reaction. Optimization to 
provide larger quantities of these advanced intermediates was postponed to a later stage. First, the 
key transformation to install the conspicuous (Z,Z)-chlorodiene had to be reduced to practice.  
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2.5.5 Hydrometalations 
As discussed in Section 2.4.2, enynes undergo hydrometalations to the corresponding functionalized 
dienes; yet, the reaction is significantly slower than that of isolated alkynes. Thus, the optimized 
conditions from the model studies were adopted for the following series of substrates toward 
chagosensine. First, the acyclic enyne 140 was exposed to the neutral ruthenium catalyst C13 at 
ambient temperature. Usually, a color change to deep purple is indicative for π-complex formation 
upon deaggregation of the tetrameric C13 by the alkyne. This conspicuous coloration was also 
observed in the case of the unadorned model enynes but failed to appear here. A stock solution of 
tributyltin hydride was added over the course of 90 minutes, but no conversion of the starting 
material was observed (Scheme 2.45). This result could not be changed by an inverse addition mode, 
namely adding a solution of starting material and tributyltin hydride to a solution of the catalyst.  
 
Scheme 2.45. Attempted trans-hydrostannylation of 140. Reagents and conditions: (a) C13 (20 mol%) or C17 (20 mol%), 
Bu3SnH, CH2Cl2. 
As ruthenium catalysts are known to exhibit a strong affinity to aromatic π-systems,[191] limitations of 
this methodology had been observed for substrates bearing such moieties. Solely electron-deficient 
arenes had been tolerated before and it was speculated that the trityl protecting group was trapping 
the ruthenium catalyst.[75b,76] Therefore, an excess of the ruthenium complex was used, but the 
starting material was still unchanged. Since utilization of the cationic complex C17 could not alter the 
result either, a model substrate based on the northern segment was prepared to reduce the degree 
of complexity (Scheme 2.46). Under the standard conditions using 20 mol% of C13 and maintaining 
the slow addition of tributyltin hydride, 150 was fully consumed. The only isolated product was the 
α/trans alkenylstannane 151, which was obtained in low yield. 
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Scheme 2.46. Model substrate for trans-hydrostannylation. Reagents and conditions: (a) AcOH, PPh3, DIAD, toluene, 
82%; (b) TBAF, THF, 0 °C, 83%; (c) C13 (20 mol%), Bu3SnH, CH2Cl2, 37%. 
For simple methyl-capped alkynes a redox-isomerization could be imagined as a side reaction.[192] 
However, no indication for such a product was found in the crude proton NMR, which was 
surprisingly clean. It was concluded, that byproducts formed in the reaction bind tightly to the 
ruthenium and were presumably removed together with the catalyst by filtration over a short pad of 
silica. Since the trityl-group was believed to contribute primarily to such complexation, another test 
substrate was subjected to the hydrostannylation conditions lacking any aromatic moiety. 
Propargylic alcohol 59 (see Section 2.4.3) was identified as a suitable model. Initial experiments 
proved the assumption wrong, as the results obtained from this exercise showed that the two test 
substrates behaved similar: despite complete conversion, the yield was only moderate in both cases. 
Nevertheless, a clear preference for the desired α- over the β-isomer was observed (r.r. 97:3) with 
only the trans-products being detectable.  
Table 2.7. Hydrostannylation reactions of model alkyne 59. 
 
Entry R Conditions Time Resulta) Yield [%]b) 
1 Bu C13 (20 mol%), 0.2 M, rt 90 min α/β 97:3 43 
2 Bu C13 (20 mol%), 0.2 M, rt 10 min α/β 97:3 49 
3 Buc) C13 (20 mol%), 0.2 M, rt 10 min α/β 97:3 48 
4 Bu C13 (20 mol%), 0.2 M, Sc(OTf)3, rt 10 min complex mixture – 
5 Bu C13 (20 mol%), 0.2 M, CuCl2, rt 10 min complex mixture 6 
6 Bu C13 (20 mol%), 0.2 M, BHT, rt 10 min α/β 97:3 60 
7 Ph AIBN, toluene, 0.2 M, 80 °C 16 h α (trans/cis 65:35) 50 
8 Ph BEt3, air, toluene, 0.2 M, rt 16 h α 68 
9 Me C13 (10 mol%), 6 mM, –50 °C 10 min α (quant.) n.d.d) 
10 Me C17 (10 mol%), 6 mM, –50 °C 10 min α trans/cis 80:20 n.d.d) 
a) determined by 1H NMR of the crude mixture and indicative JSnH herein; 
b) yield of regioisomeric mixture; c) s.m. and R3SnH 
added to catalyst solution; d) NMR experiments, products decomposed upon isolation. 
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Suspecting that the limitation was arising from the THF–propargylic alcohol as a strong chelating 
motif rather than the aromatic moieties, the hydrostannylation of 59 was studied in more detail 
(Table 2.7). Adjusting the addition time as well as changing the order of addition had no impact on 
the reaction outcome (Entries 2 and 3). To perturb the assumed chelation of the oxygen-atoms to 
ruthenium, coordination sites were tentatively saturated by addition of Lewis acids such as Sc(OTf)3 
or CuCl2 (Entries 4 and 5). In both cases, the starting material was instantaneously consumed leading 
to a complex mixture of unidentified products. In order to preclude radical background reactions, 
BHT was added resulting in a cleaner reaction with only desired product and unreacted starting 
material detectable (Entry 6). On the other hand, radical alternatives to the envisaged reaction were 
examined. A thermally initiated hydrostannylation with triphenyltin hydride almost exclusively gave 
the α-isomer as well,[193] yet the yield was in the same range than for the transition metal catalyzed 
reaction and the E/Z selectivity was significantly lower (Entry 7). Milder initiation with BEt3 and air as 
disclosed by Hale and coworkers[194] worked extremely well, delivering 68% of the α/trans-isomer as 
the only detectable product (Entry 8), possibly offering an alternative for the envisioned construction 
of the (Z,Z)-chlorodiene in the natural product.  
Since no other α-THF–propargylic alcohol had not been subjected to trans-hydroelementations in the 
Fürstner group before, NMR studies were conducted to verify the complexation mode of such 
substrates.[195] As depicted in Figure 2.14, the predicted π-complex XV was formed when 59 and 
[Cp*RuCl]4 were mixed in equimolar amounts and cooled to –30 °C in an NMR tube as indicative by 
the sp-carbon shifts and the proton shift of the hydroxy group. Importantly, no contribution from the 
THF-ring was recorded under these conditions, but the π-complex proved unstable above –30 °C, 
where decomposition was observed. Therefore, hydrostannylations were performed at –50 °C; first 
stoichiometric in ruthenium, then catalytic. For these studies trimethyltin hydride was used for the 
sake of clarity in the NMR spectra. The hydrostannylation was found to be a clean transformation, 
yet the product was unstable upon chromatographic purification (Entry 9). Additionally, an 
α/trans:α/cis 4:1 mixture was detected when utilizing the cationic catalyst C17 (Entry 10), and upon 
prolonged reaction time or at elevated reaction temperature isomerization to the cis-isomer 
occurred. The latter turned out to be rather unstable and decomposed rapidly accounting for the 
initially observed low yields.  
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Figure 2.14. Coordination of C13 to alkyne 59: XV observed π-complex, indicative proton shifts (red) and carbon shifts 
(green); XVI alternative π-complex lacking preorganization via intermolecular hydrogen bonding (not observed);  
XVII π-complex as observed for regular protected propargylic alcohols[195]; PG = protecting group. 
In summary, important conclusions can be drawn from these studies: the expected π-complex XV 
between the ruthenium catalyst and the substrate is only stable at low temperature. Thus, the 
stabilizing contribution through intermolecular hydrogen bonding seems to be rather small. 
Nevertheless, hydrostannylations of this π-complex at low temperature lead to the expected α/trans-
products with high conversion and regioselectivity; the products however are not entirely stable. 
Unfortunately, these findings do not allow drawing conclusions for the enyne case, where the 
substrate appeared to be inert. 
Since the trityl group had not been entirely ruled out as troublemaker, hydrostannylations of TBS-
ether 142 were studied next. Catalytic quantities of C13 again failed to induce conversion of the 
starting material. Thus, the reaction was conducted with dropwise addition of two separate stock 
solutions of three equivalents of Ru-complex C13 and one equivalent tin hydride in CH2Cl2 each. The 
experimental challenge notwithstanding, no product formation could be observed and more than 
80% starting material was recovered from the reaction mixture (Scheme 2.47). 
 
Scheme 2.47. Attempted hydrostannylation of 142. Reagents and conditions: (a) C13 (20 or 300 mol%), Bu3SnH, CH2Cl2. 
In order to remove further potentially coordinating functional groups, enyne 148 was projected as a 
more suitable substrate, although it was only available as an undefined C12-epimeric mixture. Using 
the same experimental setup, this intermediate was not inert, but reacted unspecifically 
(Scheme 2.48). Along with starting material, the correct high resolution mass was indeed found in 
the crude mixture, consisting of at least six compounds. However, no evidence for the desired 
product could be provided by NMR spectroscopy. Although lacking coordinating ester functionalities, 
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enyne 148 still bears eight oxygenated sites possibly interfering with metal complexation in an 
unproductive fashion. Thus, this third substrate seemed also unable to meet the criteria to be 
tolerated by the ruthenium complex. 
 
Scheme 2.48. Attempted hydrostannylation of 148. Reagents and conditions: (a) C13 (300 mol%), Bu3SnH, CH2Cl2,  
traces by ESI-HRMS (regio- and diastereoselectivity unknown). 
Overall, hydrostannylation failed to produce the desired intermediates en route to chagosensine for 
reasons that remain unclear. Hence, ruthenium-catalyzed hydrosilylation experiments were 
conducted to gain more insight into the recently developed methodology. In preparative terms, 
hydrosilylation is the more facile reaction compared to hydrostannylation, as catalyst poisoning is 
obviated and slow addition of the silane unnecessary.[75b,100] As a first foray, model propargylic 
alcohol 59 was reacted with BnMe2SiH under otherwise identical conditions. A very clean and fast 
reaction was observed providing the corresponding alkenylsilane 155 in 81% isolated yield 
(Scheme 2.49). Surprisingly, NMR analysis revealed an α/β-ratio of 1:9 as opposed to the 
hydrostannylation.  
 
Scheme 2.49. Hydrosilylation reactions of model alkyne 59. Reagents and conditions: (a) C13 (20 mol%), BnMe2SiH, 
CH2Cl2, 81%, r.r. 9:1; (b) C13 (20 mol%), BnMe2SiH, LiCl, CH2Cl2, 75%, r.r. 9:1. 
The inverted regioselectivity is unexpected and may be explained by different binding modes 
between substrate and ruthenium. To prove this assumption, lithium chloride was added to interfere 
with the coordination, but the regioselectivity remained unchanged. This result is more closely in line 
with the regioselectivity observed for protected alcohols.[76] Hydrosilylations of substrates missing a 
protic neighboring group usually favor β/trans-products as opposed to hydrostannylations, which 
preferably produce α/trans-products (albeit with decreased selectivity compared to hydroxy-directed 
versions). The pre-organization of the σ-complex dictating the regioselectivity is not only 
orchestrated by the substrate itself, but also influenced by the hydride species via interligand 
interactions (Figure 2.15).  
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Figure 2.15. Possible pre-organizations of the ligand sphere of the activated catalyst: XVIII, XIX interligand interactions 
(red) between substrate, ligand and hydroelementation reagent favoring α/trans-products; XX, XXI interligand 
interactions (red) only between ligand and hydroelementation reagent, competing intramolecular hydrogen bonding 
(blue) leading to α/trans-alkenylstannanes and β/trans-alkenylsilanes respectively. • = CMe. 
Refocusing on the enyne substrates, the more robust hydrosilylation was performed as a proof of 
concept. When dimethylbenzylsilane was added to enyne 140 and C13 at ambient temperature, the 
exact product mass could indeed be detected in a complex reaction mixture, from which still more 
than 60% of unreacted starting material was recovered (Scheme 2.50). Furthermore, the TBS-
protected substrate 142 was subjected to the hydrosilylation conditions using catalytic amounts of 
C13. Only traces of product were detected, while most of the starting material remained untouched. 
More portions of catalyst were added, until full conversion was finally achieved with three 
equivalents of C13. The major product of an isomeric mixture with at least three compounds bearing 
the same high resolution mass was characterized as the β/trans product β-157. In this particularly 
complex environment, the hydride arguably seems to be transferred preferentially from the less 
hindered position and hydrogen bonding, if available at all, plays a significantly inferior role.  
 
Scheme 2.50. Attempted hydrosilylations. Reagents and conditions: (a) C13 (300 mol%), BnMe2SiH, CH2Cl2, β-157 25%. 
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In summary, the results discussed above hint toward complexation of the ruthenium catalyst by the 
enyne and/or the numerous coordinating groups displayed within the substrate. Presumably due to 
competitive intramolecular hydrogen bonding with the THF-ring (Scheme 2.51, XXII), hydrogen 
bonding between the hydroxy group and the chloride ligand seems to be too weak to guide the 
ruthenium catalyst to engage in a productive complexation XXIII (Scheme 2.51).[99] Steric bulk is 
supposed to play a minor role, since the slim (Z)-enyne should be accessible in the flexible acyclic 
system from one side or the other, which cannot be validated at this point.  
 
Scheme 2.51. Competitive binding modes between ruthenium complex and enyne substrate. 
Overall, only small energetic differences seem to be policy makers for both reactivity and 
regioselectivity. As deduced from the model studies, the intermolecular hydrogen bond of such  
α-THF–propargylic alcohol motifs to the chloride ligand seems largely unavailable.  
A promising alternative surfaced in the radical hydrostannylation. This methodology has previously 
been applied to advanced intermediates for total syntheses[174c,196] and has the advantage of using 
mild initiation conditions. In addition, it had given the best results for converting the test substrate 
59 to the desired alkenylstannane (see Table 2.7, Entry 8). Thus, enyne 142 was subjected to the 
reported conditions and was cleanly transformed into a single product. Upon analysis, all hopes were 
dashed: the desired α/trans-alkenylstannane had indeed formed, yet the C8–C9 (Z)-double bond had 
been isomerized to the (E)-isomer 158 (Scheme 2.52). Attempts to prevent radical isomerization by 
avoiding excess of the tin hydride species met with failure.[197] Thus far, the thermodynamically more 
stable products were obtained in all literature examples utilizing this method. The challenging  
(Z,Z)-dienylstannane envisioned herein therefore seems inaccessible by this methodology. 
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Scheme 2.52. Radical trans-hydrostannylation. Reagents and conditions: (a) Ph3SnH, BEt3, toluene, air, 58%. 
Since all possible trans-hydroelementations largely remained without success and the preparation of 
the precursors was cumbersome as well, the initial strategy for the formation of the  
(Z,Z)-chlorodiene motif had to be abandoned at this stage. 
2.6 The Second Macrolactonization Approach: Bis-Metalation 
2.6.1 Retrosynthetic Analysis and Strategic Considerations 
After the unfruitful efforts with respect to RCAM or cross coupling followed by trans-
hydrostannylation – eventually dismissing both cornerstones of the original synthesis plan – the 
tactics had to be changed. The major goal was to retain the THF-rings in both fragments, with the 
most prominent retrosynthetic cut lying in the ester functionality between the two THF-rings. In 
analogy to the former approach, macrolactonization as the ring closing manoeuver would still 
precede the installation of the sidechain. Thus, the same advanced (Z,Z)-chlorodiene J needed to be 
elaborated. However, it was planned to avoid any enyne intermediates that had proven difficult to 
construct and to functionalize. While scission of the C9–C10 bond remained the most obvious 
disconnection, the order of steps was inverted compared to the previous blueprint: J was thought to 
be accessed via selective cross coupling between the terminal vinyl metal (or halogen) moiety of the 
northern fragment K and a vinyl iodide (or metal) species L (Scheme 2.53). If the vinyl chloride was 
not in place already prior to coupling, it would be obtained by metal/chloride exchange of the 
remaining vinyl metal species. 
 
Scheme 2.53. Revised retrosynthetic analysis based on cross coupling; PG = protecting group; [M] = metal; X = halide. 
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Despite the increasing number of publications on halo- and bis-metalations of alkynes,[198] there is 
still little precedence for the selective bis-functionalization of terminal aliphatic alkynes bearing 
substituents at the propargylic position. The most tantalizing methodology for the facile construction 
of a chlorodiene is found in a chlorometalation of M to give N followed by sp2-sp2 cross coupling, 
provided that the metal is delivered at the terminal position (Scheme 2.54, (a)).[198c,199] Alternatively, 
a bis-halogenation could also provide the desired vinyl chloride O with a second halide in the 
terminal position as handle for cross coupling reactions with a suitable southern fragment 
(Scheme 2.54, (b)).[200] Since such methods ensuring the required regio- and stereoselectivity were to 
no avail for (protected) propargylic alcohols,[201] an alternative scenario was conceived. A cis-selective 
bis-metalation could give rise to a hetero-bis-metalated alkene P,[202] where one metal can be 
exchanged for chloride (Scheme 2.54, (c) green) while the second metal can engage in cross coupling 
(red). This concept requires excellent regioselectivity and the possibility to discriminate between the 
two metals: the internal metal should undergo facile chloride exchange without harming the second 
metal or – alternatively – stay integer during the cross coupling event of the terminal center and get 
replaced by chloride afterward. Only a few methods allowing for such a selective reaction sequence 
were described in the literature; among them there is no oxygenated propargylic substrate. Thus, a 
forth strategy was contemplated, where bis-metalation would provide a trisubstituted alkene of 
type P ([M1] = [M2]).[203] The terminal and thus sterically less hindered metal center should engage in 
a selective cross coupling and the internal metal could be swapped for chloride in a second step. 
Based on a thorough literature search and a few preliminary studies on simple propargylic 
alcohols,[201] the forth strategy was further investigated. 
 
Scheme 2.54. Concepts for bis-functionalization of terminal alkyne M: (a) chlorometalation to vinyl chloride N; 
(b) chlorohalogenation to vinyl chloride O; (c) hetero-bis-metalation to alkene P (M1 ≠ M2); (d) bis-metalation  
to alkene P (M1 = M2).  
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2.6.2 Bis-Stannylation and Stille Coupling 
As the tin/chloride exchange is well precedented[77,101] and had proven successful for the installation 
of chlorodienes during the model studies performed within this work (see Section 2.4.2), bis-
stannylation was identified as the strategy of choice. However, little evidence was found in the 
literature for the selective cross coupling of 1,2-bis-stannylated alkenes at the outset of this 
study.[204] Therefore, the envisioned strategy was tested on commercially available 1-octin-3-ol (159). 
Following a procedure disclosed by Lautens et al.,[203f] palladium-catalyzed bis-stannylation of the 
alkyne smoothly provided the corresponding cis-bis-stannane 160 in respectable yields as long as the 
sensitive and isomerization-prone products were handled in the dark and silica gel for purification 
was deactivated with triethylamine (Scheme 2.55). The projected selective Stille coupling was then 
tested with commercially available ethyl cis-3-iodoacrylate (161) using a protocol for sensitive 
substrates reported by Fürstner and coworkers.[205] This modified procedure uses copper thiophene-
2-carboxylate (CuTC) in polar solvents to enhance the reaction rate by transmetalating the stannane 
precursor to a more reactive copper analog.[206] In addition, [Ph2PO2][NBu4] acts as a tin scavenger 
rendering the transmetalation irreversible.[207] The overall mild and efficient method has found broad 
application in the synthesis of polyfunctionalized and polyunsaturated compounds,[140b] and also 
succeeded in the present case: the desired dienylstannane 162 was obtained in acceptable yields 
after one hour at ambient temperature.  
 
Scheme 2.55. Bis-stannylation and selective Stille coupling. Reagents and conditions: (a) Pd(t-BuNC)2Cl2 (10 mol%), 
(Bu3Sn)2, THF, 85%; (b) ethyl 3-cis-iodoacrylate (161), Pd(PPh3)4 (20 mol%), CuTC, [Ph2PO2][NBu4], DMF, 59%.  
Encouraged by these results, construction of the proper (Z,Z)-alkenylstannane was pursued. With the 
formerly improved protecting group strategy in mind, bis-stannylation of terminal alkyne 123 was 
performed and the corresponding bis-stannane 163 was isolated in 75% yield. Due to the sensitivity 
of this product, it was prepared only on demand. The crucial cross coupling reaction was then 
addressed with vinyl iodide 137 as counterpart. In the event, no coupling occurred between the bis-
stannane and the vinyl iodide under the previously successful conditions (Table 2.8, Entry 1). Thus, a 
variety of other conditions used in cross couplings between vinyl iodides and vinyl stannanes were 
screened.[160b,208] In most cases, the fragile bis-stannane decomposed; the vinyl iodide could be 
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recovered from the reaction mixture, except when forcing conditions were applied, which caused 
isomerization to the (E)-double bond (Entry 5).  
Table 2.8. Stille couplings between 163 and 137. (a) Pd(t-BuNC)2Cl2 (20 mol%), (Bu3Sn)2, THF, 75%. 
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Entry Conditions Result
a)
 164 [%] 
1 Pd(PPh3)4 (20 mol%), [Bu4N][Ph2PO2], CuTC, DMF, rt 163 consumed 0 
2 Pd(PPh3)2Cl2 (20 mol%), AsPh3, THF, rt no reaction 0 
3 Pd(MeCN)2Cl2 (20 mol%), DMF, rt no reaction 0 
4 Pd(MeCN)2Cl2 (10 mol%), i-Pr2NEt, DMF no reaction 0 
5 Pd(MeCN)2Cl2 (10 mol%), AsPh3, [Bu4N][Ph2PO2], DMF, 65 °C 163 consumed
b) 0 
6 Pd2(dba)3 (20 mol%), AsPh3, DMF, rt 163 consumed 0 
a) determined by TLC analysis and 1H NMR of crude mixture; b) 137 isomerized to (E)-vinyl iodide. 
A control experiment between model bis-stannane 160 and less valuable 84 likewise showed no 
reaction, indicating that the sterically demanding vicinal TBS-ethers presumably interfered with the 
cross coupling (Scheme 2.56). In a recent total synthesis, ring closing Stille coupling between a 
similarly congested (Z)-vinyl iodide flanked by a bis-TES-protected diol was reported to be intricate as 
well; depending on the diol’s stereochemistry, the reaction gave only moderate yield or failed 
completely.[209] Hence, the southern counterpart was replaced by the acetonide 116. Selective Stille 
coupling at the terminal position was feasible in this case, but demetalation of the second tin also 
occurred to a large extent. A one-pot procedure comprising cross coupling followed by tin/chloride 
exchange was envisioned. However, the addition of either NCS or CuCl2 led to a complex reaction 
mixture with no trace of the desired product. 
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Scheme 2.56. Attempted selective Stille couplings. Reagents and conditions: (a) 84, Pd(PPh3)4 (20 mol%), CuTC, 
[Ph2PO2][NBu4], DMF; (b) 116, Pd(PPh3)4 (20 mol%), CuTC, [Ph2PO2][NBu4], DMF, 166/167 (1.2:1) approx. 50%. 
Next, bis-stannane 163 and vinyl iodide 139 were subjected to the Fürstner conditions and the 
desired dienylstannane 168 was formed within less than one hour. In the initial attempt, the product 
was isolated in 44%, but when the reaction was repeated on a slightly larger scale, the 
regioisomer 169 was obtained in 24% yield along with 168 in 40% yield (Scheme 2.57). Although far 
from perfection, this result was promising as Stille couplings with similarly complex substrates had 
shown even worse results than this yet unoptimized process.[160b,209] 
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Scheme 2.57. Stille coupling. Reagents and conditions: (a) Pd(PPh3)4 (40 mol%), CuTC, [Ph2PO2][NBu4], DMF, 
168 40%, 169 24%. 
However, the reaction proved rather capricious: besides the formation of regioisomers proto-
demetalated products were observed from time to time. The latter are expected to arise from 
transmetalation of tin to copper followed by proto-decupration. Since these products were obtained 
using exactly one equivalent of CuTC, it was assumed that CuTC can hardly distinguish between the 
internal and the terminal stannane leading to random transmetalations. While the terminal stannane 
is sterically less hindered, transmetalation of the internal stannane could be facilitated by hydrogen 
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bonding of the neighboring hydroxy group to the thiophene-2-carboxylate. The subsequent cross 
coupling occurs more readily via the cuprate than the stannane, thus purely steric effects might be 
circumstantial. Moreover, hydroxy-directed selective Suzuki cross couplings of diboranes have been 
reported by Morken and coworkers,[210] suggesting that a putative Pd-O interaction might account for 
the formation of 169. Hence, optimization of the conditions for this transformation is required, 
preferably omitting CuTC or protecting the allylic alcohol prior to the coupling process. Nevertheless, 
the material obtained via this route was used to elaborate the dienylstannane into the sophisticated 
macrocycle.    
2.6.3 Efforts Toward the Macrocycle 
Since bis-stannylation and Stille coupling allowed for the first time the isolation of the  
(Z,Z)-dienylstannane 168, the delicate chlorodiene was finally within reach. The use of five 
equivalents of anhydrous copper(II) chloride provided the desired chlorodiene in good yield 
(Scheme 2.58). 2,6-Lutidine was employed as a proton scavenger to avoid intramolecular proto-
demetalation through the neighboring hydroxy group. Subsequently, the allylic alcohol was 
protected as a TBS-ether using TBSOTf and 2,6-lutidine giving rise to 172. A priori, protection of this 
secondary alcohol might not be necessary for the construction of the macrocycle; nevertheless, the 
protected and thus less polar compound was expected to reduce hassle. A short screening was 
required for the concomitant saponification of the acetate and the methyl ester of 172. A first trial 
employing lithium hydroxide in a THF/water mixture at ambient temperature gave substantial 
amounts of the primary alcohol at C17 as a very polar byproduct resulting from TBS-cleavage. 
Interestingly, lowering the temperature to 0 °C showed that cleavage of the methyl ester occurred 
readily, while saponification of the acetate could not be achieved without damaging the primary TBS-
ether. A switch to potassium hydroxide did not improve the outcome. Finally, concurrent 
saponification was accomplished using potassium carbonate in a CH2Cl2/MeOH mixture (6:1) 
affording the secoacid 173 in 79% yield. The solvent ratio was crucial as more methanol led to 
decomposition of the compounds for reasons that remain unclear.  
 
Scheme 2.58. Elaboration to the secoacid. Reagents and conditions: (a) CuCl2, 2,6-lutidine, THF, 70%; (b) TBSOTf,  
2,6-lutidine, CH2Cl2, 83%; (c) K2CO3, CH2Cl2/aq. MeOH 6:1, 79%. 
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The stage was now set for the challenging macrolactonization.[211] In preliminary studies, 
Yamaguchi[181a,212] and Shiina[213] macrolactonizations under different reaction conditions showed no 
promising results.[214] Hence, an Evans-modified Mukaiyama macrolactonization[215] employing  
2-bromo-1-ethylpyridinium tetrafluoroborate (BEP) was performed. At first, the reaction was 
conducted in CH2Cl2, but only very little conversion was detected. Therefore, the mixture was swiftly 
concentrated and the residue diluted with dichloroethane. Stirring of the reaction mixture at reflux 
temperature was beneficial for the cyclization; despite the small scale, isolation and scrupulous 
characterization of macrolactone 174 was achieved (Scheme 2.59). High resolution mass 
spectrometry confirmed the macrocyclic monomer and NMR spectroscopy provided further 
structural information. HMBC correlations specifically between H-15 and C1 unambiguously proved 
the ring closure. Furthermore, transannular NOE contacts between the two THF-rings as well as to 
the diene motif highlight the complex architecture of the macrolactone of chagosensine. As only 
contacts between protons are being measured, it is readily understood that the high density of 
functional groups certainly creates ring strain. In combination with the experiment, where also 
starting material was recovered from the unoptimized reaction, an important conclusion can be 
drawn: the highly decorated macrocycle is only formed under forcing conditions, yet its synthesis is 
feasible following this forth strategy.  
 
Scheme 2.59. Macrolactonization and characterization of the macrocycle 174. Reagents and conditions: (a) R2, NaHCO3, 
(CH2Cl)2 (0.0005 M), 80 °C, approx. 25%; decisive HMBC correlations (red) and NOE contacts (blue). 
2.6.4 Outlook 
After detailed evaluation of four different strategies leaving no stone unturned, a route to this highly 
sophisticated intermediate was finally found. Future work will focus on optimization of the two key 
steps of the endgame, i.e. Stille cross coupling for fragment assembly and macrolactonization for ring 
closure, in order to provide sufficient material for completing the total synthesis of chagosensine. To 
this end, a few unknown steps remain to be investigated (Scheme 2.60). The primary TBS-ether 
98  STUDIES TOWARD THE TOTAL SYNTHESIS OF CHAGOSENSINE 
   
 
needs to be cleaved selectively and the resulting alcohol oxidized to the aldehyde 175. The 
sidechain 18 can then be attached by diastereoselective alkynylation before reducing the triple bond 
via a trans-hydrostannylation/destannylation sequence. Alternatively, the terminal alkyne of the 
sidechain can be converted into a vinyl iodide 177 and a Nozaki-Hiyama-Kishi reaction with 
aldehyde 175 could give rise to the allylic alcohol 178.[216] The configuration of the alcohol at C17 
must be determined by Mosher ester analysis. Cleavage of the allylic TBS-ether would provide a 
derivative 17 synthesized by the isolation team[80] and comparison of the synthetic material with the 
reported compound could already allow to draw conclusions on the structure at this point. Acetonide 
deprotection would finally precede cleavage of the methyl ester to arrive at the natural product in 26 
to 27 steps in the longest linear sequence.  
174
O
Me
H H
O
O
TBSO
O
HH
OTBS
O
Cl
O
175
O
Me
H H
O
O
TBSO
O
HH
O
O
Cl
O
178
O
Me
H H
O
O
TBSO
O
HH
O
Cl
O
OH
Me
17
O
Me
H H
O
O
HO
O
HH
O
Cl
O
OH
Me
O
Me
H H
HO
OH
O
HH
O
Cl
O
OH
Me
CO2Me
CO2Me
176
O
Me
H H
O
O
TBSO
O
HH
O
Cl
O
OH
Me
CO2Me
HO
CO2H
Me
CO2Me
15
Me
CO2Me
I
18 177
deprotection
oxidation
acetonide-
deprotection
saponification
NHKalkynylation
trans-hydrostannyl.
proto-destannyl.&
TBS-deprotection
TBS-deprotection
 
Scheme 2.60. Future work to complete the total synthesis of chagosensine (15).  
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3 Summary and Conclusion 
During the course of this thesis, the catalytic activation of π-systems was explored in two different 
research topics. The first project placed in the field of physical organic chemistry dealt with the 
detailed mechanistic study of a π-acid-catalyzed transformation. The investigated gold(I)-catalyzed 
hydroalkoxylation of allenes showed an impressive enantioinversion solely caused by reaction 
conditions. In the second part of this thesis, a total synthesis program toward chagosensine with an 
emphasis on ring closing alkyne metathesis (RCAM), cross coupling reactions and trans-
hydrometalations addressed the selective functionalization of alkynes. Both projects have led to 
significant progress in methodology development through enhanced mechanistic understanding at 
the molecular level. 
3.1 Enantioinversion in the Gold(I)-catalyzed Hydroalkoxylation of Allenes 
Since the turn of the millennium, homogeneous π-acid catalysis has become an important research 
area.[2] Intensive efforts have advanced the discovery of novel reactivities as well as the development 
of numerous ligands and catalysts.[1] In sharp contrast, asymmetric gold catalysis is still 
underexplored, mainly due to the challenge posed by the intrinsic geometrical properties of this 
noble metal.[4a] The favored linear dicoordination renders chirality transfer from the ligand to the 
substrate in an outer-sphere mechanism exceptionally difficult (Figure 3.1). Only a limited number of 
concepts to overcome this issue have been developed to date. 
 
Figure 3.1. Geometrical constraints to asymmetric gold catalysis. 
In 2010, Fürstner and coworkers reported a new type of phosphoramidites, featuring a TADDOL-
related but acyclic backbone, as one-point binding ligands for asymmetric gold catalysis.[7b] The 
derived complexes, for instance C3, proved successful in various transformations such as 
cycloadditions, enyne cycloisomerizations, indoline syntheses and hydroaminations of allenes.[7c,8] 
During the application to the intramolecular hydroalkoxylation, a striking case of enantioinversion 
was observed: the sense of induction in the cyclization of allenol 1 to tetrahydrofuran 2 could be 
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swapped from (S) to (R) solely by changing either the solvent or the temperature or the escorting 
counterion, while using the very same chiral gold complex C3 (Scheme 3.1).  
 
Scheme 3.1. Gold-catalyzed hydroalkoxylation subject to immense enantioinversion; R = 2-naphthyl. 
The perplexing phenomenon of enantioinversion, in which a single chiral source delivers either 
enantiomer of a given product, is not uncommon.[18d,41,217] However, the understanding of its origins 
at the molecular level is quite limited. Moreover, the present case seemed particularly remarkable, 
since it represents the first reported example in which three different parameters are able to trigger 
a significant switch. Therefore, a detailed mechanistic study was conducted to unravel the underlying 
secrets. 
Thorough screenings of solvent, temperature and counterion indicated that these three parameters 
can also act in synergy providing either antipode of product 2 in meaningful to outstanding optical 
purity: (R)-2 was obtained in 97% ee in EtOH at –60 °C and (S)-2 in 68% ee in EtOAc at 22 °C, both 
using complex (S,S,S,S)-C3 as precatalyst and AgBF4 for its activation. Substrates with different 
substitution pattern and ring size behaved similarly, but showed a less pronounced switch. Thus, 
allenol 1 was used as a model for further mechanistic studies. Control experiments confirmed that 
the ee changed neither with conversion nor on prolonged exposure of the product to the catalyst, 
and that ee of the precatalyst and ee of the product show a linear correlation at both high and low 
temperature. The temperature dependence of the enantioselectivity was further investigated by 
Eyring studies, which allowed the enthalpic and entropic contributions to the differential activation 
free energies to be derived. The findings point toward a remarkable entropic component which was 
analyzed in more detail by means of DFT calculations.[42] 
The major reason for the enantioinversion was found in the existence of two competing pathways: a 
pathway where proto-deauration is rate-determining favors the (S)-product, whereas an alternative 
outlet involving assisted proto-deauration preferably produces the (R)-product.[17] Such assistance 
can be provided either by a protic solvent, a coordinating counterion or a second substrate molecule 
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and accounts for the observed entropic component. In the unassisted pathway, an interconversion 
between the diastereomeric channels accounting for the (S)- and the (R)-product is possible at the 
allyl cation stage INT3. In the assisted pathway, this intermediate is bypassed and facile 
interconversion essentially impossible. A channel crossing between the unassisted and assisted 
pathway is however feasible, since association of a second substrate molecule at the allyl cation 
stage INT3 is energetically accessible. This explains a transition to the assisted pathway at low 
temperature, for which the entropic component to the reaction free energy profile is significantly 
increased and can ultimately dictate the stereochemical course. In summary, the computational 
results, which were also calibrated against NMR spectroscopic data,[44] provide a plausible 
mechanistic scenario and allow rationalizing the experimental observations (Scheme 3.2).[17]  
 
Scheme 3.2. Plausible mechanistic scenario: outer cycle unassisted pathway (grey); inner cycle assisted pathway 
(white); possible interchannel crossing at the allyl cation intermediate (red). 
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This case study represents the first example that explains the unusual effect of enantioinversion at 
the molecular level via a combined experimental and theoretical approach. Although the present 
case is fairly specific, an important lesson can be learned: for the understanding of a multi-step 
mechanism, one has to consider the whole reaction coordinate rather than merely sterics in the 
transition state, where the critical parameter of entropy is often underestimated.  
3.2 Studies Toward the Total Synthesis of Chagosensine 
During the course of this thesis, ring closing alkyne metathesis (RCAM)[65] and postmetathetic trans-
selective hydrometalations[75c] were investigated in the context of a challenging total synthesis 
campaign. The marine polyketide chagosensine (15) was deemed an ideal target for this sequence of 
transformations in order to access the unique (Z,Z)-chlorodiene motif within a highly substituted 
macrocycle.[80] An additional obstacle to this endeavor was posed by the unsecured structure 
assignment of the natural product, whose synthesis had not been tackled before.  
The original synthetic strategy was based on a key sequence comprising RCAM, trans-
hydrostannylation and tin/chloride exchange. A convergent synthesis with late stage fragment 
assembly was designed, which would also provide access to other diastereomers, if necessary. The 
envisioned key sequence should precede the installation of the sidechain 18. Further disconnections 
of the advanced intermediate Q divide the molecule into a northern alcohol B and a southern 
carboxylic acid fragment C as the key building blocks (Scheme 3.3).  
 
Scheme 3.3. Initially proposed retrosynthetic analysis of chagosensine; PG = protecting group. 
The northern alcohol fragment B was prepared from the literature-known anti-diol 50, which can be 
obtained in three steps from commercial acetyl acetone (51).[104,105c] The trans-THF moiety was 
installed via cobalt-catalyzed Mukaiyama aerobic oxidative cyclization.[110] After protection of the 
resulting diol, ozonolysis of the remaining double bond gave rise to aldehyde 58. The methyl-capped 
alkyne was introduced by Carreira alkynylation using propyne.[77] Protecting group manipulations 
provided a library of secondary alcohols in ten steps (Scheme 3.4). 
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Scheme 3.4. Synthesis of the northern alcohol fragment B; PG = protecting group. 
The synthesis of the southern fragment started with the semi-hydrogenation of 2-butyn-1-ol (63) 
followed by Sharpless asymmetric epoxidation.[111,122] After TBS-protection of the primary alcohol, 
regioselective epoxide opening and subsequent Mukaiyama oxidative cyclization afforded trans-THF-
ring 73. A sequence comprising oxidation of the primary alcohol, Still-Gennari olefination and 
Sharpless asymmetric dihydroxylation provided anti-diol 76.[111] Protection of the diol as either TBS-
ethers or cyclic acetal preceded adjustment of the oxidation state and Stork-Zhao olefination to 
produce (Z)-vinyl iodide R. Suzuki coupling[152] gave rise to the corresponding enyne, before cleavage 
of the TBS-ether and oxidation to the carboxylic acid completed the 15-step synthesis of fragment C 
with an overall yield of 6% (Scheme 3.5).  
 
 
Scheme 3.5. Synthesis of the southern fragment C; PG = protecting group. 
The two fragments were assembled by Mitsunobu esterification, setting the stage for the projected 
enyne-yne metathesis of Q, which exhibits oxygen functionalities adjacent to both π-systems. Such 
motifs proved particularly challenging and the latest generation of molybdenum catalysts endowed 
with silanolate ligands such as C9[69b] was found incompetent to induce ring closure on appropriate 
model substrates. This issue has inspired further catalyst development, which was advanced in 
parallel to this work.[96] Key to success was a new catalyst design based on multidentate silanolate 
ligands. Despite lacking a well-defined solid-state structure, precatalyst C12 and ligand L2 could be 
used for alkyne metathesis, efficiently cyclizing model substrates for the chagosensine 
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macrolactone.[92b] However, the novel two-component catalyst system failed in the attempted ring 
closing events of the highly complex enyne-ynes Q (Scheme 3.6). In contrast to the previous catalyst 
generation, the substrates were not unreactive but underwent rapid polymerization. Solely for a 
MOM-protected propargylic alcohol, the macrocyclic monomer could be isolated in 15% yield. 
Screening of other available RCAM catalysts under various reaction conditions did not improve this 
result. Neither switching or removing the protecting group on the propargylic alcohol nor replacing 
the bulky TBS-ethers of the southern diol by an acetonide could assist the cyclization. At this stage, it 
seems likely that the highly strained enyne macrocycle as well as the unusual density of potentially 
coordinating functional groups prevent a productive macrocyclization. 
 
Scheme 3.6. Fragment assembly and attempted RCAM; PG = protecting group. 
Consequently, an alternative strategy was conceived in order to avoid strained intermediates. The 
installation of the (Z,Z)-chlorodiene should precede ring closure, which had to be accomplished by 
macrolactonization.[211] The convergent design of the initial synthetic plan provided flexibility for the 
endgame tactics, largely maintaining the individual building blocks and the late stage introduction of 
the sidechain 18. The acyclic enyne G was planned to be accessed through cross coupling between 
terminal alkyne H and vinyl iodide I (Scheme 3.7).  
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Scheme 3.7. Revised retrosynthetic analysis of chagosensine; PG = protecting group. 
The required modifications at the northern fragment H were achieved starting from trans-THF 55. 
Mono-protection and Mitsunobu esterification of the secondary alcohol with acetic acid followed by 
ozonolysis afforded aldehyde S. Substrate-controlled alkynylation and desilylation provided the 
terminal alkyne H in nine steps (Scheme 3.8, a)). Vinyl iodide R could serve as coupling partner before 
or after elaboration to the methyl ester T by deprotection, oxidation and methylation (Scheme 3.8, 
b)).  
 
Scheme 3.8. Synthesis of a) the modified northern fragment H and b) the southern fragment T; PG = protecting group. 
Subsequent fragment assembly by means of Sonogashira cross coupling was cumbersome, even 
under conditions avoiding copper co-catalysis. Moreover, the obtained acyclic enynes failed to 
succumb to ruthenium-catalyzed trans-hydrostannylations, while hydrosilylations gave rise to the 
undesired regioisomer (Scheme 3.9).  
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Scheme 3.9. Fragment assembly and attempted trans-hydrometalations; PG = protecting group. 
This result can be rationalized based on the numerous potentially coordinating functional groups that 
trap and therefore inactive the ruthenium catalyst. Furthermore, the crucial intermolecular hydrogen 
bonding between the propargylic hydroxy group and the chloride ligand of the ruthenium catalyst 
seems to be unavailable due to competitive intramolecular hydrogen bonding. Thus far, conditions to 
influence the unfavorable setting were only found for α-THF–propargylic alcohols, a structural motif 
frequently displayed in marine macrolides.  
Since both enyne-based approaches to construct the intricate chlorodiene had failed, another route 
was investigated (Scheme 3.10). The chlorodiene should be obtained by tin/chloride exchange prior 
to macrolactonization and installation of the sidechain. Scission of the C9–C10 bond divided the 
crucial acyclic dienylstannane W into bis-stannane Y and southern vinyl iodide I.  
 
Scheme 3.10. Ultimately successful retrosynthetic analysis of chagosensine; PG = protecting group. 
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Palladium-catalyzed bis-stannylation[203f] of 123 followed by a selective Stille cross coupling with 139 
furnished dienylstannane 168. Tin/chloride exchange gave rise to the (Z,Z)-chlorodiene, which was 
elaborated to the secoacid 173 by protection and saponification. Preliminary studies on the 
challenging cyclization provided the desired macrolactone 174 under forcing conditions following the 
Evans-modified Mukaiyama procedure[215] (Scheme 3.11). 
 
Scheme 3.11. Successful route to macrolactone 174. 
This strategy has finally given access to the key macrocyclic (Z,Z)-chlorodiene, which was 
unambiguously characterized by HRMS and NMR spectroscopy. The observation of transannular NOE 
contacts highlights the crowded and strained nature of the 16-membered macrolactone. Future work 
will focus on the optimization and the elaboration of the remaining steps to complete the total 
synthesis, which will ultimately allow for structure validation and preliminary biological testing.  
The synthetic studies toward the challenging macrolide chagosensine have pushed the boundaries of 
two recent methodologies. For both RCAM and ruthenium-catalyzed hydrometalations, new 
substrate classes have been made available through catalyst development or adjustment of reaction 
conditions. During the course of this thesis, however, it was not possible to successfully apply these 
transformations en route to chagosensine. The highly decorated and complex framework found in 
this specific natural product prohibited the use of conventional approaches, such as RCAM, RCM[155] 
and Sonogashira reactions, which all failed despite enormous efforts. Only the design of a route 
employing a bis-metalated northern domain in the cross coupling event for fragment assembly 
followed by macrolactonization resulted in the successful synthesis of the macrocycle of 
chagosensine. The work reported herein has overcome the major obstacles and provides a promising 
perspective for the total synthesis of chagosensine, which seems now within reach. 
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4 Experimental Section 
4.1 General Experimental Methods 
All reactions were carried out under Ar in flame-dried glassware, unless H2O was used as solvent or 
otherwise noted. The following solvents and organic bases were purified by distillation over the 
drying agents indicated and were transferred under Ar: THF, Et2O (Mg/anthracene); hexanes, toluene 
(Na/K); triethylamine, diisopropylamine, diisopropylethylamine, HMPA, DMSO, CH2Cl2, DMA (CaH2); 
MeOH, EtOH, i-PrOH (Mg, stored over 3 Å MS). DMF, 1,4-dioxane, MeCN and pyridine were dried by 
an adsorption solvent purification system based on molecular sieves. All other commercially available 
compounds (ABCR, Acros, Alfa Aesar, Aldrich, Fluka, STREM, TCI) were used as received unless 
otherwise noted. The following compounds were prepared according to the cited protocol by myself 
or within the department of Prof. Fürstner: C9,[69a] C10,[69a] C8,[66a] C12,[68] L1,[92b] L2,[92b] Co(nmp)2,
[110] 
PPh3CH2I2,
[218] Me2BBr,
[219] Pd(PPh3)4,
[220] [Cp*RuCl]4, [RuCl2((S)-BINAP)]2·Et3N,
[106a]  
Pd(t-BuNC)2Cl2.
[221]
  
Thin layer chromatography (TLC) was performed on Macherey-Nagel precoated plates (POLYGRAM® 
SIL/UV254). Detection was achieved under UV light (254 nm) and by staining with acidic  
p-anisaldehyde, acidic cerium-ammonium-molybdenate or basic KMnO4 solutions.  
Flash chromatography was performed with Merck silica gel 60 (40-63 μm pore size) using pre-
distilled or HPLC-grade solvents. In some cases, fine Merck silica gel 60 (15-40 μm pore size) was 
necessary as indicated within the experimental procedures.  
NMR spectra were recorded on Bruker DPX 300, AMX 300, AV 400, AV 500 or AVIII 600 
spectrometers in the solvents indicated. Chemical shifts (δ) are reported in ppm relative to TMS; 
coupling constants (J) are given in Hz. The solvent signals were used as references and the chemical 
shifts converted to the TMS scale (CDCl3: δH ≡ 7.26 ppm, δC ≡ 77.16 ppm; CD2Cl2: δH ≡ 5.32 ppm,  
δC ≡ 53.84 ppm; C6D6: δH ≡ 7.16 ppm, δC ≡ 128.06 ppm). Multiplets are indicated by the following 
abbreviations: s: singlet, d: doublet, t: triplet, q: quartet, quint: quintet, hept: heptet, m: multiplet. 
The abbreviation br indicates a broad signal. 13C spectra were recorded in [1H]-decoupled mode and 
the values of the chemical shifts are rounded to one decimal point. All spectra from 500 MHz and 
600 MHz spectrometers were acquired by the NMR department under the guidance of Dr. 
Christophe Farès at the Max-Planck-Institut für Kohlenforschung.  
IR spectra were recorded on Alpha Platinum ATR (Bruker) at room temperature, wavenumbers (ṽ) 
are given in cm–1. 
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Mass spectrometric samples were measured by the department for mass spectrometry at the Max-
Planck-Institut für Kohlenforschung using the following devices: MS (EI): Finnigan MAT 8200 (70 eV), 
ESI-MS: Bruker ESQ3000, accurate mass determinations: Bruker APEX III FT-MS (7 T magnet) or MAT 
95 (Finnigan).  
Optical rotations were measured with a Perkin-Elmer model 343 or an A-Krüss Optronic Model 
P8000-t polarimeter at a wavelength of 589 nm. The values are given as specific optical rotation with 
exact temperature, concentration (c/(10 mg/mL)) and solvent.  
Melting points (m.p.) were measured on a Büchi Melting Point B-540 and are uncorrected. 
4.2 Enantioinversion in the Gold(I)-catalyzed Hydroalkoxylation of Allenes 
The catalysts were prepared as previously reported by our group;[7b,7c,8] the preparation of  
(S,S,S,S)-C5 and (S,S,S,S)-C6 is described below: 
Pre-activated catalyst (S,S,S,S)-C5. Silver tosylate (7.6 mg, 27 μmol) was added to a solution of gold 
catalyst (S,S,S,S)-C3 (31 mg, 27 μmol) in anhydrous CH2Cl2 (0.3 mL) at room 
temperature. The resulting pale yellow solution was stirred at ambient 
temperature for 15 min, then filtered over a pad of Celite® eluting with 
CH2Cl2 (10 mL). The solvent was removed under reduced pressure affording 
the catalyst as an amorphous yellow solid (34 mg, 98%). 1H NMR (400 MHz, 
CD2Cl2): δ = 8.47 (s, 1H), 8.28 (s, 1H), 8.01 (s, 1H), 7.97–7.73 (m, 14H),  
7.73–7.64 (m, 4H), 7.58–7.45 (m, 12H), 7.44–7.34 (m, 2H), 7.21–7.15 (m, 
3H), 7.03–6.93 (m, 4H), 5.65 (d, J = 7.3 Hz, 1H), 5.18–5.06 (m, 2H), 4.87 (d, J = 7.3 Hz, 1H), 3.39 (s, 3H), 
2.55 (s, 3H), 2.37 (s, 3H), 1.91 ppm (d, J = 7.1 Hz, 6H). 31P NMR (162 MHz, CD2Cl2): δ = 95.8 ppm.
† 
Pre-activated catalyst (S,S,S,S)-C6. To a solution of gold catalyst (S,S,S,S)-C3 (31 mg, 27 μmol) in 
anhydrous CH2Cl2 (0.3 mL) at room temperature was added silver tosylate 
(10 mg, 27 μmol). The resulting pale yellow solution was stirred at ambient 
temperature for 15 min, then filtered over a pad of Celite® eluting with 
CH2Cl2 (10 mL). The solvent was removed under reduced pressure affording 
the catalyst as an amorphous yellow solid (35 mg, 92%). 1H NMR (400 MHz, 
CD2Cl2): δ = 8.26 (s, 1H), 8.09 (s, 1H), 7.94–7.73 (m, 14H), 7.59–7.39 (m, 12H), 
7.18–7.13 (m, 2H), 7.13–7.03 (m, 8H), 5.44 (d, J = 6.8 Hz, 1H),  
5.20–5.08 (m, 2H), 5.05 (d, J = 6.7 Hz, 1H), 3.50 (s, 3H), 2.59 (s, 3H), 1.92 ppm (d, J = 7.1 Hz, 6H).  
31P NMR (162 MHz, CD2Cl2): δ = 103.8 ppm.
† 
                                                          
† For comparison: 31P NMR of (S,S,S,S)-C3 (162 MHz, CD2Cl2): δ = 113.8 ppm. 
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All substrates were prepared by a three-step protocol starting from commercial 5-methyl-3,4-
hexadien-1-ol or literature-known 4-cyclo-hexylidenebut-3-en-1-ol,[222] 3-cyclohexylidene-prop-2-en-
1-ol[223] or 4-methylpenta-2,3-dien-1-ol[224] (Scheme 4.1). 
 
Scheme 4.1 Preparation of the hydroxy-allene substrates. 
4-Methylpenta-2,3-dien-1-yl benzoate (S1). Pyridine (1.00 mL, 12.2. mmol) and DMAP (125 mg, 
1.02 mmol, 10 mol%) were added to a solution of 4-methylpenta-2,3-dien-1-ol (1.00 g, 
10.2 mmol) in CH2Cl2  (10 mL) at 0 °C. Finally, benzoyl chloride (1.78 mL, 15.3 mmol) was 
added dropwise and the resulting yellow suspension was stirred at ambient temperature 
for 15 h. The reaction was quenched with aq. sat. NH4Cl solution (10 mL) and the 
aqueous layer extracted with CH2Cl2 (3 x 15 mL). The combined extracts were washed with HCl (1 M, 
10 mL), NaOH (1 M, 10 mL) and brine (25 mL), dried over Na2SO4, filtered and concentrated. The 
residue was purified by flash chromatography (hexanes/t-butyl methyl ether 50:1) to yield 
benzoate S1 as a pale yellow oil (1.59 g, 77%). 1H NMR (400 MHz, CDCl3): δ = 8.07–8.03 (m, 2H), 7.57–
7.53 (m, 1H),  
7.45–7.42 (m, 2H), 5.22 (tsept, J = 6.4, 2.8 Hz, 1H), 4.76 (d, J = 6.4 Hz, 2H), 1.70 ppm (d, J = 2.8 Hz, 
6H). 13C NMR (100 MHz, CDCl3): δ = 203.5, 166.5, 133.0, 130.6, 129.7, 129.7, 128.6, 128.4, 97.6, 85.0, 
63.8, 20.4 ppm. IR (film): ṽ = 2938, 1715, 1602, 1584, 1451, 1362, 1315, 1268, 1176, 1108, 1068, 
1025, 939, 804, 707, 686, 581, 543 cm–1. MS (EI) m/z (%): 105 (100), 77 (28). HRMS (EI): m/z calcd for 
C13H14O2: 202.0994, found: 202.0992. The analytical and spectroscopic data are in agreement with 
those reported in the literature.[225] 
Allene ester S2. A solution of LiHMDS (1.24 g, 7.42 mmol) in THF (10 mL) was added dropwise over 
15 min to a solution of methyl diphenylacetate (1.68 g, 7.42 mmol) in THF (20 mL) at  
–78 °C and the resulting mixture was stirred at this temperature for 1.5 h. In a second 
flask, Pd(PPh3)4 (214 mg, 0.19 mmol, 5 mol%) was dissolved in THF (5 mL) and a solution 
of allene benzoate S1 (750 mg, 3.71 mmol) in THF (5 mL) was added. The resulting 
mixture was stirred for 30 min at ambient temperature, before it was added to the enolate solution 
at –78 °C via syringe. The mixture was warmed to room temperature and stirred overnight. The 
reaction was quenched with aq. sat. NH4Cl solution (20 mL) and the aqueous layer extracted with  
t-butyl methyl ether (3 x 25 mL). The combined extracts were washed with brine (50 mL), dried over 
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Na2SO4, filtered and concentrated. The residue was purified by flash chromatography (hexanes/ 
t-butyl methyl ether 40:1) to furnish the title compound as a colorless oil (715 mg, 63%). 1H NMR 
(400 MHz, CDCl3): δ = 7.30–7.27 (m, 5H), 7.25–7.20 (m, 5H), 4.72–4.65 (m, 1H), 3.68 (s, 3H), 3.06 (d,  
J = 7.5 Hz, 2H), 1.46 ppm (d, J = 2.8 Hz, 6H). 13C NMR (100 MHz, CDCl3): δ = 203.8, 174.7, 142.5, 129.2, 
127.9, 126.9, 94.6, 84.6, 60.6, 52.6, 39.2, 20.3 ppm. IR (film): ṽ = 2958, 2853, 1730, 1599, 1495, 1446, 
1362, 1275, 1218, 1036, 859, 813, 788, 750, 729, 697, 662, 612, 575, 501 cm–1. MS (EI) m/z (%): 306 
(33), 275 (12), 274 (27), 263 (15), 248 (21), 247 (100), 246 (20), 232 (19), 231 (36), 225 (39), 205 (37), 
203 (10), 197 (44), 166 (15), 165 (52), 157 (11), 105 (26), 91 (25), 77 (12). HRMS (ESIpos): m/z calcd 
for C21H22O2Na: 329.1512, found: 329.1511.   
Hydroxy-allene 1. A solution of ester S2 (840 mg, 2.74 mmol) in Et2O (4 mL) was added dropwise to a 
suspension of LiAlH4 (520 mg, 13.7 mmol) in Et2O (8 mL) at 0 °C. The resulting mixture 
was allowed to warm to ambient temperature and stirred overnight. After cooling to 
0 °C, the reaction was carefully quenched with H2O (0.52 mL) followed by NaOH (10%, 
0.52 mL) and H2O (1.56 mL). The resulting suspension was stirred for 1 h before it was 
filtered through a pad of Celite®, eluting with t-butyl methyl ether (20 mL). The combined filtrates 
were concentrated and the residue purified by flash chromatography (hexanes/t-butyl methyl ether 
19:1) to give alcohol 1 as a colorless oil that solidified upon standing (735 mg, 96%). m.p. [t-butyl 
methyl ether] = 49–50 °C. 1H NMR (400 MHz, CDCl3): δ = 7.35–7.31 (m, 4H), 7.28–7.24 (m, 6H),  
4.68–4.64 (m, 1H), 4.24 (s, 2H), 2.91 (d, J = 7.1, 2H), 1.61 (d, J = 2.5, 6H), 1.43 ppm (brs, 1H). 13C NMR 
(100 MHz, CDCl3): δ = 203.6, 145.3, 128.4, 128.3, 126.4, 94.5, 84.5, 68.4, 52.3, 37.4, 20.5 ppm.  
IR (film): ṽ = 3581, 3475, 3083, 3055, 2974, 2921, 2880, 1971, 1952, 1884, 1807, 1598, 1577, 1493, 
1443, 1377, 1363, 1308, 1227, 1189, 1154, 1121, 1105, 1072, 1035, 1017, 1004, 951, 907, 885, 818, 
771, 755, 732, 691 cm–1. MS (EI) m/z (%): 278 (23), 263 (34), 248 (34), 233 (63), 205 (100), 179 (28), 
178 (32), 165 (31), 157 (24), 115 (41), 103 (25), 91 (61), 83 (34), 77 (22), 69 (80). HRMS (ESIpos): m/z 
calcd for C20H22ONa: 301.1568, found: 301.1570. The analytical and spectroscopic data are in 
agreement with those reported in the literature.[15c,226] 
All other hydroxy-allenes were prepared analogously. Their spectral and analytical data are 
summarized below. 
Hydroxy-allene S3. The crude material was purified by flash chromatography (pentane/t-butyl 
methyl ether 10:1) to give hydroxy-allene S3 (87%) as a colorless oil. 1H NMR (400 MHz, 
CD2Cl2): δ = 4.91 (thept, J = 10.9, 2.8, 1H), 3.41 (d, J = 3.7, 2H), 1.99 (d, J = 8.1, 2H), 1.67 
(d, J = 3.2, 6H), 1.54 (brs, 1H), 1.46–1.42 (m, 5H), 1.36–1.28 ppm (m, 6H). 13C NMR 
(100 MHz, CD2Cl2): δ = 203.3, 94.2, 84.8, 68.9, 38.3, 35.5, 32.5, 26.8, 21.8, 20.7 ppm.  
IR (film): ṽ = 3356, 2977, 2924, 2851, 1972, 1965, 1451, 1403, 1362, 1237, 1214, 1188, 1134, 1112, 
OH
•
Ph
Ph
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1034, 1027, 1008, 975, 923, 894, 847, 829, 805, 704, 655 cm–1. MS (EI) m/z (%): 180 (12), 179 (100), 
95 (13), 85 (11), 83 (11), 81 (16), 69 (89), 67 (21), 55 (14), 41 (20). HRMS (ESIpos): m/z calcd for 
C13H22O: 194.1669, found: 194.1671.  
Hydroxy-allene S4. The crude material was purified by flash chromatography (hexanes/EtOAc 10:1) 
to give the title compound as a white solid (93%). m.p. [EtOAc] = 78–79 °C. 1H NMR 
(400 MHz, CDCl3): δ = 7.32–7.27 (m, 4H), 7.23–7.19 (m, 6H), 4.62 (tt, J = 7.6, 2.1 Hz, 
1H), 4.20 (d, J = 6.7, 2H), 2.88 (d, J = 7.6 Hz, 2H), 1.98–1.95 (m, 4H), 1.54–1.46 (m, 6H), 
1.30 ppm (t, J = 6.7 Hz, 1H). 13C NMR (100 MHz, CDCl3): δ = 200.5, 145.9, 128.6, 128.4, 
126.5, 102.1, 84.5, 68.4, 52.4, 37.8, 31.7, 27.8, 26.5 ppm. IR (film): ṽ = 3558, 3470, 
3059, 3021, 2921, 2880, 2851, 2832, 1963, 1597, 1575, 1494, 1470, 1443, 1323, 1260, 1234, 1104, 
1069, 1045, 1024, 977, 919, 897, 845, 834, 805, 769, 755, 695 cm–1. MS (EI) m/z (%): 288 (20), 287 
(81), 227 (37), 205 (33), 201 (27), 197 (59), 196 (35), 179 (18), 178 (19), 167 (23), 165 (35), 141 (23), 
105 (91), 91 (100), 79 (20), 77 (34), 67 (15). HRMS (ESIpos) m/z calcd for C23H26O: 318.1982, found: 
318.1984. The analytical and spectroscopic data are in agreement with those reported in the 
literature.[227] 
Hydroxy-allene 3. The crude material was purified by filtration through a short plug of SiO2 (t-butyl 
methyl ether) to give the title compound as a colorless oil (99%). 1H NMR (400 MHz, CDCl3): 
δ = 7.33–7.29 (m, 4H), 7.24–7.19 (m, 6H), 4.94–4.89 (m, 1H), 4.16 (brs, 2H),  
2.28–2.23 (m, 2H), 1.75–1.69 (m, 2H), 1.68 (d, J = 2.9 Hz, 6H), 1.17 ppm (brs, 1H). 13C NMR 
(100 MHz, CDCl3): δ = 201.5, 145.6, 128.4, 128.3, 126.5, 95.6, 89.0, 68.5, 52.2, 36.0, 24.5, 
20.9 ppm. IR (film): ṽ = 3553, 3411, 3087, 3057, 3024, 2976, 2930, 2907, 2861, 1970, 1958, 1950, 
1878, 1807, 1598, 1579, 1495, 1444, 1386, 1361, 1232, 1188, 1157, 1039, 1023, 1003, 908, 847, 801, 
755, 697 cm–1. MS (EI) m/z (%): 205 (10), 183 (23), 180 (10), 179 (12), 178 (14), 167 (13), 165 (21), 
158 (14), 157 (15), 143 (14), 105 (21), 98 (100), 91 (38), 81 (16), 79 (24), 77 (15), 41 (14). HRMS 
(ESIpos) m/z calcd for C21H24O: 292.1830, found: 292.1827. The analytical and spectroscopic data are 
in agreement with those reported in the literature.[223] 
Hydroxy-allene S5. The crude material was purified by flash chromatography (pentane/Et2O 5:1) to 
afford the title compound as a colorless oil (79%). 1H NMR (400 MHz, CD2Cl2): δ = 4.99–4.93 
(m, 1H), 3.39 (d, J = 5.8 Hz, 2H), 1.92–1.86 (m, 2H), 1.67 (d, J = 2.9  Hz, 6H), 1.45–1.39 (m, 
8H), 1.31–1.28 (m, 4H), 1.25–1.22 ppm (m, 1H). 13C NMR (100 MHz, CD2Cl2): δ = 201.7, 95.5, 
89.9, 68.4, 37.3, 34.8, 32.8, 26.8, 23.5, 21.9, 20.9 ppm. IR (film): ṽ = 3395, 2924, 2851, 1969, 
1728, 1451, 1375, 1361, 1262, 1230, 1189, 1135, 1044, 1034, 1022, 976, 848, 797, 713 cm–1. MS (EI) 
m/z (%): 121 (19), 98 (100), 96 (19), 95 (35), 93 (16), 82 (31), 81 (31), 79 (29), 67 (53), 55 (22), 41 (26). 
HRMS (ESIpos) m/z calcd for C14H24OH: 209.1903, found: 209.1905. 
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Hydroxy-allene S6. The crude material was purified by flash chromatography (pentane/Et2O 4:1) to 
afford the title compound as a colorless oil (82%). 1H NMR (400 MHz, CD2Cl2): δ = 5.00–4.96 
(m, 1H), 3.39 (s, 2H), 2.14–2.05 (m, 4H), 1.92–1.86 (m, 2H), 1.60–1.50 (m, 6H), 1.45–1.40 (m, 
7H), 1.31–1.29 ppm (m, 5H). 13C NMR (100 MHz, CD2Cl2): δ = 198.3, 103.2, 89.8, 68.6, 37.3, 
34.6, 32.9, 32.2, 28.0, 26.9, 26.6, 23.5, 21.9 ppm. IR (film): ṽ = 3382, 2924, 2851, 2358, 1996, 
1967, 1714, 1446, 1344, 1264, 1238, 1130, 1034, 979, 931, 895, 850, 797, 737, 704 cm–1. MS 
(EI) m/z (%): 248 (31), 205 (71), 187 (20), 167 (20), 166 (100), 109 (36), 108 (37), 107 (27), 97 (16), 96 
(18), 95 (34), 93 (28), 911 (23), 81 (62), 80 (16), 79 (48), 67 (57), 55 (27), 41 (18). HRMS (ESIpos) m/z 
calcd for C17H28O: 248.2141, found: 248.2140. 
 Allene ether 1-OMe. A solution of hydroxy-allene 1 (175 mg, 0.63 mmol) in THF (1 mL) was added 
dropwise to a suspension of NaH (18.1 mg, 0.76 mmol) in THF (1 mL) at 0 °C. The 
mixture was stirred at ambient temperature for 2 h before methyl iodide (78.0 μL, 
1.26 mmol) was introduced at 0 °C. The resulting solution was stirred at ambient 
temperature for another 2 h before it was diluted with t-butyl methyl ether (5 mL) 
and the reaction was quenched with water (5 mL). The aqueous layer was extracted with t-butyl 
methyl ether (3 × 10 mL), and the combined extracts were washed with brine (25 mL), dried over 
Na2SO4, filtered and concentrated. The residue was purified by flash chromatography (hexanes/ 
t-butyl methyl ether 50:1) to afford the title compound as a colorless oil that solidified upon standing 
(128 mg, 70%). m.p. [CHCl3] = 54–55 °C. 
1H NMR (400 MHz, CD2Cl2): δ = 7.29–7.25 (m, 4H), 7.20–7.16 
(m, 6H), 4.64–4.58 (m, 1H), 3.99 (s, 2H), 3.31 (s, 3H), 2.87 (d, J = 7.6 Hz, 2H), 1.57 ppm (d, J = 2.9 Hz, 
6H). 13C NMR (100 MHz, CD2Cl2): δ = 203.9, 146.8, 128.4, 128.2, 126.3, 94.5, 85.0, 78.3, 59.4, 50.9, 
37.7, 20.5 ppm. IR (film): ṽ = 2979, 2879, 2019, 1597, 1496, 1473, 1443, 1360, 1192, 1135, 1110, 
1071, 1029, 985, 940, 795, 775, 754, 739, 698, 629, 615, 571, 504, 423 cm–1. MS (EI) m/z (%): 248 
(20), 247 (100), 245 (14), 212 (11), 211 (74), 210 (33), 205 (23), 201 (14), 180 (11), 179 (41), 178 (37), 
175 (30), 169 (27), 167 (18), 165 (31), 152 (13), 115 (10), 105 (33), 91 (62), 77 (18), 41 (13). HRMS (EI): 
m/z calcd for C21H24O: 292.1827, found: 292.1825. 
Representative Procedure for Gold Catalysis. Preparation of Tetrahydrofuran 2. A mixture 
containing gold(I)-complex (S,S,S,S)-C3 (2.6 mg, 2.0 μmol, 5.5 mol%) and AgBF4 (0.4 mg, 
1.8 μmol, 5.0 mol%) in EtOH (0.2 mL) was stirred for 15 min at ambient temperature 
before it was transferred to a solution of hydroxy-allene 1 (10 mg, 36 μmol) in EtOH (0.2 
mL) at the indicated temperature via a cannula equipped with a PTFE filter (Perfect-
Flow®, 0.45 μm pore size, Ø 13 mm) to retain the precipitates. The resulting solution was stirred until 
TLC showed complete conversion. At this point, the solution was filtered through a plug of silica, the 
filtrate was concentrated and the residue purified by flash chromatography (hexane/t-butyl methyl 
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ether 19:1) to afford the title compound as a colorless oil (9.3 mg, 93%, 97% ee). Reactions 
performed in non-polar solvents were directly submitted to flash chromatography (hexane/t-butyl 
methyl ether 19:1) to yield the title compound. [α]'
( = +146.9 (c = 1.0, CHCl3). 
1H NMR (400 MHz, 
CDCl3): δ = 7.41–7.30 (m, 6H), 7.27–7.22 (m, 4H), 5.32 (dt, J = 8.7, 1.4 Hz, 1H), 4.76 (td, J = 9.2, 5.9 Hz, 
1H), 4.65 (dd, J = 8.7, 1.1 Hz, 1H), 4.20 (d, J = 8.7 Hz, 1H), 2.67 (ddd, J = 12.2, 5.9, 1.1 Hz, 1H), 2.41 (dd, 
J = 12.2, 9.6 Hz, 1H), 1.76 (d, J = 1.3 Hz, 3H), 1.68 ppm (d, J = 1.3 Hz, 3H). 13C NMR (100 MHz, CDCl3):  
δ = 146.4, 146.3, 136.5, 128.5, 128.5, 127.3, 127.3, 126.5, 126.4, 125.9, 77.0, 75.3, 56.5, 45.6, 26.0, 
18.4 ppm. IR (film): ṽ = 3459, 3058, 3026, 2976, 2924, 1784, 1730, 1598, 1579, 1494, 1446, 1378, 
1316, 1275, 1157, 1028, 1001, 972, 912, 868, 841, 754, 731, 697, 660 cm–1. MS (EI) m/z (%): 278 (69), 
263 (38), 248 (46), 233 (70), 205 (100), 180 (21), 179 (35), 178 (29), 165 (41), 157 (31), 116 (23), 115 
(32), 103 (29), 91 (71), 83 (32), 77 (20), 69 (81). HRMS (ESIpos): m/z calcd for C20H22O: 278.1670, 
found: 278.1671. The ee was determined by HPLC (250 mm, Chiralcel IA (IA00CE-LH-028), 5 μm,  
Ø 4.6 mm, n-heptane/2-propanol 98:2, flow rate = 1.0 mL/min 4.0 MPa, 298 K, UV, 220 nm): major 
enantiomer tR = 6.0 min; minor enantiomer tR = 6.9 min.  
The absolute configuration was assigned to be (R) by comparison of the optical rotation of the 
sample ([α]'
( = +146.9 (c = 1.0, CHCl3) (97% ee)) with that of the (S)-enantiomer reported in the 
literature, which had the opposite sign ([α]'
( = –74.9 (c = 0.36, CHCl3) (70% ee)).
[15c,226]  
All other tetrahydrofurans were prepared analogously. Their spectral and analytical data are 
summarized below. 
Tetrahydrofuran 7. Colorless oil (89%, 95% ee). [α]'
( = +6.2 (c = 1.0, CHCl3). 
1H NMR (400 MHz, 
CDCl3): δ = 5.21 (dt, J = 8.5, 1.4 Hz, 1H), 4.59 (td, J = 8.8, 6.6 Hz, 1H), 3.63 (d, J = 8.4 Hz, 
1H), 3.50 (d, J = 8.4 Hz, 1H), 1.88 (dd, J = 12.4, 6.6 Hz, 1H), 1.72 (d, J = 1.4 Hz, 3H), 
1.68 (d, J = 1.3 Hz, 3H), 1.47–1.39 (m, 10H), 1.34 ppm (dd, J = 12.4, 9.0 Hz, 1H). 13C NMR 
(100 MHz, CDCl3): δ = 135.7, 126.6, 78.5, 75.4, 45.6, 44.3, 37.2, 35.8, 26.2, 25.9, 24.2, 
23.8, 18.3 ppm. IR (film): ṽ = 2922, 2851, 1676, 1447, 1376, 1316, 1258, 1106, 1050, 1006, 979, 946, 
891, 866, 849, 820, 668 cm–1. MS (EI) m/z (%): 112 (48), 98 (15), 95 (25), 83 (26), 82 (100), 81 (23), 79 
(28), 69 (20), 67 (62), 55 (22), 41 (36); HRMS (ESIpos): m/z calcd for C13H22O: 194.1669, found: 
194.1671. The ee was determined by HPLC (150 mm, Chiralcel OJ-3R (OJ3RCD-QD007), 3 μm,  
Ø 4.6 mm, acetonitrile/H2O 60:40, flow rate = 0.5 mL/min 10.6 MPa, 288 K, UV, 210 nm): major 
enantiomer tR = 16.6 min; minor enantiomer tR = 17.9 min.  
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Tetrahydrofuran 8. Colorless oil (91%, 94% ee).	[α]'
( = +87.8 (c = 1.0, CHCl3). 
1H NMR (400 MHz, 
CDCl3): δ = 7.35–7.27 (m, 6H), 7.23–7.18 (m, 4H), 5.23 (dt, J = 8.7, 1.2 Hz, 1H), 4.77 (ddd, 
J = 9.7, 8.7, 5.9 Hz, 1H), 4.62 (dd, J = 8.7, 1.1 Hz, 1H), 4.16 (d, J = 8.7 Hz, 1H), 2.62 (ddd,  
J = 12.2, 5.9, 1.1 Hz, 1H), 2.38 (dd, J = 12.2, 9.7 Hz, 1H), 2.18–2.14 (m, 1H), 2.11–2.04 (m, 
3H), 1.58–1.45 ppm (m, 7H). 13C NMR (100 MHz, CDCl3): δ = 146.5, 146.3, 144.2, 128.5, 
128.5, 127.3, 127.3, 126.5, 126.3, 122.7, 77.0, 74.4, 56.6, 46.0, 37.2, 29.4, 28.5, 28.0, 26.8 ppm.  
IR (film): ṽ = 3089, 3058, 3026, 2925, 2853, 1789, 1668, 1598, 1493, 1446, 1324, 1268, 1131, 1051, 
1030, 1001, 970, 933, 909, 863, 756, 730, 697, 658 cm–1. MS (EI) m/z (%): 318 (100), 288 (52), 241 
(24), 206 (26), 205 (62), 197 (46), 194 (29), 193 (22), 180 (48), 179 (38), 178 (29), 167 (65), 165 (44), 
125 (15), 124 (48), 123 (25), 116 (22), 115 (30), 103 (26), 91 (54), 81 (30), 77 (16). HRMS (ESIpos): m/z 
calcd for C23H26O: 318.1980, found: 318.1984. The ee was determined by HPLC (250 mm, Chiralcel IA 
(IA00CE-LH-028), 5 μm, Ø 4.6 mm, n-heptane/2-propanol 98:2, flow rate = 1.0 mL/min 4.0 MPa, 298 
K, UV, 220 nm): major enantiomer tR = 5.9 min; minor enantiomer tR = 6.6 min. 
Tetrahydrofuran 4. Colorless oil (93%, 98% ee). [α]'
( = +6.2 (c = 1.0, CHCl3). 
1H NMR (400 
MHz, CDCl3): δ = 7.45–7.42 (m, 2H), 7.30–7.23 (m, 4H), 7.19–7.16 (m, 4H), 5.15 (dt, J = 8.2, 
1.4 Hz, 1H), 4.64 (dd, J = 12.1, 2.3 Hz, 1H), 4.14 (ddd, J = 10.9, 8.2, 2.5 Hz, 1 H), 3.61 (d, J = 
12.1 Hz, 1H), 2.50–2.45 (m, 2H), 1.70 (s, 6H), 1.53–1.49 (m, 1H), 1.39–1.32 ppm (m, 1H).  
13C NMR (100 MHz, CDCl3): δ = 146.9, 145.9, 136.1, 129.1, 128.4, 128.1, 127.1, 126.4, 
126.0, 125.8, 75.1, 75.0, 45.8, 34.8, 28.4, 25.9, 18.5 ppm. IR (film): ṽ = 3087, 3058, 3023, 2936, 2916, 
2848, 1678, 1598, 1579, 1494, 1445, 1375, 1319, 1243, 1195, 1139, 1090, 1076, 1032, 1011, 972, 
910, 870, 821, 764, 752, 731, 695, 661 cm–1. MS (EI) m/z (%): 214 (12), 201 (14), 194 (11), 181 (16), 
180 (100), 179 (33), 178 (25), 165 (35), 115 (12), 91 (14), 82 (19), 67 (10). HRMS (ESIpos): m/z calcd 
for C21H24O: 292.1828, found: 292.1827. The ee was determined by HPLC (250 mm, Chiralcel IA 
(IA00CE-LH-028), 5 μm, Ø 4.6 mm, n-heptane/2-propanol 98:2, flow rate = 1.0 mL/min 4.0 MPa, 
298 K, UV, 220 nm): major enantiomer tR = 4.2 min; minor enantiomer tR = 4.6 min.  
Tetrahydrofuran 5. Colorless oil (89%, 97% ee). [α]'
( = –14.2 (c = 1.3, CHCl3). 
1H NMR (400 MHz, 
CD2Cl2): δ = 5.15 (d, J = 7.9 Hz, 1H), 3.89 (ddd, J = 10.8, 7.8, 2.6 Hz, 1H), 3.69 (dd, J = 11.3, 
2.6 Hz, 1H), 3.09 (d, J = 11.2 Hz, 1H), 1.76–1.72 (m, 1H), 1.70 (s, 3H), 1.65 (s, 3H), 1.56–1.53 
(m, 1H), 1.49-1.32 (m, 9H), 1.23–1.19 (m, 1H), 1.14–1.11 ppm (m, 2H). 13C NMR (100 MHz, 
CD2Cl2): δ = 134.8, 127.0, 76.6, 75.8, 37.0, 34.5, 32.1, 31.6, 28.2, 27.3, 25.7, 21.9, 21.9, 
18.4 ppm. IR (film): ṽ = 2923, 2848, 2162, 2024, 1736, 1678, 1450, 1375, 1345, 1326, 1270, 
1259, 1222, 1184, 1157, 1129, 1080, 1071, 1054, 1007, 987, 952, 930, 906, 865, 846, 819, 713, 
668 cm–1. MS (EI) m/z (%): 208 (17), 193 (100), 175 (23), 109 (25), 95 (26), 85 (32), 82 (31), 81 (43), 69 
(21), 67 (64), 55 (25), 41 (27). HRMS (ESIpos): m/z calcd for C14H24O: 208.1827, found: 208.1827. The 
O
O
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ee was determined by GC (30 m, BGB-176/SE-52 G/510, 220/80 1/min 150 12/min 220 5min iso/320, 
flow rate 0.50 bar H2: minor enantiomer tR = 62.5 min; major enantiomer tR = 63.1 min). 
Tetrahydrofuran 6. Colorless oil (84%, 99% ee). [α]'
( = –0.8 (c = 1.3, CHCl3). 
1H NMR (400 MHz, 
CD2Cl2): δ = 5.09 (dt, J = 7.9, 1.2 Hz, 1H), 3.93 (ddd, J = 10.8, 7.8, 2.8 Hz, 1H), 3.69 (dd,  
J = 11.2, 2.7 Hz, 1H), 3.08 (d, J = 11.3 Hz, 1H), 2.18–2.12 (m, 2H), 2.09–2.04 (m, 2H), 1.74 
(dq, J = 13.1, 2.9 Hz, 1H), 1.61–1.53 (m, 4H), 1.52–1.29 (m, 12H), 1.26–1.18 (m, 1H), 
1.15–1.10 (m, 2H). 13C NMR (100 MHz, CD2Cl2): δ = 142.6, 123.8, 76.6, 75.1, 37.2, 37.0, 
34.5, 32.1, 31.6, 29.8, 28.7, 28.3, 27.3, 27.1, 21.9, 21.9 ppm. IR (film): ṽ = 3391, 2924, 
2851, 1729, 1449, 1258, 1187, 1157, 1071, 1050, 1011, 952, 905, 866, 846, 802, 736 cm–1. MS (EI) 
m/z (%): 248 (18), 207 (19), 205 (56), 187 (18), 167 (19), 166 (98), 133 (15), 123 (17), 109 (49), 108 
(53), 107 (38), 97 (27), 96 (33), 95 (54), 94 (17), 93 (43), 91 (40), 83 (17), 82 (17), 81 (100), 80 (25), 79 
(79), 77 (28), 68 (20), 67 (97), 57 (22), 55 (47), 53 (18). HRMS (ESI): m/z calcd for C17H28ONa: 
271.2030, found: 271.2032. The ee was determined by HPLC (150 mm, Chiralcel OJ-3R  
(OJ3RCD-QD007), 3 μm, Ø 4.6 mm, Acetonitrile, flow rate = 0.5 mL/min, 3.8 MPa, 298 K, UV, 
210 nm): minor enantiomer tR = 6.7 min; major enantiomer tR = 18.1 min. 
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Search for Any Non-Linear Effects. Each flame-dried finger-Schlenk was loaded with allenol 1 (11 mg, 
40 μmol) in anhydrous CH2Cl2 (0.2 mL) and stirred at the respective temperature. Accurately defined 
mixtures of (S,S,S,S)-C3 and (R,R,R,R)-C3 (total mass 2.25 mg, 2.19 μmol) were activated with AgBF4 
(0.40 mg, 2.05 μmol) in anhydrous CH2Cl2 (0.2 mL) at ambient temperature for 15 min. These 
activated catalyst solutions were transferred into the reaction vessels via cannula equipped with a 
PTFE filter (Perfect-Flow®, 0.45 μm pore size, Ø 13 mm) to retain the precipitates. The resulting 
solutions were stirred at ambient temperature for 45 min or at –60 °C for 16 h. The mixtures were 
submitted to flash chromatography (hexane/t-butyl methyl ether 19:1) and the ee of the products 
determined by HPLC (vide supra). 
Eyring Studies. Eyring studies were performed in both EtOH and CH2Cl2 using the gold precatalyst 
(S,S,S,S)-C3 and AgBF4. Every data point was independently determined three times. For each 
reaction, complex (S,S,S,S)-C3 (1.58 mg, 1.40 μmol, 5.5 mol%) and AgBF4 (0.24 mg, 1.30 μmol, 
5.0 mol%) were dissolved in anhydrous EtOH or CH2Cl2 (0.1 mL) at ambient temperature and the 
resulting mixture was stirred for 15 min. In parallel, a solution of allenol 1 (7.00 mg, 25.1 μmol) in 
anhydrous EtOH or CH2Cl2 (0.15 mL) was placed in a flame-dried finger-Schlenk flask and equilibrated 
at the indicated temperature. The solution of the activated catalyst was then introduced via a 
cannula equipped with a PTFE filter (Perfect-Flow®, 0.45 μm pore size, Ø 13 mm) and the resulting 
mixture was stirred until complete conversion was achieved. In the case of EtOH, the reaction 
mixtures were then quickly filtered through a plug of silica, the filtrate was concentrated and the 
residue submitted to flash chromatography (hexane/t-butyl methyl ether 19:1). For CH2Cl2, the 
reaction mixtures were directly submitted to flash chromatography (hexane/t-butyl methyl 
ether 19:1). The enantiomeric excess of the resulting products was determined by HPLC (vide supra).  
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4.3 Studies Toward the Total Synthesis of Chagosensine 
4.3.1 Model Studies 
4.3.1.1 Synthesis of the Diyne Model Substrates 
 
 
 
 
 
 
 
 
 
 
 
Scheme 4.2 Preparation of the diyne model substrates. 
Dodecan-1,12-dial (20). [Cu(MeCN)4]BF4 (622 mg, 1.98 mmol, 5 mol%), 2,2’-bipyridine (309 mg, 
1.98 mmol, 5 mol%), TEMPO (309 mg, 1.98 mmol, 5 mol%) and N-methyl-imidazole 
(406 mg, 4.94 mmol, 10 mol%) were added sequentially to a solution of dodecan-1,12-diol 
(10.0 g, 49.4 mmol) in CH3CN (50 mL) in an open flask. The resulting dark red mixture was 
vigorously stirred open to air for 72 h, after which time the solution had turned blue. The mixture 
was diluted with CH2Cl2/hexanes 1:1 (250 mL) and filtered through a plug of silica. Removal of the 
solvent under reduced pressure furnished the title compound 20 as a white solid, which was pure 
enough for further use (8.40 g, 86%). m.p. [CHCl3] = 49–51 °C. 
1H NMR (400 MHz, CDCl3): δ = 9.77 (t, 
J = 1.9 Hz, 2H), 2.42 (td, J = 7.3, 1.9 Hz, 4H), 1.63 (quint, J = 7.1 Hz, 4H), 1.29 ppm (brs, 12H). 13C NMR 
(100 MHz, CDCl3): δ = 203.1 (2C), 44.0 (2C), 29.4 (4C), 29.2 (2C), 22.2 ppm (2C). IR (film): ṽ = 2924, 
2853, 1721, 1464, 1391, 723, 521 cm–1. MS (EI) m/z (%): 136 (10), 121 (15), 111 (14), 110 (12), 109 
(10), 107 (13), 98 (34), 97 (21), 96 (21), 95 (100), 94 (23), 93 (17), 85 (12), 84 (20), 83 (29), 82 (41), 81 
(99), 80 (18), 79 (25), 71 (21), 70 (20), 69 (58), 68 (42), 67 (86), 57 (65), 56 (18), 55 (91), 54 (23), 53 
(11), 44 (29), 43 (43), 42 (14), 41 (75), 39 (20), 29 (13). HRMS (CI): m/z calcd for C12H22O2H: 199.1698, 
found: 199.1696. The analytical and spectroscopic data are in agreement with those reported in the 
literature.[228]  
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Octadeca-2,16-diyne-4,15-diol (21). A solution of 1-propynylmagnesium bromide in THF (0.5 M, 
41.9 mL, 20.9 mmol) was added to a solution of dial 20 (1.66 g, 8.37 mmol) in 
THF (15 mL) and the resulting mixture was stirred at ambient temperature for 
5 h. The reaction was quenched with aq. sat. NH4Cl (20 mL) and the aqueous 
layer extracted with t-butyl methyl ether (3 × 30 mL). The combined extracts were washed with brine 
(50 mL), dried over Na2SO4, filtered and concentrated. The residue was purified by flash 
chromatography (hexanes/t-butyl methyl ether 6:1 to 3:1) to afford diol 21 as an amorphous white 
solid (2.10 g, 90%). 1H NMR (400 MHz, CDCl3): δ = 4.25 (tq, J = 6.3, 2.0 Hz, 2H), 1.78 (d, J = 2.1 Hz, 6H), 
1.65 (quint, J = 7.3 Hz, 4H), 1.46–1.37 (m, 4H), 1.22 ppm (brs, 12H). 13C NMR (100 MHz, CDCl3):  
δ = 81.1 (2C), 80.6 (2C), 62.9 (2C), 38.3 (2C), 29.7 (4C), 29.4 (2C), 25.3 (2C), 3.7 ppm (2C). IR (film): 
ṽ = 3364, 2923, 2854, 1453, 1023 cm–1. MS (ESIpos) m/z (%): 301.1 (100 (M+Na)). HRMS (ESIpos): m/z 
calcd for C18H30O2Na: 301.2138, found: 301.2138. 
Silyl ethers 22 and 23. Imidazole (91.7 mg, 1.35 mmol) and DMAP (11.0 mg, 0.09 mmol, 10 mol%) 
were added to a solution of diol 21 (250 mg, 0.90 mmol) in CH2Cl2 (90 mL) at 
0 °C, followed by TESCl (0.15 mL, 0.90 mmol). The resulting mixture was 
stirred at ambient temperature for 16 h. The reaction was quenched with aq. 
sat. NH4Cl solution (40 mL) and the aqueous layer extracted with CH2Cl2 (3 × 40 mL). The combined 
extracts were dried over Na2SO4, filtered and concentrated. The residue was purified by flash 
chromatography (hexanes) to afford the mono-silyl ether 22 (150 mg, 43%) and the bis-silyl ether 23 
(97.3 mg, 21%) as colorless oil each. Analytical data for 22: 1H NMR (400 MHz, CDCl3): δ = 4.35–4.26 
(m, 2H), 1.85 (d, J = 2.1 Hz, 3H), 1.82 (d, J = 2.1 Hz, 3H), 1.68–1.58 (m, 4H), 1.46–1.35 (m, 4H), 
1.27 (brs, 12H), 0.97 (t, J = 7.9 Hz, 9H), 0.64 ppm (qd, J = 7.9, 3.5 Hz, 6H). 13C NMR (100 MHz, CDCl3):  
δ = 81.2, 81.1, 80.6, 79.9, 63.1, 62.9, 39.2, 38.3, 29.7 (4C), 29.5, 29.4, 25.4, 25.3, 7.0 (3C), 4.9 (3C), 
3.7 ppm (2C). IR (film): ṽ = 3360, 2921, 2854, 1459, 1238, 1078, 1004, 726 cm–1. MS (EI) m/z (%): 364 
(14), 363 (46), 323 (15), 243 (16), 184 (17), 183 (100), 171 (11), 161 (12), 159 (11), 147 (23), 145 (13), 
135 (17), 133 (28), 127 (18), 125 (44), 121 (28), 119 (30), 115 (36), 113 (22), 109 (31), 107 (34), 105 
(31), 103 (69), 97 (65), 95 (73), 93 (39), 91 (18), 87 (31), 81 (50), 79 (26), 75(45), 69 (74), 67 (32), 59 
(11), 55 (23), 41 (12). HRMS (ESIpos): m/z calcd for C24H44O2SiNa: 415.3003, found: 415.3002.  
Analytical data for 23:	1H NMR (400 MHz, CDCl3): δ = 4.29 (tq, J = 6.5, 2.1 Hz, 2H), 1.82 (d, J = 2.1 Hz, 
6H), 1.65–1.58 (m, 4H), 1.42–1.36 (m, 4H), 1.26 (brs, 12H), 0.97 (t, J = 7.9 Hz, 
18H), 0.64 (q, J = 7.9 Hz, 6H), 0.63 ppm (q, J = 7.9 Hz, 6H). 13C NMR (100 MHz, 
CDCl3): δ = 81.2 (2C), 79.9 (2C), 63.1 (2C), 39.2 (2C), 29.7 (4C), 29.5 (2C), 25.4 
(2C), 7.0 (6C), 4.9 (6C), 3.7 ppm (2C). IR (film): ṽ = 2922, 2876, 2855, 1460, 1340, 1239, 1084, 1005, 
743 cm–1. MS (EI) m/z (%): 479 (11), 478 (31), 477 (74), 346 (15), 345 (50), 336 (17), 335 (61), 243 
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(24), 217 (38), 205 (30), 203 (10), 190 (11), 189 (54), 184 (17), 183 (100), 177 (10), 161 (22), 159 (12), 
155 (37), 154 (12), 153 (10), 149 (19), 147 (22), 145 (14), 135 (18), 133 (27), 131 (13), 127 (38), 125 
(51), 121 (29), 119 (27), 117 (15), 115 (72), 113 (11), 109 (25), 107 (33), 105 (34), 103 (86), 97 (69), 95 
(50), 93 (32), 91 (59), 90 (10), 89 (10), 87 (66), 83 (13), 81 (41), 79 (23), 77 (16), 75 (46), 69 (18), 67 
(29), 65 (16), 59 (34), 57 (10), 55 (20), 47 (10), 45 (16), 43 (12), 41 (16), 39 (17), 29 (13). HRMS 
(ESIpos): m/z calcd for C30H58O2Si2Na: 529.3868, found: 529.3874.	 
Methoxymethyl acetals 24 and 25. Hünig’s base (0.17 mL, 1.00 mmol) and DMAP (11.0 mg, 
0.09 mmol, 10 mol%) were added to a solution of diol 21 (250 mg, 0.90 mmol) 
in CH2Cl2 (9 mL) at 0 °C, followed by MOMCl (68.2 μL, 0.90 mmol). The 
resulting mixture was stirred at ambient temperature for 16 h. The reaction 
was quenched with aq. sat. NH4Cl solution (8 mL) and the aqueous layer extracted with CH2Cl2 (3 × 10 
mL). The combined extracts were dried over Na2SO4, filtered and concentrated. The residue was 
purified by flash chromatography (hexanes/t-butyl methyl ether 9:1) to afford the mono-MOM-
derivative 24 (119 mg, 41%) and the bis-MOM-protected compound 25 (44.8 mg, 14%) as colorless 
oil each. Analytical data for 24: 1H NMR (400 MHz, CDCl3): δ = 4.94 (d, J = 6.7 Hz, 1H), 4.56 (d, 
J = 6.7 Hz, 1H), 4.29 (dtq, J = 17.3, 6.5, 2.1 Hz, 2H), 3.36 (s, 3H), 1.84 (d, J = 2.1 Hz, 6H), 1.71–1.60 (m, 
4H), 1.47–1.37 (m, 4H), 1.27 ppm (brs, 12H). 13C NMR (100 MHz, CDCl3): δ = 93.9, 81.6, 81.0, 80.7, 
78.0, 66.0, 62.9, 55.7, 38.3, 36.1, 29.7 (4C), 29.5, 29.4, 25.5, 25.3, 3.71, 3.69 ppm. IR (film): ṽ = 3457, 
2922, 2854, 1465, 1343, 1148, 1097, 1033, 921, 723 cm–1. MS (EI) m/z (%): 113 (36), 95 (19), 93 (14), 
85 (16), 83 (12), 81 (18), 79 (11), 69 (41), 68 (17), 67 (17), 55 (16), 53 (11), 45 (100), 41 (10). HRMS 
(ESIpos): m/z calcd for C20H34O3Na: 345.2400, found: 345.2403.  
Analytical data for 25:	1H NMR (400 MHz, CDCl3): δ = 4.95 (d, J = 6.8 Hz, 2H), 4.57 (d, J = 6.6 Hz, 2H), 
4.27 (tq, J = 6.5, 2.1 Hz, 2H), 3.37 (s, 6H), 1.84 (d, J = 2.1 Hz, 6H), 1.74–1.62 (m, 
4H), 1.48–1.39 (m, 4H), 1.28 (brs, 12H). 13C NMR (100 MHz, CDCl3): δ = 94.0 
(2C), 81.7 (2C), 78.0 (2C), 66.0 (2C), 55.7 (2C), 36.2 (2C), 29.71 (2C), 29.69 (2C), 
29.5 (2C), 25.5 (2C), 3.7 ppm (2C). IR (film): ṽ = 2923, 2854, 1466, 1344, 1148, 1097, 1034, 920 cm–1. 
MS (EI) m/z (%): 149 (13), 147 (10), 135 (21), 133 (12), 123 (13), 121 (21), 119 (13), 113 (77), 112 (11), 
111 (11), 109 (18), 108 (13), 107 (26), 105 (13), 98 (20), 96 (11), 95 (35), 94 (16), 93 (31), 91 (13), 85 
(31), 83 (28), 82 (17), 81 (31), 79 (22), 77 (11), 69 (12), 68 (15), 67 (24), 55 (15), 53 (14), 45 (100). 
HRMS (ESIpos): m/z calcd for C22H38O4Na: 389.2662, found: 389.2660.	 
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Acetates 26 and 27. Triethylamine (0.19 mL, 1.35 mmol) and DMAP (11.0 mg, 0.09 mmol, 10 mol%) 
were added to a solution of diol 21 (250 mg, 0.90 mmol) in CH2Cl2 (90 mL) at 
0 °C, followed by acetic anhydride (84.9 μL, 0.90 mmol). The resulting mixture 
was stirred at ambient temperature for 16 h. The reaction was quenched with 
aq. sat. NH4Cl solution (40 mL) and the aqueous layer extracted with CH2Cl2 (3 × 40 mL). The 
combined extracts were dried over Na2SO4, filtered and concentrated. The residue was purified by 
flash chromatography (hexanes/t-butyl methyl ether 10:1) to afford the mono-acetate 26 (209 mg, 
72%) and the bis-acetate 27 (67.0 mg, 21%) as pale yellow oil each. Analytical data for 26: 1H NMR 
(400 MHz, CDCl3): δ = 5.31 (tq, J = 6.6, 2.1 Hz, 1H), 4.32 (tq, J = 6.5, 2.1 Hz, 1H), 2.07 (s, 3H), 1.85 (d,  
J = 2.1 Hz, 3H), 1.84 (d, J = 2.1 Hz, 3H), 1.73–1.61 (m, 4H), 1.46–1.36 (m, 4H), 1.27 ppm (brs, 12H). 
13C NMR (100 MHz, CDCl3): δ = 170.4, 81.8, 81.0, 80.6, 77.0, 64.8, 62.9, 38.3, 35.2, 29.7 (2C), 29.6 
(2C), 29.4, 29.3, 25.3, 25.2, 21.3, 3.8, 3.7 ppm. IR (film): ṽ = 3459, 2923, 2854, 1738, 1371, 1232, 
1019, 957, 722 cm–1. MS (EI) m/z (%): 175 (10), 163 (14), 161 (18), 149 (27), 147 (19), 145 (12), 137 
(11), 136 (15), 135 (37), 133 (19), 131 (11), 129 (26), 126 (15), 125 (12), 123 (23), 122 (15), 121 (34), 
119 (20), 111 (23), 110 (20), 109 (36), 108 (21), 107 (43), 105 (25), 97 (13), 96 (15), 95 (60), 94 (23), 
93 (61), 91 (31), 84 (71), 83 (13), 82 (20), 81 (54), 80 (15), 79 (53), 77 (16), 69 (100), 68 (40), 67 (51), 
66 (17), 55 (30), 43 (64), 41 (21), 39 (14). HRMS (ESIpos): m/z calcd for C20H32O3Na: 343.2244, found: 
343.2242.  
Analytical data for 27:	1H NMR (400 MHz, CDCl3): δ = 5.31 (tq, J = 6.7, 2.1 Hz, 2H), 2.07 (s, 6H), 1.84 (d, 
J = 2.1 Hz, 6H), 1.74–1.67 (m, 4H), 1.44–1.36 (m, 4H), 1.27 ppm (brs, 12H). 
13C NMR (100 MHz, CDCl3): δ = 170.3 (2C), 81.8 (2C), 77.0 (2C), 64.8 (2C), 35.2 
(2C), 29.64 (2C), 29.59 (2C), 29.3 (2C), 25.2 (2C), 21.3 (2C), 3.8 ppm (2C). 
IR (film): ṽ = 2924, 2855, 1738, 1371, 1232, 1019, 955, 605 cm–1. MS (EI) m/z (%): 287 (12), 260 (23), 
259 (18), 245 (11), 175 (13), 163 (13), 161 (21), 159 (12), 149 (25), 147 (21), 145 (18), 143 (10), 137 
(14), 136 (16), 135 (27), 133 (22), 131 (16), 126 (27), 125 (18), 124 (11), 123 (25), 122 (13), 121 (25), 
119 (24), 117 (10), 111 (27), 110 (22), 109 (39), 108 (14), 107 (32), 105 (28), 95 (48), 94 (14), 93 (42), 
91 (31), 84 (79), 83 (10), 81 (38), 79 (41), 77 (15), 69 (23), 68 (28), 67 (37), 66 (13), 55 (23), 43 (100), 
41 (14). HRMS (ESIpos): m/z calcd for C22H34O4Na: 385.2349, found: 385.22348.	 
Benzoates 28 and 29. Triethylamine (0.19 mL, 1.35 mmol) and DMAP (11.0 mg, 0.09 mmol, 10 mol%) 
were added to a solution of diol 21 (250 mg, 0.90 mmol) in CH2Cl2 (30 mL) at 0 °C, followed by 
benzoyl chloride (115 μL, 0.99 mmol). The resulting mixture was stirred at 
ambient temperature for 16 h. The reaction was quenched with aq. sat. NH4Cl 
solution (10 mL) and the aqueous layer extracted with CH2Cl2 (3 × 15 mL). The 
combined extracts were dried over Na2SO4, filtered and concentrated. The residue was purified by 
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flash chromatography (hexanes/t-butyl methyl ether 10:1) to afford the mono-benzoate 28 (102 mg, 
30%) and the bis-protected compound 29 (210 mg, 48%) as pale yellow oil each. Analytical data for 
28: 1H NMR (400 MHz, CDCl3): δ = 8.07 (d, J = 7.1 Hz, 2H), 7.56 (t, J = 7.4 Hz, 1H), 7.44 (t, J = 7.6 Hz, 
2H), 5.56 (tq, J = 6.6, 2.1 Hz, 1H), 4.32 (tq, J = 6.5, 2.1 Hz, 1H), 1.85 (d, J = 2.1 Hz, 3H), 1.84 (d,  
J = 2.1 Hz, 3H), 1.69–1.61 (m, 4H), 1.52–1.45 (m, 2H), 1.45–1.38 (m, 2H), 1.28 ppm (brs, 12H). 
13C NMR (100 MHz, CDCl3): δ = 165.9, 133.1, 130.3, 129.9 (2C), 128.5 (2C), 81.9, 81.0, 80.6, 77.1, 65.3, 
62.9, 38.3, 35.3, 29.7 (2C), 29.6 (2C), 29.4, 29.3, 25.33, 25.26, 3.8, 3.7 ppm. IR (film): ṽ = 3473, 2924, 
2855, 1721, 1452, 1315, 1268, 1108, 1026, 712 cm–1. MS (EI) m/z (%): 105 (100), 69 (12). HRMS 
(ESIpos): m/z calcd for C25H24O3Na: 405.2400, found: 405.2403.  
Analytical data for 29:	1H NMR (400 MHz, CDCl3): δ = 8.07 (d, J = 7.1 Hz, 4H), 7.56 (t, J = 7.4 Hz, 2H), 
7.44 (t, J = 7.7 Hz, 4H), 5.56 (tq, J = 6.5, 2.1 Hz, 2H), 1.94–1.87 (m, 2H), 1.85 (d, 
J = 2.1 Hz, 6H), 1.84–1.77 (m, 2H), 1.54–1.44 (m, 4H), 1.27 ppm (brs, 12H). 
13C NMR (100 MHz, CDCl3): δ = 165.8 (2C), 133.1 (2C), 130.3 (2C), 129.9 (4C), 
128.5 (4C), 81.9 (2C), 77.1 (2C), 65.3 (2C), 35.3 (2C), 29.7 (2C), 29.6 (2C), 29.3 (2C), 25.3 (2C), 
3.8 ppm (2C). IR (film): ṽ = 2923, 2854, 1717, 1451, 1314, 1263, 1097, 1026, 709 cm–1. MS (EI) m/z 
(%): 105 (100). HRMS (ESIpos): m/z calcd for C32H38O4Na: 509.2662, found: 509.2661. 
RCAM Reactions 
Representative Procedure for RCAM Reactions using [Mo(≡CC6H4OMe)(OSiPh3)3] as Catalyst. 
Preparation of 3,14-bis(methoxymethoxy)-cyclotetradec-1-yne (S7). 5 Å MS (200 mg) was added to 
a solution of diyne 25 (36.7 mg, 100 μmol) in toluene (50 mL) and the 
resulting suspension was stirred for 30 min at room temperature. The mixture 
was then heated to 110 °C before complex C9 (20.8 mg, 20.0 μmol, 20 mol%) 
was added. Stirring was continued for 90 min, and the mixture was filtered 
through a pad of Celite®, which was carefully rinsed with EtOAc. The combined filtrates were 
concentrated and the residue purified by flash chromatography (hexanes/EtOAc 20:1 to 4:1) to 
afford the title compound as a colorless oil (16.9 mg, 54%, syn/anti-mixture). 1H NMR (400 MHz, 
CDCl3): δ = 4.91 (dd, J = 6.8, 3.4 Hz, 2H), 4.59 (dd, J = 6.8, 3.0 Hz, 2H), 4.49–4.39 (m, 2H), 3.37 (s, 6H), 
1.81–1.62 (m, 4H), 1.55–1.21 ppm (m, 16H). 13C NMR (100 MHz, CDCl3): δ = 94.3, 84.8, 84.6, 66.3, 
66.2, 55.7, 35.1, 34.9, 26.6, 26.5, 25.9, 25.8, 23.82, 23.79, 22.44, 22.38 ppm. IR (film): ṽ = 2929, 2860, 
2822, 2776, 1459, 1400, 1338, 1213, 1148, 1097, 1026, 919, 848, 792, 724, 704, 554, 441, 415 cm–1. 
MS (EI) m/z (%): 133 (11), 121 (18), 119 (11), 109 (17), 108 (12), 107 (20), 105 (13), 97 (15), 95 (30), 
94 (17), 93 (25), 92 (11), 91 (28), 82 (12), 81 (34), 80 (25), 79 (38), 77 (13), 69 (11), 67 (32), 55 (20), 45 
(100), 41 (16). HRMS (ESIpos): m/z calcd for C18H32O4Na: 355.2189, found: 335.2193. 
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Representative Procedure for RCAM Reactions using the Two-Component Catalyst System. 
Preparation of 4-(methoxymethoxy)cyclotetradec-2-yn-1-ol (S8). 5 Å MS (200 mg) was added to a 
solution of diyne 24 (32.2 mg, 100 μmol) in toluene (50 mL) at room 
temperature and stirred for 30 min. The mixture was then heated to 110 °C 
before a freshly prepared solution of trisilanol L2 (19.4 mg, 22.0 μmol, 22 mol%) 
and complex C12 (13.3 mg, 20.0 μmol, 20 mol%) in toluene (1 mL) was added, which had been stirred 
for 5 min prior to use. Stirring was continued at 110 °C for 30 min. The mixture was cooled to 
ambient temperature, the molecular sieves were filtered off through a pad of Celite®, which was 
carefully rinsed with EtOAc, and the combined filtrates were concentrated. The residue was purified 
by flash chromatography (hexanes/EtOAc 20:1 to 4:1) to afford the title compound as a colorless oil 
(18.0 mg, 67%, syn/anti-mixture). 1H NMR (400 MHz, CDCl3): δ = 4.92 (dd, J = 6.8, 5.5 Hz, 1H), 4.60 
(dd, J = 6.8, 1.8 Hz, 1H), 4.56–4.40 (m, 2H), 3.38 (s, 3H), 1.89–1.82 (m, 1H), 1.78–1.63 (m, 4H),  
1.56–1.22 ppm (m, 16H). 13C NMR (100 MHz, CDCl3): δ = 94.3, 87.11, 87.06, 84.1, 83.9, 66.3, 66.1, 
63.0, 55.8, 37.2, 37.1, 35.0, 34.9, 26.6, 26.5, 25.9, 25.81, 25.77, 25.7, 23.9, 23.8, 22.5, 22.4, 22.32, 
22.30 ppm. IR (film): ṽ = 3400, 2928, 2859, 1459, 1429, 1338, 1260, 1213, 1150, 1097, 1026, 918, 865, 
801, 731, 700, 509 cm–1. MS (EI) m/z (%): 149 (11), 147 (12), 135 (19), 133 (18), 131 (13), 123 (13), 
122 (11), 121 (30), 119 (21), 117 (14), 111 (17), 110 (16), 109 (33), 108 (23), 107 (42), 105 (28), 98 
(20), 97 (29), 96 (32), 95 (66), 94 (43), 93 (56), 92 (26), 91 (68), 84 (17), 83 (32), 82 (37), 81 (88), 80 
(61), 79 (100), 78 (19), 77 (35), 71 (13), 70 (14), 69 (35), 68 (37), 67 (93), 66 (17), 65 (19), 57 (14), 56 
(11), 55 (74), 54 (25), 53 (21), 45 (79), 43 (21), 41 (59), 39 (23), 31 (26), 30 (18). HRMS (ESIpos): m/z 
calcd for C16H28O3Na: 291.1928, found: 291.1931. 
The following compounds were prepared analogously: 
3,14-Bis((triethylsilyl)oxy)cyclotetradec-1-yne (S9). Purification by flash chromatography (fine SiO2, 
hexanes/EtOAc 100:1) afforded the title compound as a colorless oil (32.0 mg, 
71%, syn/anti-mixture). 1H NMR (400 MHz, CDCl3) δ = 4.51–4.39 (m, 2H),  
1.73–1.21 (m, 20H), 0.97 (t, J = 7.9 Hz, 18H), 0.71–0.56 ppm (m, 12H). 13C NMR 
(100 MHz, CDCl3): δ = 85.9, 85.6, 63.4, 63.2, 38.7, 38.4, 26.7, 26.4, 26.1, 25.8, 24.0, 23.8, 22.4, 22.3, 
7.0, 4.94, 4.88 ppm. IR (film): ṽ = 2949, 2935, 2875, 1732, 1459, 1414, 1378, 1348, 1334, 1260, 1239, 
1074, 1006, 975, 843, 803, 726, 675, 533, 458 cm–1. MS (EI) m/z (%): 425 (11), 424 (29), 423 (81), 291 
(28), 217 (45), 205 (10), 190 (18), 189 (100), 161 (17), 133 (11), 121 (14), 115 (23), 107 (17), 103 (31), 
95 (12), 93 (13), 87 (41), 81 (10), 75 (18), 59 (11). HRMS (ESIpos): m/z calcd for C26H52O2Si2Na: 
475.3404, found: 475.3398. 
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4-((Triethylsilyl)oxy)cyclotetradec-2-yn-1-ol (S10). Purification by flash chromatography (hexanes/ 
EtOAc 10:1 to 4:1) afforded the title compound as a colorless oil (21.8 mg, 64%, 
syn/anti-mixture). 1H NMR (400 MHz, CDCl3) δ = 4.53–4.41 (m, 2H), 1.74–1.60 (m, 
5H), 1.49–1.25 (m, 16H), 0.98 (t, J = 7.9 Hz, 9H), 0.70–0.59 ppm (m, 6H). 13C NMR 
(100 MHz, CDCl3): δ = 87.1, 86.9, 85.4, 85.1, 63.3, 63.2, 63.1, 63.0, 38.4, 38.3, 
37.2, 26.60, 26.56, 26.53, 26.47, 25.84, 25.82, 25.78, 25.7, 23.89, 23.85, 23.8, 22.4, 22.3, 7.0, 4.92, 
4.90 ppm. IR (film): ṽ = 3359, 2931, 2874, 2859, 1458, 1413, 1378, 1334, 1259, 1239, 1151, 1072, 
1006, 802, 726, 549, 427 cm–1. MS (EI) m/z (%): 121 (11), 107 (16), 105 (12), 103 (100), 95 (16), 93 
(18), 91 (16), 87 (14), 81 (18), 79 (20), 75 (89), 67 (20), 55 (12), 47 (13). HRMS (ESIpos): m/z calcd for 
C20H38O2SiNa: 361.2521, found: 361.2533. 
Cyclotetradec-2-yne-1,4-diol (S11). Purification by flash chromatography (hexanes/EtOAc 4:1 to 1:1) 
afforded the title compound as a colorless solid (11.8 mg, 53%, syn/anti-mixture). 
m.p. [EtOAc] = 110–111 °C. 1H NMR (400 MHz, CDCl3): δ = 4.58–4.44 (m, 2H),  
1.98–1.89 (m, 2H), 1.79–1.62 (m, 4H), 1.52–1.26 ppm (m, 16H). 13C NMR (100 MHz, 
CDCl3): δ = 86.5, 86.2, 63.04, 62.96, 37.2, 37.1, 26.53, 26.50, 25.74, 25.71, 23.8, 22.4, 22.3 ppm.  
IR (film): ṽ = 3273, 2923, 2856, 1729, 1457, 1443, 1341, 1297, 1146, 1107, 1020, 945, 723, 702, 590, 
533, 512, 440 cm–1. MS (EI) m/z (%): 149 (12), 135 (19), 133 (14), 131 (13), 123 (11), 122 (10), 121 
(29), 119 (18), 117 (14), 111 (19), 110 (15), 109 (28), 108 (24), 107 (48), 106 (12), 105 (24), 98 (21), 97 
(30), 96 (35), 95 (67), 94 (49), 93 (57), 92 (25), 91 (62), 84 (26), 83 (44), 82 (39), 81 (91), 80 (60), 79 
(100), 78 (18), 77 (34), 71 (21), 70 (30), 69 (40), 68 (37), 67 (93), 66 (17), 65 (19), 57 (26), 56 (14), 55 
(92), 54 (25), 53 (23), 43 (33), 42 (12), 41 (68), 39 (27). HRMS (ESIpos): m/z calcd for C14H24O2Na: 
247.1667, found: 247.1668. 
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4.3.1.2 Synthesis of the Enyne Model Substrates 
 
Scheme 4.3 Preparation of the enyne model substrates. 
12,12-Dimethoxydodecanal (S12). p-TsOH·H2O (288 mg, 1.51 mmol) was added to a solution of 
dodecan-1,12-dial (20) (3.00 g, 15.1 mmol) and MeOH (1.29 mL, 31.8 mmol) in 
toluene (100 mL) at 0 °C. The solution was stirred for 1 h before it was poured into 
aq. sat. NaHCO3 (60 mL). The aqueous layer was extracted with EtOAc (3 × 60 mL), 
and the combined extracts were dried over Na2SO4, filtered and concentrated. The residue was 
purified by flash chromatography (hexanes/EtOAc 40:1) to furnish the title compound as a colorless 
oil (2.01 g, 54%). 1H NMR (400 MHz, CDCl3): δ = 9.75 (t, J = 1.6 Hz, 1H), 4.35 (t, J = 5.7 Hz, 1H), 3.30 (s, 
6H), 2.41 (td, J = 7.3, 1.6 Hz, 2H),  1.65–1.55 (m, 4H), 1.26 ppm (brs, 14H). 13C NMR (100 MHz, CDCl3): 
δ = 203.1, 104.7, 52.7 (2C), 44.1, 32.6, 29.7, 29.6, 29.5, 29.4, 29.28, 29.26, 24.7, 22.2 ppm. IR (film): 
ṽ = 2925, 2854, 1726, 1464, 1387, 1191, 1128, 1055, 953, 723 cm–1. MS (EI) m/z (%): 75 (22), 71 (100), 
41 (22). HRMS (ESIpos): m/z calcd for C14H28O3Na: 267.1931, found: 267.1931. The analytical and 
spectroscopic data are in agreement with those reported in the literature.[229] The byproduct 
1,1,12,12-tetramethoxydodecane could be recovered and converted to aldehyde S12 by treatment 
with HCl (1 M) in THF at ambient temperature for 6 h. 
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14,14-Dimethoxytetradec-1-en-3-ol (S13). A solution of vinyl magnesium bromide (1.0 M in THF, 
6.87 mL, 6.87 mmol) was added to a solution of aldehyde S12 (1.40 g, 5.73 mmol) 
in anhydrous THF (50 mL). The resulting mixture was stirred at ambient 
temperature for 1 h. The reaction was quenched with aq. sat. NH4Cl (20 mL) and 
the aqueous layer extracted with t-butyl methyl ether (3 × 25 mL). The combined extracts were dried 
over Na2SO4, filtered and concentrated. The residue was purified by flash chromatography 
(hexanes/t-butyl methyl ether 12:1 to 3:1) to afford the allylic alcohol S13  as a colorless oil (1.03 g, 
3.78 mmol, 66%). 1H NMR (400 MHz, CDCl3): δ = 5.86 (ddd, J = 16.9, 10.4, 6.3 Hz, 1H), 5.21 (dt, 
J = 17.2, 1.4 Hz, 1H), 5.09  (dt, J = 10.4, 1.3 Hz, 1H), 4.35 (t, J = 5.8 Hz, 1H), 4.08 (q, J = 6.5 Hz, 1H), 
3.30 (s, 6H), 1.70 (brs, 1H), 1.61–1.48 (m, 4H), 1.26 ppm (brs, 16H). 13C NMR (100 MHz, CDCl3):  
δ = 141.5, 114.6, 104.7, 73.4, 52.7 (2C), 37.2, 32.6, 29.7 (4C), 29.64, 29.59, 25.5, 24.7 ppm. IR (film): 
ṽ = 3445, 2925, 2854, 1464, 1386, 1192, 1126, 1054, 991, 919 cm–1. MS (EI) m/z (%): 97 (11), 95 (16), 
94 (11), 93 (13), 82 (11), 81 (22), 80 (13), 79 (20), 75 (25), 71 (100), 68 (12), 67 (25), 57 (17), 55 (17), 
41 (27), 31 (12). HRMS (ESIpos): m/z calcd for C16H32O3Na: 295.2244, found: 295.2243. The analytical 
and spectroscopic data are in agreement with those reported in the literature.[230] 
Silyl ether 33. Imidazole (250 mg, 3.67 mmol), DMAP (22.4 mg, 0.18 mmol, 10 mol%) and TBSCl 
(415 mg, 2.75 mmol) were successively added to a solution of alcohol S13 
(500 mg, 1.84 mmol) in CH2Cl2 (18 mL) at 0 °C. The resulting mixture was allowed 
to warm to ambient temperature and stirred for 16 h. The reaction was quenched 
with aq. sat. NaHCO3 (10 mL) and the aqueous layer extracted with CH2Cl2 (3 × 15 mL). The combined 
extracts were dried over Na2SO4, filtered and concentrated. The residue was purified by flash 
chromatography (hexanes/t-butyl methyl ether 50:1) to yield silyl ether 33  as a colorless oil (653 mg, 
92%). 1H NMR (400 MHz, CDCl3): δ = 5.79 (ddd, J = 17.1, 10.4, 6.0 Hz, 1H), 5.12 (ddd, J = 17.1, 1.9, 
1.3 Hz, 1H), 5.00 (ddd, J = 10.4, 1.9, 1.2 Hz, 1H), 4.36 (t, J = 5.7 Hz, 1H), 4.06 (dtt, J = 7.2, 6.0, 1.3 Hz, 
1H), 3.31 (s, 6H), 1.62–1.55 (m, 2H), 1.50–1.39 (m, 2H), 1.26 (brs, 16H), 0.89 (s, 9H), 0.05 (s, 3H), 
0.03 ppm (s, 3H). 13C NMR (100 MHz, CDCl3): δ = 142.1, 113.5, 104.7, 74.0, 52.7 (2C), 38.3, 32.6, 
29.77, 29.75, 29.72, 29.70, 29.69, 29.6, 26.0 (3C), 25.4, 24.8, 18.4, –4.2, –4.7 ppm. IR (film): ṽ = 2926, 
2855, 1463, 1361, 1252, 1126, 1076, 920, 835, 775 cm–1. MS (EI) m/z (%): 297 (10), 223 (32), 171 (38), 
135 (10), 109 (32), 107 (22), 95 (37), 94 (11), 89 (12), 81 (20), 75 (100), 73 (16), 71 (28), 67 (17). HRMS 
(ESIpos): m/z calcd for C22H46O3SiNa: 409.3108, found: 409.3108. 
Aldehyde S14. Silyl ether 33 (650 mg, 1.68 mmol) was dissolved in CH2Cl2 (17 mL) and the resulting 
solution was cooled to –78 °C. Ozone was bubbled through the solution until the 
blue color persisted (approx. 30 min). After purging the reaction mixture with O2 
and Ar, PPh3 (573 mg, 2.19 mmol) was added in one portion, the cooling bath was 
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removed and the colorless solution stirred at ambient temperature for 6 h. The mixture was 
concentrated and the residue purified by flash chromatography (hexanes/t-butyl methyl ether 40:1 
to 20:1) to afford aldehyde S14 as a colorless oil (582 mg, 89%). 1H NMR (400 MHz, CDCl3): δ = 9.59 
(d, J = 1.7 Hz, 1H), 4.35 (t, J = 5.8 Hz, 1H), 3.95 (ddd, J = 7.1, 5.5, 1.8 Hz, 1H), 3.31 (s, 6H), 1.64–1.54 
(m, 4H), 1.26 (brs, 16H), 0.92 (s, 9H), 0.08 (s, 3H), 0.07 ppm (s, 3H). 13C NMR (100 MHz, CDCl3):  
δ = 204.7, 104.7, 77.8, 52.7 (2C), 32.8, 32.6, 29.7, 29.64 (2C), 29.62, 29.58, 29.55, 25.9 (3C), 24.7 (2C), 
18.4, –4.5, –4.8 ppm. IR (film): ṽ = 2927, 2855, 1736, 1464, 1362, 1253, 1123, 1076, 838, 778 cm–1. 
MS (EI) m/z (%): 357 (12), 327 (20), 300 (11), 299 (49), 267 (23), 175 (21), 95 (10), 89 (10), 81 (11), 75 
(100), 73 (21). HRMS (ESIpos): m/z calcd for C21H44O4SiNa: 411.2901, found: 411.2903. 
Enyne 34. A solution of n-BuLi (1.6 M in hexanes, 1.37 mL, 2.20 mmol) was added to a solution of  
2-butynyltriphenylphosphonium bromide (869 mg, 2.20 mmol) in THF (10 mL) at 
0 °C. The resulting orange mixture was stirred at ambient temperature for 30 min 
before it was cooled to –78 °C. A solution of aldehyde S14 (428 mg, 1.10 mmol) in 
THF (2 mL) was added, the cooling bath removed and the resulting mixture 
stirred for 12 h at ambient temperature. The reaction was quenched with H2O (10 mL) and the 
aqueous layer extracted with EtOAc (3 × 15 mL). The combined extracts were washed with brine 
(20 mL), dried over Na2SO4, filtered and concentrated. The residue was purified by flash 
chromatography (hexanes/t-butyl methyl ether 100:0 to 50:1) to afford an inseparable mixture of 
(E)- and (Z)-enyne 34 as a yellow oil (279 mg, 60%, E/Z 1.7:1). 1H NMR (400 MHz, CDCl3): (E)-enyne:  
δ = 6.01 (ddd, J = 15.8, 5.7, 0.8 Hz, 1H), 5.58 (dqd, J = 15.8, 2.3, 1.4 Hz, 1H), 4.36 (t, J = 5.8 Hz, 1H), 
4.10 (tdd, J = 6.3, 5.7, 1.4 Hz, 1H), 3.31 (s, 6H), 1.94 (d, J = 2.3 Hz. 3H), 1.62–1.57 (m, 2H), 1.49–1.42 
(m, 2H), 1.25 (brs, 16H), 0.89 (s, 9H), 0.04 (s, 3H), 0.02 ppm (s, 3H); (Z)-enyne: δ = 5.73 (ddd, J = 10.7, 
8.7, 0.8 Hz, 1H), 5.38 (dqd, J = 10.7, 2.4, 0.9 Hz, 1H), 4.59 (dtd, J = 8.7, 6.3, 0.9 Hz, 1H), 4.36 (t, 
J = 5.8 Hz, 1H), 3.31 (s, 6H), 1.97 (d, J = 2.4 Hz. 3H), 1.62–1.57 (m, 2H), 1.49–1.42 (m, 2H), 1.25 (brs, 
16H), 0.88 (s, 9H), 0.04 (s, 3H), 0.02 ppm (s, 3H). 13C NMR (100 MHz, CDCl3): (E)-enyne: δ = 145.4, 
109.0, 104.7, 86.0, 78.1, 72.8, 52.7 (2C), 38.1, 32.6, 29.8, 29.72 (2C), 29.70, 29.69, 29.6, 26.0 (3C), 
25.2, 24.8, 18.4, 4.5, –4.3, –4.7 ppm; (Z)-enyne: δ = 145.7, 108.6, 104.7, 90.7, 76.2, 70.8, 52.7 (2C), 
37.8, 32.6, 29.8, 29.72 (2C), 29.70, 29.69, 29.6, 26.1 (3C), 25.3, 24.8, 18.4, 4.5, –4.2, –4.8 ppm. IR 
(film): ṽ = 2926, 2855, 1463, 1361, 1253, 1126, 1074, 836, 776 cm–1. MS (EI) m/z (%): 392 (11), 335 
(15), 261 (21), 229 (12), 209 (30), 105 (12), 89 (16), 75 (100), 73 (22). HRMS (ESIpos): m/z calcd for 
C25H48O3SiNa: 447.3265, found: 447.3269. 
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Enynes 35 and 36. Pyridinium p-toluenesulfonate (40.5 mg, 0.16 mmol) was added to a solution of 
(E,Z)-34 (228 mg, 0.54 mmol) in acetone (50 mL) and water (1.4 mL), and the 
resulting mixture was stirred at 60 °C for 4 h. After cooling to ambient 
temperature, the mixture was concentrated, the residue was partitioned 
between CH2Cl2 (5 mL) and H2O (5 mL), and the aqueous layer was extracted 
with CH2Cl2 (2 × 5 mL). The combined extracts were dried over Na2SO4, filtered and concentrated to 
furnish the crude aldehyde, which was used in the next step without further purification. 
A solution of 1-propynylmagnesium bromide in THF (0.5 M, 1.62 mL, 0.81 mmol) was added to a 
solution of the crude aldehyde in THF (5 mL) and the resulting mixture stirred at ambient 
temperature for 4 h. The reaction was quenched with aq. sat. NH4Cl solution (5 mL) and the aqueous 
layer was extracted with t-butyl methyl ether (3 × 10 mL). The combined extracts were washed with 
brine (50 mL), dried over Na2SO4, filtered and concentrated. The residue was purified by flash 
chromatography (hexanes/EtOAc 15:1) to afford a mixture of (E)- and (Z)-enynes 36 and 35. The 
diastereomers were separated by preparative HPLC (Kromasil C18, 5 μm, 150×30 mm, MeCN/H2O = 
95:5, 35 °C, 25 bar, 35 mL/min, tR (E) = 11.6 min, tR (Z) = 13.4 min) to yield (E)-enyne 36 (87.9 mg, 38% 
over two steps) and (Z)-enyne 35 (50.2 mg, 23% over two steps) as a yellow oil each.  
Analytical data for (E)-enyne 36: 1H NMR (400 MHz, CDCl3): δ = 6.00 (ddd, J = 15.8, 5.7, 0.8 Hz, 1H), 
5.57 (dqd, J = 15.8, 2.3, 1.4 Hz, 1H), 4.31 (tq, J = 6.6, 2.1 Hz, 1H), 4.10 (tdd, J = 6.3, 5.7, 1.5 Hz, 1H), 
1.93 (d, J = 2.3 Hz. 3H), 1.84 (d, J = 2.1 Hz. 3H), 1.69–1.59 (m, 2H), 1.49–1.36 (m, 4H), 1.24 (brs, 14H), 
0.88 (s, 9H), 0.03 (s, 3H), 0.02 ppm (s, 3H). 13C NMR (100 MHz, CDCl3): δ = 145.4, 109.0, 86.0, 81.0, 
80.7, 78.1, 72.8, 62.9, 38.3, 38.1, 29.74, 29.70 (2C), 29.67 (2C), 29.4, 26.0 (3C), 25.3, 25.1, 18.4, 4.4, 
3.7, –4.3, –4.7 ppm.  
Analytical data for (Z)-enyne 35: 1H NMR (400 MHz, CDCl3): δ = 5.73 (dd, J = 10.6, 8.9 Hz, 1H), 5.38 
(dqd, J = 10.8, 2.4, 0.9 Hz, 1H), 4.59 (dtd, J = 8.9, 7.1, 0.9 Hz, 1H), 4.32 (tq, J = 6.5, 2.1 Hz, 1H), 1.97 (d, 
J = 2.4 Hz. 3H), 1.84 (d, J = 2.1 Hz. 3H), 1.69–1.60 (m, 2H), 1.47–1.36 (m, 4H), 1.27 (brs, 14H), 0.88 (s, 
9H), 0.07 (s, 3H), 0.04 ppm (s, 3H). 13C NMR (100 MHz, CDCl3): δ = 145.7, 108.7, 90.7, 81.0, 80.7, 76.2, 
70.8, 62.9, 38.3, 37.8, 29.77, 29.75, 29.72, 29.71, 29.70, 29.5, 26.1 (3C), 25.4, 25.3, 18.3, 4.5, 3.7,  
–4.2, –4.8 ppm. IR (film): ṽ = 3361, 2925, 2854, 1463, 1361, 1254, 1085, 955, 835, 775 cm–1. MS (EI) 
m/z (%): 362 (10), 361 (35), 269 (24), 210 (16), 209 (87), 173 (10), 171 (14), 169 (21), 159 (22), 157 
(22), 149 (18), 147 (10), 145 (35), 143 (15), 133 (18), 131 (23), 121 (13), 119 (29), 109 (15), 107 (22), 
105 (35), 95 (38), 93 (29), 91 (23), 81 (33), 79 (28), 77 (13), 75 (100), 73 (58), 69 (23), 67 (23), 578 
(12), 55 (21). HRMS (ESIpos): m/z calcd for C26H46O2SiNa: 441.3159, found: 441.3159. 
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Diol 37. A solution of TBAF (1 M in THF, 80 μL, 80 μmol) was added to a solution of (E)-enyne 36 
(28 mg, 67 μmol) in THF (0.6 mL) at 0 °C. The resulting mixture was 
stirred at ambient temperature for 1 h. The reaction was quenched with 
aq. sat. NH4Cl solution (1 mL) and the aqueous layer extracted with  
t-butyl methyl ether (3 × 3 mL). The combined extracts were washed with brine (5 mL), dried over 
Na2SO4, filtered and concentrated. The residue was purified by flash chromatography 
(hexanes/EtOAc 8:1) to afford diol 37 as a pale yellow oil (18 mg, 88%). 1H NMR (400 MHz, CDCl3):  
δ = 6.03 (dd, J = 15.9, 6.4 Hz, 1H), 5.64 (dqd, J = 15.9, 2.3, 1.4 Hz, 1H), 4.31 (tq, J = 6.7, 2.1 Hz, 1H), 
4.11 (qd, J = 6.2, 1.4 Hz, 1H), 1.93 (d, J = 2.3 Hz. 3H), 1.84 (d, J = 2.1 Hz. 3H), 1.69–1.60 (m, 2H),  
1.60–1.47 (m, 2H), 1.45–1.37 (m, 2H), 1.27 ppm (brs, 14H). 13C NMR (100 MHz, CDCl3): δ = 144.5, 
110.5, 86.7, 81.0, 80.7, 77.8, 72.6, 62.9, 38.3, 37.2, 29.6 (5C), 29.4, 25.4, 25.3, 4.4, 3.7 ppm. IR (film): 
ṽ = 3335, 2921, 2853, 1464, 1081, 956, 722 cm–1. MS (ESIpos) m/z (%): 327.2 (100 (M+Na)). HRMS 
(ESIpos): m/z calcd for C20H32O2Na: 327.2294, found: 327.2296. 
(E)-6-((t-Dimethylsilyl)oxy)cyclohexadec-4-en-2-yn-1-ol (39). This compound was prepared 
according to the representative procedure for RCAM reactions using the two-
component catalyst system (vide supra). Purification by flash chromatography 
(hexanes/t-butyl methyl ether 20:1) provided enyne 39 as a colorless oil 
(19.8 mg, 76%, syn/anti-mixture). 1H NMR (400 MHz, CDCl3): δ = 6.15 (dd, 
J = 15.8, 5.2 Hz, 1H), 6.14 (dd, J = 15.8, 5.2 Hz, 1H),  5.72–5.62 (m, 2H), 4.55–4.48 (m, 2H), 4.28–4.23 
(m, 2H), 1.84–1.65 (m, 8H), 1.48–1.38 (m, 8H), 1.35–1.19 (m, 24H), 0.89 (s, 18H), 0.04 (s, 6H), 
0.03 ppm (s, 6H). 13C NMR (100 MHz, CDCl3): δ = 148.1, 147.8, 108.1, 108.0, 90.59, 90.55, 84.5, 84.4, 
72.33, 72.27, 63.43, 63.37, 37.3, 37.2, 36.1 (2C), 28.41, 28.38, 27.9 (4C), 27.8 (2C), 27.62 (2C), 27.57, 
27.5, 26.0 (6C), 23.7, 23.5, 21.92, 21.86, 18.4 (2C), –4.6 (2C), –4.8 ppm (2C).  IR (film): ṽ = 3348, 2926, 
2855, 1462, 1361, 1255, 1073, 956, 836, 776 cm–1. MS (ESIpos) m/z (%): 387.3 (100 (M+Na)). HRMS 
(ESIpos): m/z calcd for C22H40O2SiNa: 387.2690, found: 387.2691. 
(Z)-6-((t-Dimethylsilyl)oxy)cyclohexadec-4-en-2-yn-1-ol (38). This compound was prepared 
according to the representative procedure for RCAM reactions using the two-
component catalyst system (vide supra). Colorless oil (22.3 mg, 90%); the 
diastereomers could be separated by flash chromatography (hexanes/t-butyl methyl 
ether 20:1).  
Analytical data for the faster eluting diastereomer: 1H NMR (300 MHz, CDCl3): δ = 5.84 (dd, J = 10.9, 
8.8 Hz, 1H), 5.48 (ddd, J = 10.8, 2.1, 0.8 Hz, 1H), 4.63 (td, J = 8.2, 4.9 Hz, 1H), 4.55 (ddd, J = 7.8, 5.1, 
2.0 Hz, 1H), 1.79–1.66 (m, 2H), 1.53 (brs, 1H), 1.44–1.28 (m, 18H), 0.89 (s, 9H), 0.10 (s, 3H), 0.06 ppm 
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(s, 3H). 13C NMR (75 MHz, CDCl3): δ = 147.6, 107.7, 95.2, 81.5, 71.2, 63.6, 37.9, 36.9, 27.1 (2C), 26.9, 
26.7, 26.1 (3C), 25.63, 25.60, 23.74, 23.71, 18.4, –4.1, –4.6 ppm.  
Analytical data for the slower eluting diastereomer: 1H NMR (300 MHz, CDCl3): δ = 5.82 (dd, J = 10.9, 
8.9 Hz, 1H), 5.48 (d, J = 10.9 Hz, 1H), 4.66–4.52 (m, 2H), 1.89–1.65 (m, 4H), 1.47–1.28 (m, 17H), 0.89 
(s, 9H), 0.08 (s, 3H), 0.04 ppm (s, 3H). 13C NMR (75 MHz, CDCl3): δ = 147.1, 107.7, 95.0, 81.8, 71.2, 
63.2, 37.7, 36.7, 27.3, 27.1, 26.72, 26.71, 26.1, 26.0 (3C), 25.7, 23.8, 23.7, 18.3, –4.1, –4.7 ppm.  
IR (film): ṽ = 3432, 2927, 2856, 1461, 1361, 1071, 1018, 907, 835, 776, 732 cm–1. MS (ESIpos) m/z (%): 
387.3 (100 (M+Na)). HRMS (ESIpos): m/z calcd for C22H40O2SiNa: 387.2690, found: 387.2692. 
(E)-Cyclohexadec-2-en-4-yne-1,6-diol (40). This compound was prepared according to the 
representative procedure for RCAM reactions using the two-component catalyst 
system (vide supra). Purification by flash chromatography (hexanes/EtOAc 4:1) 
provided enyne 40 as a colorless solid (3.3 mg, 40%, syn/anti-mixture). m.p. 
[EtOAc] = 92–93 °C. 1H NMR (300 MHz, CDCl3): δ = 6.16 (ddd, J = 15.9, 6.5, 3.4 Hz, 
1H), 5.71 (dt, J = 15.9, 1.6 Hz, 1H), 4.59–4.46 (m, 1H), 4.30–4.18 (m, 1H), 1.85–1.65 (m, 4H),  
1.61–1.19 ppm (m, 18H). 13C NMR (100 MHz, CDCl3): δ = 146.9, 146.8, 109.70, 109.68, 91.3, 91.2, 
83.99, 83.96, 72.63, 72.58, 63.37, 63.36, 37.14, 37.12, 35.54, 35.51, 28.4, 28.3, 27.9 (2C), 27.8, 27.74 
(2C), 27.72, 27.69, 27.64, 27.62, 27.61, 23.6, 23.5, 22.5 ppm (2C). IR (film): ṽ = 3670, 3309, 2923, 
2852, 2219, 1633, 1459, 1407, 1342, 1292, 1168, 1115, 1015, 955, 871, 798, 710, 553, 507, 469 cm–1. 
MS (ESIpos) m/z (%): 273.2 (100 (M+Na)). HRMS (ESIpos): m/z calcd for C16H26O2Na: 273.1824, found: 
273.1825. 
Representative Procedure for trans-Hydrostannylation Reactions with Enyne Substrates. 
Preparation of (2Z,4E)-6-((t-dimethylsilyl)oxy)-2-(tristannyl)cyclohexadeca-2,4-dien-1-ol (S15). A 
solution of Bu3SnH (9.3 μL, 35μmol) in CH2Cl2 (0.15 mL) was added dropwise 
over 90 min via syringe pump to a solution of enyne 39 (12 mg, 33 μmol) and 
[Cp*RuCl]4 (1.8 mg, 6.6 μmol, 20 mol%) in CH2Cl2 (0.2 mL). All volatiles were 
evaporated and the residue was purified by flash chromatography (hexanes/ 
t-butyl methyl ether 19:1) to afford stannane S15 as a pale yellow oil (17.9 mg, 83%, Z/E > 20:1,  
α/β > 95:5, syn/anti-mixture with regard to diol). 1H NMR (400 MHz, CDCl3): δ = 6.75 (d, J = 10.9 Hz, 
JSnH = 119 Hz, 1H), 6.68 (d, J = 10.7 Hz, JSnH = 117 Hz, 1H), 6.29 (ddd, J = 14.7, 10.9, 1.7 Hz, 1H), 6.08 
(dd, J = 14.9, 10.7 Hz, 1H), 5.68 (dd, J = 14.7, 4.3 Hz, 1H), 5.59 (dd, J = 14.9, 8.4 Hz, 1H), 4.40 (dt, 
J = 4.9, 2.4 Hz, 1H), 4.31–4.20 (m, 2H), 4.07 (td, J = 9.0, 3.7 Hz, 1H), 1.78–1.57 (m, 5H), 1.56–1.42 (m, 
18H), 1.38–1.28 (m, 20H), 1.27–1.10 (m, 32H), 1.04–0.98 (m, 10H), 0.92 (s, 9H), 0.90–0.89 (m, 9H), 
0.88 (s, 9H), 0.06 (s, 9H), 0.04 ppm (s, 3H). 13C NMR (100 MHz, CDCl3): δ = 153.4, 151.2, 140.2, 140.0, 
139.4, 139.3, 130.7, 128.8, 81.0, 80.4, 74.9, 71.8, 37.5, 36.9, 36.8, 36.6, 29.40 (3C), 29.39 (3C), 29.0, 
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28.9, 28.5, 28.2 (2C), 28.0 (2C), 27.9, 27.74, 27.72, 27.70, 27.6 (6C), 27.5, 26.2 (3C), 26.1 (3C), 24.2, 
23.8, 23.5, 21.8, 18.5, 18.4, 13.8 (6C), 11.5 (3C), 11.2 (3C), –4.1, –4.4, –4.6, –4.8 ppm. 119Sn NMR (150 
MHz, CDCl3): δ = –55.1, –56.2 ppm. IR (film): ṽ = 3373, 2926, 2854, 1461, 1253, 1070, 967, 835, 775, 
667 cm–1. MS (ESIpos) m/z (%): 679.4 (55 (M+Na)). HRMS (ESIpos): m/z calcd for C34H68O2SiSnNa: 
679.3902, found: 679.3903. 
(2Z,4Z)-6-((t-Dimethylsilyl)oxy)-2-(tristannyl)cyclohexadeca-2,4-dien-1-ol (45). A solution of Bu3SnH 
(5.5 μL, 20 μmol) in CH2Cl2 (0.1 mL) was added dropwise over 90 min via syringe 
pump to a solution of enyne 38 (7.1 mg, 19 μmol) and [Cp*RuCl]4 (1.0 mg, 
3.7 μmol, 19 mol%) in CH2Cl2 (0.1 mL). All volatiles were evaporated and the 
residue was purified by flash chromatography (hexanes/t-butyl methyl ether 
19:1) to afford stannane 45 as a pale yellow oil (10 mg, 79%, Z/E > 20:1, α/β > 95:5). 1H NMR (400 
MHz, CDCl3): δ = 6.84 (d, J = 11.4 Hz, JSnH = 115 Hz, 1H), 5.93 (dt, J = 11.2, 1,2 Hz, 1H), 5.42 (ddd, 
J = 11.2, 8.6, 1,1 Hz, 1H), 4.62 (q, J = 7.0 Hz, 1H), 4.24 (ddd, J = 9.6, 4.7, 2.9 Hz, 1H), 1.54–1.38 (m, 
12H), 1.36–1.25 (m, 20H), 1.03–0.96 (m, 5H), 0.91–0.86 (m, 10H), 0.88 (s, 9H), 0.05 (s, 3H), 0.03 ppm 
(s, 3H). 13C NMR (100 MHz, CDCl3): δ = 155.4, 137.3, 135.1, 127.2, 81.1, 68.5, 37.23, 37.18, 29.4 (3C), 
27.6, 27.5 (3C), 27.4, 27.2, 27.0, 26.6, 26.3, 26.1 (3C), 25.3, 24.3, 18.4, 13.9 (3C), 11.7 (3C), –4.0, –4.5 
ppm. 119Sn NMR (150 MHz, CDCl3): δ = –53.5 ppm. IR (film): ṽ = 3481, 2954, 2926, 2855, 1462, 1251, 
1071, 1005, 836, 775, 676 cm–1. MS (EI) m/z (%): 599 (13), 597 (12), 468 (14), 467 (57), 466 (25), 265 
(45), 464 (19), 463 (25), 365 (47), 364 (19), 363 (35), 362 (14), 361 (19), 281 (11), 251 (16), 249 (13), 
218 (18), 217 (100), 195 (12), 193 (11), 179 (12), 177 (17), 175 (12), 135 (35), 121 (34), 107 (12), 95 
(16), 93 (21), 91 (12), 81 (16), 79 (16), 75 (24), 73 (13), 67 (17). HRMS (ESIneg): m/z calcd for 
C34H67O2SiSn: 655.3937, found: 655.3946. 
(Z,Z)-Chlorodiene 46. A solution of dienylstannane 45 (9.7 mg, 15 μmol) in THF (0.2 mL) was added to 
a suspension of CuCl2 (5.0 mg, 37 μmol) in THF (0.15 mL). The resulting mixture was 
stirred at ambient temperature for 24 h. The mixture was diluted with t-butyl 
methyl ether (2.5 mL) and the reaction quenched with aq. sat. NaHCO3 (3 mL). The 
aqueous layer was extracted with t-butyl methyl ether (3 × 4 mL). The combined 
extracts were washed with brine (5 mL), dried over Na2SO4, filtered and concentrated. The residue 
was purified by flash chromatography (hexanes/t-butyl methyl ether 15:1 to 10:1) to afford 
chlorodiene 46 (4.0 mg, 67%) along with diene 47 (0.3 mg, 6%) as a colorless oil each. 1H NMR (400 
MHz, CDCl3): δ = 6.41 (dd, J = 11.0, 0.9 Hz, 1H), 6.30 (td, J = 11.0, 1.3 Hz, 1H), 5.64 (ddd, J = 11.0, 8.4, 
0.9 Hz, 1H), 4.49 (dddd, J = 8.3, 7.2, 5.6, 1.3 Hz, 1H), 4.33 (dd, J = 10.2, 4.6 Hz, 1H), 1.93–1.78 (m, 2H), 
1.71–1.65 (m, 1H), 1.53–1.49 (m, 1H), 1.45–1.40 (m, 1H), 1.38–1.30 (m, 11H), 1.23–1.07 (m, 4H), 0.88 
(s, 9H), 0.05 (s, 3H), 0.03 ppm (s, 3H). 13C NMR (100 MHz, CDCl3): δ = 140.6, 137.4, 122.0, 121,1, 75.4, 
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69.2, 37.1, 34.7, 27.6, 27.5, 27.1, 26.9, 26.3, 26.0 (3C), 25.9, 25.2, 24.2, 18.3, –4.1, –4.6 ppm. IR (film): 
ṽ = 3368, 2927, 2856, 1727, 1461, 1360, 1251, 1074, 835, 775, 734, 663, 584 cm–1. MS (ESIpos) m/z 
(%): 423.2 (100 (M+Na)). HRMS (ESIpos): m/z calcd for C22H41O2ClSiNa: 423.2457, found: 423.2453. 
Analytical data for 47: 1H NMR (400 MHz, CDCl3): δ = 6.31 (dd, J = 15.3, 11.2 Hz, 1H), 5.94 (t, J = 11.1 
Hz, 1H), 5.54 (dd, J = 15.1, 8.9 Hz, 1H), 5.42 (dd, J = 11.0, 8.5 Hz, 1H), 4.55 (q, J = 7.4 
Hz, 1H), 4.19 (td, J = 9.4, 4.2 Hz, 1H), 1.77–1.69 (m, 2H), 1.46–1.40 (m, 2H), 1.36–1.29 
(m, 12H), 1.17–1.06 (m, 4H), 0.88 (s, 9H), 0.06 (s, 3H), 0.03 ppm (s, 3H). IR (film): 
ṽ = 3433, 2926, 2855, 1729, 1461, 1257, 1074, 948, 835, 775, 670 cm–1. MS (ESIpos) 
m/z (%): 389.3 (100 (M+Na)). HRMS (ESIpos): m/z calcd for C22H42O2SiNa: 389.2846, found: 389.2845. 
4.3.2 Synthesis of the Northern Alcohol Fragments 48 and 49 
1,5-Dichloropentane-2,4-dione (52). An oven-dried 3-necked flask equipped with a 250 ml dropping 
funnel and a reflux condenser, which was connected to two Drechsel bottles filled 
with 1 M NaOH solution, was charged with AlCl3 (60.0 g, 450 mmol). Nitrobenzene 
(76.0 mL, 738 mmol) was added dropwise over 30 min, followed by the dropwise addition of  
1,2-dichloroethane (90.0 mL, 1.14 mol) over 30 min. The mixture was stirred vigorously for 30 min 
before it was cooled to 0 °C. Next, acetyl acetone (46.2 mL, 450 mmol) was added dropwise over 
30 min, followed by chloroacetyl chloride (79.2 mL, 994 mmol), which was added dropwise over 
40 min. The resulting mixture was allowed to warm to rt, the reflux condenser was replaced by an 
internal thermometer, and the addition funnel was replaced by a distillation head, which was 
attached to the set of Drechsel bottles. The mixture was then gently heated to 65 °C over the course 
of 2 hours. Distillation of acetyl chloride (38–39 °C) was continued for 6 h, before the mixture was 
cooled to rt and poured into a mixture of ice and conc. HCl (65 mL). The resulting suspension was 
stirred vigorously at rt for 17 h before the phases were separated. The aqueous phase was extracted 
with Et2O (4 × 200 mL) and the combined extracts were poured into sat. aq. Cu(OAc)2 solution 
(800 mL). The resulting biphasic mixture was stirred vigorously at rt for 24 h before it was filtered 
with suction. The collected precipitate was washed with Et2O (200 mL) and triturated with Et2O 
(250 mL). Filtration with suction afforded the copper complex as green powdery solid, which was 
then suspended in a mixture of Et2O (400 mL) and 10% H2SO4 (250 mL). The mixture was stirred at rt 
for 24 h, the phases were separated and the aqueous phase was further extracted with Et2O 
(250 mL). The combined organic extracts were dried over Na2SO4, filtered and concentrated. 
Purification by Kugelrohr distillation afforded 52 (16.8 g, 22%) as a yellow oil that darkened over 
time. The product was detected as a mixture of keto-enol tautomers in the NMR: Enol: 1H NMR (400 
MHz, CDCl3): δ = 14.49 (s, 1H), 6.18 (s, 1H), 4.09 ppm (s, 4H). 
13C NMR (100 MHz, CDCl3): δ = 196.5, 
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187.4, 96.9, 44.2 ppm (2C). Ketone: 1H NMR (400 MHz, CDCl3): δ = 4.18 (s, 4H), 3.98 ppm (s, 2H).  
13C NMR (100 MHz, CDCl3): δ = 196.4 (2C), 50.6, 48.4 ppm (2C). IR (film): ṽ = 2937, 1727, 1604, 1397, 
1321, 1227, 1191, 1123, 903, 723, 650, 574 cm–1. MS (EI) m/z (%): 132 (14), 121 (33), 119 (100), 79 
(10), 77 (32), 68 (12), 67 (19), 49 (12), 43 (26), 39 (16), 37 (13), 36 (17). HRMS (ESIpos): m/z calcd for 
C5H6O2Cl2Na: 190.9637; found: 190.9638. 
(2R,4R)-1,5-Dichloropentane-2,4-diol (53). Freshly distilled 52 (8.50 g, 50.3 mmol) was dissolved in 
MeOH (23 mL) and the resulting solution was degassed with an Ar stream for 
20 min. [RuCl2((S)-BINAP)]2·Et3N (45.1 mg, 0.05 mmol, 0.1 mol%) was added and 
the resulting mixture was cannulated into an oven-dried 100 mL autoclave, which was then sealed 
and pressurized with H2 (62 bar). The reaction mixture was stirred at 70 °C (external temperature) for 
16 h before it was cooled to rt and concentrated. The residue was taken up in hexanes/EtOAc (1:1, 
100 mL) and passed through a plug of silica. The filter cake was washed with hexanes/EtOAc (1:1, 
250 mL) and the combined filtrates were concentrated. Recrystallization from CH2Cl2/hexanes (3:2, 
70 mL) afforded diol 53 (3.4 g, 39%, 97% ee, d.r. > 20:1) as colorless needles. m.p. [hexanes] =  
86–88 °C. [)]'
( = +21.1 (c = 1.0, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 4.14 (tdd, J = 6.8, 5.4, 4.1 Hz, 
2H), 3.65 (dd, J = 11.1, 4.0 Hz, 2H), 3.53 (dd, J = 11.1, 6.9 Hz, 2H), 2.77 (brs, 2H), 1.75 ppm (dd, J = 6.7, 
5.3 Hz, 2H). 13C NMR (100 MHz, CDCl3): δ = 68.7 (2C), 50.1 (2C), 37.6 ppm. IR (film): ṽ = 3361, 3285, 
2959, 2890, 1433, 1402, 1326, 1294, 1215, 1186, 1102, 1072, 1052, 911, 709, 571 cm–1. MS (ESIneg) 
m/z (%): 171.0 (100 (M–H)). HRMS (ESIneg): m/z calcd for C5H9O2Cl2: 170.9985; found: 170.9987.	 
The enantiomeric excess of diol 53 was initially determined by a modified Mosher analysis as 
described by Rychnovsky and coworkers[105b] and for further batches of 
material by comparison of optical rotation values. To a solution of diol 53 
(5.0 mg, 31 μmol) in CH2Cl2 (3 mL) was added triethylamine (26 μL, 0.19 mmol) followed by  
(S)-(+)-α-methoxy-α-trifluoromethyl-phenylacetyl chloride ((S)-MTPA-Cl) (25 μL, 0.13 mmol) and 
DMAP (0.5 mg, 4.1 μmol, 13 mol%). The reaction was stirred at rt for 2 h, before it was quenched 
with sat. aq. NaHCO3 (3 mL) and extracted with CH2Cl2 (3 × 5 mL). The combined extracts were dried 
over Na2SO4, filtered and concentrated. The crude diastereomeric mixture of (R)-MTPA-53 was 
obtained as a colorless oil (17.5 mg, 47%). [)]'
( = +82.5 (c = 2.02, CHCl3). 
1H NMR (400 MHz, CDCl3): 
δ = 7.62–7.55 (m, 4H), 7.47–7.41 (m, 6H), 5.05 (ddt, J = 7.6, 5.3, 4.1 Hz, 2H), 3.73 (dd, J = 12.3, 4.0 Hz, 
2H), 3.633 (s, 3H), 3.630 (s, 3H), 3.49 (dd, J = 12.3, 4.2 Hz, 2H), 2.08 ppm (dd, J = 7.3, 5.2 Hz, 2H). 
13C NMR (100 MHz, CDCl3): δ = 166.1 (2C), 132.2 (2C), 130.0 (2C), 128.8 (4C), 127.25 (2C), 127.24 (2C), 
124.8 (2C), 121.9 (2C), 71.5 (2C), 56.0, 55.9, 45.2 (2C), 34.5 ppm. IR (film): ṽ = 2956, 2851, 1753, 1452, 
1242, 1170, 1122, 1082, 1017, 819, 765, 719, 699 cm–1. MS (ESIpos) m/z (%): 627.1 (100 (M+Na)). 
HRMS (ESIpos): m/z calcd for C25H24O6F6Cl2Na: 327.0746; found: 627.0750. The enantiomeric excess 
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was determined based on 1H NMR by integration of the central CH2 signal of each derivative at 
400 MHz in CDCl3. The signal for the (R,R)-diol derivative appears at 2.08 ppm (dd, J = 7.3, 5.2 Hz, 2H) 
whereas the signal for the (S,S)-diol derivative appears at 2.20 ppm (dd, J = 7.3, 5.5 Hz, 0.03H). 
Hence, 98.5% of the (R,R)-diol and 1.5% of the (S,S)-diol were detected in the diastereomeric 
mixture, resulting in approx. 97% ee of diol 53. 
(3R,5R)-Hepta-1,6-diene-3,5-diol (50). A solution of n-BuLi (1.59 M in hexanes, 158.4 mL, 232 mmol) 
was added dropwise over 10 min to a –40 °C cold solution of Me3SI (47.2 g, 
232 mmol) in THF (140 mL). The resulting mixture was stirred for 15 min before a 
freshly prepared solution of diol 53 (4.00 g, 23.2 mmol) in THF (20 mL) was added dropwise over 
5 min. The mixture was allowed to warm to rt over the course of 6 h and stirred for 12 h before it 
was poured into sat. aq. NH4Cl (200 mL). The aqueous layer was extracted with t-butyl methyl ether 
(3 × 250 mL). The combined organic extracts were dried over Na2SO4, filtered and concentrated. The 
residue was purified by flash chromatography (hexanes/EtOAc 10:1) to give the desired product as a 
colorless oil (1.91 g, 65%). [)]'
( = –27.8 (c = 1.0, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 5.92 (ddd,  
J = 17.2, 10.5, 5.5 Hz, 2H), 5.29 (dt, J = 17.2, 1.5 Hz, 2H), 5.15 (dt, J = 10.5, 1.4 Hz, 2H), 4.46 (tdd,  
J = 6.9, 5.4, 1.5 Hz, 2H), 2.42 (brs, 2H), 1.78 ppm (dd, J = 6.1, 5.3 Hz, 2H). 13C NMR (100 MHz, CDCl3): 
δ = 140.5 (2C), 114.8 (2C), 70.6 (2C), 42.0 ppm. IR (film): ṽ = 3328, 3082, 2983, 2915, 1645, 1422, 
1315, 1114, 1054, 991, 921, 824, 656 cm–1. MS (EI) m/z (%): 57 (40), 56 (16), 55 (36), 54 (100), 43 
(11), 39 (20), 29 (19), 27 (13). HRMS (ESIpos): m/z calcd for C7H12O2Na: 151.0729; found: 151.0731.	 
(2S,3R,5R)-2-(Hydroxymethyl)-5-vinyltetrahydrofuran-3-ol (55). Diol 50 (1.81 g, 14.1 mmol) in  
2-propanol (147 mL) was added to a flask charged with Co(nmp)2 (798 mg, 
1.41 mmol, 10 mol%). The pale red solution was purged with O2 for 15 min before  
t-BuOOH (5.5 M in decane, 0.26 mL, 1.41 mmol, 10 mol%) was added in one portion; 
the solution slowly turned green. The reaction mixture was stirred at 55 °C under an oxygen 
atmosphere (balloon) for 5 h. After cooling to rt, the oxygen atmosphere was replaced by argon. The 
solvent was removed under reduced pressure, the residue was re-dissolved in EtOAc (10 mL) and the 
solution was filtered through a pad of silica (1 cm) over packed Celite® (3 cm), eluting with EtOAc 
(100 mL). The solvent was removed under reduced pressure and the residue purified by flash 
chromatography (hexanes/EtOAc 2:1 to 1:2) to yield the desired diol 55 as a pale yellow oil (1.59 g, 
78%). [)]'
( = –37.3 (c = 1.0, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 5.97 (ddd, J = 17.0, 10.3, 6.4 Hz, 
1H), 5.28 (dt, J = 17.2, 1.4 Hz, 1H), 5.14 (dt, J = 10.3, 1.3 Hz, 1H),  4.52 (ddd, J = 7.0, 6.4, 1.0 Hz, 1H), 
4.32 (q, J = 6.1 Hz, 1H), 3.92 (td, J = 5.0, 4.0 Hz, 1H), 3.74 (dd, J = 11.7, 4.0 Hz, 1H), 3.64 (dd, J = 11.7, 
4.9 Hz, 1H), 2.41 (ddd, J = 12.8, 6.8, 6.7 Hz, 1H), 2.32 (brs, 1H), 2.26 (brs, 1H), 1.84 ppm (ddd, J = 13.2, 
7.2, 6.2 Hz, 1H). 13C NMR (100 MHz, CDCl3): δ = 139.3, 115.8, 85.3, 79.3, 73.2, 62.8, 41.2 ppm. 
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IR (film): ṽ = 3359, 2930, 2877, 1645, 1427, 1338, 1329, 1088, 1035, 989, 928, 887, 857, 670 cm–1. 
MS (EI) m/z (%): 113 (43), 95 (32), 83 (27), 71 (11), 70 (19), 69 (10), 67 (53), 60 (11), 57 (29), 56 (28), 
55 (100), 54 (16), 53 (11), 43 (30), 42 (12), 41 (37), 39 (23), 31 (20), 29 (24), 27 (14). HRMS (ESIpos): 
m/z calcd for C7H12O3Na: 167.0679, found: 167.0680.	 
Bis-TES-ether 56. A solution of diol 55 (1.00 g, 6.94 mmol) in anhydrous DMF (20 mL) was cooled to 
0 °C. Imidazole (1.89 g, 27.7 mmol) and DMAP (84.7 mg, 0.69 mmol, 10 mol%) 
were added followed by TESCl (3.14 g, 20.8 mmol). The resulting solution was 
stirred at ambient temperature for 3 h. The reaction was quenched with sat. aq. 
NaHCO3 (30 mL) and the mixture was extracted with t-butyl methyl ether (3 × 50 mL). The combined 
extracts were dried over Na2SO4, filtered and concentrated. The residue was purified by flash 
chromatography (hexanes/t-butyl methyl ether 300:1) to yield the title compound as a colorless oil 
(2.09 g, 81%). [)]'
( = –22.7 (c = 1.0, CHCl3). 
1H NMR (500 MHz, CDCl3): δ = 6.00 (ddd, J = 17.2, 10.2, 
7.5 Hz, 1H), 5.17 (ddd, J = 17.2, 1.6, 1.0 Hz. 1H), 5.05 (ddd, J = 10.2, 1.6, 1.0 Hz, 1H), 4.44 (dtt, J = 8.0, 
6.6, 1.0 Hz, 1H), 4.38 (ddd, J = 6.3, 5.3, 3,9 Hz, 1H), 3.88 (q, J = 4.3 Hz, 1H), 3.64 (dd, J = 10.9, 4.2 Hz, 
1H), 3.59 (dd, J = 10.9, 4.9 Hz, 1H), 2.30 (ddd, J = 12.6, 7.0, 6.6 Hz, 1H), 1.74 (ddd, J = 12.6, 6.6, 5.2 Hz, 
1H), 0.958 (t, J = 7.9 Hz, 9H), 0.955 (t, J = 7.9 Hz, 9H), 0.602 (q, J = 7.9 Hz, 6H), 0.600 ppm (q, 
J = 7.9 Hz, 6H). 13C NMR (125 MHz, CDCl3): δ = 140.1, 115.3, 86.6, 80.3, 73.4, 63.4, 41.6, 6.9 (6C), 4.9 
(3C), 4.5 (3C) ppm. IR (film): ṽ = 2954, 2911, 2876, 1458, 1415, 1238, 1110, 1077, 1004, 918, 835, 785, 
726 cm–1. MS (EI) m/z (%): 343 (14), 190 (24), 289 (100), 259 (27), 240 (10), 217 (12), 211 (25), 145 
(10), 117 (69), 115 (25), 87 (21). HRMS (ESIpos): m/z calcd for C19H40O3Si2Na: 395.2408, found: 
395.2411.	 
Bis-TES-ether 57. In case of instant silyl protection of the crude mixture of diol 55, a second 
compound was isolated after flash chromatography, which appeared to be the bis-
silylated starting material of the Mukaiyama oxidative cyclization 57. This undesired 
byproduct was isolated only once (302 mg, 12%) and characterized as follows: [)]'
( = –5.4 (c = 1.0, 
CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 5.81 (ddd, J = 17.3, 10.3, 7.1 Hz, 2H), 5.13 (ddd, J = 17.2, 1.8 Hz, 
2H), 5.04 (ddd, J = 10.2, 1.7, 0.9 Hz, 2H), 4.16 (tdd, J = 7.5, 6.0, 1.0 Hz, 2H), 1.70 (t, J = 6.6 Hz, 2H), 
0.94 (t, J = 7.9 Hz, 18H), 0.59 ppm (q, J = 7.6 Hz, 12H). 13C NMR (100 MHz, CDCl3): δ = 141.8 (2C), 
114.5 (2C), 71.2 (2C), 47.2, 7.0 (6C), 5.2 ppm (6C). IR (film): ṽ = 2982, 2913, 1427, 1115, 1051, 903, 
723, 650 cm–1. MS (ESIpos) m/z (%): 379.2 (100 (M+Na)). HRMS (ESIpos): m/z calcd for C19H40O2Si2Na: 
379.2459, found: 379.2460.	 
The bis-silyl ether 57 could be cleaved to diol 50 as follows: A solution of TBAF (1 M in THF, 3.31 mL, 
3.31 mmol) was added to a solution of bis-silyl ether 57 (295 mg, 0.83 mmol) in THF (8 mL) at –50 °C. 
The resulting reaction mixture was stirred at this temperature for 3.5 h. The reaction was quenched 
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with sat. aq. NH4Cl (10 mL) and the mixture was extracted with t-butyl methyl ether (3 × 15 mL). The 
combined organic extracts were dried over Na2SO4, filtered and concentrated. The residue was 
purified by flash chromatography (hexanes/EtOAc 10:1) to give the desired product 50 (85 mg, 80%) 
as a colorless oil (analytical data vide supra). 
Tetrahydrofuran-carbaldehyde 58. Ozone was bubbled through a solution of olefin 56 (2.75 g, 
7.38 mmol) in CH2Cl2 (500 mL) at –78 °C for 90 min, until the blue color persisted. 
Oxygen was then bubbled through the mixture for approx. one minute followed 
by argon until the solution was colorless. PPh3 (2.90 g, 11.1 mmol) was added in 
one portion and the mixture was allowed to reach rt overnight. The mixture was washed with sat. aq. 
NaHCO3 (100 mL) and brine (100 mL), dried over Na2SO4, filtered and concentrated. The residue was 
purified by flash chromatography (hexanes/t-butyl methyl ether 100:1 to 20:1) to afford the title 
compound as a colorless oil (2.07 g, 75%). [)]'
( = –5.7 (c = 1.0, CHCl3). 
1H NMR (400 MHz, CDCl3):  
δ = 9.72 (d, J = 1.5 Hz, 1H), 4.34 (m, 2H), 4.07 (dd, J = 6.8, 4.1 Hz, 1H), 3.64 (dd, J = 10.7, 4.1 Hz, 1H), 
3.42 (dd, J = 10.7, 6.7 Hz, 1H), 2.30 (ddd, J = 13.4, 9.4, 4.3 Hz, 1H), 2.02 (ddd, J = 13.0, 1.8, 1.8 Hz, 1H), 
0.95 (t, J = 7.9 Hz, 9H), 0.92 (t, J = 7.9 Hz, 9H), 0.60 (q, J = 7.9 Hz, 6H), 0.57 ppm (q, J = 7.9 Hz, 6H). 
13C NMR (100 MHz, CDCl3): δ = 205.7, 89.0, 83.0, 72.8, 63.5, 38.9, 6.9 (3C), 6.8 (3C), 4.8 (3C), 4.4 ppm 
(3C). IR (film): ṽ = 2954, 2912, 2877, 1735, 1459, 1415, 1239, 1177, 1091, 1042, 1005, 977, 863, 797, 
726 cm–1. MS (EI) m/z (%): 346 (15), 345 (52), 317 (25), 289 (20), 259 (15), 213 (14), 189 (13), 188 
(13), 187 (96), 171 (12), 159 (17), 157 (10), 145 (37), 131 (16), 118 (10), 117 (100), 115 (54), 103 (23), 
101 (10), 87 (47), 75 (10), 59 (21). HRMS (ESIpos): m/z calcd for C18H38O4Si2Na: 397.2201, found: 
397.2200.	 
Propargylic alcohol 59.  A Schlenk flask was charged with Zn(OTf)2 (3.82 g, 10.5 mmol) and (1R, 2S)- 
(–)-N-methylephedrine (1.88 g, 10.5 mmol) before toluene (25 mL) and Et3N 
(1.46 mL, 10.5 mmol) were added. The mixture was stirred at rt for 2 h before 
being cooled to –78 °C. Next, condensed propyne (excess, approx. 1 mL) was 
cannulated from a Schlenk tube at –78 °C into the cold solution. The reaction mixture was taken out 
of the cooling bath and stirred at rt for 1 h before a freshly prepared solution of aldehyde 58 (1.75 g, 
4.67 mmol) in toluene (25 mL) was added. After 48 h, the reaction was quenched by addition of sat. 
aq. NH4Cl (30 mL). The aqueous phase was extracted with t-butyl methyl ether (3 × 50 mL) and the 
combined extracts were dried over Na2SO4, filtered and concentrated. The residue was purified by 
flash chromatography (hexanes/t-butyl methyl ether 19:1 to 10:1) to give propargylic alcohol 59 as a 
colorless oil (1.45 g, 75%, d.r. > 12:1). [)]'
( = –12.5 (c = 1.0, CHCl3). 
1H NMR (400 MHz, CDCl3):  
δ = 4.41 (dt, J = 6.4, 2.4 Hz, 1H), 4.35 (dt, J = 5.9, 2.3 Hz, 1H), 4.15 (ddd, J = 8.5, 6.3, 3.5 Hz, 1H), 3.97 
(ddd, J = 6.2, 4.1, 2.0 Hz, 1H), 3.63 (dd, J = 10.7, 4.2 Hz, 1H), 3.45 (dd, J = 10.7, 6.3 Hz, 1H), 3.20 (d, 
EXPERIMENTAL SECTION 137 
   
J = 2.9 Hz, 1H), 2.29 (ddd, J = 13.6, 8.6, 5.9 Hz, 1H), 1.87 (m, 1H), 1.85 (d, J = 2.2 Hz, 3H), 0.953 (t, 
J = 7.9 Hz, 9H), 0.948 (t, J = 7.9 Hz, 9H), 0.61 (q, J = 7.9 Hz, 6H), 0.58 ppm (q, J = 7.9 Hz, 6H). 13C NMR 
(100 MHz, CDCl3): δ = 87.9, 82.8, 81.6, 77.8, 73.4, 65.8, 63.3, 37.2, 6.9 (3C), 6.8 (3C), 4.7 (3C), 4.5 (3C), 
3.9 ppm. IR (film): ṽ = 3450, 2953, 2912, 2876, 1458, 1414, 1238, 1109, 1035, 1003, 831, 794,  
726 cm–1. MS (EI) m/z (%): 385 (23), 253 (11), 213 (32), 146 (11), 145 (84), 133 (13), 131 (17), 118 
(11), 117 (100), 115 (43), 103 (21), 87 (29). HRMS (ESIpos): m/z calcd for C21H42O4Si2Na: 437.2514, 
found: 437.2515.	 
Mosher ester analysis of alcohol 59. Triethylamine (10 μL, 72 μmol) and DMAP (3.0 mg, 24 μmol) 
were added to a solution of alcohol 59 (10 mg, 24 μmol) in CH2Cl2 (0.25 mL) followed by  
(R)-(–)-α-methoxy-α-trifluoromethyl-phenylacetyl chloride ((R)-MTPA-Cl) (9.0 μL, 48 μmol). The 
reaction was stirred at rt for 4 h, before it was quenched with sat. aq. NaHCO3 (3 mL). The aqueous 
layer was extracted with CH2Cl2 (3 × 5 mL), the combined extracts were dried over Na2SO4, filtered 
and concentrated. The residue was purified by flash chromatography (hexanes/t-butyl methyl ether 
19:1) to give the corresponding (S)-Mosher ester (S)-MTPA-59 (11 mg, 72%), which analyzed as 
follows: 1H NMR (400 MHz, CDCl3): δ = 7.63–7.58 (m, 2H), 7.41–7.35 (m, 3H), 5.91 (dq, J = 8.5, 2.2 Hz, 
1H), 4.32 (dt, J = 6.0, 3.0 Hz, 1H), 4.17 (ddd, J = 8.5, 7.8, 3.7 Hz, 1H), 3.89 (ddd, J = 5.2, 3.8, 2.8 Hz, 
1H), 3.59 (d, J = 1.1 Hz, 3H), 3.59 (dd, J = 10.9, 3.8 Hz, 1H), 3.46 (dd, J = 10.9, 5.3 Hz, 1H), 2.17 (ddd, 
J = 13.6, 7.8, 6.0 Hz, 1H), 2.00 (dt, J = 13.3, 3.4 Hz, 1H), 1.85 (d, J = 2.2 Hz, 3H), 0.97 (t, J = 7.9 Hz, 9H), 
0.93 (t, J = 8.0 Hz, 9H), 0.61 (q, J = 7.7 Hz, 6H), 0.57 ppm (q, J = 7.9 Hz, 6H). 19F NMR (282 MHz, CDCl3): 
δ = –72.0 ppm. MS (ESIpos) m/z (%): 653.3 (100 (M+Na)). HRMS (ESI): m/z calcd for C31H49O6F3Si2Na: 
653.2912, found: 653.2921. 
The same procedure was followed for the preparation of (R)-MTPA-59 (5.0 mg, 33%), which analyzed 
as follows: 1H NMR (400 MHz, CDCl3): δ = 7.64–7.59 (m, 2H), 7.40–7.35 (m, 3H), 5.84 (dq, J = 8.9, 
2.1 Hz, 1H), 4.34 (dt, J = 5.8, 2.8 Hz, 1H), 4.23 (ddd, J = 8.9, 8.0, 3.4 Hz, 1H), 3.91 (ddd, J = 5.3, 3.8, 
2.6 Hz, 1H), 3.64 (d, J = 1.2 Hz, 3H), 3.60 (dd, J = 10.9, 3.8 Hz, 1H), 3.48 (dd, J = 10.9, 5.3 Hz, 1H), 2.22 
(ddd, J = 13.7, 8.1, 5.9 Hz, 1H), 2.00 (dt, J = 13.3, 3.2 Hz, 1H), 1.80 (d, J = 2.2 Hz, 3H), 0.97 (t, J = 7.9 Hz, 
9H), 0.94 (t, J = 7.9 Hz, 9H), 0.62 (q, J = 7.7 Hz, 6H), 0.58 ppm (q, J = 7.8 Hz, 6H). 19F NMR (282 MHz, 
CDCl3): δ = –71.8 ppm. MS (ESIpos) m/z (%): 653.3 (100 (M+Na)). HRMS (ESI): m/z calcd for 
C31H49O6F3Si2Na: 653.2912, found: 653.2920. 
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Both products were analyzed according to Hoye and co-workers:[118] 
Table 4.1. Mosher ester analysis for the assignment of the C(4) stereocenter; arbitrary numbering as shown in the insert. 
 
 
 
Assignment 59 [ppm]  (S)-MTPA-59 [ppm]  (R)-MTPA-59 [ppm] Δ (δ(S–R)) [ppm] 
1 1.85 1.85 1.80 +0.05 
4 4.41 5.91 5.84 –0.07 
5 4.15 4.17 4.23 –0.06 
6a 
6b 
2.29 
1.87 
2.17 
2.00 
2.22 
2.00 
–0.05 
0.00 
7 4.35 4.32 4.34 –0.02 
8 3.97 3.89 3.91 –0.02 
9a 
9b 
3.63 
3.45 
3.59 
3.46 
3.60 
3.48 
–0.01 
–0.02 
TES 
0.95 
0.95 
0.97 
0.93 
0.97 
0.94 
0.00 
–0.01 
TES 
0.61 
0.58 
0.61 
0.57 
0.62 
0.58 
–0.01 
–0.01 
 
t-Butyl-dimethyl silyl ether S16. Imidazole (102 mg, 1.50 mmol) was added to a solution of 
propargylic alcohol 59 (250 mg, 0.60 mmol) in DMF (4 mL) and the solution 
was cooled to 0 °C before TBSCl (109 mg, 0.72 mmol) was added. The 
resulting mixture was stirred at rt for 4 h, before the reaction was quenched 
with sat. aq. NaHCO3 (10 mL) and the aqueous layer extracted with t-butyl methyl ether (3 × 15 mL). 
The combined extracts were washed with water (50 mL) and brine (50 mL), dried over Na2SO4, 
filtered and concentrated. The residue was purified by flash chromatography (hexanes/EtOAc 40:1) 
to give the desired t-butyl-dimethyl silyl ether S16 as a colorless oil (260 mg, 82%). [)]'
( = –31.3 
(c = 1.0, CHCl3).
 1H NMR (400 MHz, CDCl3): δ = 4.50 (dq, J = 7.3, 2.1 Hz, 1H), 4.27 (ddd, J = 6.2, 4.5, 
3.7 Hz, 1H), 4.00 (td, J = 7.5, 5.1 Hz, 1H), 3.81 (dt, J = 5.5, 4.1 Hz, 1H), 3.61 (dd, J = 10.8, 4.2 Hz, 1H), 
3.51 (dd, J = 10.8, 5.4 Hz, 1H), 2.16 (ddd, J = 13.5, 7.6, 6.2 Hz, 1H), 1.96 (dt, J = 13.0, 4.9, 1H), 1.81 (d,  
J = 2.1 Hz, 3H), 0.96 (t, J = 7.9 Hz, 9H), 0.94 (t, J = 7.9 Hz, 9H), 0.91 (s, 9H), 0.60 (q, J = 7.9 Hz, 6H), 0.58 
O
H
OTES
H
OTES
MTPA-O
1
2
3
4
6
8
9
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(q, J = 7.9 Hz, 6H), 0.11 (s, 3H), 0.10 ppm (s, 3H). 13C NMR (100 MHz, CDCl3): δ = 86.6, 82.4, 81.2, 78.7, 
72.7, 67.0, 63.2, 37.0, 26.1 (3C), 18.7, 6.9 (6C), 4.8 (3C), 4.5 (3C), 3.8, –4.6, –4.7 ppm. IR (film): ṽ = 
2954, 2877, 1461, 1414, 1247, 1114, 1079, 1041, 1005, 940, 837, 778, 743, 670 cm–1. MS (EI) m/z (%): 
499 (12), 173 (12), 472 (26), 471 (63), 339 (30), 313 (24), 213 (18), 212 (18), 211 (96), 209 (31), 207 
(16), 189 (12), 183 (11), 181 (42), 161 (11), 155 (41), 147 (16), 146 (13), 145 (100), 133 (14), 131 (14), 
117 (63), 115 (51), 97 (10), 89 (50), 87 (33), 75 (12), 73 (50). HRMS (ESIpos): m/z calcd for 
C27H56O4Si3Na: 551.3379, found: 551.3383.  
Diol 119. A solution of t-butyl-dimethyl silyl ether S16 (250 mg, 0.47 mmol) in MeOH (5 mL) was 
cooled to –50 °C before p-toluenesulfonic acid monohydrate (PTSA, 9.00 mg, 
0.05 mmol) was added. The resulting mixture was stirred at  
–50 °C for 5 h. The reaction was quenched with sat. aq. NaHCO3 (5 mL) and the 
mixture was extracted with EtOAc (3 × 10 mL). The combined extracts were dried over Na2SO4, 
filtered and concentrated. The residue was purified by flash chromatography (hexanes/t-butyl 
methyl ether 10:1 to 2:1) to afford the title compound 119 as a colorless oil (103 mg, 73%). 
[)]'
( = –76.6 (c = 1.0, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 4.42 (dq, J = 4.3, 2.1 Hz, 1H), 4.18 (dt, 
 J = 8.7, 4.5 Hz, 2H), 4.04 (dt, J = 5.4, 3.9 Hz, 1H), 3.65 (dt, J = 11.6, 4.7 Hz, 1H), 3.54 (dt, J = 11.1, 4.9 
Hz, 1H), 3.20 (d, J = 8.7 Hz, 1H), 2.37 (ddd, J = 13.8, 8.6, 6.8 Hz, 1H), 2.10 (t, J = 6.1 Hz, 1H), 1.97 (dt, 
J = 13.8, 4.2, 1H), 1.86 (d, J = 2.2 Hz, 3H), 0.91 (s, 9H), 0.16 (s, 3H), 0.14 ppm (s, 3H). 13C NMR (100 
MHz, CDCl3): δ = 87.2, 82.5, 81.6, 78.6, 72.6, 66.3, 62.8, 36.7, 26.0 (3C), 18.5, 3.8, –4.5, –4.7 ppm.  
IR (film): ṽ = 3393, 2928, 2857, 1472, 1361, 1252, 1088, 1004, 939, 837, 778, 670 cm–1. MS (ESIpos) 
m/z (%): 323.2 (100 (M+Na)). HRMS (ESIpos): m/z calcd for C15H28O4SiNa: 323.1649, found: 323.1652.  
Bis-t-butyl-dimethyl silyl ether 48. Imidazole (23.1 mg, 0.34 mmol) was added to a solution of 
diol 119 (50.0 mg, 0.17 mmol) in DMF (3 mL) and the solution was cooled to 
0 °C before TBSCl (28.2 mg, 0.19 mmol) was added. The resulting mixture was 
stirred at rt for 8 h, before the reaction was quenched with sat. aq. NaHCO3 
(10 mL). The aqueous layer was extracted with t-butyl methyl ether (3 × 15 mL), the combined 
extracts were washed with water (40 mL) and brine (40 mL), dried over Na2SO4, filtered and 
concentrated. The residue was purified by flash chromatography (hexanes/EtOAc 10:1) to yield the 
title compound 48 as a colorless oil (38 mg, 54%). [)]'
( = –42.6 (c = 0.69, CHCl3). 
1H NMR (400 MHz, 
CDCl3): δ = 4.40 (dq, J = 4.3, 2.2 Hz, 1H), 4.02 (dt, J = 8.9, 4.2 Hz, 2H), 4.02 (ddt, J = 5.9, 3.8, 2.3 Hz, 
1H), 3.70 (dd, J = 10.5, 3.8 Hz, 1H), 3.52 (dd, J = 10.5, 6.2 Hz, 1H), 3.27 (d, J = 8.9 Hz, 1H), 2.41 (ddd,  
J = 13.7, 9.0, 6.5 Hz, 1H), 1.92 (dddd, J = 13.7, 4.3, 2.9, 0.7 Hz, 1H), 1.86 (d, J = 2.2 Hz, 3H), 0.92 (s, 
9H), 0.88 (s, 9H), 0.16 (s, 3H), 0.14 (s, 3H), 0.04 ppm (s, 6H). 13C NMR (100 MHz, CDCl3): δ = 87.3, 82.3, 
82.1, 78.8, 73.9, 66.2, 64.4, 36.3, 26.0 (6C), 18.5, 18.4, 3.9, –4.4, –4.7, –5.3 ppm (2C). IR (film):  
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ṽ = 3445, 2954, 2929, 2857, 1472, 1361, 1254, 1088, 1005, 937, 836, 777, 670 cm–1. MS (ESIpos) m/z 
(%): 437.3 (100 (M+Na)). HRMS (ESIpos): m/z calcd for C21H42O4Si2Na: 437.2514, found: 437.2510.  
Methoxymethyl acetal S17. A solution of propargylic alcohol 59 (160 mg, 0.39 mmol) in CH2Cl2 (5 mL) 
was cooled to 0 °C before Hünig’s base (0.27 mL, 1.54 mmol) followed by 
MOMCl (58.6 μL, 0.77 mmol) was added. The resulting mixture was stirred at 
rt for 16 h, before the reaction was quenched with sat. aq. NaHCO3 (10 mL). 
The aqueous layer was extracted with CH2Cl2 (3 × 15 mL), the combined extracts were dried over 
Na2SO4, filtered and concentrated. The residue was purified by flash chromatography (hexanes/ 
t-butyl methyl ether 30:1 to 20:1) to afford the title compound S17 as a colorless oil (160 mg, 91%). 
[)]'
( = –64.0 (c = 1.0, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 4.94 (dd, J = 6.6, 1.4 Hz, 1H), 4.67 (dd, 
J = 6.6, 1.6 Hz, 1H), 4.51 (dq, J = 8.3, 2.1 Hz, 1H), 4.33 (dt, J = 6.2, 3.4 Hz, 1H), 4.14 (tdd, J = 8.3, 4.4, 
1.4 Hz, 1H), 3.90 (dt, J = 5.8, 3.9 Hz, 1H), 3.63 (ddd, J = 10.8, 4.1, 1.4 Hz, 1H), 3.49 (ddd, J = 10.6, 5.7, 
1.3 Hz, 1H), 3.40 (s, 3H), 2.23 (ddd, J = 13.2, 7.9, 6.0 Hz, 1H), 2.01 (dt, J = 13.2, 4.2, 1H), 1.84 (d, J = 2.1 
Hz, 3H), 0.96 (t, J = 7.9 Hz, 9H), 0.94 (t, J = 7.9 Hz, 9H), 0.60 (q, J = 7.9 Hz, 6H), 0.58 ppm (q, J = 7.9 Hz, 
6H). 13C NMR (100 MHz, CDCl3): δ = 94.3, 87.4, 82.9, 81.1, 75.8, 73.0, 69.3, 63.2, 55.5, 37.5, 6.9 (6C), 
4.9 (3C), 4.5 (3C), 3.8 ppm. IR (film): ṽ = 2953, 2877, 1459, 1415, 1239, 1150, 1089, 1053, 1031, 1007, 
942, 840, 796, 726 cm–1. MS (EI) m/z (%): 399 (17), 362 (15), 213 (17), 146 (10), 145 (80), 131 (15), 
118 (11), 117 (100), 115 (38), 87 (19). HRMS (ESIpos): m/z calcd for C23H46O5Si2Na: 481.2776, found: 
481.2780.  
Diol S18. A solution of methoxymethyl acetal S17 (160 mg, 0.35 mmol) in THF (5 mL) was cooled to 
0 °C before a solution of TBAF (1 M in THF, 0.77 mL, 0.77 mmol) was added and 
the resulting mixture was stirred for 10 min. The reaction was quenched with 
sat. aq. NH4Cl (5 mL) and the aqueous layer was extracted with EtOAc 
(3 × 10 mL). The combined extracts were dried over Na2SO4, filtered and concentrated. The yellow 
residue was purified by flash chromatography (hexanes/EtOAc 1:1 to 0:1 to EtOAc/MeOH 95:5) to 
yield the title compound S18 as a colorless oil (71 mg, 88%). [)]'
( = –170.8 (c = 1.0, CHCl3). 
1H NMR 
(400 MHz, CDCl3): δ = 5.05 (d, J = 6.7 Hz, 1H), 4.66 (d, J = 6.8 Hz, 1H), 4.41 (dq, J = 4.2, 2.1 Hz, 1H), 
4.35 (dt, J = 8.7, 4.3 Hz, 1H), 4.26 (ddd, J = 7.6, 7.1, 3.3 Hz, 1H), 4.08 (ddd, J = 5.1, 4.0, 3.0 Hz, 1H), 
3.69 (dd, J = 12.0, 3.9 Hz, 1H), 3.58 (dd, J = 11.8, 5.0 Hz, 1H), 3.41 (s, 3H), 3.11 (d, J = 8.5 Hz, 1H), 2.45 
(ddd, J = 13.8, 8.7, 6.8 Hz, 1H), 1.97 (dt, J = 13.8, 3.8, 1H), 1.89 ppm (d, J = 2.1 Hz, 3H). 13C NMR (100 
MHz, CDCl3): δ = 94.0, 87.6, 83.9, 80.6, 74.9, 72.9, 68.5, 63.0, 56.2, 37.5, 3.89 ppm. IR (film): ṽ = 3401, 
2922, 2892, 1443, 1331, 1215, 1149, 1096, 1030, 930 cm–1. MS (EI) m/z (%): 117 (17), 45 (23), 36 (10), 
29 (100). HRMS (ESIpos): m/z calcd for C11H18O5Na: 253.1046, found: 253.1045.  
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Alcohol 49. Imidazole (41.4 mg, 0.61 mmol) was added to a solution of diol S18 (70.0 mg, 0.30 mmol) 
in CH2Cl2 (6 mL) and the solution was cooled to 0 °C before TBSCl (50.4 mg, 
0.33 mmol) was added followed by DMAP (3.71 mg, 0.03 mmol, 10 mol%). 
The resulting mixture was stirred at rt for 16 h, before the reaction was 
quenched with half-sat. aq. NH4Cl (5 mL). The aqueous layer was extracted with CH2Cl2 (3 × 8 mL), the 
combined extracts were dried over Na2SO4, filtered and concentrated. The residue was purified by 
flash chromatography (hexanes/EtOAc 10:1) to afford the desired alcohol 49 as a colorless oil (80 mg, 
76%). [)]'
( = –108.6 (c = 0.88, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 5.04 (d, J = 6.8 Hz, 1H), 4.65 (d, 
J = 6.8 Hz, 1H), 4.38 (dq, J = 4.3, 2.1 Hz, 1H), 4.34 (dt, J = 9.0, 4.0 Hz, 1H), 4.26 (ddt, J = 8.8, 6,4, 2.5 Hz, 
1H), 4.04 (ddd, J = 6.0, 3.6, 2.3 Hz, 1H), 3.71 (dd, J = 10.5, 3.7 Hz, 1H), 3.54 (dd, J = 10.6, 6.0 Hz, 1H), 
3.40 (s, 3H), 3.28 (d, J = 8.7 Hz, 1H), 2.48 (ddd, J = 13.7, 8.9, 6.5 Hz, 1H), 1.91 (dddd, J = 13.8, 4.3, 3.0, 
0.7 Hz, 1H), 1.88 (d, J = 2.1 Hz, 3H), 0.88 (s, 9H), 0.05 ppm (s, 6H). 13C NMR (100 MHz, CDCl3): δ = 94.0, 
87.6, 83.7, 80.9, 75.2, 74.1, 68.4, 64.5, 56.2, 37.1, 26.0 (3C), 18.4, 4.0, –5.3, –5.4 ppm. IR (film):  
ṽ = 3442, 2928, 2857, 1472, 1361, 1254, 1149, 1097, 1034, 935, 835, 778, 669 cm–1. MS (ESIpos) m/z 
(%): 367.2 (100 (M+Na)). HRMS (ESIpos): m/z calcd for C17H32O5SiNa: 367.1911, found: 367.1908.  
4.3.3 Synthesis of the Southern Acid Fragment 60 
(Z)-But-2-en-1-ol (62). Quinoline (4.21 mL, 35.7 mmol, 0.1 equiv) was added to a suspension of 
10 wt% Pd/BaSO4 (1.90 g, 17.8 mmol, 5 mol%) in MeOH (125 mL) and the resulting 
mixture was stirred for 20 min at ambient temperature. Subsequently, 2-butyn-1-ol 
(25.0 g, 357 mmol) was added and seven balloons of hydrogen were slowly bubbled through the 
suspension over 12 h. The reaction progress was monitored by GC-MS/FID (method 50:10, tR (s.m.) = 
2.74 min, tR (product) = 2.23 min) and the reaction immediately stopped by replacing the H2 
atmosphere with Ar as soon as the starting material was fully consumed (this was crucial to avoid 
overreduction or isomerization of the double bond). The reaction mixture was filtered through a pad 
of Celite®, eluting with CH2Cl2 (40 mL). The resulting yellow solution was carefully concentrated via 
distillation (vigreux, 400 mbar, 30 °C) and the residue finally distilled (75 mbar, 75–80 °C) to afford 
the title compound 62 as a pale yellow liquid (16.8 g, 232 mmol, 65%). 1H NMR (400 MHz, CDCl3):  
δ = 5.64–5.59 (m, 2H), 4.21 (d, J = 3.1 Hz, 1H), 4.20 (d, J = 4.6 Hz, 1H), 1.67 ppm (d, J = 5.3 Hz, 3H).  
13C NMR (100 MHz, CDCl3): δ = 129.3, 127.4, 58.4, 13.1 ppm. IR (film): ṽ = 3407, 3024, 2932, 1738, 
1657, 1446, 1378, 1260, 1040, 813, 696 cm–1. MS (EI) m/z (%): 72 (29), 57 (100), 54 (12), 43 (30), 41 
(20), 39 (30), 31 (12), 29 (25), 27 (12). HRMS (EI): m/z calcd for C4H8O: 72.0575, found: 72.0575. The 
analytical and spectroscopic data are in agreement with those reported in the literature.[231] 
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((2S,3R)-3-Methyloxiran-2-yl)methanol (61). A 500 mL jacketed Schlenk flask was charged with 
activated powdered 4 Å MS (14 g) and CH2Cl2 (500 mL) and cooled to –20 °C. 
Subsequently, (+)-diethyl (L)-tartrate (2.03 mL, 11.9 mmol, 6 mol%) and Ti(Oi-Pr)4 
(2.94 mL, 9.92 mmol, 5 mol%) were added, followed by allylic alcohol 62 (14.3 g, 198 mmol). The 
reaction mixture was stirred for 45 min at the same temperature, before t-BuOOH (5.5 M in decane, 
54.0 mL, 297 mmol) was added via a dropping funnel over 60 min, and the resulting mixture was 
stirred for 40 h at –20°C. The septum was removed, dimethyl sulfide (21.8 mL, 297 mmol) was added 
and the resulting mixture stirred open to atmosphere at ambient temperature for 24 h. The reaction 
mixture was filtered through a pad of Celite® and rinsed with CH2Cl2 (300 mL). The solvent was 
evaporated and the residue purified by flash chromatography (pentane/Et2O 4:1) followed by 
distillation (12 mbar, 59–64 °C) to yield epoxide 61 as a colorless oil (12.9 g, 74%, 90% ee).  
[)]'
( = –4.8 (c = 1.0, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 3.85 (dq, J = 11.3, 3.6 Hz, 1H), 3.68 (ddd, 
J = 11.6, 6.2, 3.7 Hz, 1H), 3.19–3.11 (m, 2H), 2.09 (brs, 1H), 1.31 ppm (d, J = 5.5 Hz, 3H). 13C NMR (100 
MHz, CDCl3): δ = 60.8, 56.9, 53.0, 13.5 ppm. IR (film): ṽ = 3397, 2930, 1451, 1040, 986, 877, 829, 783, 
731 cm–1. MS (EI) m/z (%): 45 (100), 44 (43), 43 (48), 31 (32), 29 (26), 27 (16). HRMS (ESIpos): m/z 
calcd for C4H8O2Na: 111.0416, found: 111.0416. The ee was determined by GC (30 m, BGB-176/BGB-
15 G/618, 80 1/min 120 8/min 220 3/min iso, flow rate 0.50 bar H2: minor enantiomer tR = 10.7 min; 
major enantiomer tR = 11.1 min). The analytical and spectroscopic data are in agreement with those 
reported in the literature.[119]  
 
((2S,3R)-3-Methyloxiran-2-yl)methyl 4-nitrobenzoate (64). A 100 mL jacketed Schlenk flask was 
charged with activated powdered 4 Å MS (320 mg) and CH2Cl2 (20 mL) and cooled to 
–20 °C. Subsequently, (+)-diethyl (L)-tartrate (71.9 μL, 0.42 mmol, 6 mol%) and  
Ti(Oi-Pr)4 (103 μL, 0.35 mmol, 5 mol%) were added, followed by allylic alcohol 62 
(500 mg, 6.93 mmol). The reaction mixture was stirred for 45 min at the same 
temperature, before t-BuOOH (5.5 M in decane, 1.89 mL, 10.4 mmol) was added via syringe pump 
over 20 min, and the resulting mixture was stirred for 20 h at –20°C. Afterward, trimethyl phosphite 
(1.23 mL, 10.4 mmol) was slowly added via syringe pump. Next, Et3N (1.16 mL, 8.32 mmol) was 
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added followed by a solution of 4-nitrobenzoyl chloride (1.29 g, 6.93 mmol) in CH2Cl2 (1.8 mL). The 
resulting mixture was warmed to 0 °C and stirred for 1 h. The reaction mixture was filtered through a 
pad of Celite® and rinsed with CH2Cl2 (10 mL). The filtrate was washed with aq. tartaric acid 
(10%, 3 × 5 mL), aq. sat. NaHCO3 (3 × 5 mL) and brine (2 × 5 mL), dried over Na2SO4, filtered and 
concentrated. The residue solidified upon standing and was recrystallized twice from Et2O to afford 
the title compound 64 as pale yellow crystals (953 mg, 58%, 94% ee). m.p. [Et2O] = 69–71 °C.  
[)]'
( = –26.3 (c = 1.2, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 8.32–8.28 (m, 2H), 8.27–8.23 (m, 2H), 
4.65 (dd, J = 12.1, 4.0 Hz, 1H), 4.33 (dd, J = 12.1, 7.2 Hz, 1H), 3.32 (dt, J = 7.1, 4.1 Hz, 1H), 3.22 (qd, 
J = 5.6, 4.3 Hz, 1H), 1.40 ppm (d, J = 5.6 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ = 164.7, 150.8, 135.2, 
131.0 (2C), 123.7 (2C), 64.4, 53.6, 52.3, 13.6 ppm. IR (film): ṽ = 3111, 1731, 1523, 1336, 1271, 1119, 
1066, 949, 807, 718 cm–1. MS (EI) m/z (%): 150 (100), 104 (15). HRMS (ESIpos): m/z calcd for 
C11H11NO5Na: 260.0529, found: 260.0529. The ee was determined by HPLC (150 mm, Chiralpak IC-3, 
Ø 4.6 mm, n-heptane/2-propanol 95:5, flow rate = 1.0 mL/min, 56 bar, 293 K, UV, 255 nm): minor 
enantiomer tR = 22.2 min; major enantiomer tR = 26.3 min. 
  
Triethyl(((2S,3R)-3-methyloxiran-2-yl)methoxy)silane (65). Pyridine (1.98 mL, 25.6 mmol), DMAP 
(444 mg, 3.63 mmol, 20 mol%) and TESCl (3.96 mL, 23.6 mmol) were sequentially 
added to a solution of epoxy alcohol 61 (1.60 g, 18.2 mmol) in CH2Cl2 (80 mL) at 0 °C. 
The resulting mixture was stirred at ambient temperature for 2 h. The reaction was quenched with 
aq. half-sat. NH4Cl (60 mL) and the aqueous layer extracted with CH2Cl2 (3 × 50 mL). The combined 
extracts were dried over Na2SO4, filtered and concentrated. The residue was purified by flash 
chromatography (pentane) to yield the title compound as a colorless oil (3.60 g, 98%). [)]'
( = +6.2 
(c = 1.0, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 3.73 (d, J = 5.3 Hz, 2H), 3.14–3.09 (m, 2H), 1.29 (d,  
J = 5.4 Hz, 3H), 0.97 (t, J = 7.9 Hz, 9H), 0.63 ppm (q, J = 8.1 Hz, 6H). 13C NMR (100 MHz, CDCl3):  
δ = 61.1, 57.0, 52.5, 13.4, 6.8 (3C), 4.5 ppm (3C). IR (film): ṽ = 2955, 2913, 2877, 1459, 1415, 1339, 
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1240, 1091, 1006, 975, 783, 742, 728, 673 cm–1. MS (EI) m/z (%): 173 (18), 146 (11), 145 (100), 143 
(54), 129 (31), 117 (14), 115 (81), 101 (24), 87 (44), 75 (13), 59 (19), 45 (13). HRMS (ESIpos): m/z calcd 
for C10H22O2SiNa: 225.1281, found: 225.1283.  
(2R,3R)-3-Methyl-1-((triethylsilyl)oxy)hex-5-en-2-ol (66). A solution of allyl-MgCl (2 M in THF, 
17.3 mL, 34.6 mmol) was added to a suspension of CuI (659 mg, 3.46 mmol, 
20 mol%) in THF (70 mL) at –25 °C. The resulting mixture was stirred for 5 min, 
before a solution of epoxy silyl ether 65 (3.50 g, 17.3 mmol) in THF (40 mL) was 
added dropwise over 30 min. The resulting mixture was stirred at –25 °C for 6 h. The reaction was 
quenched with aq. half-sat. NH4Cl (30 mL) and the aqueous layer extracted with t-butyl methyl ether 
(3 × 40 mL). The combined extracts were dried over Na2SO4, filtered and concentrated. The residue 
was purified by flash chromatography (hexanes/t-butyl methyl ether 99:1) to afford the title 
compound 66 as a pale yellow oil (2.82 g, 67%, r.r. 10:1). [)]'
( = –8.7 (c = 1.0, CHCl3). 
1H NMR 
(400 MHz, CDCl3): δ = 5.80 (dddd, J = 16.8, 10.1, 7.9, 6.5 Hz, 1H), 5.10–4.97 (m, 2H), 3.70 (dd, J = 9.3, 
2.7 Hz, 1H), 3.70 (dd, J = 9.3, 8.0 Hz, 1H), 3.42 (ddd, J = 8.0, 6.8, 2.5 Hz, 1H), 2.42–2.34 (m, 1H),  
2.00–1.91 (m, 1H), 1.65 (dqt, J = 11.4, 4.5, 2.2 Hz, 1H), 0.96 (t, J = 7.9 Hz, 9H), 0.85 (d, J = 6.9 Hz, 3H), 
0.62 ppm (q, J = 8.0 Hz, 6H). 13C NMR (100 MHz, CDCl3): δ = 137.3, 116.2, 75.2, 64.9, 37.3, 35.7, 15.2, 
6.9 (3C), 4.5 ppm (3C). IR (film): ṽ = 3440, 2956, 2913, 2877, 1459, 1414, 1239, 1092, 1005, 910, 789, 
743 cm–1. MS (EI) m/z (%): 215 (14), 117 (29), 115 (19), 105 (71), 104 (10), 103 (88), 95 (100), 87 (22), 
75 (53), 67 (22), 59 (18), 47 (12). HRMS (ESIpos): m/z calcd for C13H28O2SiNa: 267.1751, found: 
267.1751.  
((2R,4R,5R)-4-Methyl-5-(((triethylsilyl)oxy)methyl)tetrahydrofuran-2-yl)methanol (67). A solution of 
alcohol 66 (1.40 g, 5.73 mmol) in i-PrOH (10 mL) was added to a solution of 
Co(nmp)2 (323 mg, 0.57 mmol, 10 mol%) in i-PrOH (40 mL). The pale red 
solution was purged with O2 for 15 min before t-BuOOH (5.5 M in decane, 
0.21 mL, 1.15 mmol, 20 mol%) was added in one portion. The reaction mixture was stirred at 55 °C 
under oxygen atmosphere (balloon) for 5 h; the solution turned green. After cooling to ambient 
temperature, the atmosphere was replaced by Ar and the solvent was evaporated. The crude oil was 
partitioned between aq. half-sat. NH4Cl (25 mL) and t-butyl methyl ether (25 mL) and the aqueous 
layer extracted with t-butyl methyl ether (2 × 30 mL). The combined extracts were washed with 
water (3 × 20 mL) and brine (20 mL), dried over Na2SO4, filtered and concentrated. The residue was 
purified by flash chromatography (hexanes/t-butyl methyl ether 4:1) to yield the title compound 67 
as a pale yellow oil (1.16 g, 78%). [)]'
( = –20.8 (c = 1.0, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 4.08 
(dtd, J = 9.6, 5.6, 3.1 Hz, 1H), 3.70 (dd, J = 10.7, 1.8 Hz, 1H), 3.69 (dd, J = 12.0, 5.0 Hz, 1H), 3.64 (dd,  
J = 11.0, 5.0 Hz, 1H), 3.56–3.52 (m, 1H), 3.49 (dd, J = 11.0, 5.0 Hz, 1H), 3.67–3.52 (m, 2H), 1.84 (brs, 
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1H), 1.42 (dt, J = 11.7, 10.1 Hz, 1H), 1.07 (d, J = 6.3 Hz, 3H), 0.96 (t, J = 7.9 Hz, 9H), 0.61 ppm (q, 
J = 8.0 Hz, 6H). 13C NMR (100 MHz, CDCl3): δ = 86.3, 79.3, 65.0, 64.7, 36.7, 36.5, 17.4, 6.9 (3C), 
4.5 ppm (3C). IR (film): ṽ = 3395, 2955, 2913, 2875, 1458, 1414, 1381, 1239, 1086, 1052, 1016, 911, 
741, 671 cm–1. MS (EI) m/z (%): 232 (17), 231 (100), 229 (20), 214 (12), 213 (76), 185 (14), 170 (20), 
145 (16), 115 (32), 105 (29), 103 (57), 93 (28), 87 (14), 81 (11), 77 (15), 75 (26), 73 (13), 69 (23), 67 
(25). HRMS (ESIpos): m/z calcd for C13H28O3SiNa: 283.1700, found: 283.1699.	 
The relative stereochemistry was confirmed by single crystal x-ray analysis of a p-nitrobenzoate 
derivative, which was prepared in analytical quantities by the following two-step protocol: 
Nitrobenzoate 68. Pyridine (7.5 μL, 92 μmol), 4-nitrobenzoyl chloride (17.5 mg, 92.1 μmol) and 
DMAP (1.9 mg, 15 μmol, 20 mol%) were sequentially added to a solution 
of alcohol 67 (20.0 mg, 76.8 μmol) in CH2Cl2 (0.5 mL) at 0 °C. The 
resulting solution was stirred at rt for 3.5 h. The reaction was quenched 
with aq. half-sat. NH4Cl (2 mL) and the aqueous layer extracted with 
CH2Cl2 (3 × 5 mL). The combined extracts were dried over Na2SO4, filtered and concentrated to yield 
the crude benzoate (26 mg), which was used in the next step without further purification.  
A mixture of acetic acid/H2O/THF (6:3:1, 1 mL) was added to the crude benzoate (26 mg, 64 μmol) 
and the resulting mixture was vigorously stirred at rt for 20 min. The layers were separated and the 
aqueous layer was extracted with EtOAc (3 × 5 mL). The combined extracts were dried over Na2SO4, 
filtered and concentrated. The residue was purified by flash chromatography (hexanes/EtOAc 4:1 to 
1:1) to yield the title compound 68 as a yellow oil (16 mg, 68% over two steps). [)]'
( = –35.4 
(c = 0.24, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 8.29 (dt, J = 9.0, 1.9 Hz, 2H) 8.23 (dd, J = 9.1, 2.1 Hz, 
2H), 4.45 (dd, J = 10.8, 2.6 Hz, 1H), 4.42–4.36 (m, 1H), 4.33 (dd, J = 10.8, 6.4 Hz, 1H), 3.79 (dd,  
J = 11.7, 2.6 Hz, 1H), 3.62 (ddd, J = 8.8, 4.8, 2.5 Hz, 1H), 3.56 (dd, J = 11.7, 4.8 Hz, 1H), 2.29 (ddd,  
J = 11.5, 7.1, 5.7 Hz, 1H), 2.21 (ddt, J = 10.7, 9.0, 6.5 Hz, 1H), 1.93 (brs, 1H), 1.46 (ddd, J = 11.5, 10.5, 
9.2 Hz, 1H), 1.08 ppm (d, J = 6.4 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ = 164.8, 150.7, 135.5, 131.0 
(2C), 123.7 (2C), 86.3, 76.4, 68.1, 62.9, 37.7, 34.9, 16.5 ppm. IR (film): ṽ = 3433, 2928, 2875, 1722, 
1606, 1526, 1456, 1346, 1320, 1271, 1108, 1049, 1014, 973, 913, 873, 842, 784, 719 cm–1. MS (EI) 
m/z (%): 265 (15), 264 (94), 150 (100), 128 (11), 115 (51), 104 (21), 97 (40), 71 (50), 69 (23), 41 (13). 
HRMS (ESIpos): m/z calcd for C14H17NO6Na: 318.0948, found: 318.0949. Single crystals were grown by 
slow evaporation from CH2Cl2. Only the racemate (10%) was crystallizing (see Appendix). 
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Aldehyde 74. NaHCO3 (197 mg, 2.34 mmol) was added to a solution of DMP (250 mg, 0.59 mmol) in 
CH2Cl2 (2 mL) at 0 °C. Next, a solution of alcohol 67 (97.5 mg, 0.39 mmol) in 
CH2Cl2 (2 mL) was added. The resulting mixture was allowed to reach ambient 
temperature and stirred for 90 min. Aqueous CH2Cl2 (10 μL H2O in 2 mL CH2Cl2) 
was added over 1 h via syringe pump. After the addition was completed, the mixture was diluted 
with hexanes (5 mL), filtered through cotton and rinsed with additional hexanes. Removal of the 
solvent afforded the crude aldehyde 74 as a pale yellow oil (65 mg). The crude aldehyde was used in 
the next step without further purification.  
(Z)-Olefin 69. 18-Crown-6 (286 mg, 1.08 mmol) was added to a solution of KHMDS (80.3 mg, 
0.40 mmol) in THF (1.3 mL). After cooling to –78 °C methyl O,O'-bis(2,2,2-trifluoroethyl)-phosphono-
acetate (85.1 μL, 0.40 mmol) was added dropwise and the resulting solution 
stirred for 20 min. Next, a solution of crude aldehyde 74 (65.0 mg, 0.25 mmol) 
in THF (1 mL) was added dropwise over 10 min. The resulting mixture was 
stirred for 3 h at –78 °C before it was poured into aq. half-sat. NH4Cl (50 mL). The aqueous layer was 
extracted with EtOAc (3 × 50 mL). The combined extracts were washed with brine (50 mL), dried over 
Na2SO4, filtered and concentrated. The residue was purified by flash chromatography (fine SiO2, 
hexanes/t-butyl methyl ether 99:1) to yield the title compound as a pale yellow oil (22 mg, 28% over 
two steps, Z/E 8:1). The major byproduct was the desilylated alcohol, which was co-eluting with the 
phosphonate and thus not pure enough for full characterization. [)]'
( = +31.8 (c = 1.0, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 6.34 (dd, J = 11.7, 7.2 Hz, 1H), 5.74 (dd, J = 11.7, 1.6 Hz, 1H), 5.37 
(dddd, J = 9.7, 7.4, 5.9, 1.6 Hz, 1H), 3.69 (s, 3H), 3.67–3.65 (m, 2H), 3.61 (ddd, J = 8.0, 5.2, 4.1 Hz, 1H), 
2.49 (ddd, J = 12.5, 6.9, 5.9 Hz, 1H), 2.22–2.11 (m, 1H), 1.30 (ddd, J = 12.2, 10.6, 9.8 Hz, 1H), 1.07 (d, 
J = 6.6 Hz, 3H), 0.95 (t, J = 7.9 Hz, 9H), 0.61 ppm (q, J = 7.7 Hz, 6H). 13C NMR (100 MHz, CDCl3):  
δ = 166.4, 152.3, 118.5, 86.6, 75.8, 64.7, 51.4, 41.4, 36.7, 17.5, 6.9 (3C), 4.5 ppm (3C). IR (film):  
ṽ = 2954, 2875, 1723, 1649, 1458, 1438, 1405, 1196, 1179, 1081, 1037, 1004, 819, 773, 726 cm–1. 
MS (EI) m/z (%): 285 (13), 153 (16), 225 (32), 207 (12), 185 (21), 169 (20), 165 (20), 165 (17), 151 (14), 
145 (26), 139 (23), 137 (36), 133 (46), 123 (12), 121 (50), 117 (78), 115 (47), 113 (15), 111 (69), 109 
(28), 108 (10), 107 (45), 106 (11), 105 (100), 103 (73), 101 (12), 99 (21), 98 (12), 97 (10), 95 (27), 93 
(25), 91 (23), 89 (36), 88 (12), 87 (80), 85 (31), 83 (14), 81 (45), 80 (12), 79 (68), 77 (33), 75 (87), 73 
(13), 71 (11), 69 (11), 68 (11), 67 (15), 61 (17), 59 (93), 58 (15), 57 (17), 55 (41), 53 (25), 47 (30), 45 
(29), 43 (24), 41 (21), 40 (23), 39 (16), 29 (15). HRMS (ESIpos): m/z calcd for C16H30O4SiNa: 337.1806, 
found: 337.1804. 
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t-Dimethyl(((2S,3R)-3-methyloxiran-2-yl)methoxy)silane (S19). Imidazole (12.9 g, 190 mmol), DMAP 
(892 mg, 7.30 mmol, 5 mol%) and TBSCl (26.5 g, 176 mmol) were sequentially added 
to a solution of epoxy alcohol 61 (12.9 g, 146 mmol) in CH2Cl2 (280 mL) at 0 °C. The 
resulting mixture was stirred at ambient temperature for 3.5 h. The reaction was quenched with aq. 
half-sat. NH4Cl (200 mL) and the aqueous layer extracted with CH2Cl2 (3 × 200 mL). The combined 
extracts were dried over Na2SO4, filtered and concentrated. The residue was purified by flash 
chromatography (pentane/Et2O 99:1) to yield the title compound as a colorless oil (28.4 g, 96%). 
[)]'
( = +7.1 (c = 1.0, CHCl3). 
1H NMR (400 MHz, CD2Cl2): δ = 3.76 (d, J = 11.5, 4.8 Hz, 1H), 3.67 (ddd, 
J = 11.6, 6.0 Hz, 1H), 3.05 (qd, J = 5.5, 4.3 Hz, 1H), 2.99 (dt, J = 6.0, 4.6 Hz, 1H), 1.25 (d, J = 5.5 Hz, 3H), 
0.90 (s, 9H), 0.082 (s, 3H), 0.076 ppm (s, 3H). 13C NMR (100 MHz, CD2Cl2): δ = 61.9, 57.1, 52.4, 
25.9 (3C), 18.5, 13.5, –5.2, –5.3 ppm. IR (film): ṽ = 2955, 2930, 2857, 1472, 1391, 1361, 1254, 1091, 
1006, 975, 939, 886, 834, 775, 666 cm–1. MS (EI) m/z (%): 145 (46), 116 (11), 115 (100), 101 (65), 85 
(25), 75 (38), 73 (20), 59 (30). HRMS (ESIpos): m/z calcd for C10H22O2SiNa: 225.1281, found: 225.1281.  
(2R,3R)-1-((t-Dimethylsilyl)oxy)-3-methylhex-5-en-2-ol (71). A solution of allyl-MgCl (2 M in THF, 
22.2 mL, 44.5 mmol) was added to a suspension of CuI (847 mg, 4.45 mmol, 
15 mol%) in THF (70 mL) at –25 °C. The resulting mixture was stirred for 10 min, 
before a solution of epoxy silyl ether S19 (6.00 g, 29.6 mmol) in THF (20 mL) was 
added dropwise over 30 min. The resulting mixture was stirred at –25 °C for 6 h. The reaction was 
quenched with aq. half-sat. NH4Cl (50 mL) and the aqueous layer extracted with t-butyl methyl ether 
(3 × 50 mL). The combined extracts were dried over Na2SO4, filtered and concentrated. The residue 
was purified by flash chromatography (hexanes/t-butyl methyl ether 300:1) to afford the title 
compound 71 as a pale yellow oil (5.57 g, 77%, r.r. 10:1) and its regioisomer 72 as a colorless oil 
(310 mg, 4%). [)]'
( = –13.4 (c = 1.0, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 5.80 (dddd, J = 16.8, 10.1, 
7.9, 6.4 Hz, 1H), 5.09–4.97 (m, 2H), 3.70 (dd, J = 9.6, 3.0 Hz, 1H), 3.48 (dd, J = 9.6, 7.7 Hz, 1H), 3.41 
(td, J = 7.4, 3.0 Hz, 1H), 2.54 (brs, 1H), 2.43–2.34 (m, 1H), 1.95 (dddt, J = 13.9, 8.9, 7.9, 1.1 Hz, 1H), 
1.66 (dddd, J = 12.9, 11.0, 5.8, 2.8 Hz, 1H), 0.90 (s, 9H), 0.85 (d, J = 6.9 Hz, 3H), 0.08 ppm (s, 6H). 
13C NMR (100 MHz, CDCl3): δ = 137.3, 116.2, 75.2, 65.2, 37.3, 35.7, 26.0 (3C), 18.4, 15.2, –5.2,  
–5.3 ppm. IR (film): ṽ = 3484, 2955, 2929, 2858, 1463, 1362, 1254, 1093, 993, 911, 835, 777,  
670 cm–1. MS (EI) m/z (%): 187 (15), 145 (13), 105 (57), 95 (100), 89 (13), 75 (82), 73 (25), 67 (11). 
HRMS (ESIpos): m/z calcd for C13H28O2SiNa: 267.1751, found: 267.1751.	 
Regioisomer 72: [)]'
( = +2.1 (c = 0.7, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 5.77 (ddt, J = 17.0, 10.1, 
7.1 Hz, 1H), 5.09–4.97 (m, 2H), 4.02 (qd, J = 6.5, 2.7 Hz, 1H), 3.76 (dd, J = 10.0, 5.9 Hz, 
1H), 3.72 (dd, J = 10.0, 4.0 Hz, 1H), 2.15–2.06 (m, 2H), 1.69 (dddd, J = 10.2, 8.7, 4.0, 
2.7 Hz, 1H), 1.19 (d, J = 6.5 Hz, 3H), 0.90 (s, 9H), 0.07 ppm (s, 6H). 13C NMR (100 MHz, 
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CDCl3): δ = 137.3, 116.4, 70.8, 65.1, 44.9, 30.1, 26.0 (3C), 19.5, 18.2, –5.5 ppm (2C). IR (film): ṽ = 3443, 
2956, 2929, 2858, 1472, 1362, 1254, 1094, 992, 911, 836, 776, 670 cm–1. MS (EI) m/z (%): 105 (63), 95 
(34), 75 (100), 73 (16). HRMS (ESIpos): m/z calcd for C13H28O2SiNa: 267.1751, found: 267.1749.	 
Alcohol 73. A solution of alcohol 71 (4.00 g, 16.4 mmol) in i-PrOH (10 mL) was added to a solution of 
Co(nmp)2 (925 mg, 1.64 mmol, 10 mol%) in i-PrOH (90 mL). The pale red 
solution was purged with O2 for 15 min before t-BuOOH (5.5 M in decane, 
0.29 mL, 1.64 mmol, 10 mol%) was added in one portion. The reaction mixture 
was stirred at 55 °C under oxygen atmosphere (balloon) for 5 h; the solution turned green. After 
cooling to ambient temperature, the atmosphere was replaced by Ar and the solvent evaporated. 
The crude oil was partitioned between aq. half-sat. NH4Cl (50 mL) and t-butyl methyl ether (50 mL) 
and the aqueous layer extracted with t-butyl methyl ether (2 × 80 mL). The combined extracts were 
washed with water (3 × 50 mL) and brine (50 mL), dried over Na2SO4, filtered and concentrated. The 
residue was purified by flash chromatography (hexanes/t-butyl methyl ether 25:1 to 20:1) to yield 
the title compound 73 as a pale yellow oil (3.36 g, 79%). [)]'
( = –16.4 (c = 1.0, CHCl3). 
1H NMR 
(500 MHz, CDCl3): δ = 4.52 (dtd, J = 9.8, 5.7, 3.2 Hz, 1H, H-5), 3.69 (ddd, J = 11.6, 6.4, 3.2 Hz, 1H, H-6), 
3.69 (dd, J = 11.0, 4.5 Hz, 1H, H-1), 3.66 (dd, J = 11.0, 4.5 Hz, 1H, H-1),  3.58 (dt, J = 8.4, 4.5 Hz, 1H, H-
2), 3.49 (dt, J = 11.9, 5.8 Hz, 1H, H-6), 2.15 (dddq, J = 10.8, 8.2, 7.0, 6.6 Hz, 1H, H-3), 2.06 (ddd, J = 
12.0, 7.1, 5.8 Hz, 1H, H-4), 1.95 (t, J = 6.2 Hz, 1H, 6-OH), 1.41 (ddd, J = 11.9, 10.5, 9.8 Hz, 1H, H-4), 
1.07 (d, J = 6.6 Hz, 3H, H-23), 0.90 (s, 9H, TBS), 0.07 ppm (s, 6H, TBS). 13C NMR (125 MHz, CDCl3):  
δ = 86.2 (C2), 79.3 (C5), 65.1 (C6), 65.0 (C1), 36.8 (C4), 36.5 (C3), 26.1 (3C, TBS), 18.6 (TBS), 17.5 
(C23), –5.1 (TBS), –5.2 ppm (TBS). IR (film): ṽ = 3432, 2955, 2929, 2857, 1729, 1462, 1388, 1361, 1253, 
1128, 1085, 1054, 1005, 906, 834, 775, 729, 649 cm–1. MS (EI) m/z (%): 229 (15), 203 (49), 185 (29), 
117 (28), 115 (17), 111 (12), 105 (28), 103 (10), 101 (11), 93 (33), 89 (10), 83 (12), 81 (22), 75 (100), 
73 (48), 69 (21), 59 (17), 57 (21), 55 (22), 43 (12), 41 (18). HRMS (ESIpos): m/z calcd for C13H28O3SiNa: 
283.1700, found: 283.1700.	 
Aldehyde 74. Hünig’s base (11.0 mL, 63.4 mmol) was added to a solution of alcohol 73 (3.30 g, 
12.7 mmol) in CH2Cl2 (110 mL) at –25 °C. In a second flask, SO3·pyridine (5.04 g, 
31.7 mmol) was suspended in DMSO (9.00 mL, 126 mmol) and stirred for 10 min 
at rt, before it was added to the alcohol solution at –25 °C and the flask was 
rinsed with CH2Cl2 (5 mL). The resulting mixture was stirred for 30 min at –25 °C. The mixture was 
poured into pH 7 phosphate buffer (50 mL) and t-butyl methyl ether (50 mL), and the aqueous layer 
was layer extracted with t-butyl methyl ether (3 × 100 mL). The combined extracts were washed with 
pH 7 phosphate buffer (100 mL), and brine (100 mL), dried over Na2SO4, filtered and concentrated  
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under high vacuum to yield the crude aldehyde 74 as a yellow oil. An analytical sample was purified 
by flash chromatography (hexanes/t-butyl methyl ether 9:1) for characterization. The crude aldehyde 
was used in the next step without further purification. [)]'
( = +3.4 (c = 1.0, CHCl3).
 1H NMR 
(400 MHz, CDCl3): δ = 9.66 (d, J = 2.2 Hz, 1H), 4.28 (ddd, J = 8.8, 7.4, 2.2 Hz, 1H), 3.77–3.71 (m, 1H), 
3.68 (d, J = 4.1 Hz, 1H), 3.64 (dd, J = 7.9, 4.0 Hz, 1H), 2.35 (dt, J = 12.2, 7.4 Hz, 1H), 2.22 (dtd, J = 14.2, 
7.4, 2.4 Hz, 1H), 1.58 (dt, J = 12.2, 9.0 Hz, 1H), 1.06 (d, J = 6.6 Hz, 3H), 0.89 (s, 9H), 0.059 (s, 3H), 
0.057 ppm (s, 3H). 13C NMR (100 MHz, CDCl3): δ = 203.1, 87.8, 82.8, 64.3, 36.5, 35.4, 26.1 (3C), 18.5, 
17.3, –5.19, –5.25 ppm. IR (film): ṽ = 2956, 2929, 2857, 1734, 1462, 1388, 1361, 1254, 1130, 1087, 
1058, 1004, 939, 834, 776, 671 cm–1. MS (EI) m/z (%): 229 (25), 201 (34), 185 (13), 145 (12), 143 (11), 
129 (13), 117 (11), 115 (18), 105 (11), 103 (19), 101 (20), 89 (13), 75 (100), 73 (72), 59 (23), 57 (12), 
55 (12), 41 (14). HRMS (ESIpos): m/z calcd for C13H26O3SiNa: 281.1543, found: 281.1545.	 
Olefin (Z)-75. 18-Crown-6 (7.37 g, 27.9 mmol) was added to a solution of KHMDS (3.03 g, 15.2 mmol) 
in THF (60 mL). After cooling to –78 °C methyl O,O'-bis(2,2,2-trifluoroethyl)phosphono-acetate 
(3.22 mL, 15.2 mmol) was added dropwise and the resulting mixture was stirred 
for 20 min. Next, a solution of aldehyde 74 (3.27 g, 12.7 mmol) in THF (15 mL) 
was added dropwise over 10 min. The resulting mixture was stirred for 3 h at  
–78 °C before it was poured into aq. half-sat. NH4Cl (70 mL). The aqueous layer was extracted with 
EtOAc (3 × 70 mL). The combined extracts were washed with brine (100 mL), dried over Na2SO4, 
filtered and concentrated. The residue was purified by flash chromatography (fine SiO2, hexanes/t-
butyl methyl ether 99:1) to yield the title compound (Z)-75 as a pale yellow oil (2.50 g, 63% over two 
steps, Z/E 12:1); the undesired (E)-75 (190 mg, 5% over two steps) could also be isolated in high 
purity. 
Analytical data for (Z)-75: [)]'
( = +40.8 (c = 1.0, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 6.33 (dd,  
J = 11.7, 7.3 Hz, 1H), 5.75 (dd, J = 11.7, 1.6 Hz, 1H), 5.37 (dddd, J = 9.8, 7.4, 5.9, 1.6 Hz, 1H), 3.69 (s, 
3H), 3.68–3.65 (m, 2H), 3.61 (ddd, J = 8.2, 5.0, 4.1 Hz, 1H), 2.48 (ddd, J = 12.4, 7.0, 5.9 Hz, 1H),  
2.24–2.13 (m, 1H), 1.30 (ddd, J = 12.1, 10.6, 9.8 Hz, 1H), 1.07 (d, J = 6.6 Hz, 3H), 0.89 (s, 9H), 0.06 ppm 
(s, 6H). 13C NMR (100 MHz, CDCl3): δ = 166.4, 152.3, 118.5, 86.5, 75.8, 65.0, 51.5, 41.4, 36.7, 26.1 
(3C), 18.6, 17.5, –5.16, –5.17 ppm. IR (film): ṽ = 2954, 2929, 2857, 1724, 1648, 1462, 1438, 1404, 
1254, 1198, 1180, 1083, 1038, 1005, 837, 777, 674 cm–1. MS (EI) m/z (%): 258 (18), 257 (100), 227 
(16), 225 (30), 197 (28), 169 (15), 165 (13), 139 (28), 137 (15), 133 (39), 121 (35), 117 (58), 111 (35), 
107 (20), 105 (33), 89 (23), 81 (11), 79 (18), 75 (45), 73 (37), 59 (13). HRMS (ESIpos): m/z calcd for 
C16H30O4SiNa: 337.1806, found: 337.1806. 
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Analytical data for (E)-75: [)]'
( = +17.3 (c = 0.93, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 6.94 (dd,  
J = 15.6, 5.2 Hz, 1H), 6.04 (dd, J = 15.6, 1.6 Hz, 1H), 4.54 (dddd, J = 9.9, 6.0, 
5.2, 1.6 Hz, 1H), 3.73 (s, 3H), 3.70 (d, J = 4.4 Hz, 1H), 3.68 (d, J = 4.2 Hz, 
1H), 3.60 (dd, J = 8.1, 4.1 Hz, 1H), 2.30 (ddd, J = 11.5, 7.0, 5.9 Hz, 1H), 2.22 
(ddq, J = 10.4, 8.1, 6.5 Hz, 1H), 1.39 (dt, J = 11.6, 10.0 Hz, 1H), 1.07 (d, J = 6.5 Hz, 3H), 0.89 (s, 9H), 
0.062 (s, 3H), 0.058 ppm (s, 3H). 13C NMR (100 MHz, CDCl3): δ = 167.2, 149.0, 119.5, 86.5, 77.7, 64.6, 
51.7, 41.7, 36.5, 26.1 (3C), 18.5, 17.4, –5.15, –5.19 ppm. IR (film): ṽ = 2955, 2930, 2857, 1728, 1662, 
1462, 1436, 1361, 1300, 1258, 1166, 1125, 1089, 1006, 837, 777, 675 cm–1. MS (ESIpos) m/z (%): 
337.2 (100 (M+Na)). HRMS (ESIpos): m/z calcd for C16H30O4SiNa: 337.1806, found: 337.1807. 
Diol 76 and 77. K3Fe(CN)6 (5.61 g, 17.0 mmol), K2CO3 (2.36 g, 17.0 mmol), K2OsO4 (126 mg, 
0.34 mmol, 6 mol%), (DHQD)2PYR (150 mg, 0.17 mmol, 3 mol%) and 
MeSO2NH2 (540 mg, 5.68 mmol) were sequentially added to a mixture of 
(Z)-75 (1.79 g, 5.68 mmol) in t-BuOH/H2O (1:1, 100 mL) at 0 °C. The 
resulting mixture was stirred at 0 °C for 48 h before it was poured into a solution of NH4Cl, NaS2O3 
and water (1:1:2, 100 mL). The mixture was vigorously stirred for 10 min at rt, diluted with EtOAc and 
the aqueous layer extracted with EtOAc (3 × 100 mL). The combined extracts were washed with brine 
(200 mL), dried over Na2SO4, filtered and concentrated. The residue was purified by flash 
chromatography (fine SiO2, hexanes/EtOAc 19:1 to 8:1) to yield the desired diol 76 (1.33 g, 67%, d.r. 
5:1) and its undesired diastereomer 77 (215 mg, 11%) as colorless oil each.  
Analytical data for 76: [)]'
( = –8.0 (c = 1.0, CHCl3). 
1H NMR (500 MHz, CDCl3): δ = 4.29 (dd, J = 9.2, 4.3 
Hz, 1H, H-7), 4.05 (ddd, J = 10.0, 5.6, 3.4 Hz, 1H, H-5), 3.78 (s, 3H, H-9), 3.74 (ddd, J = 8.4, 4.4, 3.6 Hz, 
1H, H-6), 3.67 (dd, J = 10.9, 4.0 Hz, 1H, H-1), 3.62 (dd, J = 10.9, 4.6 Hz, 1H, H-1), 3.54 (ddd, J = 8.6, 4.6, 
4.0 Hz, 1H, H-2), 3.39 (d, J = 9.6 Hz, 1H, 7-OH), 2.75 (d, J = 8.5 Hz, 1H, 6-OH), 2.12 (ddqd, J = 10.6, 8.6, 
6.8, 6.6 Hz, 1H, H-3), 2.07 (ddd, J = 11.8, 6.8, 5.6 Hz, 1H, H-4), 1.64 (dt, J = 11.4, 10.6 Hz, 1H, H-4), 
1.07 (d, J = 6.4 Hz, 3H, H-23), 0.89 (s, 9H, TBS), 0.06 ppm (s, 6H, TBS). 13C NMR (125 MHz, CDCl3):  
δ = 172.9 (C8), 87.0 (C2), 78.7 (C5), 73.7 (C7), 73.4 (C6), 64.6 (C1), 52.5 (C9), 37.4 (C4), 36.0 (C3), 26.0 
(3C, TBS), 18.5 (TBS), 17.0 (C23), –5.19 (TBS), –5.23 ppm (TBS). IR (film): ṽ = 3458, 2954, 2929, 2857, 
1740, 1461, 1440, 1388, 1253, 1128, 1080, 1004, 836, 777, 647 cm–1. MS (EI) m/z (%): 292 (14), 291 
(77), 259 (25), 155 (11), 231 (39), 230 (15), 229 (82), 213 (11), 186 (12), 185 (80), 181 (17), 171 (24), 
167 (11), 157 (12), 153 (11), 149 (15), 145 (13), 143 (14), 139 (27), 129 (11), 127 (13), 126 (12), 121 
(19), 117 (48), 115 (66), 113 (11), 109 (23), 107 (11), 105 (24), 103 (12), 101 (14), 97 (19), 93 (23), 89 
(22), 85 (12), 81 (23), 75 (88), 73 (100), 69 (12), 59 (16), 55 (14), 43 (12), 41 (11). HRMS (ESIpos): m/z 
calcd for C16H32O6SiNa: 371.1860, found: 371.1863. 
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Analytical data for 77: [)]'
( = –17.6 (c = 1.4, CHCl3).  
1H NMR (500 MHz, CDCl3): δ = 4.32 (t, J = 4.4 Hz, 
1H, H-7), 4.03 (ddd, J = 9.2, 7.4, 6.0 Hz, 1H, H-5), 3.80 (s, 3H, H-9), 3.81 
(ddd, J = 9.2, 7.4, 6.0 Hz, 1H, H-6), 3.64 (dd, J = 11.7, 4.3 Hz, 1H, H-1), 3.60 
(dd, J = 11.0, 4.6 Hz, 1H, H-1), 3.48 (dt, J = 8.6, 4.4 Hz, 1H, H-2), 3.31 (d,  
J = 4.8 Hz, 1H, 7-OH), 2.53 (d, J = 6.0 Hz, 1H, 6-OH), 2.28 (ddd, J = 12.4, 6.8, 6.0 Hz, 1H, H-4), 2.10 
(dddq, J = 10.8, 8.5, 7.0, 6.6 Hz, 1H, H-3), 1.55 (ddd, J = 12.4, 10.6, 9.2 Hz, 1H, H-4), 1.07 (d, J = 6.6 Hz, 
3H, H-23), 0.89 (s, 9H, TBS), 0.05 ppm (s, 6H, TBS). 13C NMR (125 MHz, CDCl3): δ = 173.2 (C8), 86.6 
(C2), 78.4 (C5), 75.2 (C6), 72.7 (C7), 64.8 (C1), 52.7 (C9), 38.4 (C4), 36.2 (C3), 26.1 (3C, TBS), 18.5 
(TBS), 17.3 (C23), –5.19 (TBS), –5.21 ppm (TBS). IR (film): ṽ = 3439, 2954, 2929, 2857, 1741, 1462, 
1388, 1254, 1129, 1087, 1004, 837, 777, 671 cm–1. MS (ESIpos) m/z (%): 371.2 (100 (M+Na)). HRMS 
(ESIpos): m/z calcd for C16H32O6SiNa: 371.1860, found: 371.1858. 
Methyl ester 78. 2,6-Lutidine (1.75 mL, 15.0 mmol), DMAP (51.0 mg, 0.42 mmol, 20 mol%) and 
TBSOTf (2.88 mL, 12.5 mmol) were sequentially added to a solution of 
diol 76 (728 mg, 2.09 mmol) in CH2Cl2 (10 mL) at 0 °C. The resulting 
mixture was stirred at rt for 24 h. The reaction was quenched with aq. 
half-sat. NH4Cl (10 mL) and the aqueous layer extracted with CH2Cl2 (3 × 10 mL). The combined 
extracts were dried over Na2SO4, filtered and concentrated. The residue was purified by flash 
chromatography (hexanes/t-butyl methyl ether 99:1) to afford the title compound 78 as a colorless 
oil (1.12 g, 86%). [)]'
( = –4.9 (c = 1.0, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 4.22 (d, J = 3.4 Hz, 1H), 
4.04 (ddd, J = 10.0, 6.6, 5.2 Hz, 1H), 3.84 (dd, J = 6.7, 3.4 Hz, 1H), 3.69 (s, 3H), 3.64 (dd, J = 10.7, 4.8 
Hz, 1H), 3.60 (dd, J = 10.7, 4.6 Hz, 1H), 3.43 (dt, J = 8.8, 4.6 Hz, 1H), 2.14–2.00 (m, 2H), 1.47–1.36 (m, 
1H), 1.04 (d, J = 6.1 Hz, 3H), 0.89 (s, 9H), 0.88 (s, 9H), 0.87 (s, 9H), 0.08 (s, 3H), 0.06 (s, 3H), 0.05 (s, 
3H), 0.04 (s, 3H), 0.039 ppm (s, 6H). 13C NMR (100 MHz, CDCl3): δ = 172.5, 85.1, 79.3, 78.1, 75.2, 65.0, 
51.7, 37.5, 37.0, 26.09 (3C), 26.08 (3C), 25.8 (3C), 18.5, 18.43, 18.42, 17.0, –4.1, –4.7, –5.0, –5.17,  
–5.23 ppm (2C). IR (film): ṽ = 2954, 2927, 2856, 1736, 1462, 1388, 1361, 1253, 1129, 1091, 1005, 836, 
778, 673 cm–1. MS (EI) m/z (%): 521 (16), 520 (35), 519 (83), 388 (10), 387 (34), 355 (11), 295 (15), 256 
(11), 255 (57), 229 (42), 223 (18), 185 (50), 163 (14), 149  (21), 147 (18), 117 (20), 115 (18), 89 (24), 
75 (18), 73 (100). HRMS (ESIpos): m/z calcd for C28H60O6Si3Na: 599.3590, found: 599.3596. 
Alcohol 79. Diisobutylaluminum hydride (1.2 M in toluene, 2.86 mL, 3.43 mmol) was added to a 
solution of ester 78 (900 mg, 1.56 mmol) in toluene (18 mL) at –78 °C. The 
resulting mixture was stirred at –78 °C for 1 h. The mixture was then 
poured via cannula into aq. sat. Rochelle salt (15 mL) and the emulsion was 
vigorously stirred at rt for 2 h. The layers were separated and the aqueous layer was extracted with  
t-butyl methyl ether (3 × 20 mL). The combined extracts were washed with brine (25 mL), dried over 
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Na2SO4, filtered and concentrated. The residue was purified by flash chromatography (hexanes/ 
t-butyl methyl ether 19:1) to afford the title compound 79 as a colorless oil (838 mg, 98%).  
[)]'
( = –4.3 (c = 1.0, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 4.00 (ddd, J = 10.2, 5.7, 3.3 Hz, 1H), 3.78 
(ddd, J = 10.5, 6.9, 3.6 Hz, 1H), 3.73 (ddd, J = 6.8, 3.4, 1.9 Hz, 1H), 3.67–3.59 (m, 3H), 3.57–3.53 (m, 
1H), 3.53–3.49 (m, 1H), 3.45 (ddd, J = 10.4, 8.9, 3.3 Hz, 1H), 2.09 (ddt, J = 11.3, 8.9, 6.6 Hz, 1H), 2.00 
(dt, J = 12.4, 6.2 Hz, 1H), 1.66–1.56 (m, 1H), 1.05 (d, J = 6.4 Hz, 3H), 0.91 (s, 9H), 0.89 (s, 9H), 0.88 (s, 
9H), 0.12 (s, 3H), 0.08 (s, 3H), 0.07 (s, 6H), 0.04 ppm (s, 6H). 13C NMR (100 MHz, CDCl3): δ = 86.1, 79.9, 
78.3, 75.9, 64.6, 62.8, 37.6, 36.5, 26.3 (3C), 26.1 (3C), 26.0 (3C), 18.6, 18.44, 18.39, 16.5, –3.9, –4.47, 
–4.53, –4.8, –5.3 ppm (2C). IR (film): ṽ = 3461, 2954, 2929, 2886, 2857, 1472, 1462, 1388, 1361, 1252, 
1129, 1075, 1004, 832, 773, 672 cm–1. MS (EI) m/z (%): 493 (14), 492 (30), 491 (72), 360 (18), 359 
(63), 267 (47), 231 (12), 229 (54), 228 (12), 227 (71), 209 (24), 199 (11), 197 (11), 186 (13), 185 (83), 
171 (22), 159 (10), 149 (20), 147 (15), 135 (33), 117 (39), 115 (24), 107 (13), 103 (15), 89 (25), 75 (29), 
73 (100). HRMS (ESIpos): m/z calcd for C27H60O5Si3Na: 571.3641, found: 571.3642. 
The absolute configuration at C6 and C7 was assigned by NMR analysis and comparison of indicative 
coupling constants J5,6 and J6,7 (green) with the available data of the fragments of amphidinolides C 
and F (right).[140a] The diol was later unambiguously assigned by preparation of the cyclic acetal and 
NOE studies as well as by Mosher ester analysis at C6 of a derivative. 
 
Aldehyde 80. Hünig’s base (1.60 mL, 9.21 mmol) was added to a solution of alcohol 79 (722 mg, 
1.32 mmol) in CH2Cl2 (10 mL) at –25 °C. In a second flask, SO3·pyridine 
(523 mg, 3.29 mmol) was suspended in DMSO (0.93 mL, 13.2 mmol) and the 
suspension was stirred for 10 min at rt, before it was added to the alcohol 
solution at –25 °C and the flask was rinsed with CH2Cl2 (2 mL). The resulting mixture was stirred for 
45 min at –25 °C. The mixture was poured into pH 7 phosphate buffer (15 mL) and t-butyl methyl 
ether (15 mL), the layers were separated and the aqueous layer was extracted with t-butyl methyl 
ether (3 × 20 mL). The combined extracts were washed with pH 7 phosphate buffer (20 mL), followed 
by brine (20 mL), dried over Na2SO4, filtered and concentrated. The residue was purified by flash 
chromatography (hexanes/t-butyl methyl ether 50:1 to 30:1) to yield aldehyde 80 as a colorless oil 
(678 mg, 94%). [)]'
( = +12.6 (c = 1.0, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 9.62 (d, J = 1.0 Hz, 1H), 
4.08–3.99 (m, 2H), 3.90 (dd, J = 6.2, 1.9 Hz, 1H), 3.65–3.61 (m, 2H), 3.47 (dt, J = 8.7, 4.4 Hz, 1H),  
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2.16–1.99 (m, 2H), 1.58–1.48 (m, 1H), 1.05 (d, J = 6.2 Hz, 3H), 0.92 (s, 9H), 0.89 (s, 9H), 0.88 (s, 9H), 
0.09 (s, 6H), 0.08 (s, 3H), 0.07 (s, 3H), 0.05 ppm (s, 6H). 13C NMR (100 MHz, CDCl3): δ = 202.8, 85.8, 
81.0, 79.6, 78.7, 64.8, 37.5, 36.6, 26.11 (3C), 26.09 (3C), 26.0 (3C), 18.50, 18.47, 18.4, 16.8, –4.4, –4.5, 
–4.6, –4.8, –5.18, –5.21 ppm. IR (film): ṽ = 2954, 2929, 2886, 2857, 1736, 1472, 1463, 1388, 1361, 
1252, 1131, 1084, 1005, 832, 774, 672 cm–1. MS (EI) m/z (%): 505 (12), 490 (13), 489 (33), 475 (10), 
373 (13), 357 (24), 231 (17), 230 (18), 229 (100), 289 (13), 186 (12), 185 (71), 183 (10), 171 (15), 149 
(14), 147 (14), 115 (21), 103 (14), 75 (31), 73 (83), 57 (12). HRMS (ESIpos): m/z calcd for 
C27H58O5Si3Na: 569.3484, found: 569.3485. 
1,4-Di-(t-butyldimethylsilyloxy)but-2-ene (S20). Imidazole (1.85 g, 27.2 mmol), DMAP (139 mg, 
1.13 mmol, 10 mol%) and TBSCl (3.76 g, 25.0 mmol) were sequentially added to a 
solution of trans-2-butene-1,4-diol (1.00 g, 11.3 mmol) in CH2Cl2 (100 mL) at 0 °C. 
The resulting mixture was stirred at rt for 5 h. The reaction was quenched with 
water (30 mL) and the aqueous layer was extracted with CH2Cl2 (3 × 40 mL). The combined organic 
extracts were dried over Na2SO4, filtered and concentrated. The residue was purified by flash 
chromatography (hexanes/t-butyl methyl ether 50:1) to yield the title compound S20 as a colorless 
oil (3.58 mg, quant.). 1H NMR (400 MHz, CDCl3): δ = 5.55 (td, J = 2.9, 0.7 Hz, 2H), 4.23 (dd, J = 2.9, 
0.7 Hz, 4H), 0.90 (s, 18H), 0.07 ppm (s, 12H). 13C NMR (100 MHz, CDCl3): δ = 130.3 (2C), 59.8 (2C), 26.1 
(6C), 18.5 (2C), –5.0 ppm (4C). IR (film): ṽ = 2955, 2929, 2886, 2857, 1463, 1389, 1253, 1079, 1006, 
834, 774, 669 cm–1. MS (EI) m/z (%): 259 (13), 189 (13), 148 (16), 147 (100), 75 (13), 73 (53). HRMS 
(ESIneg): m/z calcd for C16H36O2Si2Na: 339.2146, found: 339.2148. The analytical and spectroscopic 
data are in agreement with those reported in the literature.[232] 
Aldehyde 81. Ozone was bubbled through a solution of olefin S20 (1.00 g, 3.16 mmol) in CH2Cl2 
(20 mL) at –78 °C until the solution turned blue. Argon was then bubbled through the 
solution until the reaction mixture turned colorless. Triphenylphosphine (994 mg, 
3.79 mmol) was added, and the mixture was warmed to room temperature and stirred for 3 h. The 
solvent was removed in vacuo, and the residue was purified by flash chromatography (hexanes/ 
t-butyl methyl ether 20:1) to yield the title compound as a colorless oil (1.04 g, 94%). 1H NMR 
(400 MHz, CDCl3): δ = 9.70 (t, J = 0.9 Hz, 1H), 4.22 (d, J = 0.8 Hz, 2H), 0.93 (s, 9H), 0.10 ppm (s, 6H).
 
13C NMR (100 MHz, CDCl3): δ = 202.5, 69.8, 25.9 (3C), 18.5, –5.3 ppm (2C). IR (film): ṽ = 2953, 2930, 
2885, 2858, 1741, 1472, 1362, 1255, 1104, 1006, 939, 836, 778, 669 cm–1. MS (EI) m/z (%): 117 (100), 
89 (59), 73 (26), 59 (31). HRMS (ESIneg): m/z calcd for C8H18O2SiNa: 197.0968, found: 197.0968. The 
analytical and spectroscopic data are in agreement with those reported in the literature.[143] 
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(E)-Enyne (E)-83. A solution of KHMDS (58.1 mg, 0.29 mmol) in THF (0.4 mL) was added to a solution 
of 2-(but-2-yn-1-ylsulfonyl)benzo[d]thiazole (77.5 mg, 0.29 mmol) in 
THF (0.4 mL) at –55 °C. The dark red solution was stirred for 30 min at 
this temperature before a solution of aldehyde 80 (53.0 mg, 96.9 μmol) 
in THF (0.2 mL) was added dropwise. The resulting mixture was stirred at –55 °C for 13 h before it 
was poured into brine (1 mL) and warmed to ambient temperature. The mixture was diluted with 
H2O (2 mL) and t-butyl methyl ether (2 mL), the layers separated and the aqueous layer extracted 
with t-butyl methyl ether (3 × 5 mL). The combined extracts were dried over Na2SO4, filtered and 
concentrated. The residue was purified by flash chromatography (hexanes) to afford the title 
compound (E)-83 as a colorless oil (15.7 mg, 28%, E/Z 7:1). [)]'
( = –1.6 (c = 1.0, CHCl3). 
1H NMR 
(400 MHz, CDCl3): δ = 6.07 (dd, J = 16.0, 6.7 Hz, 1H), 5.54 (dqd, J = 16.0, 2.4, 1.3 Hz, 1H), 4.13 (ddd,  
J = 6.7, 3.4, 1.3 Hz, 1H), 3.87 (dt, J = 10.1, 5.8 Hz, 1H), 3.66 (dd, J = 10.6, 4.9 Hz, 1H), 3.60 (dd, J = 10.6, 
4.7 Hz, 1H), 3.50 (dd, J = 6.0, 3.4 Hz, 1H), 3.42 (dt, J = 9.0, 4.7 Hz, 1H), 2.15–1.97 (m, 2H), 1.94 (d,  
J = 2.4 Hz, 3H), 1.36 (ddd, J = 11.3, 10.9, 6.2 Hz, 1H), 1.05 (d, J = 6.4 Hz, 3H), 0.90 (s, 9H), 0.891 (s, 9H), 
0.886 (s, 9H), 0.07 (s, 6H), 0.06 (s, 3H), 0.05 (s, 6H), 0.03 ppm (s, 3H). 13C NMR (100 MHz, CDCl3):  
δ = 142.6, 111.2, 86.2, 85.2, 79.7, 79.5, 78.3, 75.3, 65.2, 37.9, 37.2, 26.3, (3C), 26.2 (3C), 26.1 (3C), 
18.6, 18.5, 18.4, 17.2, 4.5, –4.0, –4.1, –4.2, –4.5, –5.2 ppm (2C). IR (film): ṽ = 2954, 2929, 2856, 1462, 
1388, 1361, 1252, 1084, 1005, 960, 832, 774, 675 cm–1. MS (EI) m/z (%): 583 (10), 582 (21), 525 (11), 
373 (13), 229 (26), 209 (41), 186 (16), 185 (100), 149 (12), 147 (13), 115 (13), 89 (16), 75 (16), 73 (91). 
HRMS (ESIpos): m/z calcd for C31H62O4Si3Na: 605.3848, found: 605.3847. 
(Z)-Vinyl iodide 84. Iodomethyltriphenylphosphonium iodide (997 mg, 2.29 mmol) was added in 
portions to a solution of NaHMDS (386 mg, 2.10 mmol) in THF (15 mL). The 
resulting yellow mixture was stirred at rt for 30 min before it was cooled to  
–78 °C. HMPA (0.80 mL, 4.57 mmol) was added, followed by a solution of 
aldehyde 80 (500 mg, 0.91 mmol) in THF (3 mL). The resulting mixture was stirred at –78 °C for 7 h. 
The reaction was quenched with H2O (8 mL) and the aqueous layer was extracted with t-butyl methyl 
ether (3 × 10 mL). The combined extracts were dried over Na2SO4, filtered and concentrated. The 
residue was purified by flash chromatography (hexanes/t-butyl methyl ether 300:1) to afford the title 
compound 84 as a colorless oil (596 mg, 97%, Z/E > 20:1). [)]'
( = +6.9 (c = 1.0, CHCl3). 
1H NMR 
(400 MHz, CDCl3): δ = 6.40 (dd, J = 8.2, 7.7 Hz, 1H), 6.27 (dd, J = 7.7, 0.5 Hz, 1H), 4.31 (ddd, J = 8.3, 
1.9, 0.8 Hz, 1H), 3.75 (ddd, J = 9.8, 8.0, 5.7 Hz, 1H), 3.67–3.59 (m, 3H), 3.46 (dt, J = 9.2, 4.7 Hz, 1H), 
2.29 (ddd, J = 12.3, 7.0, 5.7 Hz, 1H), 2.06 (ddt, J = 11.0, 8.8, 6.7 Hz, 1H), 1.31 (td, J = 11.6, 10.0 Hz, 1H), 
1.07 (d, J = 6.6 Hz, 3H), 0.90 (s, 9H), 0.882 (s, 9H), 0.875 (s, 9H), 0.11 (s, 3H), 0.09 (s, 6H), 0.07 (s, 3H), 
0.04 ppm (s, 6H). 13C NMR (100 MHz, CDCl3): δ = 141.9, 84.9, 81.8, 80.7, 79.3, 76.7, 65.2, 38.7, 37.2, 
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26.3 (3C), 26.10 (3C), 26.05 (3C), 18.6, 18.5, 18.3, 17.2, –3.9, –4.0, –4.2, –4.5, –5.2 ppm (2C). IR (film): 
ṽ = 2954, 2928, 2886, 2856, 1471, 1462, 1388, 1361, 1252, 1131, 1075, 1005, 959, 832, 774, 672, 
594 cm–1. MS (EI) m/z (%): 615 (13), 614 (28), 413 (69), 543 (13), 481 (15), 375 (17), 374 (25), 371 
(27), 349 (12), 298 (15), 297 (100), 230 (13), 229 (73), 186 (16), 185 (97), 147 (12), 115 (12), 89 (13), 
75 (16), 73 (91). HRMS (ESIpos): m/z calcd for C28H59O4ISi3Na: 693.2658, found: 693.2657. 
(Z)-Enyne (Z)-83. THF was degassed by three freeze-pump-thaw cycles prior to use. A flame-dried 
two-necked round-bottom flask equipped with a reflux condenser was 
charged with 1-propynyllithium (87.0 mg, 1.89 mmol), which was suspended 
in degassed THF (12 mL). Trimethyl borate (0.21 mL, 1.89 mmol) was added 
dropwise via syringe at rt. After stirring for 20 min, [Pd(dppf)Cl2]·CH2Cl2 
(108 mg, 0.13 mmol, 15 mol%) was added, causing the reaction mixture to turn bright red. Next, a 
solution of (Z)-vinyl iodide 84 (590 mg, 0.88 mmol) in degassed THF (3 mL + 1 mL rinse) was added 
and the mixture was stirred at 65°C for 7 h. The pale orange mixture was cooled to ambient 
temperature; the reaction was quenched with aq. half-sat. NH4Cl (15 mL) and the aqueous layer 
extracted with EtOAc (3 × 20 mL). The combined extracts were dried over Na2SO4, filtered and 
concentrated. The residue was purified by flash chromatography (hexanes/t-butyl methyl ether 
100:1) to afford the title compound (Z)-83 as a colorless oil (440 mg, 86%). [)]'
( = +3.2 (c = 1.0, 
CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 5.95 (ddd, J = 10.8, 9.1, 0.8 Hz, 1H), 5.45 (dqd, J = 10.9, 2.4, 0.7 
Hz, 1H), 4.59 (ddd, J = 9.1, 1.8, 0.8 Hz, 1H), 3.73 (ddd, J = 9.9, 8.0, 5.6 Hz, 1H), 3.67–3.58 (m, 3H), 3.43 
(dt, J = 9.3, 4.7 Hz, 1H), 2.16 (ddd, J = 12.1, 7.0, 5.6 Hz, 1H), 2.03 (ddt, J = 11.1, 8.6, 6.7 Hz, 1H), 1.96 
(dd, J = 2.4, 0.6 Hz, 3H), 1.34–1.26 (m, 1H), 1.05 (d, J = 6.5 Hz, 3H), 0.89 (s, 9H), 0.882 (s, 9H), 0.875 (s, 
9H), 0.08 (s, 9H), 0.042 (s, 6H), 0.036 ppm (s, 3H). 13C NMR (100 MHz, CDCl3): δ = 142.0, 109.9, 90.6, 
84.8, 80.9, 79.8, 77.0, 72.0, 65.3, 38.3, 37.2, 26.2 (3C), 26.12 (3C), 26.09 (3C), 18.6, 18.5, 18.4, 17.2, 
4.5, –4.1, –4.3, –4.6, –4.6, –5.2 ppm (2C). IR (film): ṽ = 2954, 2928, 2887, 2856, 1472, 1462, 1388, 
1361, 1252, 1131, 1065, 1005, 967, 834, 775, 679 cm–1. MS (ESIpos) m/z (%): 605.4 (100 (M+Na)). 
HRMS (ESIpos): m/z calcd for C31H62O4Si3Na: 605.3848, found: 605.3843. 
Alcohol 85. Pyridine (2.40 mL, 29.6 mmol) was slowly added to a Teflon® vial charged with 
HF·pyridine (0.58 mL, 6.43 mmol) and the resulting mixture diluted with THF 
(5 mL). This solution was added dropwise to a solution of silyl ether (Z)-83 
(150 mg, 0.26 mmol) in THF (2 mL) in a second Teflon® vial. The resulting 
mixture was stirred at ambient temperature for 11 h. The mixture was diluted 
with EtOAc (5 mL) and the reaction was carefully quenched with aq. sat. 
NaHCO3 (10 mL). The layers were separated and the aqueous layer was extracted with EtOAc  
(4 × 15 mL). The combined organic extracts were dried over Na2SO4, filtered and concentrated. The 
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residue was purified by flash chromatography (hexanes/EtOAc 50:1) to afford the title compound 85 
as a colorless oil (104 mg, 85%). [)]'
( = +1.8 (c = 1.0, CHCl3). 
1H NMR (500 MHz, CDCl3): δ = 5.93 (ddd, 
J = 10.9, 9.1, 0.7 Hz, 1H, H-8), 5.47 (dqd, J = 10.9, 2.4, 0.7 Hz, 1H, H-9), 4.60 (ddd, J = 9.2, 1.9, 0.8 Hz, 
1H, H-7), 3.78 (ddd, J = 10.1, 7.9, 5.6 Hz, 1H, H-5), 3.69 (ddd, J = 8.6, 5.2, 3.3 Hz, 1H, H-1), 3.64 (dd,  
J = 7.9, 1.9 Hz, 1H, H-6), 3.52–3.47 (m, 2H, H-1 and H-2), 2.22 (ddd, J = 12.0, 7.2, 6.0 Hz, 1H, H-4), 2.07 
(dddq, J = 11.3, 8.8, 6.8, 6.6 Hz, 1H, H-3), 1.96 (d, J = 2.4 Hz, 3H, H-12), 1.92 (t, J = 6.1 Hz, 1H, 1-OH), 
1.34 (ddd, J = 12.0, 11.2, 10.2 Hz, 1H, H-4), 1.03 (d, J = 6.5 Hz, 3H, H-23), 0.91 (s, 9H, 6-TBS), 0.89 (s, 
9H, 7-TBS), 0.094 (s, 3H, 6-TBS), 0.089 (s, 3H, 7-TBS), 0.08 (s, 3H, 6-TBS), 0.04 ppm (s, 3H, 7-TBS). 
13C NMR (125 MHz, CDCl3): δ = 141.8 (C8), 110.2 (C9), 90.8 (C11), 84.8 (C2), 81.0 (C6), 80.1 (C5), 76.9 
(C10), 72.3 (C7), 63.4 (C1), 38.3 (C4), 35.4 (C3), 26.2 (3C, 6-TBS), 26.1 (3C, 7-TBS), 18.6 (6-TBS), 18.4 
(7-TBS), 16.5 (C23), 4.5 (C12), –4.1 (6-TBS), –4.2 (7-TBS), –4.3 (6-TBS), –4.6 ppm (7-TBS). IR (film):  
ṽ = 3457, 2954, 2928, 2885, 2856, 1472, 1462, 1388, 1361, 1250, 1150, 1107, 1079, 1060, 1005, 964, 
834, 775, 679 cm–1. MS (EI) m/z (%): 469 (11), 468 (28), 411 (25), 260 (13), 259 (68), 209 (27), 189 
(13), 185 (24), 171 (30), 159 (10), 147 (17), 144 (12), 133 (12), 127 (48), 115 (62), 109 (11), 97 (15), 75 
(34), 73 (100), 71 (38). HRMS (ESIpos): m/z calcd for C25H48O4Si2Na: 491.2983, found: 491.2984. 
Carboxylic acid 60. NMO·H2O (242 mg, 2.07 mmol) and TPAP (7.27 mg, 0.02 mmol, 10 mol%) were 
sequentially added to a solution of alcohol 85 (97 mg, 0.21 mmol) in MeCN (1 mL). 
The resulting mixture was stirred at rt for 7 h. The reaction was quenched with aq. 
pH 5 phosphate buffer (2 mL), the layers were separated and the aqueous layer 
extracted with EtOAc (4 × 5 mL). The combined organic extracts were dried over 
Na2SO4, filtered and concentrated. The residue was purified by flash chromatography 
(hexanes/EtOAc 6:1 to 2:1) affording the title compound 60 as a colorless oil (82.5 mg, 83%).  
[)]'
( = +18.4 (c = 1.0, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 5.88 (ddd, J = 10.9, 9.0, 0.8 Hz, 1H), 5.50 
(dqd, J = 10.9, 2.4, 0.8 Hz, 1H), 4.61 (ddd, J = 9.0, 2.0, 0.8 Hz, 1H), 4.01 (ddd, J = 10.7, 7.0, 5.0 Hz, 1H), 
3.93 (d, J = 9.3 Hz, 1H), 3.70 (dd, J = 7.0, 2.0 Hz, 1H), 2.34 (dddq, J = 10.9, 9.3, 6.6, 6.4 Hz, 1H), 2.27 
(ddd, J = 11.8, 6.6, 5.0 Hz, 1H), 1.97 (d, J = 2.4, Hz, 3H), 1.48 (ddd, J = 11.8, 10.9, 10.7 Hz, 1H), 1.28 (d, 
J = 6.4 Hz, 3H), 0.91 (s, 9H), 0.88 (s, 9H), 0.11 (s, 3H), 0.09 (s, 3H), 0.08 (s, 3H), 0.05 ppm (s, 3H). 
13C NMR (100 MHz, CDCl3): δ = 173.1, 141.4, 110.7, 91.5, 82.6, 81.8, 79.9, 76.7, 72.7, 39.9, 38.1, 26.12 
(3C), 26.10 (3C), 18.5, 18.5, 17.3, 4.5, –4.0, –4.2, –4.4, –4.7 ppm. IR (film): ṽ = 2954, 2928, 2856, 1722, 
1462, 1388, 1361, 1251, 1152, 1080, 1006, 966, 835, 777, 681 cm–1. MS (ESIneg) m/z (%): 481.3 (100 
(M–H)). HRMS (ESIneg): m/z calcd for C25H45O5Si2: 481.2811, found: 481.2814. 
EXPERIMENTAL SECTION 157 
   
4.3.4 Synthesis of the Sidechain 18 
Methyl-(E)-3-methyl-5-(triisopropylsilyl)pent-2-en-4-ynoate (88). Methyl-2-butynoate (980 mg, 
10.0 mmol) and TIPS-acetylene (2.80 mL, 12.5 mmol) were added to a solution 
of Pd(OAc)2 (67.3 mg, 0.30 mmol, 3 mol%) and TDMPP (133 mg, 0.30 mmol, 
3 mol%) in toluene. The resulting mixture was stirred at rt for 20 h before it was diluted with 
CH2Cl2/Et2O (1:1, 10 mL) and filtered through a plug of Florisil®. The filter cake was washed with 
CH2Cl2/Et2O (1:1, 30 mL) and Et2O (50 mL). The filtrates were concentrated and the residue purified 
by flash chromatography (pentane/Et2O 20:1) to afford the title compound 88 as a pale yellow oil 
(2.56 g, 91%). 1H NMR (400 MHz, CDCl3): δ = 6.10 (q, J = 1.5 Hz, 1H), 3.71 (s, 3H), 2.30 (d, J = 1.5 Hz, 
3H), 1.10–1.07 ppm (m, 21H). 13C NMR (100 MHz, CDCl3): δ = 166.7, 138.3, 124.3, 108.7, 96.5, 51.4, 
20.1, 18.7 (6C), 11.3 ppm (3C). IR (film): ṽ = 2945, 2866, 1721, 1615, 1463, 1341, 1240, 1150, 999, 
882, 678, 624 cm–1. MS (EI) m/z (%): 280 (10), 238 (22), 237 (100), 209 (21), 195 (14), 181 (14), 167 
(21), 89 (12). HRMS (ESIpos): m/z calcd for C16H28O2SiNa: 303.1751, found: 303.1752. The analytical 
and spectroscopic data are in agreement with those reported in the literature.[157] 
Methyl-(R)-3-methyl-5-(triisopropylsilyl)pent-4-ynoate (89). A solution of Cu(OAc)2 (14.0 mg, 
70.0 μmol, 5 mol%) and (S,SFC)-WalPhos (65.0 mg, 70.0 μmol, 5 mol%) in 
toluene (1 mL) was stirred at rt for 30 min. Methyl-diethoxysilane (375 mg, 
2.80 mmol) was added and the resulting mixture stirred at rt for 30 min before 
the mixture was cooled to 0 °C. Next, a solution of enyne 88 (392 mg, 1.40 mmol) in toluene (0.8 mL) 
was added followed by t-BuOH (0.27 mL, 2.80 mmol). The resulting mixture was stirred at 4 °C for 
4 d. The mixture was filtered through a pad of silica, the filter cake was washed with Et2O (20 mL) and 
the filtrates were concentrated. The residue was purified by flash chromatography (pentane/Et2O 
50:1) to afford the title compound 89 as a pale yellow oil (364 mg, 79%, 98% ee).	[)]'
( = –25.6 
(c = 1.54, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 3.68 (s, 3H), 2.99 (tq, J = 7.4, 6.9 Hz, 1H), 2.55 (dd, 
J = 15.2, 7.4 Hz, 1H), 2.41 (dd, J = 15.2, 7.4 Hz, 1H), 1.23 (d, J = 6.9 Hz, 3H), 1.07–1.00 ppm (m, 21H). 
13C NMR (100 MHz, CDCl3): δ = 172.1, 111.6, 80.7, 51.8, 41.9, 24.1, 21.1, 18.7 (6C), 11.3 ppm (3C). 
IR (film): ṽ = 2943, 2865, 2166, 1743, 1463, 1437, 1356, 1249, 1169, 1065, 997, 882, 675, 660, 
627 cm–1. MS (EI) m/z (%): 240 (11), 239 (63), 209 (22), 198 (15), 197 (100), 169 (64), 167 (13), 155 
(15), 145 (26), 141 (58), 127 (17), 117 (17), 99 (13), 95 (11), 91 (15), 89 (30), 75 (29), 59 (23). HRMS 
(ESIpos): m/z calcd for C16H30O2SiNa: 305.1907, found: 305.1909.	 
The enantiomeric excess was determined by chiral HPLC of the benzoate derivative, which was 
prepared in analytical quantities by the following two-step protocol: 
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(R)-3-Methyl-5-(triisopropylsilyl)pent-4-yn-1-ol (S21). LiAlH4 (7.86 mg, 0.21 mmol) was added to a 
solution of methyl ester 89 (27.2 mg, 0.10 mmol) in THF (10 mL) at 0 °C. The 
suspension was stirred at 0 °C for 20 min, then at rt for 1 h. The mixture was 
diluted with t-butyl methyl ether (10 mL) and the reaction was quenched with aq. 
sat. Rochelle salt solution (10 mL). The biphasic mixture was stirred for 16 h, the layers were 
separated and the aqueous layer was extracted with t-butyl methyl ether (3 × 10 mL). The combined 
extracts were washed with brine (15 mL), dried over Na2SO4, filtered and concentrated. The residue 
was purified by flash chromatography (hexanes/t-butyl methyl ether 20:1 to 10:1) to afford 
alcohol S21 as a colorless oil (20.2 mg, 82%). [)]'
( = –57.5 (c = 1.09, CHCl3). 
1H NMR (400 MHz, 
CDCl3): δ = 3.86–3.77 (m, 2H), 2.66 (dqd, J = 9.4, 6.9, 5.1 Hz, 1H), 1.81 (brs, 1H), 1.79–1.61 (m, 2H), 
1.22 (d, J = 7.0 Hz, 3H), 1.08–1.02 ppm (m, 21H). 13C NMR (100 MHz, CDCl3): δ = 113.2, 81.1, 61.6, 
39.7, 24.2, 21.7, 18.8 (6C), 11.3 ppm (3C). IR (film): ṽ = 3318, 2941, 2891, 2865, 2165, 1463, 1382, 
1326, 1243, 1134, 1078, 1052, 996, 883, 675, 660, 620 cm–1. MS (EI) m/z (%): 211 (55), 169 (58), 167 
(13), 157 (19), 155 (37), 141 (33), 139 (28), 131 (28), 129 (16), 127 (44), 125 (21), 123 (12), 115 (55), 
114 (13), 113 (37), 111 (23), 109 (16), 103 (53), 101 (21), 99 (18), 97 (20), 95 (16), 87 (56), 85 (26), 83 
(18), 81 (11), 79 (14), 77 (14), 75 (85), 73 (82), 71 (14), 69 (18), 67 (13), 61 (43), 59 (100), 55 (16), 53 
(14), 45 (40), 43 (29), 42 (27), 41 (58), 40 (12), 39 (33), 29 (89), 27 (11). HRMS (ESIpos): m/z calcd for 
C15H30OSiNa: 277.1958, found: 277.1956.	 
(R)-3-Methyl-5-(triisopropylsilyl)pent-4-yn-1-yl benzoate (90). Pyridine (19.5 μL, 0.24 mmol) and 
benzoyl chloride (27.9 μL, 0.24 mmol) were sequentially added to a solution of 
alcohol S21 (20.2 mg, 0.08 mmol) in CH2Cl2 (0.8 mL) at 0 °C. The resulting mixture 
was stirred at rt for 1.5 h. The reaction was quenched with H2O (1.5 mL) and the 
aqueous layer was extracted with CH2Cl2 (3 × 5 mL). The combined extracts were washed with HCl 
(2 M, 10 mL), aq. sat. NaHCO3 (10 mL) and aq. half-sat. brine (10 mL), dried over Na2SO4, filtered and 
concentrated. The residue was purified by flash chromatography (hexanes/t-butyl methyl ether 25:1) 
to afford benzoate 90 as a colorless oil (22.6 mg, 80%).  [)]'
( = –29.3 (c = 0.97, CHCl3). 
1H NMR 
(400 MHz, CDCl3): δ = 8.07–8.00 (m, 2H), 7.58–7.53 (m, 1H), 7.46–7.41 (m, 2H), 4.57–4.42 (m, 2H), 
2.74 (dddd, J = 12.5, 9.1, 6.9, 5.5 Hz, 1H), 1.99–1.81 (m, 2H), 1.27 (d, J = 6.9 Hz, 3H), 1.10–0.99 ppm 
(m, 21H). 13C NMR (100 MHz, CDCl3): δ = 166.6, 133.0, 130.5, 129.7 (2C), 128.5 (2C), 112.2, 81.0, 63.3, 
36.0, 24.2, 21.5, 18.8 (6C), 11.4 ppm (3C). IR (film): ṽ = 2942, 2865, 2164, 1723, 1452, 1384, 1272, 
1115, 1070, 921, 771, 676, 661, 619 cm–1. MS (EI) m/z (%): 316 (10), 315 (41), 236 (19), 235 (100), 105 
(31), 77 (11). HRMS (ESIpos): m/z calcd for C22H34O2SiNa: 381.2220, found: 381.2220.	The ee was 
determined by HPLC (150 mm, Chiralcel OJ-3R, Ø 4.6 mm, MeOH/H2O 85:15, flow rate = 0.5 mL/min, 
132 bar, 298 K, UV, 225 nm): major enantiomer tR = 21.8 min; minor enantiomer tR = 23.9 min.  
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Methyl-(R)-3-methylpent-4-ynoate (18). TBAF (1 M in Et2O, 1.06 mL, 1.06 mmol) was added to a 
solution of TIPS-alkyne 89 (250 mg, 0.89 mmol) in Et2O (9 mL). The resulting mixture 
was stirred at ambient temperature for 17 h. The reaction was quenched with aq. 
sat. NH4Cl (15 mL) and the aqueous layer extracted with Et2O (3 × 20 mL). The combined extracts 
were dried over Na2SO4, filtered and concentrated. The residue was purified by flash 
chromatography (pentane/Et2O 25:1) to afford the title compound as a colorless liquid (90.9 mg, 
81%). 1H NMR (400 MHz, CDCl3): δ = 3.70 (s, 3H), 2.96 (hd, J = 7.1, 2.4 Hz, 1H), 2.57 (dd, J = 15.6, 
7.3 Hz, 1H), 2.42 (dd, J = 15.6, 7.4 Hz, 1H), 2.07 (d, J = 2.4 Hz, 1H), 1.24 ppm (d, J = 6.9 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 171.9, 87.2, 68.9, 51.9, 41.3, 22.7, 20.7 ppm.  
4.3.5 Fragment Assembly and Attempted RCAM 
Representative Procedure for Mitsunobu Esterification of Northern Alcohol with Southern Acid 
Fragments. Preparation of Diyne 91. PPh3 (18 mg, 70 μmol) was added to a solution of alcohol 48 
(5.0 mg, 12 μmol) and carboxylic acid 60 (7.0 mg, 14 μmol) in toluene 
(0.5 mL) at 0 °C. The resulting mixture was stirred for 5 min before DIAD 
(13.8 μL, 70.0 μmol) was added dropwise and the stirring continued at rt for 
3 h. The mixture was diluted with hexanes (2 mL), washed with water (3 mL) 
and brine (3 mL). The combined extracts were dried over Na2SO4, filtered and 
concentrated. The residue was purified by flash chromatography (hexanes/t-butyl methyl ether 19:1 
to 10:1) to yield diyne 91 as a colorless oil (8.3 mg, 79%). [)]'
( = +12.4 (c = 0.5, CHCl3). 
1H NMR 
(400 MHz, CDCl3): δ = 5.95 (dd, J = 10.5, 9.6 Hz, 1H), 5.54–5.39 (m, 2H), 4.61 (dd, J = 9.3, 1.4 Hz, 1H), 
4.40 (dq, J = 4.3, 2.0 Hz, 1H), 4.21–4.14 (m, 1H), 4.12 (dd, J = 5.9, 3.5 Hz, 1H),  4.01–3.95 (m, 1H), 3.94 
(d, J = 8.8 Hz, 1H), 3.78–3.72 (m, 1H), 3.74 (dd, J = 6.4, 3.0 Hz, 1H), 3.71 (dd, J = 7.6, 1.9 Hz, 1H),  
2.36–2.24 (m, 2H), 2.20 (ddd, J = 11.9, 6.9, 5.2 Hz, 1H), 2.05 (ddd, J = 14.2, 6.7, 1.3 Hz, 1H), 1.96 (d,  
J = 2.3 Hz, 3H), 1.83 (d, J = 2.1 Hz, 3H), 1.38 (q, J = 11.2 Hz, 1H), 1.19 (d, J = 6.4 Hz, 3H), 0.889 (s, 9H), 
0.885 (s, 9H), 0.88 (s, 9H), 0.86 (s, 9H), 0.12 (s, 3H), 0.09 (s, 6H), 0.08 (s, 3H), 0.07 (s, 3H), 0.04 (s, 3H), 
O
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0.03 (s, 3H), 0.02 ppm (s, 3H). 13C NMR (100 MHz, CDCl3): δ = 172.6, 141.9, 110.2, 90.9, 82.6, 82.3, 
81.9, 81.7, 80.8, 80.2, 78.0, 77.0, 74.5, 72.2, 65.9, 61.0, 40.3, 37.5, 35.0, 26.2 (3C), 26.1 (3C), 26.0 
(6C), 18.6, 18.42, 18.36, 18.3, 17.6, 4.5, 3.8, –4.27, –4.32, –4.48, –4.49, –4.6, –4.9, –5.2, –5.3 ppm. 
IR (film): ṽ = 2955, 2929, 2885, 2857, 1761, 1734, 1472, 1463, 1361, 1253, 1091, 1006, 837, 777 cm–1. 
MS (ESIpos) m/z (%): 901.5 (100 (M+Na)). HRMS (ESIpos): m/z calcd for C46H86O8Si4Na: 901.5292, 
found: 901.5290.	 
Diyne 92. This compound was prepared according to the representative procedure for Mitsunobu 
esterification (vide supra) from alcohol 49 and carboxylic acid 60. Purification 
by flash chromatography (hexanes/t-butyl methyl ether 30:1 to 20:1) 
provided diyne 92 as a colorless oil (34.9 mg, 93%). [)]'
( = –9.7 (c = 1.0, 
CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 5.95 (dd, J = 10.7, 9.5 Hz, 1H),  
5.50–5.44 (m, 2H), 4.94 (d, J = 6.7 Hz, 1H), 4.62 (d, J = 6.7 Hz, 1H), 4.65–4.59 
(m, 1H), 4.35 (ddq, J = 6.9, 4.9, 2.4 Hz, 1H), 4.32–4.26 (m, 1H), 4.15 (ddd, J = 7.5, 5.7, 3.5 Hz, 1H), 
4.00–3.94 (m, 1H), 3.94 (d, J = 8.8 Hz, 1H), 3.80–3.73 (m, 2H), 3.71 (dd, J = 7.6, 1.8 Hz, 1H), 3.38 (s, 
3H), 2.39–2.30 (m, 1H), 2.29–2.19 (m, 2H), 2.14 (ddd, J = 14.1, 6.3, 1.0 Hz, 1H), 1.96 (d, J = 2.3 Hz, 3H), 
1.85 (d, J = 2.0 Hz, 3H), 1.38 (q, J = 11.1 Hz, 1H), 1.19 (d, J = 6.5 Hz, 3H), 0.89 (s, 9H), 0.88 (s, 9H), 0.86 
(s, 9H), 0.089 (s, 3H), 0.085 (s, 3H), 0.08 (s, 3H), 0.04 (s, 3H), 0.03 (s, 3H), 0.02 ppm (s, 3H). 13C NMR 
(100 MHz, CDCl3): δ = 172.5, 141.9, 110.2, 94.1, 90.9, 83.5, 82.6, 82.3, 81.9, 80.2, 79.6, 77.0, 74.7, 
74.2, 72.2, 68.4, 60.9, 55.8, 40.3, 37.5, 35.7, 26.2 (3C), 26.1 (3C), 25.9 (3C), 18.6, 18.4, 18.3, 17.7, 4.5, 
3.8, –4.3, –4.4, –4.5, –4.6, –5.2, –5.3 ppm. IR (film): ṽ = 2954, 2927, 2855, 1733, 1463, 1379, 1255, 
1151, 1098, 1033, 965, 837, 778 cm–1. MS (ESIpos) m/z (%): 826.5 (100 (M+NH4)). HRMS (ESIpos): m/z 
calcd for C42H76O9Si3Na: 831.4689, found: 831.4690.	 
Enyne 93b. 5 Å MS (200 mg) was added to a solution of diyne 92 (10.0 mg, 12.4 μmol) in toluene 
(5.2 mL) at room temperature and the suspension was stirred for 30 min. 
The mixture was then heated to 110 °C before a freshly prepared solution of 
trisilanol L2 (2.4 mg, 3.1 μmol, 25 mol%) and complex C12 (1.9 mg, 2.8 μmol, 
23 mol%) in toluene (1 mL) was added, which had been stirred for 20 min 
prior to use. Stirring was continued at 110 °C for 30 min. The mixture was 
cooled to ambient temperature, the molecular sieves were filtered off 
through a pad of Celite®, which was carefully rinsed with EtOAc, and the combined filtrates were 
concentrated. The residue was purified by flash chromatography (hexanes/EtOAc 30:1) to afford the 
title compound as a colorless oil (1.4 mg, 15%). [)]'
( = +26.7 (c = 0.03, CHCl3). 
1H NMR (600 MHz, 
CDCl3): see Table 4.2. 
13C NMR (150 MHz, CDCl3): see Table 4.2. IR (film): ṽ = 2956, 2929, 2897, 2857, 
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1747, 1471, 1463, 1255, 1154, 1097, 1074, 1034, 837, 778 cm–1. MS (ESIpos) m/z (%): 777.4 (100 
(M+Na)). HRMS (ESIpos): m/z calcd for C38H70O9Si3Na: 777.4220, found: 777.4222.	 
Table 4.2. 1H and 13C NMR data of enyne 93b (0.5 mg in 0.25 mL CDCl3); chagosensine numbering.* 
atom 
n° 
1H NMR (600 MHz, CDCl3) 
13C NMR (150 MHz, CDCl3) 
δ [ppm] m J [Hz] COSY NOESY δ [ppm] HMBC 
1 - - - - - 170.5 2, 3, (15) 
2 3.97 d 8.4 3 3, 4b, 15, (16), 23 84.0 3, 4a, 23 
3 2.62 m - 2, 4(a)b, 23 2, 4a, (5), 23 36.94 2, 4, 23 
4a 
4b 
2.13 
1.66 
ddd 
ddd 
12.0, 7.8, 6.0 
12.0, 10.6, 9.8 
(3), 4b, 5 
3, 4a, 5 
3, 4b, 5 
2, 4a, 6, 23 
36.2 (2), 3, 5, 23 
5 4.29 ddd 9.8, 6.5, 2.1 4ab, (6) 3, 4a, 7, 13 80.17 (2), 4, 7 
6 3.56 dd 4.8, 2.1 (5), 7 4b, 5, 7, 8 78.6 4b, 5, (8) 
7 4.82 dd 9.7, 4.8 6,8 5, 6, (9), 15 73.2 6, 9 
8 5.95 dd 10.8, 9.6 7,9 6, 6-TBS, 7-TBS 145.3 6, (7), 9 
9 5.58 dd 10.8, 2.6 8, (12) (7), 6-TBS, 7-TBS 110.2 7,8 
10 - - - - - 84.7 8, 12 
11 - - - - - 91.0 9, 12, 13 
12 4.47 dd 7.3, 2.6 13, (9) 14b, 18ab, 19 69.3 13, 14b, 18 
13 4.39 td 7.6, 5.9 12, 14ab 5, 14a 80.20 12, 14b, 15  
14a 
14b 
2.36 
2.17 
ddd 
ddd 
13.1, 6.0, 4.2 
13.0, 8.0, 6.0 
13, 14b, 15 
13, 14a, 15 
13, 14b 
12, 14a, 15 
36.85 12, (16) 
15 5.69 dt 5.6, 4.1 14(a)b, 16 2, 7, 14b, (16) 75.9 14a, 16, 17 
16 4.26 dt 6.6, 5.2 15,17ab (2), (14b), 15, 17 81.4 14(a)b, 17 
17a 
17b 
3.82 
3.78 
dd 
dd 
10.3, 6.9 
10.3, 5.2 
16 
16 
13, 15, 17-TBS 61.5 (16) 
18a 
18b 
4.92 
4.64 
d 
d 
6.7 
6.7 
18b 
18a 
12, 19, 18b 
12, 19, 18a 
94.3 12, 19 
19 3.39 s - - 12, (13), 18ab 55.8 18 
23 1.10 d 6.6 3 2, 4(a)b, 6-TBS 16.5 2, 4b 
 
* The signals of the TBS groups are not listed and appear as follows: 1H NMR (600 MHz, CDCl3): 
δ = 0.91 (s, 9H), 0.87 (s, 9H), 0.86 (s, 9H), 0.10 (s, 3H), 0.080 (s, 3H), 0.078 (s, 3H), 0.06 (s, 3H), 0.04 (s, 
3H), 0.03 ppm (s, 3H). 13C NMR (150 MHz, CDCl3): δ = 26.4 (3C), 26.0 (6C), 18.4, 18.3, 18.2, –2.9, –3.9, 
–4.1, –4.7, –5.2, –5.3 ppm. 
Dichloroacetate S22. A solution of propargylic alcohol 59 (200 mg, 0.48 mmol) in CH2Cl2 (10 mL) was 
cooled to 0 °C before pyridine (1.00 mL, 12.4 mmol) and dichloroacetic 
anhydride (0.13 mL, 0.89 mmol) were added. The resulting mixture was 
stirred for 20 min, concentrated and the residue purified by flash 
chromatography (hexanes/t-butyl methyl ether 100:1) to provide the desired dichloroacetate S22 as 
a colorless oil (200 mg, 79%). [)]'
( = –52.1 (c = 1.0, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 5.99 (s, 
1H), 5.73 (dq, J = 8.7, 2.2 Hz, 1H), 4.34 (dt, J = 5.5, 2.6 Hz, 1H), 4.25 (ddd, J = 8.7, 8.1, 3.3 Hz, 1H), 3.90 
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(ddd, J = 6.1, 3.9, 2.4 Hz, 1H), 3.60 (dd, J = 10.8, 3.9 Hz, 1H), 3.46 (dd, J = 10.8, 5.7 Hz, 1H), 2.24 (ddd,  
J = 13.6, 8.0, 5.7 Hz, 1H), 2.02 (dt, J = 13.4, 3.0, 1H), 1.86 (d, J = 2.2 Hz, 3H), 0.97 (t, J = 7.9 Hz, 9H), 
0.94 (t, J = 7.9 Hz, 9H), 0.61 (q, J = 7.9 Hz, 6H), 0.58 ppm (q, J = 7.9 Hz, 6H). 13C NMR (100 MHz, CDCl3):  
δ = 163.8, 87.9, 84.6, 80.3, 73.4, 73.0, 70.7, 64.5, 63.2, 37.6, 6.88 (3C), 6.86 (3C), 4.8 (3C), 4.5 (3C), 
3.9 ppm. IR (film): ṽ = 2954, 2912, 2877, 1772, 1750, 1459, 1415, 1293, 1239, 1155, 1114, 1092, 1045, 
1005, 988, 812, 741, 729 cm–1. MS (ESIpos) m/z (%): 547.2 (100 (M+Na)). HRMS (ESIpos): m/z calcd 
for C23H42O5Cl2Si2Na: 547.1840, found: 547.1841.  
Diol S23. A solution of dichloroacetate S22 (200 mg, 0.38 mmol) in THF (6 mL) was cooled to –30 °C. 
Dichloroacetic acid (104 μL, 1.26 mmol) was added, followed by a solution 
of TBAF (1 M in THF, 0.84 mL, 0.84 mmol) and the reaction mixture was 
stirred at –30 °C for 75 min. The reaction was quenched with sat. aq. NH4Cl 
(5 mL) and the aqueous layer was extracted with EtOAc (3 × 10 mL). The combined extracts were 
dried over Na2SO4, filtered and concentrated. The residue was purified by flash chromatography 
(hexanes/EtOAc 1:1 to 0:1 to EtOAc/MeOH 95:5) to yield the title compound as a colorless oil 
(110 mg, 97%). [)]'
( = –92.8 (c = 1.0, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 6.02 (s, 1H), 5.64 (dq,  
J = 8.7, 2.2 Hz, 1H), 4.35 (dt, J = 6.8, 4.4 Hz, 1H), 4.29 (td, J = 7.8, 4.9 Hz, 1H), 3.94 (q, J = 4.3 Hz, 1H), 
3.69 (dd, J = 11.8, 4.2 Hz, 1H), 3.62 (dd, J = 11.8, 4.5 Hz, 1H), 2.52 (brs, 2H), 2.41 (ddd, J = 13.7, 7.9, 
6.8 Hz, 1H), 2.05 (dt, J = 13.6, 4.7, 1H), 1.87 ppm (d, J = 2.2 Hz, 3H). 13C NMR (100 MHz, CDCl3):  
δ = 163.9, 86.1, 85.4, 79.5, 72.8, 72.7, 69.9, 64.4, 62.6, 37.3, 3.9 ppm. IR (film): ṽ = 3391, 2924, 1764, 
1439, 1337, 1296, 1159, 1093, 1058, 977, 919, 812, 668 cm–1. MS (ESIpos) m/z (%): 319.0 (100 
(M+Na)). HRMS (ESIpos): m/z calcd for C11H14O5Cl2Na: 319.0111, found: 319.0109.  
Alcohol 104. Imidazole (30.2 mg, 0.44 mmol) was added to a solution of diol S23 (110 mg, 
0.37 mmol) in DMF (5.5 mL) and the solution was cooled to 0 °C before 
TBSCl (58.6 mg, 0.39 mmol) was added. The resulting mixture was stirred 
at rt for 6 h, the reaction was quenched with half-sat. aq. NH4Cl (5 mL) 
and the aqueous layer was extracted with EtOAc (3 × 8 mL). The combined extracts were washed 
with brine (20 mL), dried over Na2SO4, filtered and concentrated. The residue was purified by flash 
chromatography (hexanes/EtOAc 6:1 to 0:1) to afford the desired alcohol 104 as a colorless oil 
(90.1 mg, 59%). [)]'
( = –41.6 (c = 1.0, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 5.99 (s, 1H), 5.61 (dq,  
J = 7.6, 2.2 Hz, 1H), 4.35 (dq, J = 6.6, 4.1 Hz, 1H), 4.28 (td, J = 7.8, 4.9 Hz, 1H), 3.90 (dt, J = 6.0, 3.7 Hz, 
1H), 3.74 (dd, J = 10.5, 3.8 Hz, 1H), 3.54 (dd, J = 10.5, 6.1 Hz, 1H), 2.42 (ddd, J = 13.5, 8.0, 6.7 Hz, 1H), 
2.13 (d, J = 4.1 Hz, 1H), 2.01 (dt, J = 13.5, 4.6 Hz, 1H), 1.87 (d, J = 2.2 Hz, 3H), 0.88 (s, 9H), 0.05 ppm (s, 
6H). 13C NMR (100 MHz, CDCl3): δ = 163.8, 86.1, 85.1, 79.6, 73.1, 74.1, 70.1, 64.4, 64.2, 36.9, 26.0 
(3C), 18.4, 3.9, –5.34, –5.31 ppm. IR (film): ṽ = 3444, 2928, 2857, 1769, 1471, 1294, 1256, 1156, 1088, 
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983, 929, 835, 778, 668 cm–1. MS (ESIpos) m/z (%): 433.1 (100 (M+Na)). HRMS (ESIpos): m/z calcd for 
C17H28O5Cl2SiNa: 433.0975, found: 433.0979.  
Diyne 105. This compound was prepared according to the representative procedure for Mitsunobu 
esterification (vide supra) from alcohol 104 and carboxylic acid 60. 
Purification by flash chromatography (hexanes/t-butyl methyl ether 19:1 to 
10:1) provided diyne 92 as a colorless oil (37.6 mg, 65%). [)]'
( = +8.1 
(c = 0.5, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 5.96 (s, 1H), 5.93 (dd,  
J = 10.0, 0.8 Hz, 1H), 5.52–5.44 (m, 2H), 5.40 (dq, J = 6.6, 2.1 Hz, 1H), 4.61 
(dd, J = 9.3, 1.8 Hz, 1H), 4.37 (q, J = 7.6 Hz, 1H), 4.13 (td, J = 6.5, 3.5 Hz, 1H), 
4.00–3.90 (m, 1H), 3.94 (d, J = 8.8 Hz, 1H), 3.76–3.72 (m, 1H), 3.74 (d, J = 6.4 Hz, 1H), 3.70 (dd, J = 7.6, 
1.9 Hz, 1H), 2.33 (ddt, J = 10.8, 8.8, 6.6 Hz, 1H), 2.25–2.17 (m, 3H), 1.96 (d, J = 2.3 Hz, 3H), 1.86 (d,  
J = 2.1 Hz, 3H), 1.42–1.32 (m, 1H), 1.19 (d, J = 6.5 Hz, 3H), 0.89 (s, 9H), 0.88 (s, 9H), 0.86 (s, 9H), 0.09 
(s, 3H), 0.08 (s, 6H), 0.04 (s, 3H), 0.03 (s, 3H), 0.02 ppm (s, 3H). 13C NMR (100 MHz, CDCl3): δ = 172.5, 
163.6, 141.9, 110.3, 90.9, 85.3, 82.6, 82.4, 82.1, 80.3, 78.2, 73.9, 72.30, 72.25, 69.7, 64.2, 60.8, 55.8, 
40.3, 37.6, 35.8, 26.2 (3C), 26.1 (3C), 25.9 (3C), 18.6, 18.4, 18.3, 17.7, 4.5, 3.9, –4.3, –4.36, –4.40,  
–4.6, –5.2, –5.3 ppm. IR (film): ṽ = 2955, 2928, 2856, 1737, 1471, 1389, 1361, 1252, 1153, 1082, 1006, 
967, 834, 814, 776, 681 cm–1. MS (ESIpos) m/z (%): 897.4 (100 (M+Na)). HRMS (ESIpos): m/z calcd for 
C42H72O9Cl2Si3Na: 897.3753, found: 897.3761.	 
Diyne 98. A solution of LiOH (0.5 M in H2O, 5.7 μmol, 11 μL) was added to a solution of diyne 105 
(5.0 mg, 5.7 μmol) in 1,4-dioxane (50 μL). The resulting mixture was stirred at 
4-10 °C for 1 h, before it was diluted with EtOAc (2 mL). The reaction was 
quenched with NH4Cl (1 mL), the layers were separated and the aqueous 
layer was extracted with EtOAc (3 × 2 mL). The combined extracts were 
washed with brine (5 mL), dried over Na2SO4, filtered and concentrated. The 
residue was purified by flash chromatography (hexanes/t-butyl methyl ether 10:1 to 2:1) to afford 
diyne 98 as a colorless oil (3.8 mg, 87%). [)]'
( = +23.4 (c = 1.0, CHCl3). 
1H NMR (400 MHz, CDCl3):  
δ = 5.95 (dd, J = 10.8, 9.5 Hz, 1H), 5.50–5.43 (m, 2H), 4.61 (ddd, J = 9.0, 2.0, 0.8 Hz, 1H), 4.25–4.18 (m, 
2H), 4.11 (ddd, J = 7.1, 5.9, 3.5 Hz, 1H), 4.00–3.92 (m, 1H), 3.94 (d, J = 8.8 Hz, 1H), 3.79–3.74 (m, 2H), 
3.70 (dd, J = 7.6, 1.9 Hz, 1H), 2.37–2.30 (m, 1H), 2.28 (d, J = 4.4 Hz, 1H), 2.21 (ddd, J = 11.8, 6.8, 5.1 
Hz, 1H), 2.16–2.10 (m, 2H), 1.97 (d, J = 2.4 Hz, 3H), 1.84 (d, J = 1.8 Hz, 3H), 1.38 (q, J = 11.1 Hz, 1H), 
1.20 (d, J = 6.5 Hz, 3H), 0.90 (s, 9H), 0.88 (s, 9H), 0.86 (s, 9H), 0.092 (s, 3H), 0.087 (s, 3H), 0.08 (s, 3H), 
0.05 (s, 3H), 0.04 (s, 3H), 0.03 ppm (s, 3H). 13C NMR (100 MHz, CDCl3): δ = 172.5, 141.9, 110.3, 90.9, 
82.7, 82.6, 82.4, 81.9, 81.2, 80.3, 77.4, 77.0, 74.4, 72.3, 65.5, 61.0, 40.3, 37.6, 35.6, 26.2 (3C), 26.1 
(3C), 26.0 (3C), 18.6, 18.4, 18.3, 17.7, 4.5, 3.8, –4.3, –4.4, –4.5, –4.6, –5.2, –5.3 ppm. IR (film):  
O
HH OTBS
O
O
O
O
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ṽ = 3452, 2954, 2928, 2886, 2856, 1734, 1472, 1389, 1361, 1252, 1081, 1007, 965, 836, 777,  
682 cm–1. MS (ESIpos) m/z (%): 787.4 (100 (M+Na)). HRMS (ESIpos): m/z calcd for C40H72O8Si3Na: 
787.4427, found: 787.4433.	 
Diyne 112. This compound was prepared according to the representative procedure for Mitsunobu 
esterification (vide supra) from alcohol 49 and 9-undecynoic acid. 
Purification by flash chromatography (hexanes/t-butyl methyl 
ether 30:1) provided diyne 112 as a colorless oil (24.0 mg, 54%). 
[)]'
( = –32.1 (c = 1.0, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 5.42 
(ddd, J = 5.0, 3.5, 1.6 Hz, 1H), 4.94 (d, J = 6.7 Hz, 1H), 4.62 (d, J = 6.7 Hz, 1H), 4.35 (dq, J = 6.0, 2.0 Hz, 
1H), 4.30 (dt, J = 8.6, 6.2 Hz, 1H), 4.12 (ddd, J = 7.3, 5.6, 3.6 Hz, 1H), 3.77 (dd, J = 10.1, 5.6 Hz, 1H), 
3.74 (dd, J = 10.1, 7.3 Hz, 1H), 3.38 (s, 3H), 2.30 (t, J = 7.6 Hz, 2H), 2.24 (ddd, J = 13.6, 8.5, 5.0 Hz, 1H), 
2.18–2.07 (m, 3H), 1.84 (d, J = 2.0 Hz, 3H), 1.77 (t, J = 2.6 Hz, 3H), 1.64–1.59 (m, 2H), 1.49–1.42 (m, 
2H), 1.38–1.29 (m, 6H), 0.86 (s, 9H), 0.03 (s, 3H), 0.02 ppm (s, 3H). 13C NMR (100 MHz, CDCl3):  
δ = 173.1, 94.1, 83.4, 81.8, 79.6, 79.4, 75.6, 74.8, 73.8, 68.4, 60.9, 55.8, 35.6, 34.6, 29.2, 29.1, 29.0, 
28.8, 25.9 (3C), 25.0, 18.8, 18.3, 3.8, 3.6, –5.3, –5.4 ppm. IR (film): ṽ = 2929, 2857, 1737, 1464, 1251, 
1150, 1093, 1030, 903, 837, 777, 650 cm–1. MS (ESIpos) m/z (%): 531.3 (100 (M+Na)). HRMS (ESIpos): 
m/z calcd for C28H48O6SiNa: 531.3112, found: 531.3118.	 
Macrolactone 113. 5 Å MS (100 mg) was added to a solution of diyne 112 (5.0 mg, 10 μmol) in 
toluene (9 mL) at room temperature and the suspension was stirred for 
30 min. The mixture was then heated to 110 °C before a freshly prepared 
solution of trisilanol L2 (2.2 mg, 2.5 μmol, 25 mol%) and complex C12 
(1.3 mg, 2.0 μmol, 20 mol%) in toluene (1 mL) was added, which had been 
stirred for 20 min prior to use. Stirring was continued at 110 °C for 3 h. The mixture was cooled to 
ambient temperature, the molecular sieves were filtered off through a pad of Celite®, which was 
carefully rinsed with EtOAc, and the combined filtrates were concentrated. The residue was purified 
by flash chromatography (hexanes/t-butyl methyl ether 20:1) to afford the title compound as a 
colorless oil (3.9 mg, 87%). [)]'
( = +11.3 (c = 0.75, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 5.44 (t,  
J = 3.6 Hz, 1H), 4.90 (d, J = 6.6 Hz, 1H), 4.73 (d, J = 6.6 Hz, 1H), 4.33–4.24 (m, 2H), 4.14 (dd, J = 9.3, 2.7 
Hz, 1H), 3.81 (dd, J = 9.8, 6.1 Hz, 1H), 3.77 (dd, J = 9.8, 8.3 Hz, 1H), 3.41 (s, 3H), 2.51–2.43 (m, 1H), 
2.33–2.23 (m, 1H), 2.23–2.06 (m, 3H), 1.84 (ddd, J = 13.4, 11.6, 3.6 Hz, 1H), 1.71–1.65 (m, 2H),  
1.46–1.40 (m, 4H), 1.39–1.31 (m, 4H), 0.85 (s, 9H), 0.03 (s, 3H), 0.02 ppm (s, 3H). 13C NMR (100 MHz, 
CDCl3): δ = 173.4, 94.5, 88.5, 82.4, 81.6, 77.4, 73.3, 69.6, 60.8, 55.7, 39.2, 35.5, 28.4, 28.01, 27.99, 
27.6, 26.2, 25.9 (3C), 19.1, 18.4, –5.2, –5.4 ppm. IR (film): ṽ = 2929, 2857, 1738, 1462, 1361, 1247, 
O
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1127, 1081, 1030, 918, 838, 778 cm–1. MS (ESIpos) m/z (%): 477.3 (100 (M+Na)). HRMS (ESIpos): m/z 
calcd for C24H42O6SiNa: 477.2643, found: 477.2647. 
Ester 114. p-TsOH·H2O (15.3 mg, 0.08 mmol, 5 mol%) was added to a solution of diol 76 (561 mg, 
1.61 mmol) in 2,2-dimethoxypropane (16 mL). The resulting mixture was 
stirred at rt for 5 h. The reaction was quenched with aq. sat. NaHCO3 
(10 mL), the layers were separated and the aqueous layer extracted with 
EtOAc (3 × 15 mL). The combined extracts were dried over Na2SO4, filtered and concentrated. The 
residue was purified by flash chromatography (hexanes/EtOAc 20:1) to afford the title compound 
114 as a colorless oil (552 mg, 88%). [)]'
( = +10.3 (c = 1.0, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 4.55 
(d, J = 6.8 Hz, 1H), 4.24 (t, J = 6.8 Hz, 1H), 3.97 (ddd, J = 9.4, 6.7, 5.7 Hz, 1H), 3.73 (s, 3H), 3.71 (dd,  
J = 10.7, 3.9 Hz, 1H), 3.63 (dd, J = 10.5, 5.3 Hz, 1H), 3.56 (ddd, J = 7.3, 5.2, 3.6 Hz, 1H), 2.26–2.17 (m, 
2H), 1.62 (s, 3H), 1.46–1.36 (m, 1H), 1.40 (s, 3H), 1.09 (d, J = 6.1 Hz, 3H), 0.87 (s, 9H), 0.03 ppm (s, 
6H). 13C NMR (100 MHz, CDCl3): δ = 170.9, 111.5, 85.9, 81.3, 75.7, 64.7, 52.3, 38.1, 36.8, 26.9, 26.0 
(C3), 25.8, 18.4, 17.8, –5.2, –5.3 ppm. IR (film): ṽ = 2954, 2930, 2858, 1765, 1734, 1461, 1380, 1253, 
1202, 1166, 1091, 1005, 871, 838, 777 cm–1. MS (EI) m/z (%): 331 (25), 241 (19), 230 (11), 229 (57), 
185 (39), 171 (10), 159 (16), 157 (14), 139 (51), 117 (95), 115 (14), 107 (12), 101 (10), 89 (22), 75 (54), 
73 (100), 59 (24), 55 (10), 43 (26), 41 (12), 40 (42). HRMS (ESIpos): m/z calcd for C19H36O6SiNa: 
411.2173, found: 411.2174. 
The desilylated byproduct 115 was also isolated from the crude mixture as a colorless oil (17 mg, 4%). 
[)]'
( = –2.9 (c = 0.5, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 4.56 (d, J = 6.9 Hz, 
1H), 4.27 (dd, J = 6.9, 6.1 Hz, 1H), 4.04 (dt, J = 9.5, 6.1 Hz, 1H), 3.77 (dd,  
J = 11.9, 2.8 Hz, 1H), 3.74 (s, 3H), 3.58 (ddd, J = 9.1, 4.2, 2.8 Hz, 1H), 3.48 (dd,  
J = 11.9, 4.2 Hz, 1H), 2.25 (ddd, J = 11.5, 7.3, 6.0 Hz, 1H), 2.17 (dddq, J = 10.5, 9.1, 7.9, 6.4 Hz, 1H), 
1.97 (brs, 1H), 1.62 (s, 3H), 1.49 (ddd, J = 11.6, 10.5, 9.3 Hz, 1H), 1.40 (s, 3H), 1.04 ppm (d, J = 6.4 Hz, 
3H). 13C NMR (100 MHz, CDCl3): δ = 171.0, 111.5, 86.3, 81.2, 76.5, 75.6, 62.4, 52.3, 37.8, 34.8, 26.8, 
25.8, 16.2 ppm. IR (film): ṽ = 3485, 2984, 2954, 2935, 2874, 1757, 1733, 1457, 1438, 1371, 1244, 
1204, 1088, 1042, 920, 871, 788 cm–1. MS (ESIpos) m/z (%): 297.1 (100 (M+Na)). HRMS (ESIpos): m/z 
calcd for C13H22O6Na: 297.1309, found: 297.1306.  
Alcohol S24. A solution of LiAlH4 (1 M in THF, 2.83 mL, 2.83 mmol) was added to a solution of ester 
114 (550 mg, 1.42 mmol) in THF (14 mL) at 0 °C. The resulting mixture was 
stirred at ambient temperature for 1 h. The reaction was cooled to 0 °C and 
carefully quenched with MeOH until gas evolution ceased. The mixture was 
then poured via cannula into aq. sat. Rochelle salt (15 mL), the flask rinsed was rinsed with t-butyl 
methyl ether (5 mL) and the emulsion was vigorously stirred at rt overnight. The layers were 
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separated and the aqueous layer was extracted with t-butyl methyl ether (3 × 20 mL). The combined 
extracts were washed with brine (25 mL), dried over Na2SO4, filtered and concentrated. The residue 
was purified by flash chromatography (hexanes/t-butyl methyl ether 19:1) to afford the title 
compound S24 as a colorless oil (487 mg, 95%). [)]'
( = +2.8 (c = 1.0, CHCl3). 
1H NMR (400 MHz, 
CDCl3): δ = 3.72–3.65 (m, 2H), 4.08 (dd, J = 6.3, 3.8 Hz, 1H), 3.72–3.65 (m, 3H), 3.65–3.59 (m, 2H), 
3.12 (t, J = 6.5 Hz, 1H), 2.24–2.12 (m, 2H), 1.63 (ddd, J = 14.0, 13.8, 9.7 Hz, 1H) 1.50 (s, 3H), 1.37 (s, 
3H), 1.08 (d, J = 6.1 Hz, 3H), 0.88 (s, 9H), 0.04 ppm (s, 6H). 13C NMR (100 MHz, CDCl3): δ = 108.7, 86.5, 
78.9, 77.5, 76.0, 64.4, 61.6, 38.3, 36.0, 27.6, 26.0 (3C), 25.8, 18.4, 17.1, –5.28, –5.31 ppm. IR (film): 
ṽ = 3475, 2955, 2930, 2857, 1462, 1378, 1251, 1216, 1168, 1124, 1078, 1040, 1005, 836, 777,  
668 cm–1. MS (EI) m/z (%): 303 (28), 245 (30), 229 (43), 227 (35), 215 (14), 197 (14), 185 (38), 171 
(11), 157 (18), 153 (18), 145 (21), 143 (12), 135 (57), 131 (17), 129 (10), 127 (12), 117 (47), 115 (15), 
113 (12), 109 (20), 107 (13), 105 (29), 103 (13), 101 (15), 97 (16), 95 (19), 93 (15), 89 (18), 85 (14), 81 
(28), 75 (98), 73 (100), 69 (14), 59 (73), 57 (22), 55 (24), 43 (52), 41 (25), 31 (10), 29 (12). HRMS 
(ESIpos): m/z calcd for C18H36O5SiNa: 383.2224, found: 383.2226. 
Aldehyde S25. Hünig’s base (1.40 mL, 8.03 mmol) was added to a solution of alcohol S24 (579 mg, 
1.61 mmol) in CH2Cl2 (8 mL) at –25 °C. In a second flask, SO3·pyridine 
(639 mg, 4.01 mmol) was suspended in DMSO (1.15 mL, 16.1 mmol) and the 
suspension was stirred for 10 min at rt, before it was added to the alcohol 
solution at –25 °C and the flask was rinsed with CH2Cl2 (2 mL). The resulting mixture was stirred at  
–25 °C for 45 min. The reaction mixture was poured into pH 7 phosphate buffer (15 mL) and t-butyl 
methyl ether (15 mL), the layers were separated and the aqueous layer was extracted with t-butyl 
methyl ether (3 × 20 mL). The combined extracts were washed with pH 7 phosphate buffer (20 mL), 
followed by brine (20 mL), dried over Na2SO4, filtered and concentrated under high vacuum to yield 
crude aldehyde S25 as a pale yellow oil, which was pure by NMR spectroscopy. [)]'
( = –30.9 (c = 1.0, 
CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 9.66–9.59 (m, 1H), 4.34–4.29 (m, 2H), 4.01 (dtd, J = 8.0, 3.8, 2.0 
Hz, 1H), 3.65–3.59 (m, 2H), 3.55 (dt, J = 8.7, 4.4 Hz, 1H), 2.17–2.06 (m, 2H), 1.57 (s, 3H), 2.52 (ddd, 
J = 14.8, 5.2, 1.5 Hz, 1H), 1.40 (s, 3H), 1.05 (d, J = 6.1 Hz, 3H), 0.86 (s, 9H), 0.023 (s, 3H), 0.020 ppm (s, 
3H). 13C NMR (100 MHz, CDCl3): δ = 201.6, 111.3, 86.7, 81.6, 81.3, 75.6, 64.6, 37.0, 36.7, 27.1, 26.0 
(3C), 25.5, 18.4, 17.1, –5.3 ppm (2C). IR (film): ṽ = 2956, 2930, 2857, 1732, 1461, 1381, 1361, 1252, 
1214, 1164, 1075, 1004, 835, 776, 667 cm–1. MS (EI) m/z (%): 302 (12), 301 (59), 243 (24), 230 (18), 
229 (100), 225 (11), 213 (15), 201 (38), 197 (13), 187 (11), 185 (57), 183 (27), 171 (38), 157 (29), 155 
(11), 151 (11), 145 (15), 143 (16), 129 (22), 123 (11), 117 (40), 115 (15), 113 (18), 105 (17), 103 (20), 
101 (22), 97 (10), 95 (12), 89 (13), 85 (14), 81 (14), 75 (59), 73 (63), 59 (18), 55 (14), 43 (15). HRMS 
(ESIpos): m/z calcd for C18H34O5SiNa: 381.2068, found: 381.2068. 
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(Z)-Vinyl iodide 116. Iodomethyltriphenylphosphonium iodide (1.82 g, 4.17 mmol) was added in 
portions to a solution of NaHMDS (753 mg, 4.11 mmol) in THF (25 mL). The 
resulting yellow mixture was stirred at rt for 30 min before it was cooled to  
–78 °C. HMPA (1.40 mL, 8.02 mmol) was added, followed by a solution of 
aldehyde S25 (575 mg, 1.60 mmol) in THF (6 mL). The resulting mixture was stirred at –78 °C for 4 h. 
The reaction was quenched with H2O (15 mL) and the aqueous layer was extracted with t-butyl 
methyl ether (3 × 20 mL). The combined extracts were dried over Na2SO4, filtered and concentrated. 
The residue was purified by flash chromatography (hexanes/t-butyl methyl ether 70:1 to 40:1) to 
afford the title compound 116 as a colorless oil (517 mg, 67% two steps, Z/E > 20:1). [)]'
( = –53.2 
(c = 0.875, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 6.47 (dd, J = 7.7, 0.9 Hz, 1H), 6.36 (dd, J = 8.6, 7.7 Hz, 
1H), 4.82 (ddd, J = 8.6, 6.3, 0.6 Hz, 1H), 4.14 (t, J = 6.6 Hz, 1H), 3.89 (dt, J = 9.8, 6.3 Hz, 1H), 3.72 (dd,  
J = 10.6, 3.9 Hz, 1H), 3.65 (dd, J = 10.6, 5.1 Hz, 1H), 3.56 (ddd, J = 8.9, 5.1, 3.9 Hz, 1H), 2.18 (ddq,  
J = 13.9, 10.1, 6.5 Hz, 1H), 2.07 (ddd, J = 13.0, 7.2, 5.9 Hz, 1H), 1.50 (s, 3H), 1.41 (s, 3H), 1.33 (dt,  
J = 11.9, 10.1 Hz, 1H), 1.09 (d, J = 6.5 Hz, 3H), 0.88 (s, 9H), 0.04 ppm (s, 6H). 13C NMR (100 MHz, 
CDCl3): δ = 137.6, 110.0, 86.0, 85.6, 81.1, 79.8, 77.2, 64.9, 38.1, 36.7, 27.8, 26.0 (3C), 25.8, 18.4, 17.8, 
–5.2 ppm (2C). IR (film): ṽ = 2955, 2929, 2857, 1461, 1378, 1252, 1214, 1164, 1125, 1085, 1059, 999, 
837, 777, 677 cm–1. MS (EI) m/z (%): 483 (11), 482 (24), 467 (12), 426 (19), 425 (87), 367 (22), 337 
(12), 293 (11), 243 (21), 230 (19), 229 (100), 186 (12), 185 (61), 171 (28), 157 (34), 149 (17), 117 (18), 
93 (11), 75 (31), 73 (43). HRMS (ESIpos): m/z calcd for C19H35O4ISiNa: 505.1242, found: 505.1244. 
(Z)-Enyne 117. THF was degassed by three freeze-pump-thaw cycles prior to use. A flame-dried Young 
Schlenk was charged with 1-propynyllithium (17.3 mg, 0.65 mmol), 
which was suspended in degassed THF (1.4 mL). Trimethyl borate 
(72.0 μL, 0.65 mmol) was added dropwise via syringe at rt. After stirring 
for 20 min, [Pd(dppf)Cl2]·CH2Cl2 (17.3 mg, 21.1 μmol, 10 mol%) was added, causing the reaction 
mixture to turn bright red. Next, a solution of (Z)-vinyl iodide 116 (102 mg, 0.21 mmol) in degassed 
THF (0.4 mL + 0.2 mL rinse) was added and the mixture stirred at 65°C for 7 h. The pale orange 
mixture was cooled to ambient temperature; the reaction was quenched with aq. half-sat. NH4Cl 
(3 mL) and the aqueous layer extracted with EtOAc (3 × 5 mL). The combined extracts were dried 
over Na2SO4, filtered and concentrated. The residue was purified by flash chromatography 
(hexanes/t-butyl methyl ether 19:1 to 15:1) to yield the title compound 117 as a colorless oil (68 mg, 
82%). [)]'
( = –67.1 (c = 1.0, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 5.87 (ddd, J = 10.7, 9.8, 0.8 Hz, 
1H), 5.61 (dqd, J = 10.7, 2.4, 0.8 Hz, 1H), 5.09 (ddd, J = 9.8, 6.3, 0.9 Hz, 1H), 4.11 (dd, J = 7.4, 6.3 Hz, 
1H), 3.89 (ddd, J = 9.7, 7.4, 5.6 Hz, 1H), 3.74 (dd, J = 10.4, 3.7 Hz, 1H), 3.64 (dd, J = 10.4, 5.5 Hz, 1H), 
3.56 (ddd, J = 7.6, 5.5, 3.7 Hz, 1H), 2.18 (ddd, J = 10.2, 5.2, 2.1 Hz, 1H), 2.10 (ddd, J = 11.8, 7.2, 5.5 Hz, 
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1H), 1.98 (dd, J = 2.4, 0.7 Hz, 3H), 1.50 (s, 3H), 1.40 (s, 3H), 1.32–1.23 (m, 1H), 1.08 (d, J = 6.4 Hz, 3H), 
0.87 (s, 9H), 0.03 ppm (s, 6H). 13C NMR (100 MHz, CDCl3): δ = 137.2, 113.4, 109.7, 92.4, 85.8, 81.6, 
77.6, 75.4, 74.9, 65.0, 37.9, 36.9, 28.1, 26.0 (3C), 25.9, 18.4, 17.9, 4.7, –5.2, –5.3 ppm. IR (film):  
ṽ = 2955, 2929, 2857, 1461, 1378, 1251, 1214, 1165, 1125, 1088, 1058, 1021, 999, 868, 836, 777, 
673 cm–1. MS (EI) m/z (%): 338 (11), 337 (45), 279 (38), 243 (32), 230 (17), 229 (95), 187 (23), 186 
(16), 185 (100), 171 (13), 159 (14), 157 (45), 145 (18), 136 (57), 135 (19), 133 (11), 129 (11), 121 (60), 
117 (21), 115 (15), 108 (23), 107 (30), 105 (16), 93 (21), 91 (10), 79 (16), 77 (14), 75 (49), 73 (63), 59 
(10), 43 (13). HRMS (ESIpos): m/z calcd for C22H38O4SiNa: 417.2432, found: 417.2435. 
Alcohol S26. Pyridine (1.00 mL, 12.4 mmol) was slowly added to a Teflon® vial charged with 
HF·pyridine (0.20 mL, 2.22 mmol) and the resulting mixture was diluted 
with THF (2 mL). An aliquot of this solution (1.6 mL) was added dropwise 
to a solution of silyl ether 117 (68.0 mg, 0.17 mmol) in THF (0.4 mL) in a 
second Teflon® vial. The resulting mixture was stirred at ambient temperature for 18 h. The mixture 
was diluted with EtOAc (3 mL) and the reaction was carefully quenched with aq. sat. NaHCO3 (5 mL). 
The layers were separated and the aqueous layer was extracted with EtOAc (4 × 8 mL). The combined 
organic extracts were dried over Na2SO4, filtered and concentrated. The residue was purified by flash 
chromatography (hexanes/EtOAc 12:1 to 4:1) to afford the title compound S26 as a colorless oil 
(43.3 mg, 90%). [)]'
( = –64.2 (c = 1.0, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 5.93 (ddd, J = 10.8, 9.8, 
0.6 Hz, 1H), 5.63 (dqd, J = 10.8, 2.4, 0.6 Hz, 1H), 5.09 (ddd, J = 9.8, 6.2, 0.8 Hz, 1H), 4.14 (dd, J = 7.7, 
6.2 Hz, 1H), 3.95 (ddd, J = 9.6, 7.6, 5.4 Hz, 1H), 3.82 (dd, J = 12.0, 2.7 Hz, 1H), 3.58 (ddd, J = 8.8, 3.8, 
2.7 Hz, 1H), 3.51 (dd, J = 11.9, 3.8 Hz, 1H), 2.23–2.11 (m, 2H), 1.98 (d, J = 2.4 Hz, 3H), 1.51 (s, 3H), 1.42 
(s, 3H), 1.33–1.27 (m, 1H), 1.04 ppm (d, J = 6.1 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ = 136.9, 113.8, 
109.8, 92.7, 86.2, 81.8, 77.7, 75.3, 74.8, 62.2, 37.6, 34.5, 28.2, 25.9, 16.3, 4.7 ppm. IR (film): ṽ = 3457, 
2954, 2928, 2885, 2856, 1472, 1462, 1388, 1361, 1250, 1150, 1107, 1079, 1060, 1005, 964, 834, 775, 
679 cm–1. MS (EI) m/z (%): 136 (100), 135 (19), 121 (75), 115 (47), 108 (34), 107 (49), 97 (10), 93 (17), 
79 (19), 77 (14), 71 (69), 69 (13), 43 (14), 41 (10). HRMS (ESIpos): m/z calcd for C16H24O4Na: 303.1567, 
found: 303.1565. 
Carboxylic acid 118. NMO·H2O (104 mg, 0.89 mmol) and TPAP (3.1 mg, 8.9 μmol, 10 mol%) were 
sequentially added to a solution of alcohol S26 (25 mg, 89 μmol) in MeCN 
(0.4 mL). The resulting mixture was stirred at rt for 7 h. The reaction was 
quenched with aq. pH 5 phosphate buffer (1 mL), the layers were 
separated and the aqueous layer extracted with EtOAc (4 × 3 mL). The 
combined organic extracts were dried over Na2SO4, filtered and concentrated. The residue was 
purified by flash chromatography (hexanes/EtOAc 4:1 to 0:1) to yield the title compound 118 as a 
EXPERIMENTAL SECTION 169 
   
colorless oil (19.6 mg, 75%). [)]'
( = –59.9 (c = 0.5, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 8.45 (brs, 
1H, 1-OH), 5.90 (ddd, J = 10.7, 9.5, 0.8 Hz, 1H, H-8), 5.65 (dqd, J = 10.7, 2.4, 0.9 Hz, 1H, H-9), 5.13 
(ddd, J = 9.5, 6.3, 0.9 Hz, 1H, H-7), 4.16 (dd, J = 6.3, 5.7 Hz, 1H, H-6), 4.11 (ddd, J = 9.5, 6.1, 5.7 Hz, 1H, 
H-5), 4.02 (d, J = 8.5 Hz, 1H, H-2), 2.37 (dddq, J = 10.0, 8.5, 7.3, 6.5 Hz, 1H, H-3), 2.18 (ddd, J = 12.4, 
7.3, 6.1 Hz, 1H, H-4), 1.97 (d, J = 2.4, Hz, 3H, H-12), 1.50 (s, 3H, H-14), 1.40 (s, 3H, H-14), 1.39 (ddd,  
J = 12.4, 10.0, 9.5 Hz, 1H, H-4), 1.24 ppm (d, J = 6.5 Hz, 3H, H-23). 13C NMR (100 MHz, CDCl3):  
δ = 175.6 (C1), 136.9 (C8), 113.9 (C9), 109.8 (C13), 92.9 (C11), 83.2 (C2), 80.7 (C6), 79.3 (C5), 75.3 
(C10), 75.0 (C7), 39.7 (C3), 37.3 (C4), 27.9 (C14), 25.7 (C14), 17.9 (C23), 4.6 ppm (C12). IR (film):  
ṽ = 2983, 2933, 1731, 1456, 1372, 1250, 1216, 1164, 1130, 1096, 1054, 914, 868, 809, 733 cm–1. 
MS (ESIneg) m/z (%): 293.1 (100 (M–H)). HRMS (ESIneg): m/z calcd for C16H21O5: 293.1396, found: 
293.1398. 
Nitrobenzoate S27. Pyridine (3.8 μL, 46 μmol), 4-nitrobenzoyl chloride (8.1 mg, 43 μmol) and DMAP 
(0.9 mg, 7.1 μmol, 20 mol%) were sequentially added to a 
solution of alcohol S26 (10 mg, 36 μmol) in CH2Cl2 (0.4 mL) at 
0 °C. The resulting solution was stirred at rt for 3.5 h. The 
reaction was quenched with aq. half-sat. NH4Cl (1 mL) and the 
aqueous layer extracted with CH2Cl2 (3 × 3 mL). The combined extracts were dried over Na2SO4, 
filtered and concentrated. The residue was purified by flash chromatography (hexanes/EtOAc 9:1) to 
afford the title compound S27 (12.2 mg, 80%). [)]'
( = –64.9 (c = 1.0, CHCl3). 
1H NMR (400 MHz, 
CDCl3): δ = 8.29 (dd, J = 8.9, 2.2 Hz, 2H), 8.21 (dd, J = 8.9, 2.2 Hz, 2H), 5.90 (dd, J = 10.8, 9.7 Hz, 1H), 
5.63 (dq, J = 10.8, 2.4 Hz, 1H), 5.12 (dd, J = 9.7, 6.3 Hz, 1H), 4.49 (dd, J = 11.8, 3.4 Hz, 1H), 4.40 (dd,  
J = 11.8, 5.1 Hz, 1H), 4.16 (dd, J = 7.0, 6.3 Hz, 1H), 4.00 (ddd, J = 10.1, 7.0, 5.5 Hz, 1H), 3.88 (ddd,  
J = 8.5, 5.1, 3.4 Hz, 1H), 2.20 (dt, J = 11.1, 6.0 Hz, 1H), 2.14 (tdq, J = 10.7, 8.5, 6.2 Hz, 1H), 1.98 (d,  
J = 2.4 Hz, 3H), 1.51 (s, 3H), 1.42 (s, 3H), 1.44–1.37 (m, 1H), 1.14 ppm (d, J = 6.2 Hz, 3H). 13C NMR 
(100 MHz, CDCl3): δ = 164.8, 150.6, 137.0, 135.5, 130.9 (2C), 123.7 (2C), 113.7, 109.8, 92.7, 83.3, 81.4, 
77.8, 75.3, 74.9, 66.4, 37.4, 36.5, 28.1, 25.9, 16.8, 4.7 ppm. IR (film): ṽ = 2960, 2933, 1726, 1608, 
1528, 1456, 1369, 1347, 1275, 1216, 1164, 1101, 1057, 1015, 872, 720 cm–1. MS (EI) m/z (%): 371 
(12), 264 (33), 140 (43), 137 (10), 136 (100), 135 (20), 121 (86), 108 (46), 107 (44), 97 (41), 93 (17), 79 
(17), 69 (15). HRMS (ESIpos): m/z calcd for C23H27NO7Na: 452.1680, found: 452.1681. Attempts to 
obtain single crystals suitable for x-ray crystallography have thus far met with failure.  
Alcohol 120. Triethylamine (20 μL, 0.1 mmol) was added to a solution of diol 119 (28 mg, 90 μmol) in 
CH2Cl2 (1 mL) at 0 °C. Trityl chloride (28.6 mg, 0.10 mmol) was added in 
portions and the reaction mixture stirred at rt for 4 h. The reaction was 
quenched with H2O (5 mL) and extracted with CH2Cl2 (3 × 8 mL). The 
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combined extracts were dried over Na2SO4, filtered and concentrated. The residue was purified by 
flash chromatography (hexanes/EtOAc 19:1 to 9:1) to afford the desired alcohol 120 as a colorless oil 
(48.3 mg, 95%). [)]'
( = –20.4 (c = 1.0, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 7.46–7.40 (m, 6H),  
7.32–7.19 (m, 9H), 4.42 (dq, J = 4.3, 2.2 Hz, 1H), 4.26–4.17 (m, 3H), 3.35 (brd, J = 9.1 Hz, 1H), 3.18 (dd, 
J = 9.6, 4.5 Hz, 1H), 3.00 (dd, J = 9.6, 6.3 Hz, 1H), 2.34 (ddd, J = 13.9, 9.2, 6.2 Hz, 1H), 1.90 (dt, J = 13.9, 
3.2 Hz, 1H), 1.87 (d, J = 2.2 Hz, 3H), 0.93 (s, 9H), 0.18 (s, 3H), 0.16 ppm (s, 3H). 13C NMR (100 MHz, 
CDCl3): δ = 144.0 (3C), 128.8 (6C), 128.0 (6C), 127.2 (3C), 87.0, 86.5, 82.4, 81.8, 78.8, 73.9, 66.1, 64.4, 
36.1, 26.0 (3C), 18.5, 3.9, –4.4, –4.7 ppm. IR (film): ṽ = 3457, 3059, 2927, 2856, 1491, 1471, 1448, 
1251, 1076, 837, 776, 705, 633 cm–1. MS (ESIpos) m/z (%): 565.3 (100 (M+Na)). HRMS (ESIpos): m/z 
calcd for C34H42O4SiNa: 565.2745, found: 565.2744.  
Diyne S28. This compound was prepared according to the representative procedure for Mitsunobu 
esterification (vide supra) from alcohol 120 and carboxylic acid 118. 
Purification by flash chromatography (hexanes/EtOAc 19:1) provided 
diyne S28 as a colorless oil (18.4 mg, 79%). [)]'
(	= –22.2 (c = 1.0, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 7.41–7.37 (m, 6H), 7.31–7.27 (m, 6H),  
7.26–7.19 (m, 3H), 5.90 (dd, J = 10.8, 9.5 Hz, 1H), 5.62 (ddt, J = 10.8, 2.8, 2.0 
Hz, 1H), 5.52 (t, J = 3.6 Hz, 1H), 5.11 (ddd, J = 9.5, 6.5, 0.9 Hz, 1H), 4.37 (dq, J = 4.3, 2.0 Hz, 1H), 4.30 
(td, J = 6.3, 3.4 Hz, 1H), 4.20–4.14 (m, 1H), 4.05 (t, J = 6.2 Hz, 1H), 3.88–3.81 (m, 2H), 3.43 (dd, J = 9.2, 
6.0 Hz, 1H), 3.11 (dd, J = 9.2, 6.7 Hz, 1H), 2.27 (ddd, J = 13.9, 8.8, 5.0 Hz, 1H), 2.08 (ddd, J = 14.4, 6.7, 
1.3 Hz, 1H), 2.04–2.00 (m, 1H), 1.99 (d, J = 2.4 Hz, 3H), 1.93–1.87 (m, 1H), 1.84 (d, J = 2.1 Hz, 3H), 1.48 
(s, 3H), 1.40 (s, 3H), 1.30–1.24 (m, 1H), 1.03 (d, J = 6.6 Hz, 3H), 0.91 (s, 9H), 0.14 (s, 3H), 0.11 ppm (s, 
3H). 13C NMR (100 MHz, CDCl3): δ = 172.4, 143.9 (3C), 136.9, 128.8 (6C), 127.9 (6C), 127.1 (3C), 114.0, 
109.7, 92.4, 86.9, 83.5, 81.8, 80.9, 80.4, 80.2, 79.4, 78.0, 75.5, 75.1, 75.0, 65.9, 62.0, 39.7, 36.9, 35.1, 
27.8, 26.0 (3C), 25.9, 18.6, 18.5, 4.7, 3.8, –4.5, –4.8 ppm. IR (film): ṽ = 2928, 2856, 1733, 1491, 1449, 
1378, 1252, 1216, 1077, 909, 837, 776, 731, 705, 648, 633 cm–1. MS (ESIpos) m/z (%): 841.4 (100 
(M+Na)). HRMS (ESIpos): m/z calcd for C50H62O8SiNa: 841.4106, found: 841.4112.	 
Diyne 121. A solution of TBAF (1 M in THF, 7.3 μL, 7.3 μmol) was added to a solution of diyne S28 
(5 mg, 6.1 μmol) in THF (0.1 mL) at –30 °C and the resulting mixture was 
stirred for 4 h slowly warming to rt. The reaction was quenched with aq. sat. 
NH4Cl (1 mL), the layers were separated and the aqueous layer was 
extracted with EtOAc (3 × 2 mL). The combined extracts were washed with 
brine (5 mL), dried over Na2SO4, filtered and concentrated. The residue was 
purified by flash chromatography (hexanes/EtOAc 8:1) to afford diyne 121 as a colorless oil (2.9 mg, 
67%). [)]'
( = –13.7 (c = 0.35, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 7.39–7.34 (m, 6H), 7.31–7.27 (m, 
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6H), 7.25–7.21 (m, 3H), 5.90 (dd, J = 10.7, 9.4 Hz, 1H), 5.62 (ddd, J = 10.7, 2.5, 0.8 Hz, 1H), 5.57–5.49 
(m, 1H), 5.11 (ddd, J = 9.4, 6.4, 0.8 Hz, 1H), 4.28–4.20 (m, 2H), 4.17 (dt, J = 8.7, 6.5 Hz, 1H) , 4.06 (dd,  
J = 5.9, 6.5 Hz, 1H), 3.85 (d, J = 7.4 Hz, 1H), 3.87–3.80 (m, 1H), 3.45 (dd, J = 9.2, 5.9 Hz, 1H), 3.16 (dd,  
J = 9.2, 6.9 Hz, 1H), 2.31 (brd, J = 2.7 Hz, 1H) 2.19–2.08 (m, 2H), 2.04–1.97 (m, 1H), 1.99 (d, J = 2.2 Hz, 
3H), 1.90 (ddd, J = 12.6, 7.3, 5.5 Hz, 1H), 1.84 (d, J = 2.1 Hz, 3H), 1.49 (s, 3H), 1.40 (s, 3H), 1.32–1.24 
(m, 1H), 1.04 ppm (d, J = 6.6 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ = 172.3, 143.8 (3C), 136.9, 128.8 
(6C), 128.0 (6C), 127.2 (3C), 114.0, 109.7, 92.5, 87.0, 83.5, 82.8, 81.2, 80.5, 80.1, 79.4, 76.8, 75.5, 
75.1, 74.7, 65.4, 61.9, 39.7, 36.9, 35.6, 27.8, 25.9, 18.5, 4.7, 3.8 ppm. IR (film): ṽ = 3444, 2931, 2856, 
1733, 1492, 1449, 1379, 1256, 1216, 1078, 869, 765, 707, 633 cm–1. MS (ESIpos) m/z (%): 727.3 (100 
(M+Na)). HRMS (ESIpos): m/z calcd for C44H48O8Na: 727.3241, found: 727.3242.	 
4.3.6 Synthesis of the Northern Alcohol Fragments 122 and 123 
Alcohol (12R)-124. TMS-acetylene (0.23 mL, 1.61 mmol) was added to a solution of (R,R)-ProPhenol 
(68.5 mg, 0.11 mmol, 20 mol%) and TPPO (59.7 mg, 0.54 mmol) in toluene 
(0.6 mL), followed by Me2Zn (1.34 mL, 1.61 mmol). The resulting mixture 
was stirred at 4 °C for 45 min, before a solution of aldehyde 58 (201 mg, 
0.54 mmol) in toluene (0.4 mL) was added. The resulting mixture was stirred at 4 °C for 72 h. The 
reaction was quenched aq. sat. NH4Cl (2 mL) and the aqueous layer extracted with t-butyl methyl 
ether (3 × 5 mL). The combined extracts were washed with brine (10 mL), dried over Na2SO4, filtered 
and concentrated. The residue was purified by flash chromatography (hexanes/EtOAc 20:1) to afford 
alcohol (12R)-124 (104 mg, 41%, d.r. 5:1) and its diastereomer (12S)-124 (16.7 mg, 7%) as a colorless 
oil each. 
Analytical data for (12R)-124: [)]'
( = –6.3 (c = 1.0, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 4.51 (d,  
J = 7.0 Hz, 1H), 4.34 (dt, J = 5.8, 2.3 Hz, 1H), 4.15 (ddd, J = 8.3, 7.0, 3.3 Hz, 1H), 3.96 (ddd, J = 6.2, 4.2, 
2.1 Hz, 1H), 3.62 (dd, J = 10.8, 4.1 Hz, 1H), 3.46 (dd, J = 10.7, 6.1 Hz, 1H), 2.96 (d, J = 2.5 Hz, 1H), 2.27 
(ddd, J = 14.0, 8.4, 5.9 Hz, 1H), 1.91 (dt, J = 13.5, 2.9 Hz, 1H), 0.96 (t, J = 7.9 Hz, 9H), 0.95 (t, J = 7.9 Hz, 
9H), 0.60 (q, J = 7.8 Hz, 6H), 0.59 (q, J = 7.9 Hz, 6H), 0.16 ppm (s, 9H). 13C NMR (100 MHz, CDCl3):  
δ = 104.0, 90.3, 88.0, 82.7, 73.3, 66.2, 63.3, 37.9, 6.88 (3C), 6.86 (3C), 4.8 (3C), 4.5 (3C), 0.0 ppm (3C). 
IR (film): ṽ = 3432, 2954, 2911, 2877, 1459, 1414, 1378, 1249, 1111, 1065, 1003, 841, 741, 725, 
660 cm–1. MS (EI) m/z (%): 443 (20), 213 (26), 147 (13), 146 (12), 145 (95), 131 (10), 118 (11), 117 
(100), 115 (44), 103 (12), 87 (43), 75 (13), 73 (18), 59 (13). HRMS (ESIpos): m/z calcd for 
C23H48O4Si3Na: 495.2753, found: 495.2755.	 
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Analytical data for (12S)-124: 1H NMR (500 MHz, CDCl3): δ = 4.48 (dd, J = 6.8, 3.5 Hz, 1H), 4.37 (dt,  
J = 5.8, 1.8 Hz, 1H), 4.35 (dt, J = 9.0, 3.4 Hz, 1H), 4.24 (d, J = 7.1 Hz, 1H), 
4.05 (ddd, J = 6.4, 4.3, 1.6 Hz, 1H), 3.59 (dd, J = 10.6, 4.2 Hz, 1H), 3.41 (dd,  
J = 10.6, 6.7 Hz, 1H), 2.30 (ddd, J = 14.0, 9.0, 5.7 Hz, 1H), 2.16 (ddd,  
J = 13.9, 3.0, 1.9 Hz, 1H), 0.98 (t, J = 7.9 Hz, 9H), 0.95 (t, J = 8.0 Hz, 9H), 0.64 (q, J = 8.0 Hz, 6H), 0.59 
(q, J = 8.0 Hz, 6H), 0.15 ppm (s, 9H). 13C NMR (125 MHz, CDCl3): δ = 105.0, 90.4, 88.6, 81.9, 73.2, 64.9, 
63.3, 35.1, 6.8 (3C), 6.7 (3C), 4.6 (3C), 4.4 (3C), 0.0 ppm (3C). 
(2S,3R,5R)-2-((Trityloxy)methyl)-5-vinyltetrahydrofuran-3-ol (S29). Et3N (0.65 mL, 4.68 mmol) and 
trityl chloride (958 mg, 3.43 mmol) were sequentially added to a solution of 
diol 55 (450 mg, 3.12 mmol) in CH2Cl2 (30 mL) at 0 °C. The resulting mixture was 
stirred at rt overnight. The reaction was quenched with H2O (25 mL) and the 
aqueous layer extracted with EtOAc (3 × 20 mL). The combined extracts were washed with brine 
(50 mL), dried over Na2SO4, filtered and concentrated. The residue was purified by flash 
chromatography (hexanes/EtOAc 6:1) to afford alcohol S29 as a pale yellow oil (1.06 g, 88%). 	
[)]'
( = –1.9 (c = 0.5, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 7.47–7.40 (m, 6H), 7.34–7.27 (m, 6H), 
7.26–7.21 (m, 3H), 5.98 (ddd, J = 17.2, 10.3, 6.3 Hz, 1H), 5.28 (ddd, J = 17.2, 1.5, 1.4 Hz, 1H), 5.13 (dt, 
J = 10.3, 1.3 Hz, 1H), 4.55 (dtt, J = 7.6, 6.5, 1,3 Hz, 1H), 4.30 (dtd, J = 6.6, 5.4, 4.2 Hz, 1H), 4.05 (dt, 
J = 6.3, 4.4 Hz, 1H), 3.30 (dd, J = 9.5, 4.6 Hz, 1H), 3.13 (dd, J = 9.5, 6.2 Hz, 1H), 2.42 (dt, J = 12.9, 
6.9 Hz, 1H), 1.91 (d, J = 5.2 Hz, 1H), 1.82 ppm (ddd, J = 12.6, 6.7, 5.5 Hz, 1H). 13C NMR (100 MHz, 
CDCl3): δ = 143.9 (3C), 139.8, 128.8 (6C), 128.0 (6C), 127.2 (3C), 115.5, 87.0, 84.3, 79.4, 75.4, 65.0, 
40.7 ppm. IR (film): ṽ = 3424, 3085, 3060, 3023, 2958, 2928, 2871, 1491, 1448, 1220, 1079, 987, 764, 
699, 633 cm–1. MS (EI) m/z (%): 244 (20), 243 (100), 165 (24), 143 (13). HRMS (ESIpos): m/z calcd for 
C26H26O3Na: 409.1774, found: 409.1777.	 
Acetate 125. PPh3 (1.70 g, 6.47 mmol) was added to a solution of alcohol S29 (1.00 g, 2.59 mmol) and 
acetic acid (0.30 mL, 5.17 mmol) in toluene (30 mL). The resulting mixture was 
stirred for 5 min and then cooled to 0 °C. DIAD (1.27 mL, 6.47 mmol) was added 
dropwise and the resulting mixture stirred at rt for 1 h. The reaction mixture was 
diluted with hexanes (30 mL), washed with water (30 mL) and brine (30 mL). The combined extracts 
were dried over Na2SO4, filtered and concentrated. The residue was purified by flash 
chromatography (hexanes/t-butyl methyl ether 19:1) to yield acetate 125 as a colorless oil (1.05 g, 
95%). [)]'
(* = +41.0 (c = 1.0, CHCl3). 
1H NMR (600 MHz, CDCl3): δ = 7.45–7.41 (m, 6H), 7.32–7.28 (m, 
6H), 7.26–7.22 (m, 3H), 5.86 (ddd, J = 17.0, 10.3, 6.7 Hz, 1H), 5.58 (ddd, J = 5.0, 3.8, 1.5 Hz, 1H), 5.28 
(dt, J = 17.1, 1.3 Hz, 1H), 5.15 (dt, J = 10.3, 1.3 Hz, 1H), 4.54 (dt, J = 9.5, 6.4 Hz, 1H), 4.34 (ddd, J = 7.4, 
5.4, 3.8 Hz, 1H), 3.40 (dd, J = 9.0, 5.4 Hz, 1H), 3.16 (dd, J = 9.0, 7.4 Hz, 1H), 2.19 (ddd, J = 13.8, 6.1, 
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1.5 Hz, 1H), 2.00 (ddd, J = 13.8, 9.5, 5.0 Hz, 1H), 1.85 ppm (s, 3H). 13C NMR (150 MHz, CDCl3):  
δ = 170.2, 143.9 (3C), 138.3, 128.8 (6C), 127.9 (6C), 127.1 (3C), 116.4, 86.8, 79.8, 78.8, 74.4, 61.6, 
39.6, 21.0 ppm. IR (film): ṽ = 3086, 3058, 3023, 2984, 2937, 2880, 1742, 1491, 1448, 1373, 1233, 
1075, 930, 748, 706, 633 cm–1. MS (EI) m/z (%): 244 (21), 243 (100), 165 (29), 155 (25), 125 (12). 
HRMS (ESIpos): m/z calcd for C28H28O4Na: 451.1880, found: 451.1884.	 
Aldehyde 126. 2,6-lutidine (0.11 mL, 0.93 mmol), potassium osmate (3.44 mg, 9.30 μmol, 2 mol%) 
and sodium periodate (400 mg, 1.87 mmol) were sequentially added to a 
solution of olefin 125 (200 mg, 0.47 mmol) in 1,4-dioxane/water (3:1, 16 mL). 
The resulting mixture was stirred at rt for 16 h. The reaction mixture was diluted 
with CH2Cl2 (10 mL) and the aqueous layer was extracted with CH2Cl2 (3 × 10 mL). The combined 
extracts were dried over Na2SO4, filtered and concentrated. The residue was purified by flash 
chromatography (hexanes/EtOAc 3:1 to 2:1) to afford the title compound as a colorless oil (185 mg, 
92%). [)]'
(* = +57.8 (c = 0.5, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 9.72 (d, J = 1.8 Hz, 1H), 7.43–7.40 
(m, 6H), 7.32–7.28 (m, 6H), 7.25–7.21 (m, 3H), 5.51 (q, J = 3.6 Hz, 1H), 4.46 (td, J = 8.2, 1.4 Hz, 1H), 
4.28 (ddd, J = 6.7, 5.4, 3.7 Hz, 1H), 3.42 (dd, J = 9.2, 5.4 Hz, 1H), 3.22 (dd, J = 9.3, 6.8 Hz, 1H), 2.29 (d, 
J = 3.5 Hz, 1H), 2.27 (d, J = 3.5 Hz, 1H), 1.85 ppm (s, 3H). 13C NMR (100 MHz, CDCl3): δ = 201.6, 170.1, 
143.7 (3C), 128.8 (6C), 128.0 (6C), 127.3 (3C), 87.0, 81.5, 81.4, 73.2, 61.3, 34.5, 20.9 ppm. IR (film):  
ṽ = 3086, 3058, 3023, 2951, 2925, 1742, 1491, 1448, 1373, 1231, 1076, 749, 699 cm–1. MS (EI) m/z 
(%): 259 (11), 244 (22), 243 (100), 171 (24), 165 (27), 105 (10). HRMS (ESIpos): m/z calcd for 
C27H26O5Na: 453.1672, found: 453.1675.	 
Alkynol 128. A solution of n-BuLi (1.6 M in hexane, 0.29 mL, 0.45 mmol) was added to a solution of 
TIPS-acetylene (139 μL, 0.61 mmol) in Et2O (4 mL) at –78 °C and the 
resulting mixture was stirred at that temperature for 30 min. Next, a 
solution of LiI (207 mg, 1.55 mmol) in Et2O (1 mL) was added and the 
resulting mixture stirred for 30 min at –40 °C. In a second flask, a solution of aldehyde 126 (134 mg, 
0.31 mmol) in Et2O (3 mL) was cooled to –25 °C. The lithium-acetylene solution was added dropwise 
to the aldehyde solution and stirring was continued overnight. The reaction was quenched with aq. 
sat. NH4Cl (8 mL) and the aqueous layer extracted with EtOAc (3 × 10 mL). The combined extracts 
were dried over Na2SO4, filtered and concentrated. The residue was purified by flash 
chromatography (hexanes/EtOAc 4:1) to afford alkynol 128 as a colorless oil (125 mg, 65%, 
diastereomeric mixture, d.r. 3:1). The diastereomeric mixture could be separated by flash 
chromatography (fine SiO2, hexanes/EtOAc 19:1) to yield the desired diastereomer (12R)-128 (88 mg, 
46%) and the undesired diastereomer (12S)-128 (29 mg, 15%).  
O
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Analytical data for alcohol (12R)-128: [)]'
(* = +40.9 (c = 1.0, CHCl3). 
1H NMR (600 MHz, CDCl3):  
δ = 7.41–7.39 (m, 6H), 7.30–7.27 (m, 6H), 7.25–7.22 (m, 3H), 5.54 (ddd, J = 5.1, 3.5, 1.8 Hz, 1H), 4.36 
(dd, J = 6.8, 3.9 Hz, 1H), 4.30 (ddd, J = 7.3, 5.1, 3.6 Hz, 1H), 4.22 (ddd, J = 8.3, 6.8, 0.5 Hz, 1H), 
3.36 (dd, J = 9.1, 5.1 Hz, 1H), 3.17 (dd, J = 9.0, 7.3 Hz, 1H), 2.26–2.16 (m, 3H), 1.83 (s, 3H),  
1.08–1.06 ppm (m, 21H). 13C NMR (150 MHz, CDCl3): δ = 170.2, 143.8 (3C), 128.8 (6C), 127.9 (6C), 
127.2 (3C), 104.9, 87.9, 86.8, 80.7, 80.3, 74.1, 66.1, 61.3, 35.5, 21.0, 18.7 (6C), 11.3 ppm (3C). 
IR (film): ṽ = 3440, 3058, 2942, 2891, 2865, 1743, 1491, 1449, 1374, 1237, 1077, 883, 705, 678, 
633 cm–1. MS (EI) m/z (%): 244 (21), 243 (100), 165 (14). HRMS (ESIpos): m/z calcd for C38H48O5SiNa: 
635.3163, found: 635.3164.	  
Analytical data for alcohol (12S)-128: [)]'
(* = +33 (c = 0.5, CHCl3). 
1H NMR (600 MHz, CDCl3):  
δ = 7.41–7.37 (m, 6H), 7.29–7.26 (m, 6H), 7.24–7.20 (m, 3H), 5.56 (ddd, 
J = 5.3, 3.6, 1.6 Hz, 1H), 4.47 (dd, J = 6.7, 2.9 Hz, 1H), 4.45 (ddd, J = 7.2, 
5.1, 3.6 Hz, 1H), 4.30 (ddd, J = 9.2, 6.7, 2.9 Hz, 1H), 3.33 (dd, J = 9.0, 
5.1 Hz, 1H), 3.14 (dd, J = 9.0, 7.2 Hz, 1H), 2.41 (ddd, J = 14.1, 8.9, 5.3 Hz, 1H), 2.32 (d, J = 6.7 Hz, 1H), 
2.10 (ddd, J = 14.0, 6.8, 1.6 Hz, 1H), 1.81 (s, 3H), 1.10–1.05 ppm (m, 21H). 13C NMR (150 MHz, CDCl3): 
δ = 170.2, 143.9 (3C), 128.8 (6C), 127.9 (6C), 127.2 (3C), 104.7, 87.9, 86.8, 81.2, 80.3, 74.3, 65.2, 61.4, 
34.0, 21.0, 18.7 (6C), 11.3 ppm (3C). IR (film): ṽ = 3440, 3059, 2942, 2891, 2865, 1742, 1491, 1449, 
1374, 1236, 1076, 883, 705, 678, 633 cm–1. 
Mosher ester analysis of alcohol (12S)-128. Triethylamine (7.3 μL, 52 μmol) was added to a solution 
of alcohol (12S)-128 (8.0 mg, 13 μmol) in CH2Cl2 (1 mL) followed by (R)-(–)-α-methoxy-α-
trifluoromethyl-phenylacetyl chloride ((R)-MTPA-Cl) (4.9 μL, 26 μmol). The reaction was stirred at rt 
for 16 h, then quenched with sat. aq. NaHCO3 (2 mL) and the mixture was extracted with CH2Cl2 
(3 × 5 mL). The combined extracts were dried over Na2SO4, filtered and concentrated. The residue 
was purified by flash chromatography (hexanes/EtOAc 19:1 to 9:1) to give the corresponding  
(S)-Mosher ester (S)-MTPA-128 (9.5 mg, 87%), which analyzed as follows: 1H NMR (600 MHz, CDCl3): 
δ = 7.59–7.53 (m, 2H), 7.40–7.34 (m, 9H), 7.30–7.27 (m, 6H), 7.25–7.22 (m, 3H), 5.70 (d, J = 2.9 Hz, 
1H), 5.42 (ddd, J = 5.4, 3.6, 1.8 Hz, 1H), 4.48 (ddd, J = 8.8, 6.9, 3.0 Hz, 1H), 4.23 (ddd, J = 6.7, 5.3, 
3.6 Hz, 1H), 3.55 (d, J = 1.0 Hz, 3H), 3.27 (dd, J = 9.1, 5.3 Hz, 1H), 3.12 (dd, J = 9.1, 6.7 Hz, 1H), 2.35 
(ddd, J = 14.0, 8.7, 5.3 Hz, 1H), 2.17 (ddd, J = 14.0, 7.0, 1.9 Hz, 1H), 1.82 (s, 3H), 1.14–0.96 ppm (m, 
21H). MS (ESIpos) m/z (%): 851.4 (100 (M+Na)). HRMS (ESI): m/z calcd for C48H55O7F3SiNa: 851.3561, 
found: 851.3565. 
The same procedure was followed for the preparation of (R)-MTPA-128 (15 mg, 49%), which 
analyzed as follows: 1H NMR (600 MHz, CDCl3): δ = 7.56–7.55 (m, 2H), 7.39–7.37 (m, 6H), 7.36–7.32 
(m, 3H), 7.30–7.27 (m, 6H), 7.24–7.22 (m, 3H), 5.75 (d, J = 2.9 Hz, 1H), 5.35 (ddd, J = 5.6, 3.8, 2.0 Hz, 
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1H), 4.44 (ddd, J = 8.5, 6.9, 2.9 Hz, 1H), 4.02 (ddd, J = 6.8, 5.1, 3.8 Hz, 1H), 3.61 (d, J = 1.1 Hz, 3H), 3.18 
(dd, J = 9.1, 5.1 Hz, 1H), 3.06 (dd, J = 9.1, 6.8 Hz, 1H), 2.35 (ddd, J = 13.9, 8.6, 5.4 Hz, 1H), 2.16 (ddd, 
J = 13.9, 7.0, 2.0 Hz, 1H), 1.80 (s, 3H), 1.08–1.05 ppm (m, 21H). MS (ESIpos) m/z (%): 851.4 (100 
(M+Na)). HRMS (ESI): m/z calcd for C48H55O7F3Si7Na: 851.3561, found: 851.3564. 
Both products were analyzed according to Hoye and co-workers:[118] 
Table 4.3. Mosher ester analysis for the assignment of the C(3) stereocenter; arbitrary numbering as shown in the insert. 
 
 
 
Assignment (12S)-128 [ppm] (S)-MTPA-128 [ppm] (R)-MTPA-128 [ppm] Δ (δ(S–R)) [ppm] 
3 4.47 5.70 5.75 –0.05 
4 4.45 4.48 4.44 +0.04 
5a 
5b 
2.41 
2.10 
2.35 
2.17 
2.35 
2.16 
0.00 
+0.01 
6 5.56 5.42 5.35 +0.07 
7 4.30 4.23 4.02 +0.21 
8a 
8b 
3.33 
3.14 
3.27 
3.12 
3.18 
3.06 
+0.09 
+0.06 
10 1.81 1.82 1.80 +0.02 
TIPS-Me 1.07 1.03 1.06 –0.03 
 
Alcohol 122. A solution of TBAF (1 M in THF, 61.2 μL, 61.2 μmol) was added to a solution of 
alkynol (12R)-128 (30.0 mg, 48.9 μmol) in THF (3 mL). The resulting mixture 
was stirred at rt for 20 min. The reaction was quenched with aq. sat. NH4Cl 
(5 mL) and the aqueous layer extracted with EtOAc (5 × 5 mL). The combined 
extracts were washed with brine (10 mL), dried over Na2SO4, filtered and concentrated. The residue 
was purified by flash chromatography (hexanes/EtOAc 3:1 to 2:1) to yield the terminal alkyne 122 as 
a colorless oil (20.0 mg, 90%). [)]'
(* = +51.0 (c = 1.0, CHCl3). 
1H NMR (400 MHz, CDCl3):  
δ = 7.42–7.39 (m, 6H), 7.32–7.27 (m, 6H), 7.26–7.21 (m, 3H), 5.55 (dt, J = 3.7, 3.4 Hz, 1H), 4.33–4.20 
(m, 3H), 3.39 (dd, J = 9.1, 5.2 Hz, 1H), 3.18 (dd, J = 9.0, 7.4 Hz, 1H), 2.47 (d, J = 2.1 Hz, 1H), 2.38 (brs, 
1H), 2.23–2.14 (m, 2H), 1.83 ppm (s, 3H). 13C NMR (100 MHz, CDCl3): δ = 170.2, 143.8 (3C), 128.8 (6C), 
127.9 (6C), 127.2 (3C), 86.9, 81.6, 80.60, 80.57, 74.4, 74.1, 64.9, 61.3, 35.2, 21.0 ppm. IR (film):  
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ṽ = 3435, 3284, 3058, 3022, 2929, 2889, 1737, 1491, 1448, 1374, 1236, 1075, 749, 705, 633 cm–1.  
MS (EI) m/z (%): 244 (21), 243 (100), 183 (19), 165 (21). HRMS (ESIpos): m/z calcd for C29H28O5Na: 
479.1829, found: 479.1832.	 
Alcohol S30. Et3N (1.36 mL, 9.73 mmol), TBSCl (1.03 g, 6.81 mmol) and DMAP (39.6 mg, 0.32 mmol, 
5 mol%) were sequentially added to a solution of diol 55 (935 mg, 6.49 mmol) in 
CH2Cl2 (40 mL) at 0 °C. The resulting mixture was stirred at rt for 7 h. The reaction 
was quenched with sat. aq. NaHCO3 (25 mL) and the aqueous layer extracted with 
CH2Cl2 (3 × 30 mL). The combined extracts were dried over Na2SO4, filtered and concentrated. The 
residue was purified by flash chromatography (hexanes/EtOAc 15:1 to 9:1) to afford alcohol S30 as a 
colorless oil (1.35 g, 81%). [)]'
( = –10.7 (c = 1.0, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 5.97 (ddd,  
J = 16.9, 10.3, 6.3 Hz, 1H), 5.27 (ddd, J = 17.1, 1.5, 1.4 Hz, 1H), 5.11 (ddd, J = 10.3, 1.4, 1.2 Hz, 1H), 
4.52 (tdt, J = 7.2, 6.2, 1,3 Hz, 1H), 4.34 (ddd, J = 6.6, 5.9, 4.4 Hz, 1H), 3.89 (dt, J = 6.5, 4.3 Hz, 1H), 3.81 
(dd, J = 10.2, 4.1 Hz, 1H), 3.58 (dd, J = 10.2, 6.6 Hz, 1H), 2.42 (ddd, J = 12.7, 6.9, 6.7 Hz, 1H), 1.82 (ddd, 
J = 12.8, 6.9, 5.9 Hz, 1H), 1.79 (brs, 1H), 0.90 (s, 9H), 0.07 ppm (s, 6H). 13C NMR (100 MHz, CDCl3):  
δ = 139.9, 115.4, 85.0, 79.5, 75.3, 64.7, 40.7, 26.0 (3C), 18.4, –5.3 ppm (2C). IR (film): ṽ = 3431, 2954, 
2929, 2857, 1472, 1361, 1255, 1131, 1091, 1005, 919, 836, 778, 673 cm–1. MS (EI) m/z (%): 193 (17), 
147 (14), 117 (52), 109 (11), 89 (14), 77 (10), 75 (100), 73 (20), 67 (13), 59 (14), 55 (18), 45 (10), 41 
(14), 39 (13). HRMS (ESIpos): m/z calcd for C13H26O3SiNa: 281.1543, found: 281.1542.	 
Acetate 129. PPh3 (2.70 g, 10.3 mmol) was added to a solution of alcohol S30 (1.33 g, 5.15 mmol) and 
acetic acid (0.59 mL, 10.3 mmol) in toluene (40 mL). The resulting mixture was 
stirred for 5 min and then cooled to 0 °C. DIAD (2.03 mL, 10.3 mmol) was added 
dropwise and the resulting mixture stirred at rt for 1 h. The reaction mixture was 
diluted with hexanes (40 mL), washed with water (50 mL) and brine (50 mL), dried over Na2SO4, 
filtered and concentrated. The residue was purified by flash chromatography (hexanes/t-butyl 
methyl ether 19:1) to yield acetate 129 as a colorless oil (1.30 g, 84%). [)]'
(* = +51.0 (c = 0.5, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 5.84 (ddd, J = 17.0, 10.3, 6.6 Hz, 1H), 5.47–5.41 (m, 1H), 5.27 (ddd,  
J = 17.1, 1.4, 1.3 Hz, 1H), 5.11 (ddd, J = 10.1, 1.2, 1.0 Hz, 1H), 4.58 (dt, J = 9.4, 6.5 Hz, 1H), 4.11 (ddd, 
J = 7.1, 5.8, 3.8 Hz, 1H), 3.80–3.72 (m, 2H), 2.19 (ddd, J = 13.8, 6.2, 1.4 Hz, 1H), 2.08 (s, 3H), 1.96 (ddd, 
J = 14.1, 9.4, 5.0 Hz, 1H), 0.87 (s, 9H), 0.05 (s, 3H), 0.04 ppm (s, 3H). 13C NMR (100 MHz, CDCl3):  
δ = 170.3, 138.4, 116.1, 81.1, 79.0, 74.4, 61.1, 39.6, 25.9 (3C), 21.3, 18.4, –5.2, –5.4 ppm. IR (film):  
ṽ = 3083, 2954, 2930, 2884, 2857, 1743, 1472, 1426, 1373, 1232, 1186, 1088, 1017, 987, 932, 836, 
776, 726, 666, 624, 602 cm–1. MS (ESIpos) m/z (%): 323.2 (100 (M+Na)). HRMS (ESIpos): m/z calcd for 
C15H28O4SiNa: 323.1649, found: 323.1646.	 
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Aldehyde 130. Ozone was bubbled through a solution of olefin 129 (250 mg, 0.83 mmol) in CH2Cl2 
(55 mL) at –78 °C for 30 min, until the blue color persisted. Oxygen was then 
bubbled through the mixture for approx. one minute followed by argon until the 
solution was colorless. PPh3 (327 mg, 1.25 mmol) was added in one portion and 
the mixture was allowed to reach rt overnight. The mixture was washed with sat. aq. NaHCO3 (30 mL) 
and brine (30 mL). The organic layer was dried over Na2SO4, filtered and concentrated. The residue 
was purified by flash chromatography (hexanes/t-butyl methyl ether 10:1 to 2:1) to afford the title 
compound as a colorless oil (220 mg, 87%). [)]'
(* = +37.5 (c = 0.4, CHCl3). 
1H NMR (400 MHz, CDCl3):  
δ = 9.71 (d, J = 1.8 Hz, 1H), 5.42 (td, J = 4.2, 3.0 Hz, 1H), 4.49 (td, J = 8.2, 1.8 Hz, 1H), 4.11 (ddd, J = 6.7, 
5.6, 3.8 Hz, 1H), 3.83 (dd, J = 10.4, 5.5 Hz, 1H), 3.79 (dd, J = 10.2, 6.4 Hz, 1H), 2.28 (dd, J = 3.6. 1.8 Hz, 
1H), 2.26 (dd, J = 3.6. 2.2 Hz, 1H), 2.08 (s, 3H), 0.88 (s, 9H), 0.06 (s, 3H), 0.05 ppm (s, 3H). 13C NMR 
(100 MHz, CDCl3): δ = 201.8, 170.2, 82.7, 81.6, 73.2, 61.0, 34.5, 25.9 (3C), 21.1, 18.4, –5.3, –5.4 ppm. 
IR (film): ṽ = 2955, 2930, 2885, 2857, 1738, 1472, 1443, 1374, 1237, 1092, 837, 777 cm–1. MS (ESIpos) 
m/z (%): 325.1 (100 (M+Na)). HRMS (ESIpos): m/z calcd for C14H26O5SiNa: 325.1442, found: 325.1440.	 
Alkynol 131. A solution of n-BuLi (1.6 M in hexane, 93.6 μL, 0.15 mmol) was added to a solution of 
TMS-acetylene (28.0 μL, 0.20 mmol) in Et2O (1 mL) at –78 °C and the 
resulting mixture was stirred at that temperature for 30 min. Next, a 
solution of LiI (66.8 mg, 0.50 mmol) in Et2O (1 mL) was added and the 
resulting mixture was stirred for 30 min at –40 °C. In a second flask, a solution of aldehyde 130 
(30 mg, 0.10 mmol) in Et2O (1 mL) was cooled to –25 °C. The lithium-acetylene solution was added 
dropwise to the aldehyde solution and stirring was continued overnight. The reaction was quenched 
with aq. sat. NH4Cl (4 mL) and the aqueous layer extracted with EtOAc (3 × 8 mL). The combined 
extracts were dried over Na2SO4, filtered and concentrated. The residue was purified by flash 
chromatography (hexanes/EtOAc 9:1) to afford alkynol 131 as a colorless oil (15.0 mg, 37%, 
diastereomeric mixture, d.r. 1:1). The diastereomeric mixture was oxidized to the ynone S31. 
Ynone S31. NaHCO3 (25.2 mg, 56.2 μmol) was added to a solution of alkynol 131 (15 mg, 37.4 μmol) 
in CH2Cl2 (1 mL). DMP (23.8 mg, 56.2 μmol) was added in one portion and 
the resulting mixture was stirred at rt for 3 h. The reaction was quenched 
with aq. sat. NaHCO3 (1 mL) and the aqueous layer extracted with CH2Cl2 
(3 × 4 mL). The combined extracts were dried over Na2SO4, filtered and concentrated. The residue 
was purified by flash chromatography (hexanes/t-butyl methyl ether 9:1) to afford ynone S31 as a 
colorless oil (9.1 mg, 61%). [)]'
( = +30.2 (c = 0.42, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 5.47–5.41 
(m, 1H), 4.63 (td, J = 8.2, 0.7 Hz, 1H), 4.21 (ddd, J = 7.2, 5.3, 3.7 Hz, 1H), 3.84 (dd, J = 10.2, 5.3 Hz, 1H), 
3.78 (dd, J = 10.1, 7.2 Hz, 1H), 2.39 (dd, J = 8.0, 2.3 Hz, 1H), 2.37 (dd, J = 8.4, 4.9 Hz, 1H), 2.08 (s, 3H), 
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0.87 (s, 9H), 0.25 (s, 9H), 0.054 (s, 3H), 0.045 ppm (s, 3H). 13C NMR (100 MHz, CDCl3): δ = 187.1, 170.2, 
102.7, 99.8, 82.7, 82.6, 73.3, 60.7, 36.5, 25.9 (3C), 21.1, 18.3, –0.7 (3C), –5.3, –5.4 ppm. IR (film):  
ṽ = 2957, 2930, 2857, 1745, 1683, 1472, 1374, 1252, 1231, 1091, 846, 778 cm–1. MS (ESIpos) m/z (%): 
421.2 (100 (M+Na)). HRMS (ESIpos): m/z calcd for C19H34O5Si2Na: 421.1837, found: 421.1837.	 
Alkynol (12R)-131. A solution of ynone S31 (9.0 mg, 23 μmol) in CH2Cl2 (0.5 mL) was added to a 
solution of (S,S)-Teth-TsDpen-RuCl (1.0 mg, 1.6 μmol, 7 mol%) in 
HCO2H/Et3N (38 μL) and the resulting mixture was stirred at rt for 45 min. 
The reaction was quenched with aq. half-sat. NH4Cl (1 mL) and the 
aqueous layer extracted with EtOAc (3 × 2 mL). The combined extracts were dried over Na2SO4, 
filtered and concentrated. The residue was purified by flash chromatography (fine SiO2, 
hexanes/EtOAc 10:1) to afford alkynol (12R)-131 as a colorless oil (7.5 mg, 83%, d.r. > 20:1).  
[)]'
( = +37.8 (c = 0.5, CHCl3).
 1H NMR (400 MHz, CDCl3): δ = 5.42 (ddd, J = 3.5, 3.5, 3.4 Hz, 1H),  
4.31–4.21 (m, 2H), 4.09 (ddd, J = 7.1, 5.3, 3.6 Hz, 1H), 3.80–3.72 (m, 2H), 2.39 (brs, 1H), 2.22–2.14 (m, 
2H), 2.08 (s, 3H), 0.87 (s, 9H), 0.16 (s, 9H), 0.05 (s, 3H), 0.04 ppm (s, 3H). 13C NMR (100 MHz, CDCl3):  
δ = 170.3, 102.9, 91.4, 81.8, 80.8, 74.2, 65.8, 61.0, 35.4, 25.9 (3C), 21.2, 18.4, –0.1 (3C), –5.2,  
–5.3 ppm. IR (film): ṽ = 3435, 2956, 2930, 2886, 2858, 1745, 1374, 1251, 1095, 842, 778 cm–1. MS (EI) 
m/z (%): 343 (17), 283 (25), 213 (18), 193 (14), 153 (13), 149 (12), 147 (42), 146 (10), 145 (80), 143 
(26), 129 (16), 119 (15), 117 (43), 115 (119, 91 (13), 89 (87), 75 (46), 73 (100), 43 (21). HRMS (ESIpos): 
m/z calcd for C19H36O5Si2Na: 423.1994, found: 423.1995.	 
Alkynol S32. A solution of n-BuLi (1.6 M in hexane, 0.66 mL, 1.01 mmol) was added to a solution of 
TIPS-acetylene (0.35 mL, 1.57 mmol) in Et2O (4 mL) at –78 °C and the 
resulting mixture was stirred at that temperature for 30 min. Next, a 
solution of LiI (420 mg, 3.14 mmol) in Et2O (1 mL) was added and the 
resulting mixture stirred for 30 min at –40 °C. In a second flask, a solution of aldehyde 130 (190 mg, 
0.63 mmol) in Et2O (3 mL) was cooled to –25 °C. The lithium-acetylene solution was added dropwise 
to the aldehyde solution and stirring was continued overnight. The reaction was quenched with aq. 
sat. NH4Cl (8 mL) and the aqueous layer extracted with EtOAc (3 × 10 mL). The combined extracts 
were dried over Na2SO4, filtered and concentrated. The residue was purified by flash 
chromatography (hexanes/t-butyl methyl ether 9:1) to afford alkynol S32 as a colorless oil (171 mg, 
67%, diastereomeric mixture, d.r. 5:1). The diastereomeric mixture was oxidized to the ynone 135. 
Ynone 135. NaHCO3 (25.2 mg, 1.65 mmol) was added to a solution of alkynol S32 (100 mg, 
0.21 mmol) in CH2Cl2 (5 mL). DMP (131 mg, 0.31 mmol) was added in one 
portion and the resulting mixture was stirred at rt for 3 h. The reaction 
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was quenched with aq. sat. NaHCO3 (5 mL) and the aqueous layer extracted with CH2Cl2 (3 × 5 mL). 
The combined extracts were dried over Na2SO4, filtered and concentrated. The residue was purified 
by flash chromatography (hexanes/t-butyl methyl ether 19:1) to afford ynone 135 as a colorless oil 
(65 mg, 65%). [)]'
( = +36.7 (c = 1.0, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 5.45 (ddd, J = 4.9, 3.6, 
2.5 Hz, 1H), 4.63 (td, J = 8.2, 0.7 Hz, 1H), 4.23 (ddd, J = 7.5, 5.2, 3.7 Hz, 1H), 3.83 (dd, J = 10.0, 5.2 Hz, 
1H), 3.77 (dd, J = 10.0, 7.5 Hz, 1H), 2.39 (dd, J = 6.2, 1.8 Hz, 1H), 2.38 (dd, J = 8.0, 3.9 Hz, 1H), 2.08 (s, 
3H), 1.19–1.08 (m, 21H), 0.87 (s, 9H), 0.044 (s, 3H), 0.035 ppm (s, 3H). 13C NMR (100 MHz, CDCl3):  
δ = 187.1, 170.2, 101.9, 100.5, 82.8, 82.7, 73.3, 60.5, 36.7, 25.9 (3C), 21.1, 18.6 (3C), 18.3, 11.1 (6C),  
–5.3, –5.4 ppm. IR (film): ṽ = 2946, 2867, 1747, 1682, 1464, 1373, 1230, 1097, 1069, 838, 778, 
608 cm–1. MS (EI) m/z (%): 427 (12), 426 (31), 425 (95), 366 (20), 365 (65), 213 (19), 209 (19), 173 
(18), 163 (10), 159 (17), 157 (12), 146 (13), 145 (100), 133 (13), 131 (11), 130 (11), 129 (84), 119 (10), 
117 (53), 115 (29), 103 (16), 91 (10), 89 (100), 87 (11), 75 (42), 73 (74), 59 (15), 43 (21). HRMS 
(ESIpos): m/z calcd for C25H46O5Si2Na: 505.2776, found: 505.2778.	 
Alkynol (12R)-S32. A solution of ynone 135 (63.2 mg, 0.13 mmol) in CH2Cl2 (2.4 mL) was added to a 
solution of (S,S)-Teth-TsDpen-RuCl (5.7 mg, 9.2 μmol, 7 mol%) in 
HCO2H/Et3N (0.22 mL) and the resulting mixture was stirred at rt for 45 
min. The reaction was quenched with aq. half-sat. NH4Cl (2 mL) and the 
aqueous layer extracted with EtOAc (3 × 5 mL). The combined extracts were dried over Na2SO4, 
filtered and concentrated. The residue was purified by flash chromatography (fine SiO2, hexanes/ 
t-butyl methyl ester 9:1) to afford alkynol (12R)-S32 as a colorless oil (58.0 mg, 96%, d.r. > 20:1). 
[)]'
( = +40.7 (c = 1.0, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 5.43 (ddd, J = 4.1, 3.9, 2.9 Hz, 1H), 4.34 
(d, J = 6.7 Hz, 1H), 4.26 (dt, J = 7.7, 7.0 Hz, 1H), 4.10 (ddd, J = 6.6, 5.8, 3.6 Hz, 1H), 3.78–3.72 (m, 2H), 
2.21–2.14 (m, 2H), 2.08 (s, 3H), 1.10–1.02 (m, 21H), 0.87 (s, 9H), 0.044 (s, 3H), 0.037 ppm (s, 3H). 
13C NMR (100 MHz, CDCl3): δ = 170.3, 104.9, 87.7, 81.7, 81.0, 74.1, 66.0, 61.0, 35.5, 25.9 (3C), 21.2, 
18.7 (3C), 18.3, 11.2 (6C), –5.3, –5.4 ppm. IR (film): ṽ = 3425, 2930, 2891, 2865, 1745, 1463, 1374, 
1238, 1094, 1074, 837, 777, 678 cm–1. MS (EI) m/z (%): 441 (12), 427 (25), 367 (23), 273 (14), 213 
(22), 173 (14), 157 (24), 146 (13), 145 (100), 143 (22), 129 (15), 119 (17), 117 (24), 115 (32), 103 (10), 
91 (13), 89 (66), 87 (15), 75 (33), 73 (46), 59 (15), 43 (11). HRMS (ESIpos): m/z calcd for C25H48O5Si2Na: 
507.2933, found: 507.2935.	 
Mosher ester analysis of alcohol (12R)-S32. Triethylamine (5.8 μL, 41 μmol) was added to a solution 
of alcohol (12R)-S32 (5.0 mg, 10 μmol) in CH2Cl2 (0.5 mL) followed by (R)-(–)-α-methoxy-α-
trifluoromethyl-phenylacetyl chloride ((R)-MTPA-Cl) (3.9 μL, 21 μmol). The reaction was stirred at rt 
for 16 h, then quenched with sat. aq. NaHCO3 (3 mL) and the mixture was extracted with CH2Cl2 
(3 × 5 mL). The combined extracts were dried over Na2SO4, filtered and concentrated. The residue 
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was purified by flash chromatography (hexanes/EtOAc 19:1 to 9:1) to give the corresponding  
(S)-Mosher ester (S)-MTPA-S32 (5.5 mg, 76%), which analyzed as follows: 1H NMR (400 MHz, CDCl3): 
δ = 7.59–7.52 (m, 2H), 7.41–7.36 (m, 3H), 5.68 (d, J = 6.3 Hz, 1H), 5.38 (ddd, J = 5.1, 3.5, 1.3 Hz, 1H), 
4.34 (dt, J = 8.2, 6.6 Hz, 1H), 4.10 (ddd, J = 6.3, 6.1, 3.5 Hz, 1H), 3.74–3.70 (m, 1H), 3.70–3.67 (m, 1H), 
3.57 (d, J = 1.2 Hz, 3H), 2.28 (ddd, J = 13.9, 8.3, 5.3 Hz, 1H), 2.10 (ddd, J = 14.4, 7.0, 1.4 Hz, 1H), 2.05 
(s, 3H), 1.09–1.03 (m, 21H), 0.85 (s, 9H), 0.03 (s, 3H), 0.02 ppm (s, 3H). MS (EI) m/z (%): 657 (11), 276 
(24), 275 (100), 233 (14), 189 (62), 183 (12), 173 (10), 145 (37), 117 (13), 115 (11), 89 (55), 73 (28). 
HRMS (ESIpos): m/z calcd for C35H55O7F3Si2Na: 723.3331, found: 723.3336. 
The same procedure was followed for the preparation of (R)-MTPA-S32 (4.6 mg, 63%), which 
analyzed as follows: 1H NMR (400 MHz, CDCl3): δ = 7.57–7.53 (m, 2H), 7.40–7.34 (m, 3H), 5.59 (d, 
J = 7.5 Hz, 1H), 5.42 (ddd, J = 5.0, 3.5, 1.6 Hz, 1H), 4.41 (dt, J = 8.4, 7.3 Hz, 1H), 4.12 (ddd, J = 6.7, 5.8, 
3.5 Hz, 1H), 3.74 (dd, J = 10.2, 6.8 Hz, 1H), 3.70 (dd, J = 10.2, 5.9 Hz, 1H), 3.58 (d, J = 1.2 Hz, 3H), 2.27 
(ddd, J = 13.5, 8.3, 5.1 Hz, 1H), 2.19 (ddd, J = 14.4, 7.0, 1.5 Hz, 1H), 2.07 (s, 3H), 1.04–1.01 (m, 21H), 
0.86 (s, 9H), 0.03 (s, 3H), 0.02 ppm (s, 3H). MS (EI) m/z (%): 657 (11), 276 (24), 275 (100), 233 (14), 
189 (62), 183 (12), 173 (10), 145 (37), 117 (13), 115 (11), 89 (55), 73 (28). HRMS (ESIpos): m/z calcd 
for C35H55O7F3Si2Na: 723.3331, found: 723.3336. 
Both products were analyzed according to Hoye and co-workers:[118] 
Table 4.4. Mosher ester analysis for the assignment of the C(3) stereocenter; arbitrary numbering as shown in the insert. 
 
 
 
Assignment (12R)-S32 [ppm] (S)-MTPA-S32 [ppm] (R)-MTPA-S32 [ppm] Δ (δ(S–R)) [ppm] 
3 4.34 5.68 5.59 +0.09 
4 4.26 4.34 4.41 –0.07 
5a 
5b 
2.19 
2.16 
2.28 
2.10 
2.27 
2.19 
+0.01 
–0.09 
6 5.43 5.38 5.42 –0.04 
7 4.10 4.10 4.12 –0.02 
8a 
8b 
3.76 
3.74 
3.72 
3.69 
3.74 
3.70 
–0.02 
–0.01 
10 2.08 2.05 2.07 –0.02 
TIPS-Me 1.05 1.06 1.02 +0.04 
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Alcohol 123. A solution of TBAF (0.5 M in THF, 0.24 mL, 0.12 mmol) was added to a solution of 
alkynol (12R)-S32 (58 mg, 0.12 mmol) in THF (22 mL) at –35 °C. The resulting 
mixture was stirred at this temperature for 30 h. The reaction was quenched 
with aq. half-sat. NH4Cl (10 mL) and the aqueous layer extracted with EtOAc 
(5 × 15 mL). The combined extracts were washed with brine (50 mL), dried over Na2SO4, filtered and 
concentrated. The residue was purified by flash chromatography (hexanes/EtOAc 9:1) to yield the 
terminal alkyne 123 as a colorless oil (24.0 mg, 61%) along with the desilylated alcohol as a 
byproduct. [)]'
( = +46.9 (c = 1.0, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 5.43 (ddd, J = 4.1, 4.0, 2.8 Hz, 
1H), 4.32–4.25 (m, 2H), 4.11 (ddd, J = 6.8, 5.7, 3.7 Hz, 1H), 3.81–3.74 (m, 2H), 2.46 (d, J = 2.1 Hz, 1H), 
2.21–2.15 (m, 2H), 2.07 (s, 3H), 0.87 (s, 9H), 0.05 (s, 3H), 0.04 ppm (s, 3H). 13C NMR (100 MHz, CDCl3): 
δ = 170.3, 81.9, 81.6, 80.7, 74.3, 74.1, 65.0, 61.0, 35.2, 25.9 (3C), 21.2, 18.4, –5.3, –5.4 ppm. IR (film): 
ṽ = 3454, 2929, 2857, 1742, 1472, 1375, 1250, 1093, 838, 778 cm–1. MS (EI) m/z (%): 271 (16), 213 
(12), 212 (13), 211 (79), 193 (19), 169 (11), 167 (17), 159 (11), 145 (44), 143 (29), 129 (47), 119 (15), 
117 (74), 91 (16), 89 (55), 81 (119, 75 (100), 73 (58), 43 (38). HRMS (ESIpos): m/z calcd for 
C16H28O5SiNa: 351.1598, found: 351.1599.	 
Diol 132. Obtained as a byproduct from the reaction described above via TBS-deprotection followed 
by acetate migration as a colorless oil (5.7 mg, 22%). [)]'
( = +33.0 (c = 0.33, 
CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 4.43 (dd, J = 11.6, 7.2 Hz, 1H), 4.32–4.25 
(m, 2H), 4.23 (dd, J = 5.8, 2.2 Hz, 1H), 4.10 (dd, J = 11.6, 5.3 Hz, 1H), 3.98 (ddd, 
J = 7.2, 5.3, 3.0 Hz, 1H), 2.41 (d, J = 2.2 Hz, 1H), 2.12 (ddd, J = 13.5, 6.3, 1.1 Hz, 1H), 2.04 (s, 3H), 
2.02 ppm (m, 1H). 13C NMR (100 MHz, CDCl3): δ = 171.9, 81.7, 81.1, 80.7, 74.3, 72.0, 65.1, 62.2, 37.1, 
21.1 ppm. IR (film): ṽ = 3436, 3310, 2930, 2886, 2858, 1742, 1472, 1375, 1250, 1095, 838, 778 cm–1. 
MS (ESIpos) m/z (%): 237.1 (100 (M+Na)). HRMS (ESIpos): m/z calcd for C10H14O5Na: 237.0733, found: 
237.0731.	 
4.3.7 Synthesis of the Southern Vinyl Iodide Fragments 137 and 139 
Alcohol 136. Pyridine (2.78 mL, 34.4 mmol) was slowly added to a Teflon® vial charged with 
HF·pyridine (0.49 mL, 5.43 mmol) and the resulting mixture diluted with THF 
(3 mL). This solution was added dropwise to a solution of silyl ether 84 (140 mg, 
0.21 mmol) in THF (1 mL) in a second Teflon® vial. The resulting mixture was 
stirred at ambient temperature for 9 h. The mixture was diluted with EtOAc (5 mL) and the reaction 
was carefully quenched with aq. sat. NaHCO3 (10 mL). The layers were separated and the aqueous 
layer was extracted with EtOAc (4 × 15 mL). The combined organic extracts were dried over Na2SO4, 
filtered and concentrated. The residue was purified by flash chromatography (hexanes/EtOAc 30:1) 
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to afford the title compound 136 as a colorless oil (105 mg, 91%). [)]'
( = +5.8 (c = 1.0, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 6.38 (ddd, J = 8.2, 7.7 Hz, 1H), 6.30 (d, J = 7.7 Hz, 1H), 4.32 (dd, J = 8.2, 
2.0 Hz, 1H), 3.81 (ddd, J = 10.0, 7.7, 5.6 Hz, 1H), 3.74–3.70 (m, 1H), 3.63 (dd, J = 7.7, 2.1 Hz, 1H),  
3.54–3.47 (m, 2H), 2.33 (ddd, J = 12.1, 7.2, 6.2 Hz, 1H), 2.10 (ddqd, J = 13.3, 9.0, 6.5, 4.4 Hz, 1H), 1.91 
(brt, J = 6.1 Hz, 1H), 1.37 (td, J = 12.1, 11.2, 10.0 Hz, 1H), 1.04 (d, J = 6.5 Hz, 3H), 0.91 (s, 9H), 0.88 (s, 
9H), 0.12 (s, 3H), 0.10 (s, 3H), 0.09 (s, 3H), 0.07 ppm (s, 3H). 13C NMR (100 MHz, CDCl3): δ =141.8, 
84.9, 82.0, 80.7, 79.6, 76.9, 63.2, 38.6, 35.4, 26.2 (3C), 26.1 (3C), 18.6, 18.3, 16.4, –3.9, –4.1, –4.17,  
–4.20 ppm. IR (film): ṽ = 3447, 2954, 2928, 2856, 1462, 1388, 1361, 1252, 1145, 1077, 1055, 1005, 
959, 833, 776, 674 cm–1. MS (ESIpos) m/z (%): 579.2 (100 (M+Na)). HRMS (ESIpos): m/z calcd for 
C22H45O4ISi2Na: 579.1793, found: 579.1794. 
Ester 137. NaHCO3 (38.0 mg, 0.45 mmol), PIDA (107 mg, 0.33 mmol) and TEMPO (4.7 mg, 30 μmol) 
were sequentially added to a solution of alcohol 136 (84.0 mg, 0.15 mmol) in 
MeCN/H2O (1:1, 1.5 mL). The resulting mixture was stirred at rt for 20 h. The 
mixture was diluted with MeCN (5 mL) and the reaction was quenched with pH 5 
phosphate buffer (0.5 mL). After filtration through a short pad of Na2SO4, the solvent was removed 
under reduced pressure. The residue was partitioned between MeCN (5 mL) and cyclohexane (5 mL). 
The cyclohexane layer was extracted with MeCN (3 × 8 mL). The combined MeCN-extracts were dried 
over Na2SO4, filtered and concentrated. The crude acid was used in the next step without further 
purification. 
A solution of TMSCHN2 (2 M in Et2O, 0.14 mL, 0.27 mmol) was added to a solution of the crude acid 
(86 mg, 0.15 mmol) in THF (1.5 mL) at 0 °C. The resulting yellow mixture was stirred at 0 °C for 30 min 
before the reaction was carefully quenched with pH 5 phosphate buffer (2 mL). The layers were 
separated and the aqueous layer was extracted with t-butyl methyl ether (3 × 5 mL). The combined 
organic extracts were dried over Na2SO4, filtered and concentrated. The residue was purified by flash 
chromatography (hexanes/t-butyl methyl ether 49:1) to yield the title compound 137 as a colorless 
oil (58.0 mg, 66%, two steps). [)]'
( = +16.7 (c = 1.0, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 6.39 (dd,  
J = 8.3, 7.6 Hz, 1H), 6.29 (dd, J = 7.6, 0.7 Hz, 1H), 4.37 (ddd, J = 8.2, 2.3, 0.8 Hz, 1H), 4.03 (ddd,  
J = 10.3, 7.2, 5.3 Hz, 1H), 3.98 (d, J = 8.6 Hz, 1H), 3.74 (s, 3H), 3.71 (dd, J = 7.2, 2.3 Hz, 1H), 2.36 (dddq, 
J = 10.5, 8.5, 6.6, 6.5 Hz, 1H), 2.27 (ddd, J = 12.1, 6.9, 5.3 Hz, 1H), 1.44 (dt, J = 11.8, 10.5 Hz, 1H), 1.20 
(d, J = 6.5 Hz, 3H), 0.90 (s, 9H), 0.88 (s, 9H), 0.13 (s, 3H), 0.09 (s, 6H), 0.08 ppm (s, 3H). 13C NMR 
(100 MHz, CDCl3): δ = 173.6, 141.9, 82.7, 82.3, 81.4, 79.5, 76.8, 52.0, 39.9, 37.7, 26.2 (3C), 26.1 (3C), 
18.5, 18.3, 17.5, –3.9, –4.2 (2C), –4.3 ppm. IR (film): ṽ = 2954, 2928, 2888, 2956, 1759, 1738, 1611, 
1472, 1462, 1389, 1361, 1253, 1201, 1146, 1078, 1005, 962, 835, 777, 674 cm–1. MS (EI) m/z (%): 528 
(18), 527 (59), 457 (12), 371 (22), 331 (35), 325 (20), 321 (12), 297 (38), 288 (13), 287 (60), 241 (12), 
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186 (12), 185 (73), 175 (36), 171 (23), 159 (10), 155 (77), 143 (39), 133 (15), 127 (19), 115 (87), 113 
(10), 95 (14), 89 (149, 83 (13), 75 (21), 73 (100), 59 (10). HRMS (ESIpos): m/z calcd for C23H45O5ISi2Na: 
607.1742, found: 607.1746. 
Alcohol 138. Pyridine (3.46 mL, 42.7 mmol) was slowly added to a Teflon® vial charged with 
HF·pyridine (0.61 mL, 6.74 mmol) and the resulting mixture was diluted with 
THF (3.5 mL). This solution was added dropwise to a solution of silyl ether 116 
(125 mg, 0.26 mmol) in THF (1.5 mL) in a second Teflon® vial. The resulting 
mixture was stirred at ambient temperature for 4 h. The mixture was diluted with EtOAc (5 mL) and 
the reaction was carefully quenched with aq. sat. NaHCO3 (5 mL). The layers were separated and the 
aqueous layer was extracted with EtOAc (4 × 10 mL). The combined organic extracts were dried over 
Na2SO4, filtered and concentrated. The residue was purified by flash chromatography 
(hexanes/EtOAc 4:1 to 2:1) to afford the title compound 138 as a colorless oil (94.0 mg, 98%). 	
[)]'
( = –50.7 (c = 1.0, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 6.50 (dd, J = 7.7, 1.0 Hz, 1H), 6.34 (dd,  
J = 8.7, 7.7 Hz, 1H), 4.82 (ddd, J = 8.6, 6.3, 1.0 Hz, 1H), 4.16 (t, J = 6.6 Hz, 1H), 3.94 (ddd, J = 9.7, 7.0, 
5.7 Hz, 1H), 3.80 (dd, J = 11.9, 2.7 Hz, 1H), 3.58 (ddd, J = 8.9, 3.9, 2.7 Hz, 1H), 3.50 (dd, J = 11.9, 4.0 
Hz, 1H), 2.21–2.12 (m, 1H), 2.12–2.06 (m, 1H), 1.98 (brs, 1H), 1.51 (s, 3H), 1.42 (s, 3H), 1.42–1.32 (m, 
1H), 1.05 ppm (d, J = 6.2 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ = 137.3, 110.1, 86.3, 85.8, 81.2, 79.7, 
77.3, 62.4, 37.9, 34.7, 27.9, 25.7, 16.3 ppm. IR (film): ṽ = 3442, 2983, 2957, 2930, 2872, 1455, 1372, 
1249, 1251, 1160, 1088, 1053, 926, 866, 816 cm–1. MS (ESIpos) m/z (%): 391.0 (100 (M+Na)). HRMS 
(ESIpos): m/z calcd for C13H21O4INa: 391.0377, found: 391.0375. 
Ester 139. NaHCO3 (65.9 mg, 0.78 mmol), PIDA (185 mg, 0.57 mmol) and TEMPO (8.1 mg, 52 μmol) 
were sequentially added to a solution of alcohol 138 (94.0 mg, 0.26 mmol) in 
MeCN/H2O (1:1, 3 mL). The resulting mixture was stirred at rt for 20 h. The 
mixture was diluted with MeCN (5 mL) and the reaction was quenched with 
pH 5 phosphate buffer sat. with NaCl (1 mL). After filtration through a short pad of Na2SO4, the 
solvent was removed under reduced pressure. The residue was partitioned between MeCN (5 mL) 
and cyclohexane (5 mL). The cyclohexane layer was extracted with MeCN (3 × 8 mL). The combined 
MeCN-extracts were dried over Na2SO4, filtered and concentrated. The crude acid was used in the 
next step without further purification. 
A solution of TMSCHN2 (2 M in Et2O, 0.23 mL, 0.46 mmol) was added to a solution of the crude acid 
(97.6 mg, 0.26 mmol) in THF (2.5 mL) at 0 °C. The resulting yellow mixture was stirred at 0 °C for 1 h 
before the reaction was carefully quenched with pH 5 phosphate buffer (3 mL). The layers were 
separated and the aqueous layer was extracted with t-butyl methyl ether (3 × 5 mL). The combined 
organic extracts were dried over Na2SO4, filtered and concentrated. The residue was purified by flash 
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chromatography (hexanes/t-butyl methyl ether 6:1) to yield the title compound 139 as a colorless oil 
(73.2 mg, 72%, two steps). [)]'
( = –62.5 (c = 0.8, CHCl3). 
1H NMR (500 MHz, CDCl3): δ = 6.51 (dd, 
J = 7.7, 1.0 Hz, 1H), 6.45 (dd, J = 8.3, 7.7 Hz, 1H), 4.86 (ddd, J = 8.3, 6.3, 0.9 Hz, 1H), 4.18 (t, J = 6.3 Hz, 
1H), 4.12 (dt, J = 9.4, 6.0 Hz, 1H), 4.06 (d, J = 7.7 Hz, 1H), 3.72 (s, 3H), 2.43–2.31 (m, 1H), 2.12 (ddd,  
J = 12.1, 7.4, 5.8 Hz, 1H), 1.51 (s, 3H), 1.41 (s, 3H), 1.44 – 1.36 (m, 1H), 1.20 ppm (d, J = 6.6 Hz, 3H). 
13C NMR (125 MHz, CDCl3): δ = 173.3, 137.5, 110.1, 85.8, 83.8, 80.1, 79.9, 78.9, 52.1, 39.6, 37.2, 27.6, 
25.7, 18.2 ppm. IR (film): ṽ = 2981, 2961, 2933, 2875, 1753, 1615, 1437, 1379, 1274, 1249, 1212, 
1164, 1130, 1086, 1057, 867 cm–1. MS (ESIpos) m/z (%): 419.0 (100 (M+Na)). HRMS (ESIpos): m/z 
calcd for C14H21O5INa: 419.0326, found: 419.0322. 
4.3.8 Fragment Assembly and Hydrometalations 
Enyne 140. Et3N was degassed by three freeze-pump-thaw cycles prior to use. CuI (0.8 mg, 4.5 μmol, 
20 mol%) and Pd(dppf)Cl2·CH2Cl2 (0.9 mg, 1.1 μmol, 5 mol%) were added to a 
solution of vinyl iodide 84 (15 mg, 22 μmol) in Et3N (0.3 mL) and the resulting 
mixture was warmed to 55 °C. A solution of alkyne 122 (10 mg, 22 μmol) in 
Et3N (0.3 mL) was added via syringe over 2.5 h. The dark brown suspension 
was stirred for additional 1.5 h at 55 °C. All volatiles were removed in vacuo 
and the residue was purified by flash chromatography (pentane/t-butyl methyl ether 15:1 to 5:1) to 
yield the title compound 140 as a colorless oil (7.7 mg, 34%). [)]'
( = +21.1 (c = 1.0, CHCl3). 
1H NMR 
(400 MHz, CDCl3): δ = 7.41–7.38 (m, 6H), 7.32–7.27 (m, 6H), 7.26–7.20 (m, 3H), 6.08 (dd, J = 11.0, 9.4 
Hz, 1H), 5.58 (td, J = 3.8, 2.4 Hz, 1H), 5.51 (dd, J = 11.0, 1.9 Hz, 1H), 4.56 (dd, J = 9.5, 2.3 Hz, 1H), 4.38 
(dd, J = 5.7, 1.9 Hz, 1H), 4.29 (ddd, J = 8.3, 5.0, 3.4 Hz, 1H), 4.20 (dt, J = 8.2, 6.5 Hz, 1H), 3.71 (ddd,  
J = 10.0, 7.6, 5.6 Hz, 1H), 3.63–3.58 (m, 3H), 3.45 (dt, J = 9.1, 4.7 Hz, 1H), 3.39 (dd, J = 8.9, 5.1 Hz, 1H), 
3.17 (dd, J = 8.9, 7.8 Hz, 1H), 2.58 (d, J = 5.7 Hz, 1H), 2.22–2.12 (m, 3H), 1.99 (ddqd, J = 11.0, 8.7, 6.5, 
4.3 Hz, 1H), 1.82 (s, 3H), 1.32–1.23 (m, 1H), 0.99 (d, J = 6.5 Hz, 3H), 0.89 (s, 9H), 0.88 (s, 9H), 0.86 (s, 
9H), 0.08 (s, 3H), 0.07 (s, 3), 0.05 (s, 3H), 0.04 (s, 6H), 0.02 ppm (s, 3H). 13C NMR (100 MHz, CDCl3):  
δ = 170.1, 144.5, 143.8 (3C), 128.8 (6C), 127.9 (6C), 127.2 (3C), 108.8, 91.6, 86.8, 84.9, 83.0, 80.7, 
80.5, 80.4, 79.6, 74.1, 71.7, 65.5, 65.4, 61.2, 38.2, 37.1, 35.5, 26.2 (3C), 26.1 (6C), 21.0, 18.6, 18.5, 
18.3, 17.1, –4.0, –4.2, –4.4, –4.5, –5.20, –5.22 ppm. IR (film): ṽ = 3465, 2953, 2927, 2855, 1744, 1491, 
1462, 1449, 1375, 1250, 1076, 965, 938, 836, 776, 705, 633 cm–1. MS (ESIpos) m/z (%): 1021.5 (100 
(M+Na)). HRMS (ESIpos): m/z calcd for C57H86O9Si3Na: 1021.5472, found: 1021.5482. 
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Enyne 142. A flame-dried Schlenk flask was charged with Cs2CO3 (8.9 mg, 27 μmol), Pd(OAc)2 (0.4 mg, 
1.7 μmol, 10 mol%) and 2-amino-4,6-dihydrixypyrimidine (0.4 mg, 3.4 μmol, 
20 mol%), evacuated and backfilled with argon three times. A solution of 
vinyl iodide 137 (10 mg, 17 μmol) in DMF (0.2 mL) was added and the 
resulting mixture stirred at rt. Next, a solution of alkyne 123 (6.7 mg, 
21 μmol) in DMF (0.2 mL) was added via syringe over 10 min. The resulting 
mixture was stirred at rt for 1h. All volatiles were removed in vacuo and the residue was purified by 
flash chromatography (hexanes/t-butyl methyl ether 15:1 to 4:1) to yield the title compound 142 as a 
colorless oil (4.8 mg, 36%, 51% b.r.s.m). [)]'
( = +29.5 (c = 0.5, CHCl3). 
1H NMR (600 MHz, CDCl3):  
δ = 6.07 (dd, J = 11.0, 9.4 Hz, 1H, H-8), 5.54 (ddd, J = 11.1, 2.0, 0.6 Hz, 1H, H-9), 5.43 (ddd, J = 4.4, 3.8, 
2.0 Hz, 1H, H-15), 4.62 (ddd, J = 9.4, 2.5, 0.6 Hz, 1H, H-7), 4.39 (td, J = 5.7, 1.9 Hz, 1H, H-12), 4.26 
(ddd, J = 8.8, 6.6, 6.0 Hz, 1H, H-13), 4.11 (ddd, J = 7.2, 5.6, 3.8 Hz, 1H, H-16), 4.02 (ddd, J = 10.4, 6.8, 
5.2 Hz, 1H, H-5), 3.99 (d, J = 8.7 Hz, 1H, H-2), 3.76 (dd, J = 10.0, 5.8 Hz, 1H, H-17), 3.74 (dd, J = 10.0, 
7.2 Hz, 1H, H-17), 3.73 (s, 3H), 3.72 (dd, J = 6.6, 2.6 Hz, 1H, H-6), 2.57 (d, J = 5.6 Hz, 1H, 12-OH), 2.34 
(ddq, J = 10.8, 8.8, 6.8 Hz, 1H, H-3), 2.21 (ddd, J = 11.9, 6.8, 5.6 Hz, 1H, H-4), 2.18 (ddd, J = 14.0, 6.8, 
2.0 Hz, 1H, H-14), 2.14 (ddd, J = 14.0, 8.8, 4.8 Hz, 1H, H-14), 2.07 (s, 3H, H-19), 1.43 (dt, J = 11.9, 10.6 
Hz, 1H, H-4), 1.18 (d, J = 6.6 Hz, 3H, H-23), 0.89 (s, 9H, 6-TBS), 0.88 (s, 9H, 7-TBS), 0.87 (s, 9H, 17-TBS), 
0.09 (s, 3H, 7-TBS), 0.079 (s, 3H, 6-TBS), 0.077 (s, 3H, 6-TBS), 0.048 (s, 3H, 7-TBS), 0.046 (s, 3H,  
17-TBS), 0.04 ppm (s, 3H, 17-TBS). 13C NMR (150 MHz, CDCl3): δ = 173.7 (C1), 170.2 (C18), 144.3 (C8), 
109.1 (C9), 92.0 (C11), 82.9 (C10), 82.8 (C2), 81.8 (C16), 81.6 (C5), 80.9 (C13), 79.6 (C6), 74.1 (C15), 
71.9 (C7), 65.7 (C12), 60.9 (C17), 52.0 (C20), 39.8 (C3), 37.4 (C4), 35.4 (C14), 26.2 (3C, 6-TBS), 26.1 
(3C, 7-TBS), 25.9 (3C, 17-TBS), 21.2 (C19), 18.5 (6-TBS), 18.4 (17-TBS), 18.3 (7-TBS), 17.5 (C23), –4.1 
(6-TBS), –4.2 (7-TBS), –4.4 (6-TBS), –4.6 (7-TBS), –5.3 (17-TBS), –5.4 ppm (17-TBS). IR (film): ṽ = 3471, 
2954, 2928, 2856, 1743, 1463, 1374, 1250, 1147, 1078, 967, 938, 836, 777, 668 cm–1. MS (ESIpos) m/z 
(%): 807.4 (100 (M+Na)). HRMS (ESIpos): m/z calcd for C39H72O10Si3Na: 807.4326, found: 807.4337. 
Iodoalkyne 143. A solution of AgNO3 (1.6 mg, 9.1 μmol, 15 mol%) in DMF (0.2 mL) was added to a 
solution of alkyne 123 (20.0 mg, 60.9 μmol) and NIS (20.5 mg, 91.3 μmol)  in 
DMF (0.4 mL). The resulting mixture was stirred for 90 min at rt. The reaction 
was quenched with of water (5 mL) and the aqueous layer extracted with 
EtOAc (5 × 10 mL). The combined extracts were washed with brine (20 mL), dried over Na2SO4, 
filtered and concentrated. The residue was purified by flash chromatography (hexanes/t-butyl 
methyl ether 19:1) to yield the title compound as a yellow oil (23.0 mg, 83%). [)]'
( = +27.6 (c = 1.0, 
CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 5.42 (td, J = 4.0, 2.4 Hz, 1H), 4.41 (t, J = 5.1 Hz, 1H), 4.31–4.20 
(m, 1H), 4.09 (ddd, J = 6.8, 5.8, 3.7 Hz, 1H), 3.82–3.71 (m, 2H), 2.46 (brd, J = 5.3 Hz, 1H), 2.19–2.12 (m, 
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2H), 2.07 (s, 3H), 0.87 (s, 9H), 0.05 (s, 3H), 0.04 ppm (s, 3H). 13C NMR (100 MHz, CDCl3): δ = 170.3, 
92.3, 81.9, 80.9, 74.1, 66.6, 61.0, 53.6, 35.3, 25.9 (3C), 21.2, 18.4, –5.3, –5.4 ppm. IR (film): ṽ = 3422, 
2928, 2884, 2856, 1727, 1471, 1374, 1249, 1182, 1092, 939, 836, 777, 667 cm–1. MS (ESIpos) m/z (%): 
477.1 (100 (M+Na)). HRMS (ESIpos): m/z calcd for C16H27O5ISiNa: 477.0565, found: 477.0563.	 
Vinyl silane 145. A solution of t-BuLi (1.7 M in pentane, 48 μL, 82 μmol) was slowly added to a 
solution of vinyl iodide 84 (25.0 mg, 37.3 μmol) in THF (0.4 mL) at –78 °C 
and the resulting mixture was stirred for 20 min. Bu3SnCl (11 μL, 41 μmol) 
was added, the reaction mixture warmed to ambient temperature and 
stirred for 20 min. The reaction was cooled to –78 °C, quenched with H2O (1 mL) followed by NaOH 
(1 M, 2 mL) and the resulting mixture was vigorously stirred for 1 h at rt. The biphasic mixture was 
diluted with Et2O (4 mL), the layers were separated and the aqueous layer was extracted with EtOAc 
(4 × 10 mL). The combined organic extracts were dried over Na2SO4, filtered and concentrated. The 
residue was purified by flash chromatography (hexanes/t-butyl methyl ether 100:1) to afford the title 
compound 145 as a colorless oil (12.3 mg, 61%). [)]'
( = –6.1 (c = 1.0, CHCl3). 
1H NMR (600 MHz, 
CDCl3): δ = 6.26 (ddd, J = 14.9, 9.0, 1.0 Hz, 1H, H-8), 5.72 (d, J = 14.9 Hz, 1H, H-9), 4.32 (dd, J = 9.0, 6.4 
Hz, 1H, H-7), 4.17 (ddd, J = 9.5, 5.6, 3.5 Hz, 1H, H-5), 3.65 (dd, J = 11.0, 4.6 Hz, 1H, H-1), 3.64 (dd, 
J = 11.0, 4.3 Hz, 1H, H-1), 3.51 (dt, J = 8.8, 4.6 Hz, 1H, H-2), 3.20 (td, J = 6.5, 3.2 Hz, 1H, H-6), 2.22 (d,  
J = 6.7 Hz, 1H, 6-OH), 2.11 (ddd, J = 9.9, 5.3, 2.7 Hz, 1H, H-3), 2.06 (dt, J = 12.5, 6.2 Hz, 1H, H-4), 1.57 
(q, J = 10.8 Hz, 1H, H-4), 1.07 (d, J = 6.3 Hz, 3H, H-23),  0.90 (s, 18H, TBS), 0.87 (s, 9H, TBS), 0.14 (s, 3H, 
TBS), 0.12 (s, 3H, TBS), 0.07 (s, 3H, TBS), 0.06 (s, 6H, TBS), 0.05 ppm (s, 3H, TBS). 13C NMR (150 MHz, 
CDCl3): δ = 150.2 (C8), 128.4 (C9), 86.3 (C2), 77.1 (C5), 76.0 (C6), 74.2 (C7), 65.1 (C1), 38.2 (C4), 36.8 
(C3), 26.7 (3C, TBS), 26.1 (3C, TBS), 26.0 (3C, TBS), 18.5 (TBS), 18.3 (TBS), 17.2 (C23), 16.8 (TBS), –3.6 
(TBS), –3.7 (TBS), –4.15 (TBS), –4.24 (TBS), –5.12 (TBS), –5.14 ppm (TBS). IR (film): ṽ = 3515, 2954, 
2928, 2856, 1462, 1389, 1361, 1251, 1084, 1006, 938, 834, 810, 774, 729 cm–1. MS (ESIpos) m/z (%): 
567.4 (100 (M+Na)). HRMS (ESIpos): m/z calcd for C28H60O4Si3Na: 567.3692, found: 567.3697. 
Mosher ester analysis of alcohol 145. Triethylamine (4.6 μL, 33 μmol) and DMAP (0.3 mg, 2.2 μmol, 
20 mol%) were added to a solution of alcohol 145 (6.0 mg, 11 μmol) in CH2Cl2 (0.3 mL) followed by 
(R)-(–)-α-methoxy-α-trifluoromethyl-phenylacetyl chloride ((R)-MTPA-Cl) (4.1 μL, 22 μmol). The 
resulting mixture was stirred at rt for 48 h, before the reaction was quenched with aq. sat. NaHCO3 
(3 mL). The aqueous layer was extracted with CH2Cl2 (3 × 5 mL), the combined extracts were dried 
over Na2SO4, filtered and concentrated. The residue was purified by flash chromatography 
(hexanes/t-butyl methyl ether 19:1) to give the corresponding (S)-Mosher ester (S)-MTPA-145 
(1.6 mg, 19%), which analyzed as follows: [)]'
( = –43.4 (c = 0.25, CHCl3). 
1H NMR (400 MHz, CDCl3):  
δ = 7.68–7.62 (m, 2H), 7.39–7.34 (m, 3H), 6.32 (dd, J = 15.0, 9.2 Hz, 1H), 5.70 (dd, J = 15.0, 1.0 Hz, 
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1H), 5.10 (dd, J = 7.7, 3.1 Hz, 1H), 4.52 (ddd, J = 9.1, 3.2, 1.0 Hz, 1H), 4.15 (ddd, J = 9.0, 7.7, 5.5 Hz, 
1H), 3.60 (dd, J = 10.7, 3.9 Hz, 1H), 3.55 (dd, J = 10.8, 4.5 Hz, 1H), 3.52 (s, 3H), 3.43 (dt, J = 8.3, 4.2 Hz, 
1H), 2.25–2.17 (m, 1H), 2.17–2.09 (m, 1H), 1.34–1.31 (m, 1H), 1.03 (d, J = 6.1 Hz, 3H), 0.89 (s, 9H), 
0.85 (s, 18H),  012 (s, 3H), 0.09 (s, 3H), 0.05 (s, 3H), 0.04 (s, 3H), –0.01 (s, 3H), –0.02 ppm (s, 3H). MS 
(ESIpos) m/z (%): 778.5 (100 (M+NH4)). HRMS (ESIpos): m/z calcd for C38H67O6F3Si3Na: 783.4090, 
found: 783.4089. 
The same procedure was followed for the preparation of (R)-MTPA-145 (1.1 mg, 13%), which 
analyzed as follows: [)]'
( = +55.0 (c = 0.11, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 7.67–7.60 (m, 2H), 
7.39–7.31 (m, 3H), 6.16 (dd, J = 15.0, 8.9 Hz, 1H), 5.58 (dd, J = 15.0, 1.1 Hz, 1H), 5.02 (dd, J = 8.2, 2.7 
Hz, 1H), 4.33 (ddd, J = 8.9, 2.8, 1.1 Hz, 1H), 4.25 (ddd, J = 9.4, 8.2, 5.5 Hz, 1H), 3.66 (s, 3H), 3.63–3.60 
(m, 2H), 3.49 (dt, J = 8.1, 3.9 Hz, 1H), 2.25–2.20 (m, 1H), 2.20–2.16 (m, 1H), 1.38–1.34 (m, 1H), 1.07 
(d, J = 6.2 Hz, 3H), 0.89 (s, 9H), 0.87 (s, 18H),  006 (s, 3H), 0.04 (s, 3H), 0.02 (s, 3H), 0.01 (s, 3H), –0.16 
(s, 3H), –0.18 ppm (s, 3H). MS (ESIpos) m/z (%): 783.4 (100 (M+Na)). HRMS (ESIpos): m/z calcd for 
C38H67O6F3Si3Na: 783.4090, found: 783.4087. 
Both products were analyzed according to Hoye and co-workers:[118] 
Table 4.5. Mosher ester analysis for the assignment of the C(6) stereocenter; chagosensine numbering as shown in the 
insert. 
 
 
Assignment 145 [ppm] (S)-MTPA-145 [ppm] (R)-MTPA-145 [ppm] Δ (δ(S–R)) [ppm] 
1a 
1b 
3.65 
3.64 
3.60 
3.55 
3.62 
3.61 
–0.02 
–0.06 
2 3.51 3.43 3.49 –0.06 
3 
4a 
4b 
2.11 
2.06 
1.57 
2.21 
2.13 
1.33 
2.22 
2.19 
1.36 
–0.01 
–0.06 
–0.03 
5 4.17 4.15 4.25 –0.10 
6 3.20 5.10 5.02 +0.08 
7 
8 
4.32 
6.26 
4.52 
6.32 
4.33 
6.16 
+0.19 
+0.16 
9 5.72 5.70 5.58 +0.12 
23 1.07 1.03 1.07 –0.04 
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Enyne 147. THF was degassed by three freeze-pump-thaw cycles prior to use. A flame-dried Young 
Schlenk was charged with 1-ethynylsodium (4.2 mg, 88 μmol), which was 
suspended in degassed THF (0.2 mL). Trimethyl borate (10 μL, 88 μmol) was 
added dropwise via syringe at rt. After stirring for 20 min, [Pd(dppf)Cl2]·CH2Cl2 
(2.0 mg, 2.4 μmol, 15 mol%) was added, causing the reaction mixture to turn bright red. Next, a 
solution of (Z)-vinyl iodide 84 (10 mg, 16 μmol) in degassed THF (0.1 mL + 0.1 mL rinse) was added 
and the mixture stirred at 65°C for 2 h. The pale orange mixture was cooled to ambient temperature; 
the reaction was quenched with aq. half-sat. NH4Cl (3 mL) and the aqueous layer extracted with 
EtOAc (3 × 5 mL). The combined extracts were dried over Na2SO4, filtered and concentrated. The 
residue was purified by flash chromatography (hexanes/t-butyl methyl ether 100:1) to afford the title 
compound 147 as a colorless oil (5.6 mg, 62%). [)]'
( = +8.8 (c = 0.5, CHCl3). 
1H NMR (400 MHz, 
CDCl3): δ = 6.14 (ddd, J = 11.1, 9.3, 0.9 Hz, 1H), 5.49 (dd, J = 11.3, 2.4 Hz, 1H), 4.60 (dd, J = 9.3, 1.8 Hz, 
1H), 3.71 (ddd, J = 9.8, 8.0, 5.6 Hz, 1H), 3.67–3.58 (m, 3H), 3.43 (dt, J = 9.2, 4.7 Hz, 1H), 3.09 (dd,  
J = 2.4, 1.0 Hz, 1H), 2.21 (ddd, J = 12.2, 7.0, 5.6 Hz, 1H), 2.04 (dddd, J = 13.3, 8.7, 6.7, 4.4 Hz, 1H), 
1.33–1.25 (m, 1H), 1.05 (d, J = 6.5 Hz, 3H), 0.89 (s, 9H), 0.882 (s, 9H), 0.877 (s, 9H), 0.10–0.07 (m, 9H), 
0.04 ppm (s, 9H). 13C NMR (100 MHz, CDCl3): δ = 145.4, 108.4, 84.9, 82.2, 81.0, 80.7, 79.7, 71.9, 65.2, 
38.4, 37.2, 26.2 (3C), 26.1 (6C), 18.6, 18.5, 18.3, 17.3, –4.0, –4.2, –4.58, –4.59, –5.2 ppm (2C). 
IR (film): ṽ = 2955, 2928, 2856, 1472, 1388, 1361, 1252, 1132, 1070, 1005, 977, 939, 834, 775, 679, 
640, 611 cm–1. MS (ESIpos) m/z (%): 591.4 (100 (M+Na)). HRMS (ESIpos): m/z calcd for C30H60O4Si3Na: 
591.3692, found: 591.3690. 
Enyne 148. A solution of n-BuLi (1.6 M in hexane, 5.5 μL, 8.8 μmol) was added to a solution of 
enyne 147 (5.0 mg, 8.8 μmol) in THF (0.2 mL) at –78 °C. After stirring for 
30 min, a solution of aldehyde 58 (3.1 mg, 8.4 μmol) in THF (0.2 mL) was 
added over 2 h via syringe pump. The resulting solution was stirred overnight. 
The reaction was diluted with t-butyl methyl ether (2 mL) and quenched with 
water (2 mL). The aqueous phase was extracted with t-butyl methyl ether 
(3 × 4 mL), the combined extracts were dried over Na2SO4, filtered and concentrated. The residue 
was purified by flash chromatography (hexanes/t-butyl methyl ether 19:1) to yield the title 
compound 148 as a colorless oil (2.3 mg, 29% C12-epimeric mixture). 1H NMR (400 MHz, CDCl3):  
δ = 6.03 (dd, J = 11.1, 9.3 Hz, 1H), 5.56–5.50 (m, 1H), 4.67 (dd, J = 6.3, 3.1 Hz, 1H), 4.52 (dd, J = 9.3, 
1.9 Hz, 1H), 4.41 (d, J = 5.4 Hz, 1H), 4.39–4.33 (m, 1H), 4.15–4.09 (m, 2H), 4.08–4.03 (m, 1H),  
3.64–3.57 (m, 3H) 3.45–3.39 (m, 2H), 2.39–2.20 (m, 3H), 2.17–2.07 (m, 1H), 1.24–1.19 (m, 1H), 1.05 
(d, J = 6.5 Hz, 3H), 0.99–0.92 (m, 18H), 0.89 (s, 9H), 0.884 (s, 9H), 0.876 (s, 9H), 0.65 (q, J = 8.0 Hz, 6H), 
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0.60 (q, J = 7.7 Hz, 6H), 0.09 (s, 6H), 0.08 (s, 3H), 0.04 ppm (s, 9H). MS (ESIpos) m/z (%): 965.6 (100 
(M+Na)). HRMS (ESIpos): m/z calcd for C48H98O8Si5Na: 965.6000, found: 965.6002. 
Acetate S33. PPh3 (24.2 mg, 92.1 μmol) was added to a solution of alcohol 120 (25.0 mg, 46.1 μmol) 
and acetic acid (5.3 μL, 92.1 μmol) in toluene (0.5 mL). The resulting mixture 
was stirred for 5 min and then cooled to 0 °C. DIAD (18.1 μL, 92.1 μmol) was 
added dropwise and the resulting mixture stirred at rt for 1 h. The mixture 
was diluted with hexanes (2 mL), washed with water (3 mL) and brine (3 mL), dried over Na2SO4, 
filtered and concentrated. The residue was purified by flash chromatography (hexanes/t-butyl 
methyl ether 19:1 to 9:1) to afford acetate S33 as a colorless oil (22.1 mg, 82%). [)]'
( = +28.4 
(c = 1.0, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 7.44–7.37 (m, 6H), 7.31–7.26 (m, 6H), 7.24–7.19 (m, 
3H), 5.52 (ddd, J = 5.1, 3.5, 1.5 Hz, 1H), 4.39 (dq, J = 4.4, 2.1 Hz, 1H), 4.31 (ddd, J = 7.4, 5.2, 3.4 Hz, 
1H), 4.15 (ddd, J = 8.6, 6.7, 5.0 Hz, 1H), 3.38 (dd, J = 8.9, 5.2 Hz, 1H), 3.14 (dd, J = 8.9, 7.5 Hz, 1H), 2.30 
(ddd, J = 13.9, 8.5, 5.1 Hz, 1H), 2.09 (ddd, J = 14.2, 6.7, 1.5 Hz, 1H), 1.84 (d, J = 2.2 Hz, 3H), 1.81 (s, 
3H), 0.90 (s, 9H), 0.13 (s, 3H), 0.10 ppm (s, 3H). 13C NMR (100 MHz, CDCl3): δ = 170.4, 143.9 (3C), 
128.8 (6C), 127.9 (6C), 127.1 (3C), 86.7, 81.8, 80.8, 80.3, 78.0, 74.4, 65.8, 61.4, 34.9, 26.0 (3C), 21.1, 
18.5, 3.8, –4.5, –4.8 ppm. IR (film): ṽ = 2927, 2855, 1741, 1491, 1448, 1373, 1242, 1183, 1076, 939, 
899, 837, 777, 747, 705, 650, 633 cm–1. MS (EI) m/z (%): 244 (20), 243 (100), 165 (19). HRMS (ESIpos): 
m/z calcd for C36H44O5SiNa: 607.2850, found: 607.2857.	 
Propargylic alcohol 150. TBAF (1.0 M in THF, 20.5 μL, 20.5 μmol) was added to a solution of 
acetate S33 (10.0 mg, 17.1 μmol) in THF (0.5 mL) at 0 °C. The resulting 
mixture was stirred for 60 min. The reaction was diluted with t-butyl methyl 
ether (2 mL), quenched with aq. sat. NH4Cl (2 mL) and the aqueous layer was 
extracted with t-butyl methyl ether (3 × 4 mL). The combined extracts were washed with brine 
(5 mL), dried over Na2SO4, filtered and concentrated. The residue was purified by flash 
chromatography (hexanes/t-butyl methyl ether 12:1 to 2:1) to afford the title compound 150 as a 
colorless oil (6.7 mg, 83%). [)]'
( = +58.1 (c = 1.0, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 7.43–7.37 (m, 
6H), 7.32–7.27 (m, 6H), 7.26–7.21 (m, 3H), 5.54 (td, J = 4.0, 2.3 Hz, 1H), 4.27 (ddd, J = 7.7, 5.2, 3.5 Hz, 
1H), 4.22 (tq, J = 4.4, 2.2 Hz, 1H), 4.17 (dt, J = 8.5, 6.6 Hz, 1H), 3.39 (dd, J = 9.0, 5.2 Hz, 1H), 3.18 (dd,  
J = 9.0, 7.6 Hz, 1H), 2.30 (d, J = 4.8 Hz, 1H), 2.20–2.09 (m, 2H), 1.84 (d, J = 2.1 Hz, 3H), 1.83 ppm (s, 
3H). 13C NMR (100 MHz, CDCl3): δ = 170.2, 143.8 (3C), 128.8 (6C), 127.9 (6C), 127.2 (3C), 86.8, 82.7, 
81.1, 80.4, 76.8, 74.2, 65.4, 61.2, 35.4, 21.0, 3.8 ppm. IR (film): ṽ = 3467, 3059, 3023, 2922, 2886, 
1739, 1491, 1448, 1374, 1239, 1076, 1022, 749, 706, 649, 633 cm–1. MS (EI) m/z (%): 244 (21), 243 
(100), 165 (27). HRMS (ESIpos): m/z calcd for C30H30O5Na: 493.1985, found: 493.1989. 
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Alkenylstannane 151. An aliquot of a stock solution of tributyltin hydride (0.07 M in CH2Cl2, 0.15 mL, 
10.0 μmol) was added dropwise over 2 h to a solution of [Cp*RuCl]4 
(0.5 mg, 2.0 μmol, 20 mol%) and propargylic alcohol 150 (4.5 mg, 
9.6 μmol) in CH2Cl2 (0.2 mL). The brown reaction mixture was 
immediately filtered through a short pad of silica, which was rinsed with CH2Cl2 (5 mL). All volatiles 
were removed in vacuo and the residue was purified by flash chromatography (hexanes/t-butyl 
methyl ether 19:1) to give the title compound 151 as a pale yellow oil (2.7 mg, 37%, r.r. > 20:1). 
[)]'
( = +69.4 (c = 0.25, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 7.44–7.38 (m, 6H), 7.32–7.27 (m, 6H), 
7.26–7.21 (m, 3H), 6.32 (q, J = 6.6 Hz, JSnH = 122 Hz, 1H), 5.51–5.44 (m, 1H), 4.22 (ddd, J = 7.2, 5.2, 3.6 
Hz, 1H), 4.05–3.83 (m, 2H), 3.37 (dd, J = 9.0, 5.3 Hz, 1H), 3.16 (dd, J = 9.0, 7.3 Hz, 1H), 2.46 (d, J = 1.5 
Hz, 1H), 1.99–1.85 (m, 2H), 1.82 (s, 3H), 1.74 (d, J = 6.5 Hz, 3H), 1.51–1.39 (m, 6H), 1.36–1.23 (m, 6H), 
1.00–0.89 (m, 6H), 0.86 ppm (t, J = 7.3 Hz, 9H). 13C NMR (100 MHz, CDCl3): δ = 170.2, 144.5, 143.9 
(3C), 138.4, 128.8 (6C), 127.9 (6C), 127.2 (3C), 86.8, 83.6, 81.1, 79.7, 74.5, 61.4, 35.9, 29.3 (3C), 27.5 
(3C), 21.0, 19.6, 13.8 (3C), 11.3 ppm (3C). 119Sn NMR (150 MHz, CDCl3): δ = –52.7 ppm. IR (film):  
ṽ = 3481, 2954, 2925, 2870, 2853, 1743, 1491, 1449, 1374, 1232, 1076, 1021, 937, 746, 705,  
633 cm–1. MS (EI) m/z (%): 244 (20), 243 (100), 165 (10). HRMS (ESIpos): m/z calcd for C42H58O5SnNa: 
785.3198, found: 785.3206. 
Alkenylstannane 152. An aliquot of a stock solution of tributyltin hydride (0.07 M in CH2Cl2, 0.57 mL, 
38.0 μmol) was added dropwise over 2 h to a solution of [Cp*RuCl]4 
(1.8 mg, 7.2 μmol, 20 mol%) and propargylic alcohol 59 (15 mg, 36.2 μmol) 
in CH2Cl2 (0.5 mL). The brown reaction mixture was immediately filtered 
through a short pad of silica, which was rinsed with CH2Cl2 (5 mL). All volatiles were removed in 
vacuo and the residue was purified by flash chromatography (hexanes/t-butyl methyl ether 25:1) to 
give the title compound 152 as a pale yellow oil (11 mg, 43%, r.r. 97:3). [)]'
( = –10.2 (c = 1.0, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 6.32 (q, J = 6.6 Hz, JSnH = 126 Hz, 1H), 4.30 (dt, J = 6.4, 3.3 Hz, 1H), 4.14 
(d, J = 7.2 Hz, 1H), 3.93–3.85 (m, 2H), 3.61 (dd, J = 10.8, 4.2 Hz, 1H), 3.51 (dd, J = 10.8, 5.5 Hz, 1H), 
3.00 (d, J = 1.5 Hz, 1H), 2.09 (ddd, J = 13.1, 8.2, 6.3 Hz, 1H), 1.74 (d, J = 6.6 Hz, 3H), 1.78–1.67 (m, 1H), 
1.56–1.40 (m, 6H), 1.36–1.28 (m, 6H), 1.00–0.92 (m, 24H), 0.89 (t, J = 7.3 Hz, 9H), 0.60 (q, J = 7.9 Hz, 
6H), 0.59 ppm (q, J = 7.9 Hz, 6H). 13C NMR (100 MHz, CDCl3): δ = 145.9, 137.6, 87.0, 83.2, 82.8, 73.5, 
63.4, 37.2, 29.4 (3C), 27.6 (3C), 19.5, 13.9 (3C), 11.5 (3C), 6.89 (3C), 6.88 (3C), 4.8 (3C), 4.6 ppm (3C). 
119Sn NMR (150 MHz, CDCl3): δ = –54.4 ppm. IR (film): ṽ = 3446, 2955, 2914, 2876, 1622, 1459, 1415, 
1376, 1239, 1111, 1076, 1004, 831, 744, 671, 593 cm–1. MS (EI) m/z (%): 653 (17), 651 (26), 650 (40), 
649 (100), 648 (51), 647 (75), 646 (35), 645 (37), 517 (11), 407 (24), 405 (18), 403 (11), 355 (12), 251 
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(15), 249 (11), 177 (11), 117 (20), 115 (21), 87 (17). HRMS (ESIpos): m/z calcd for C33H70O4Si2SnNa: 
729.3726, found: 729.3727. 
Alkenylsilane 155. Benzyl dimethyl silane (4.6 μL, 29 μmol) was added to a solution of [Cp*RuCl]4 
(0.7 mg, 2.4 μmol, 10 mol%) and propargylic alcohol 59 (10.0 mg, 24.1 μmol) 
in CH2Cl2 (0.15 mL). The resulting solution was stirred at rt for 10 min before 
all volatiles were removed in vacuo. The residue was purified by flash 
chromatography (hexanes/t-butyl methyl ether 15:1) to yield the title compound 155 as a pale yellow 
oil (11 mg, 81%, r.r. 9:1). [)]'
( = –32.4 (c = 0.5, CHCl3). 
1H NMR (500 MHz, CDCl3): δ = 7.22–7.17 (m, 
2H), 7.09–7.04 (m, 1H), 7.03–6.99 (m, 2H), 6.07 (dq, J = 9.4, 1.6 Hz, 1H), 4.36 (dt, J = 6.1, 3.0 Hz, 1H), 
4.10 (ddd, J = 9.4, 4.7, 2.6 Hz, 1H), 3.98–3.89 (m, 2H), 3.62 (dd, J = 10.7, 4.3 Hz, 1H), 3.48 (dd, J = 10.8, 
6.1 Hz, 1H), 3.30 (d, J = 2.6 Hz, 1H), 2.28–2.19 (m, 3H), 1.77 (d, J = 1.6 Hz, 3H), 1.71 (ddd, J = 13.3, 4.9, 
3.3 Hz, 1H), 0.96 (t, J = 7.9 Hz, 9H), 0.95 (t, J = 7.9 Hz, 9H), 0.62 (q, J = 9.5, 8.7 Hz, 6H), 0.60 (q, J = 7.8 
Hz, 6H), 0.15 (s, 3H), 0.12 ppm (s, 3H). 13C NMR (125 MHz, CDCl3): δ = 142.0, 140.1, 139.0, 128.4 (2C), 
128.2 (2C), 124.2, 87.3, 82.5, 73.4, 72.9, 63.2, 37.5, 26.3, 25.3, 6.88 (3C), 6.85 (3C), 4.7 (3C), 4.5 (3C), 
–1.6, –1.7 ppm. IR (film): ṽ = 3443, 2954, 2911, 2877, 1601, 1493, 1456, 1414, 1248, 1110, 1005, 831, 
792, 744, 699 cm–1. MS (EI) m/z (%): 473 (21), 323 (19), 213 (14), 209 (18), 191 (15), 153 (29), 149 
(18), 145 (64), 131 (12), 118 (11), 117 (100), 115 (34), 87 (23), 75 (11). HRMS (ESIpos): m/z calcd for 
C30H56O4Si3Na: 587.3379, found: 587.3378. 
Dienylsilane 157. An aliquot of a stock solution of benzyl dimethyl silane (1 M in CH2Cl2, 5.3 μL, 
5.3 μmol) was added to a solution of [Cp*RuCl]4 (4.2 mg, 15.3 μmol) and 
enyne 142 (4.0 mg, 5.1 μmol) in CH2Cl2 (0.2 mL). The resulting dark brown 
solution was stirred for 2 h at rt before all volatiles were removed in vacuo. 
The residue was purified by flash chromatography (hexanes/t-butyl methyl 
ether 4:1 to 3:1) to yield the title compound β-157 as a pale yellow oil 
(1.2 mg, 25%). [)]'
( = –23.8 (c = 0.08, CHCl3). 
1H NMR (600 MHz, CDCl3): 
see Table 4.6. 13C NMR (150 MHz, CDCl3): see Table 4.6. IR (film): ṽ = 3537, 
2954, 2927, 2855, 1743, 1462, 1373, 1249, 1093, 1058, 1005, 947, 833, 776, 699 cm–1. MS (ESIpos) 
m/z (%): 952.6 (100 (M+NH4)). HRMS (ESIpos): m/z calcd for C48H86O10Si4Na: 957.5190, found: 
957.5196. 
  
192  EXPERIMENTAL SECTION  
   
 
Table 4.6. 1H and 13C NMR data of 157 (1.2 mg in 0.25 mL CDCl3); chagosensine numbering.* 
atom 
n° 
1H NMR (600 MHz, CDCl3) 
13C NMR (150 MHz, CDCl3) 
δ [ppm] m J [Hz] COSY NOESY δ [ppm] HMBC 
1 - - - - - 173.2 20 
2 3.98 d 9.1 3 (3), 4b, 23 82.9 (3), 4a, 23 
3 2.39 ddq 11.4, 9.0, 6.5 2, 4(a)b, 23 (2), 4a, (5), 23 39.8 2, 4b, 23 
4a 
4b 
1.97 
1.69 
ddd 
q 
11.4, 6.5, 5.3 
11.4 
(3), 4b, 5 
3, 4a, 5 
3, 4b, 5 
(2), 4a, (6), 7, 23 
36.9 23 
5 4.36 ddd 10.7, 5.3, 2.0 4(a)b 3, 4a, 6, 7, 7-TBS 80.9 (6), 7, 4b 
6 3.42 dd 7.7, 2.0 7 5, 7, 8, 6-TBS 76.3 4b, 5 
7 5.01 ddd 9.7, 7.7, 1.0 6,8 5, 6, 11, 12-OH 69.0 6, 9 
8 5.35 dd 11.4, 9.7 7,9 (6), 9, 6-TBS 132.3 7 
9 6.02 ddd 11.4, 1.2, 1.0 8 21, 22, 6-TBS 134.3 7, 11 
10 - - - - - 138.8 8, 21, 22  
11 6.55 dd 10.1, 1.4 12 7, 12-OH, 13 145.0 9, 12-OH 
12 4.05 ddd 10.0, 7.8, 4.6 11, 12-OH 21, 22, (24) 72.8 12-OH, 14a 
12-OH 2.67 d 7.8 12 11 - - 
13 4.01 m - 14 11, 12-OH, 15  81.2 11, 12-OH 
14a 
14b 
2.00 
1.91 
ddd 
ddd 
14.0, 9.4, 4.8 
13.8, 6.2, 1.5 
13, 14b, 15 
13, 14a, 15 
(12), (13), 15 
13, (15) 
35.2 - 
15 5.38 ddd 5.0, 3.8, 1.5 14a(b) 2, 14a, 6-TBS 74.2 14b, 17b 
16 4.01 m - 17 6-TBS, 15, 17-TBS 81.4 14, 17 
17a 
17b 
3.74 
3.70 
m 
m 
- 
- 
17b 
17a 
16, 17b 
15, 16 
60.8 - 
18 - - - - - 170.2 19 
19 2.07 s - - 20 21.3 - 
20 3.73 s - - - 52.0 - 
21 0.21 s - - 26, 9, 12 –0.9 22, 24a 
22 0.072 s - - 26, 9, 24, 6-TBS –1.5 21, 24b 
23 1.21 d 6.6 3 2, 3, 4b, 6-TBS 17.5 2, 4b 
24a 
24b 
2.28 
2.21 
d 
d 
13.7 
13.7 
24b 
24a 
12, 21, 22, 26 
9, (12), 21, 22, 26 
26.8 21, 22, 26 
25 - - - - - 139.7 24ab, 27 
26 6.98 d 7.0 27 21, 22, 24ab, 27 128.5 21, 22, 28 
27 7.19 dd 8.3, 7.0 26, 28 26, 28 128.3 24ab, 28 
28 7.07 t 7.4 (26), 27 27 124.4 26, (27) 
* The C10-C11 double bond geometry can be unambiguously assigned as trans from NOESY 
experiments and 29Si-HR-HMBC measurements: 1H NMR (500 MHz, CDCl3): δ = 6.55 (
3
JSiH = 14.5 Hz,  
H-11). The signals of the TBS groups are not listed and appear as follows: 1H NMR (600 MHz, CDCl3): 
δ = 0.89 (s, 9H), 0.86 (s, 9H), 0.85 (s, 9H), 0.07 (s, 3H), 0.06 (s, 3H), 0.05 (s, 3H), 0.03 (s, 3H), 0.02 (s, 
3H), 0.01 ppm (s, 3H). 13C NMR (150 MHz, CDCl3): δ = 26.4 (3C), 26.1 (3C), 25.9 (3C), 18.4, 18.3, 18.2, 
–2.8, –3.7, –3.8, –4.6, –5.3, –5.4 ppm. 
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Dienylstannane 158. BEt3 (1 M in hexane, 0.3 μL, 0.3 μmol) was added to a mixture of enyne 142 
(2.5 mg, 3.2 μmol) and Ph3SnH (3.3 mg, 9.6 μmol) in toluene (0.2 mL). 
The resulting mixture was stirred for 5 min, before air (2 mL) was 
pumped into the reaction via syringe. The resulting mixture was stirred 
at rt overnight, then diluted with t-butyl methyl ether (2 mL) and water 
(1 mL). The aqueous layer was separated and extracted with t-butyl 
methyl ether (3 × 2 mL). The combined extracts were dried over 
Na2SO4, filtered and concentrated. The residue was purified by flash chromatography (hexanes/ 
t-butyl methyl ether 25:1 to 9:1) to yield the title compound 158 as a pale yellow oil (2.1 mg, 58%). 
[)]'
( = +4.0 (c = 0.25, CHCl3). 
1H NMR (600 MHz, CDCl3): see Table 4.7.
 13C NMR (150 MHz, CDCl3): see 
Table 4.7. IR (film): ṽ = 3528, 2955, 2928, 2894, 2856, 1742, 1471, 1429, 1373, 1253, 1094, 1073, 
1022, 967, 835, 777, 729, 699 cm–1. MS (ESIpos) m/z (%): 1159.5 (100 (M+Na)). HRMS (ESIpos): m/z 
calcd for C57H88O10Si3SnNa: 1159.4599, found: 1159.4607. 
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Table 4.7. 1H and 13C NMR data of 158 (2.1 mg in 0.25 mL CDCl3); chagosensine numbering.* 
atom 
n° 
1H NMR (600 MHz, CDCl3) 
13C NMR (150 MHz, CDCl3) 
δ [ppm] m J [Hz] COSY NOESY δ [ppm] HMBC 
1 - - - - - 173.4 20 
2 3.78 d 8.9 3 4a, (6), 23 82.4 4b, 23 
3 2.10 m - 2, 4, 23 4a, (5), 23, 24, 25 39.8 2, 4a, 23 
4a 
4b 
1.29 
0.86 
ddd 
m 
11.6, 7.0, 5.6 
- 
3, 4b, (5) 
3, 4a, 5 
3, 4b, 5, (7), 23 
(2), 4a, 6, 7 
37.2 23 
5 3.63 ddd 10.3, 7.9, 5.5 4a(b), 6 3, 4b, (6) 81.6 (3), 4a, 6 
6 3.38 dd 7.8, 2.2 5 4a, 6-TBS, 7 80.8 4a, (7) 
7 3.51 dd 8.5, 2.2 8 5, 6, 7-TBS 75.3 (5), 6, 9 
8 5.82 dd 15.2, 8.5 7,9 (5), 7, 10, 6-TBS 137.7 6, (7), 10 
9 6.00 dd 15.2, 10.7 8, 10 7, 22, 7-TBS 130.8 7, (10) 
10 6.99 d 10.6 9 8, 12, (13), (22) 143.0 8, (9)  
11 - - - - - 146.9 9, (10) 
12 4.22 t 5.3 13, 16 12-OH, 14a, 22 81.4 10, (14a) 
12-OH 2.40 d 5.4 12 12, 22 - - 
13 4.11 ddd 9.6, 6.0, 5.6 12, 14 10, 14a, 22  81.8 (14a) 
14a 
14b 
2.02 
1.93 
m 
ddd 
- 
13.9, 6.2, 1.6 
13, 14b, 15 
13, 14a 
(12), 14b, 15 
13, 14a, (15) 
35.4 - 
15 5.34 ddd 5.2, 4.0, 1.6 14a, 16 14a(b), 16 74.0 14b, 17 
16 3.81 ddd 7.5, 5.5, 3.9 15, 17 15, 17, (19), (22) 81.2 14, 17 
17a 
17b 
3.55 
3.45 
dd 
dd 
10.1, 7.4 
10.1, 5.5 
16, 17b 
16, 17a 
(16), 17b 
16, 17a, 17-TBS 
60.9 - 
18 - - - - - 170.2 19 
19 2.02 s - - 12, 16, 17-TBS 21.2 - 
20 3.76 s - - (3), 4b 51.9 - 
21 - - - - - 140.0 22, 24, 25 
22 7.56 m - 24, 25 9, 13, 17b, 24, 25 137.2 24, 25 
23 1.07 d 6.6 3 2, 3, 4b, 24, 25 17.3 2, 4a 
24 7.33 m - 22 (3), 22, 23, 7-TBS 128.7 22 
25 7.33 m - 22 (3), 22, 23, 7-TBS 128.9 22 
* The C10-C11 double bond geometry can be unambiguously assigned as trans from NOESY 
experiments and tin-proton coupling: 1H NMR (600 MHz, CDCl3): δ = 6.99 (
3
JSnH = 148 Hz, H-10), 6.00 
(4JSnH = 7.5 Hz, H-9), 5.82 (
5
JSnH = 3.5 Hz, H-8). The signals of the TBS groups are not listed and appear 
as follows: 1H NMR (600 MHz, CDCl3): δ = 0.88 (s, 9H), 0.83 (s, 9H), 0.75 (s, 9H), 0.04 (s, 3H), 0.00 (s, 
3H), –0.226 (s, 3H), –0.231 (s, 3H), –0.02 (s, 3H), –0.03 ppm (s, 3H). 13C NMR (150 MHz, CDCl3): 
δ = 26.3 (3C), 26.1 (3C), 25.9 (3C), 18.7, 18.34, 18.28, –4.1, –4.2, –4.57, –4.64, –5.3, –5.4 ppm. 
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4.3.9 Synthesis of the Macrolactone 174 
Bis-stannane 160. A solution of 1-octin-3-ol (58 μL, 0.4 mmol) in THF (1 mL) was added to a solution 
of Pd(t-BuNC)2Cl2 (14 mg, 40 μmol, 10 mol%) in THF (1 mL). Hexabutylditin 
(0.22 mL, 0.44 mmol) was added in one portion and the resulting mixture 
stirred at rt for 7 h. The solvent was evaporated and the residue purified by 
flash chromatography (hexanes/Et3N 200:1) to yield the bis-stannane 160 as a yellow oil (239 mg, 
85%). 1H NMR (300 MHz, CDCl3): δ = 6.73 (d, J = 1.2 Hz, JSnH = 179, 66.8 Hz, 1H), 4.05 (tdd, J = 6.5, 3.6, 
1.1 Hz, 1H), 2.52 (q, J = 7.2 Hz, 1H), 1.52–1.44 (m, 15H), 1.37–1.30 (m, 17H), 1.03 (t, J = 7.2 Hz, 3H), 
0.92–0.87 (m, 12H), 0.90 (t, J = 7.2 Hz, 9H), 0.89 ppm (t, J = 7.2 Hz, 9H). 13C NMR (75 MHz, CDCl3):  
δ = 172.0, 140.3, 84.0, 37.3, 32.0, 29.5 (3C), 29.3 (3C), 27.8 (3C), 27.6 (3C), 25.7, 22.8, 14.2, 13.8 (6C), 
11.3 (3C), 11.0 ppm (3C). 119Sn NMR (112 MHz, CDCl3): δ = –60.5, –65.5 ppm. IR (film): ṽ = 3464, 2955, 
2921, 2871, 2854, 1463, 1376, 1340 1291, 1071, 1021, 961, 863, 826, 666, 594 cm–1. MS (ESIpos) m/z 
(%): 731.3 (100 (M+Na)). HRMS (ESIpos): m/z calcd for C32H68OSn2Na: 731.3205, found: 731.3212.	 
Dienylstannane 162. DMF was degassed by three freeze-pump-thaw cycles prior to use. Tetrabutyl-
ammonium diphenylphosphinate (52.1 mg, 11.3 mmol) was placed in a 
Schlenk tube, which was evacuated and flame-dried. A solution of bis-
stannane 160 (50.0 mg, 70.8 μmol) in degassed DMF (0.5 mL) was added, 
followed by Pd(PPh3)4 (16.4 mg, 14.2 μmol). The resulting mixture was stirred 
at rt for 5 min before CuTC (20.2 mg, 106 μmol) was introduced, followed by a solution of ethyl 3-cis-
iodoacrylate (17.0 mg, 76.3 μmol) in degassed DMF (0.5 mL). The resulting mixture was stirred at rt 
for 1 h before the reaction was quenched with water (3 mL). The aqueous layer was separated and 
extracted with t-butyl methyl ether (3 × 5 mL). The combined extracts were dried over Na2SO4, 
filtered and concentrated. The residue was purified by flash chromatography (hexanes/t-butyl 
methyl ether/Et3N 95:5:0.5) to yield the title compound 162 as a colorless oil (21.5 mg, 59%). 
1H NMR 
(300 MHz, CDCl3): δ = 7.94 (d, J = 11.5 Hz, JSnH = 113 Hz, 1H), 6.57 (t, J = 11.4 Hz, 1H), 5.70 (dd,  
J = 11.3, 1.1 Hz, 1H), 4.32 (t, J = 6.2 Hz, 1H), 4.19 (q, J = 7.1 Hz, 2H), 1.61 (brs, 1H), 1.52–1.44 (m, 6H), 
1.40–1.22 (m, 18H), 1.05–0.97 (m, 5H), 0.89 ppm (t, J = 7.2 Hz, 12H). 13C NMR (75 MHz, CDCl3):  
δ = 166.4, 144.9, 134.7, 130.2, 117.9, 79.9, 60.2, 37.5, 31.9, 29.3 (3C), 27.5 (3C), 25.6, 22.8, 14.5, 
1.45, 13.8 (3C), 11.8 ppm (3C). 119Sn NMR (112 MHz, CDCl3): δ = –53.6 ppm. IR (film): ṽ = 3483, 2956, 
2925, 2855, 1716, 1613, 1561, 1463, 1179, 1027, 821, 671, 596 cm–1. MS (ESIpos) m/z (%): 539.3 (100 
(M+Na)). HRMS (ESIpos): m/z calcd for C25H48O3SnNa: 539.2517, found: 539.2522.  
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Bis-stannane 163. A solution of alkyne 123 (24 mg, 73 μmol) in THF (0.2 mL) was added to a solution 
of Pd(t-BuNC)2Cl2 (5.0 mg, 15 μmol, 20 mol%) in THF (0.2 mL). 
Hexabutylditin (41 μL, 80 μmol) was added in one portion and the 
resulting mixture was stirred at rt for 14 h. The solvent was evaporated 
and the residue purified by flash chromatography (hexanes/t-butyl methyl ether/Et3N 50:1:0.5) to 
yield the bis-stannane 163 as a colorless oil (50 mg, 75%). [)]'
( = +15.8 (c = 1.0, CHCl3). 
1H NMR (400 
MHz, C6D6): δ = 7.02 (d, J = 1.2 Hz, JSnH = 177, 67.4 Hz, 1H), 5.42 (ddd, J = 5.3, 3.6, 1.6 Hz, 1H),  
4.33–4.26 (m, 1H), 4.02–3.89 (m, 2H), 3.85–3.79 (m, 2H), 2.77 (brs, 1H), 2.01 (ddd, J = 14.0, 6.4, 1.6 
Hz, 1H), 1.90–1.82 (m, 1H), 1.79–1.70 (m, 6H), 1.68 (s, 3H), 1.70–1.62 (m, 6H), 1.54–1.39 (m, 12H), 
1.27–1.19 (m, 6H), 1.18–1.10 (m, 6H), 1.03–0.97 (m, 18H), 0.97 (s, 9H), 0.07 (s, 3H), 0.05 ppm (s, 3H). 
13C NMR (100 MHz, C6D6): δ = 169.7, 169.2, 144.2, 87.8, 81.6, 81.1, 74.5, 61.6, 36.0, 29.9 (3C), 29.8 
(3C), 28.1 (3C), 27.9 (3C), 26.0 (3C), 20.6, 18.5, 14.04 (3C), 14.02 (3C), 12.1 (3C), 11.5 (3C), –5.2, –5.3 
ppm. 119Sn NMR (150 MHz, C6D6): δ = –59.3, –67.3 ppm. IR (film): ṽ = 3498, 2955, 2925, 2855, 1746, 
1463, 1375, 1232, 1071, 938, 837, 777, 667, 595 cm–1. MS (ESIpos) m/z (%): 933.4 (100 (M+Na)). 
HRMS (ESIpos): m/z calcd for C40H82O5SiSn2Na: 933.3866, found: 933.3874.	 
Dienylstannane 168. DMF was carefully degassed by three freeze-pump-thaw cycles prior to use. 
Tetrabutylammonium diphenylphosphinate (23.3 mg, 50.7 μmol) was 
placed in a Schlenk tube, evacuated and flame-dried. A solution of bis-
stannane 163 (41.9 mg, 46.1 μmol) in degassed DMF (0.7 mL) was added, 
followed by Pd(PPh3)4 (21.3 mg, 18.4 μmol, 40 mol%). The resulting 
mixture was stirred at rt for 5 min before CuTC (9.2 mg, 48 μmol) was 
introduced, followed by a solution of vinyl iodide 139 (10.4 mg, 46.1 μmol) in degassed DMF (0.5 mL). 
The resulting mixture was stirred at rt for 30 min before the reaction was quenched with water 
(3 mL). The aqueous layer was separated and extracted with t-butyl methyl ether (3 × 5 mL). The 
combined extracts were dried over Na2SO4, filtered and concentrated. The residue was purified by 
flash chromatography (hexanes/t-butyl methyl ether 9:1 to 4:1) to yield the title compound 168 
(16.2 mg, 40%) and its regioisomer 169 (9.7 mg, 24%) as a colorless oil each; 169 was fully 
characterized at the more stable vinyl chloride stage 171 (vide infra). [)]'
( = +32.0 (c = 0.25, CHCl3). 
1H NMR (400 MHz, CD2Cl2): δ = 7.03 (d, J = 11.4 Hz, JSnH = 111 Hz, 1H), 6.17 (td, J = 11.2, 1.0 Hz, 1H), 
5.59 (t, J = 10.5 Hz, 1H), 5.37 (ddd, J = 5.6, 3.8, 1.9 Hz, 1H), 5.10 (dd, J = 9.7, 5.5 Hz, 1H),  
4.13–4.01 (m, 5H), 3.99 (d, J = 7.9 Hz, 1H), 3.74 (d, J = 6.1 Hz, 2H), 3.71 (s, 3H), 2.62 (d, J = 2.1 Hz, 1H), 
2.31 (dq, J = 10.0, 7.4 Hz, 1H), 2.08–2.04 (m, 1H), 2.03 (s, 3H), 1.99–1.87 (m, 2H), 1.52–1.45 (m, 6H), 
1.49 (s, 3H), 1.38 (s, 3H), 1.35–1.28 (m, 9H), 1.25–1.21 (m, 1H), 1.16 (d, J = 6.6 Hz, 3H), 1.03–0.98 (m, 
6H), 0.91–0.89 (m, 6H), 0.88 (s, 9H), 0.06 (s, 3H), 0.05 ppm (s, 3H). 13C NMR (100 MHz, CD2Cl2):  
O
H
OTBS
H
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δ = 173.4, 170.3, 154.9, 135.2, 132.4, 128.5, 109.7, 83.8, 83.5, 81.7, 81.4, 81.2, 79.5, 74.5, 73.0, 61.6, 
52.1, 39.8, 37.5, 36.0, 29.5 (3C), 28.0, 27.7 (3C), 26.0 (3C), 25.8, 21.2, 18.5, 18.1, 13.9 (3C), 12.0 (3C), 
–5.3, –5.4 ppm. IR (film): ṽ = 3507, 2957, 2928, 2856, 1743, 1462, 1375, 1259, 1093, 1020, 799 cm–1. 
MS (ESIpos) m/z (%): 911.4 (100 (M+Na)). HRMS (ESIpos): m/z calcd for C42H76O10SiSnNa: 911.4121, 
found: 911.4119. 
(Z,Z)-Chlorodiene 170. A solution of dienylstannane 168 (16.2 mg, 18.2 μmol) in THF (0.25 mL) was 
added to a suspension of CuCl2 (12.3 mg, 91.2 μmol) in THF (0.25 mL).  
2,6-Lutidine (5.3 μL, 45.6 μmol) was added and the resulting mixture was 
stirred at rt for 24 h. The reaction was diluted with t-butyl methyl ether 
(2.5 mL) and quenched with aq. sat. NaHCO3 (3 mL). The aqueous layer was 
separated and extracted with t-butyl methyl ether (3 × 5 mL). The combined 
extracts were dried over Na2SO4, filtered and concentrated. The residue was purified by flash 
chromatography (hexane/t-butyl methyl ether 5:1 to 2:1) to yield the title compound 170 as a 
colorless oil (8.1 mg, 70%). [)]'
( = +8.2 (c = 0.44, CHCl3). 
1H NMR (600 MHz, CDCl3): see Table 4.8. 
13C NMR (150 MHz, CDCl3): see Table 4.8. IR (film): ṽ = 3397, 2960, 2926, 2854, 1740, 1669, 1456, 
1377, 1260, 1091, 1019, 798 cm–1. MS (ESIpos) m/z (%): 655.3 (100 (M+Na)). HRMS (ESIpos): m/z 
calcd for C30H49O10ClSiNa: 655.2676, found: 655.2672. 
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Table 4.8. 1H and 13C NMR data of 170 (1.0 mg in 0.25 mL CDCl3); chagosensine numbering.* 
atom 
n° 
1H NMR (600 MHz, CDCl3) 
13C NMR (150 MHz, CDCl3) 
δ [ppm] m J [Hz] COSY NOESY δ [ppm] HMBC 
1 - - - - - 173.4 (2), (3), 23 
2 4.05 d 7.8 3 4b, 23 83.8 (4a), 23 
3 2.37 dq 9.9, 6.9 2, 4, 23 2, 5, 19, 23, (24) 39.6 2, 23 
4a 
4b 
2.06 
1.28 
m 
m 
- 
- 
(3), 4b, 5 
3, 4a, 5 
3, 4b, 5, (23) 
2, 4a, (5), 6, (7) 
37.2 23 
5 4.17 dt 9.8, 6.2 4a(b), 6 3, 4a(b), 8,  79.14 4b, (7) 
6 4.10 m - 5, 7 4b, 7, 15, 22  80.8 4b 
7 5.00 dd 9.8, 6.4 8 6, 8, 10, 22 73.2 9 
8 5.81 dd 11.0, 9.8 7,9 5, (7), 21 130.4 6, 10 
9 6.57 t 11.0 8, 10 8 126.5 7 
10 6.74 d 11.0 9 2, 12, (13), 21 121.0 8 
11 - - - - - 136.5 9, 10, (13) 
12 4.08 t 4.6 12-OH, 13 10, 13, 14, 21 77.5 10 
12-OH 2.84 d 4.6 12 - - - 
13 4.41 ddd 8.4, 7.0, 5.6 12, 14 12, 14, 21 79.06 12, 14a 
14a 
14b 
2.08 m - 13, 15 12, 15 35.8 - 
15 5.43 ddd 5.6, 5.1, 2.6 14, (16) 14, 16, 17, 19 74.1 (14), 17 
16 4.10 m - 15, 17 4b, 7, 15, (22) 82.0 17 
17a 
17b 
3.75 d 6.4 16 15, 16, 17-TBS 61.2 - 
18 - - - - - 170.2 19 
19 2.07 s - - (23), 17-TBS 21.2 - 
20 - - - - - 110.0 21, 22 
21 1.53 s - 22 (2), 8, 22 27.8 - 
22 1.41 s - 21 6, 7, 21 25.8 - 
23 1.19 d 6.6 3 2, 3, 4a, (19), (24) 18.2 2 
24 3.73 s - - 2 52.1 - 
 
* The signals of the TBS group are not listed and appear as follows: 1H NMR (600 MHz, CDCl3): 
δ = 0.87 (s, 9H), 0.05 (s, 3H), 0.04 ppm (s, 3H). 13C NMR (150 MHz, CDCl3): δ = 25.9 (3C), 18.4, –5.2,  
–5.3 ppm. 
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Chlorodiene 171. Prepared analogously from the corresponding dienylstannane 169 and obtained as 
a colorless oil (3.5 mg, 51%).	[)]'
( = –18.3 (c = 0.06, CHCl3). 
1H NMR 
(600 MHz, CDCl3): see Table 4.9. 
13C NMR (150 MHz, CDCl3): see Table 
4.9. IR (film): ṽ = 3433, 2959, 2926, 2873, 2855, 1736, 1439, 1373, 
1258, 1183, 1069, 1047, 798, 758 cm–1. MS (ESIpos) m/z (%): 655.3 
(100 (M+Na)). HRMS (ESIpos): m/z calcd for C30H49O10ClSiNa: 
655.2676, found: 655.2672. 
Table 4.9. 1H and 13C NMR data of 171 (1.0 mg in 0.25 mL CDCl3); chagosensine numbering.* 
atom 
n° 
1H NMR (600 MHz, CDCl3) 
13C NMR (150 MHz, CDCl3) 
δ [ppm] m J [Hz] COSY NOESY δ [ppm] HMBC 
1 - - - - - 173.6 (2), 24 
2 4.05 d 7.8 3 14, 21, 23, 24 83.8 (4a), 23 
3 2.35 dq 9.8, 7.1 4, 23 2, 4a, 5, 23 39.5 2, 23 
4a 
4b 
2.14 
1.49 
ddd 
ddd 
12.1, 7.4, 6.1 
12.1, 9.9, 9.9 
(3), 4b 
3, 4a 
3, 4b, 5 
4a, (5), 6, 23 
37.1 23 
5 4.25 ddd 9.8, 5.8, 4.6 4, 6 3, 4a(b), 6, 8  79.2 4b, (2) 
6 4.13 dd 6.4, 4.5 5, 7 4b, 5, 7, 22  79.3 5, 21 
7 4.72 dd 9.9, 6.6 6, 8 6, (8), 12, 22 73.8 9 
8 6.05 dd 11.5, 9.9 7,9 5, (7), 21 131.3 9 
9 6.13 dd 11.6, 1.5 8 13 127.6 11 
10 - - - - - 137.9 8, 11 
11 6.38 dd 1.5, 0.8 - 12, 12-OH 119.5 9 
12 4.07 m - 12-OH 7, 11, 12-OH, 14 77.1 11 
12-OH 2.67 d 4.1 12 (11), 12, (13) - - 
13 4.16 ddd 9.2, 6.4, 6.4 12, 14 9, (11), 12, 14   80.2 14a 
14a 
14b 
2.07 
1.97 
ddd 
ddd 
14.1, 6.4, 1.4 
14.1, 9.2, 5.0 
14b 
14a 
13 
12, 15 
35.4 - 
15 5.38 ddd 5.0, 3.6, 1.2 14, (16) 14, 16, 17 74.4 14, 17 
16 4.06 td 6.4, 3.7 15, 17 14b, 15, 17 81.7 14, 17 
17a 
17b 
3.74 m - 16 15, 16, 17-TBS 61.1 - 
18 - - - - - 170.2 19 
19 2.05 s - - (12), 15, 17-TBS 21.2 - 
20 - - - - - 109.4 21, 22 
21 1.48 s - 22 2, 6, (5), 22 27.5 - 
22 1.35 s - 21 6, 7, 21 25.6 21 
23 1.18 d 6.8 3 2, 3, 4a 18.0 2 
24 3.73 s - - 2 52.0 - 
 
* The signals of the TBS group are not listed and appear as follows: 1H NMR (600 MHz, CDCl3): 
δ = 0.87 (s, 9H), 0.05 (s, 3H), 0.04 ppm (s, 3H). 13C NMR (150 MHz, CDCl3): δ = 25.9 (3C), 18.4, –5.2,  
–5.3 ppm. 
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(Z,Z)-Chlorodiene 172. 2,6-Lutidine (6.8 μL, 59 μmol) and TBSOTf (9.3 μL, 40.5 μmol) were 
sequentially added to a solution of alcohol 170 (5.7 mg, 9.0 μmol) in CH2Cl2 
(0.2 mL) at 0 °C. The resulting mixture was stirred at rt for 30 h. The reaction 
was diluted with t-butyl methyl ether (3 mL) and quenched with pH 7 
phosphate buffer (3 mL). The aqueous layer was separated and extracted 
with t-butyl methyl ether (3 × 5 mL). The combined extracts were washed 
with brine (10 mL), dried over Na2SO4, filtered and concentrated. The residue was purified by flash 
chromatography (hexane/t-butyl methyl ether 6:1 to 4:1) to yield the title compound 172 as a 
colorless oil (5.6 mg, 83%). [)]'
( = +4.8 (c = 0.5, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 6.68 (d,  
J = 11.1 Hz, 1H), 6.55 (td, J = 11.0, 1.1 Hz, 1H), 5.77 (ddd, J = 10.8, 9.6, 1.0 Hz, 1H), 5.36 (ddd, J = 5.2, 
3.6, 1.8 Hz, 1H), 4.99 (ddd, J = 9.6, 6.4, 1.1 Hz, 1H), 4.36 (ddd, J = 8.6, 6.9, 4.5 Hz, 1H), 4.17 (dt, J = 9.6, 
6.1 Hz, 1H), 4.13–4.07 (m, 2H), 4.05 (d, J = 7.7 Hz, 1H), 4.02 (dd, J = 6.8, 3.4 Hz, 1H), 3.73 (s, 3H),  
3.73–3.70 (m, 2H), 2.37 (dq, J = 9.5, 7.1 Hz, 1H), 2.13–2.06 (m, 2H), 2.05 (s, 3H), 2.03–1.98 (m, 1H), 
1.53 (s, 3H), 1.39 (s, 3H), 1.30–1.27 (m, 1H), 1.18 (d, J = 6.6 Hz, 3H), 0.92 (s, 9H), 0.86 (s, 9H), 0.09 (s, 
3H), 0.05 (s, 3H), 0.033 (s, 3H), 0.027 ppm (s, 3H). 13C NMR (100 MHz, CDCl3): δ = 173.4, 170.4, 137.5, 
129.6, 126.7, 120.5, 109.8, 83.8, 81.7, 80.9, 79.2, 79.1, 78.5, 74.4, 73.3, 61.1, 52.1, 39.6, 37.1, 35.0, 
27.8, 25.94 (3C), 25.90 (3C), 25.7, 21.2, 18.3 (2C), 18.2, –4.7, –4.8, –5.2, –5.4 ppm. IR (film): ṽ = 2954, 
2929, 2885, 2857, 1741, 1462, 1371, 1248, 1087, 393, 836, 777, 666 cm–1. MS (ESIpos) m/z (%): 769.4 
(100 (M+Na)). HRMS (ESIpos): m/z calcd for C36H63O10ClSi2Na: 769.3541, found: 769.3538. 
Secoacid 173. A solution of chlorodiene 172 (4.8 mg, 6.4 μmol) in CH2Cl2 (0.2 mL + 0.2 mL rinse) was 
added to a solution of K2CO3 (3.0 mg, 22 μmol) in CH2Cl2/aq. MeOH (6:1, 
1.2 mL) at 0 °C and the resulting mixture (CH2Cl2/MeOH 8:1) was stirred at rt 
for 48 h. The reaction was quenched with pH 5 phosphate buffer (3 mL). The 
aqueous layer was separated and extracted with EtOAc (5 × 5 mL). The 
combined extracts were dried over Na2SO4, filtered and concentrated. The 
residue was purified by flash chromatography (hexane/EtOAc/AcOH 135:65:1) to afford the title 
compound 173 as a colorless oil (3.5 mg, 79%). 1H NMR (400 MHz, CDCl3): δ = 6.64 (d, J = 11.1 Hz, 
1H), 6.56 (t, J = 10.8 Hz, 1H), 5.69 (t, J = 10.1 Hz, 1H), 5.01 (dd, J = 9.4, 5.4 Hz, 1H), 4.50 (dt, J = 5.6, 2.6 
Hz, 1H), 4.42 (ddd, J = 8.6, 6.6, 4.7 Hz, 1H), 4.29 (ddt, J = 9.0, 6.1, 3.3 Hz, 1H), 4.17–4.07 (m, 3H), 3.98 
(d, J = 8.7 Hz, 1H), 3.94–3.87 (m, 3H), 2.41–2.28 (m, 1H), 2.13–2.03 (m, 1H), 1.99–1.87 (m, 2H), 1.52 
(s, 3H), 1.40 (s, 3H), 1.33–1.28 (m, 1H), 1.24 (d, J = 6.7 Hz, 3H), 0.91 (s, 9H), 0.89 (s, 9H), 0.09 (s, 6H), 
0.08 (s, 3H), 0.04 ppm (s, 3H). 13C NMR (100 MHz, CDCl3): δ = 167.8, 138.4, 129.1, 126.8, 120.1, 109.9, 
83.3, 81.1, 80.8, 79.9, 78.8, 74.1, 73.3, 66.3, 63.0, 39.6, 37.8, 37.5, 27.8, 25.9 (6C), 25.5, 18.4, 18.3, 
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17.9, –4.7, –4.8, –5.3, –5.4 ppm. MS (ESIneg) m/z (%): 689.3 (100 (M–H)). HRMS (ESIneg): m/z calcd 
for C33H58O9ClSi2: 689.3313, found: 689.3321. 
Macrolactone 174. A solution of 2-bromo-1-ethylpyridinium tetrafluoroborate (9.1 mg, 33 μmol) in 
dichloroethane (1 mL) was added to a suspension of secoacid 173 (2.3 mg, 
3.3 μmol) and NaHCO3 (35 mg, 0.4 mmol) in dichloroethane (5.6 mL). The 
reaction mixture was warmed to 80 °C and stirred for 24 h. The reaction was 
quenched with pH 5 phosphate buffer (3 mL). The aqueous layer was 
separated and extracted with EtOAc (5 × 5 mL). The combined extracts were 
dried over Na2SO4, filtered and concentrated. The residue was purified by flash chromatography 
(hexane/EtOAc 19:1 to 15:1) to afford the title compound 174 as a colorless oil   (approx. 0.6 mg, 
25%). 1H NMR (600 MHz, CDCl3): see Table 4.10.
 13C NMR (100 MHz, CDCl3): see Table 4.10. 
MS (ESIpos) m/z (%): 695.3 (100 (M+Na)). HRMS (ESIpos): m/z calcd for C33H57O8ClSi2Na: 695.3173, 
found: 695.3172. 
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Table 4.10. 1H and 13C NMR data of macrolactone 174 (0.5 mg in 0.25 mL CDCl3); chagosensine numbering.* 
atom 
n° 
1H NMR (600 MHz, CDCl3) 
13C NMR (150 MHz, CDCl3) 
δ [ppm] m J [Hz] COSY NOESY δ [ppm] HMBC 
1 - - - - - 170.2 15 
2 3.89 d 9.2 3 (4b), 15, 23 80.5 23 
3 2.80 ddq 9.0, 6.6, 6.2 2, 4(a)b, 23 (2), (4a), 5, 23 37.6 (2), 23 
4a 
4b 
2.16 
1.57 
ddd 
m 
12.0, 6.6, 5.1 
- 
3, 4b, 5 
3, 4a, 5 
(3), 4b, 5 
(2), 4a, 8, (23) 
36.8 (6), 23 
5 4.15 m - 4(a)b, (6) 3, 4a, 6  81.3 4b, (7) 
6 4.65 m 7.0, 3.6 (5), 7 5, 7, 10, (22) 78.0 4b 
7 5.19 m - 6, 8 (8), 10, 22 75.4 9 
8 5.88 dd 11.0, 5.3 7,9 4b, (7), 9 130.5 (7), 10 
9 6.56 td 11.1, 2.3 8, 10 8 123.4 (10) 
10 6.69 d 11.6 9 6, 7, (14a) 123.0 (8) 
11 - - - - - 135.7 12, 13 
12 4.40 d 4.1 13 - 75.3 (10), 14b 
13 4.37 dd 8.6, 4.2 14b 14b, 12-TBS 82.1 14b 
14a 
14b 
2.52 
2.26 
dd 
ddd 
12.5, 7.8 
12.0, 10.3, 5.2 
14b, 15 
13, 14a, 15 
10, 14b, 15 
13, 14a, (17) 
31.6 12 
15 4.92 dt 10.3, 7.9 14, 16 2, (6), 14a, 16 76.1 14(a)b, (13) 
16 4.05 m - 15, 17 15, 17 78.8 14a 
17a 
17b 
3.73 m - 16 17-TBS 63.0 15 
20 - - - - - 107.8 21, 22 
21 1.48 s - - (8), 22 27.1 - 
22 1.34 s - - (6), 7, 21 24.2 - 
23 1.12 d 6.4 3 2, 3, (4b) 16.9 2 
 
* The signals of the TBS groups are not listed and appear as follows: 1H NMR (600 MHz, CDCl3): 
δ = 0.92 (s, 9H), 0.90 (s, 9H), 0.083 (s, 3H), 0.082 (s, 3H), 0.054 (s, 3H), 0.045 ppm (s, 3H). 13C NMR 
(150 MHz, CDCl3): δ = 26.1 (3C), 25.7 (3C), 18.5, 18.0, –4.8, –5.0, –5.2, –5.3 ppm. 
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5 Glossary 
Ac   acetyl 
acac   acetylacetonate 
AIBN   azobis-iso-butyronitrile 
aq.   aqueous 
Ar   aryl 
BArF   tetrakis[3,5-bis(trifluoromethyl)phenyl]borate ion  
Bn   benzyl 
br   broad  
b.r.s.m.   based on recovered starting material 
Bu   butyl 
Bz   benzoyl 
calcd   calculated 
cat.   catalytic 
CD   circular dichroism 
cm   centimeter 
conc.   concentrated 
CSA   camphorsulfonic acid 
Cy   cyclohexyl 
d   day 
d   doublet 
d.r.   diastereomeric ratio 
DABCO   1,4-diazabicyclo[2.2.2]octane 
DBU   1,8-diazabicyclo[5.4.0]undec-7-ene 
DCE   1,2-dichloroethane 
(DHQD)2PYR  hydroquinidine-2,5-diphenyl-4,6-pyrimidinediyl diether 
DIAD   diisopropyl azodicarboxylate 
DIBAL-H  diisobuylaluminum hydride 
DMA   dimethylacetamide 
DMAP   N,N-dimethyl-4-aminopyridine 
DMF   dimethylformamide 
DMP   Dess-Martin periodinane 
DMPU   1,3-dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidinone 
DMS   dimethyl sulfide 
DMSO   dimethyl sulfoxide 
ee   enantiomeric excess 
ent   enantiomeric 
epi   epimeric 
equiv   equivalent(s) 
Et   ethyl 
exp.   experimental 
g   gram 
GC   gas chromatography 
h   hour 
hep   heptet 
HFIP   hexafluoroisopropanol 
HMPA   hexamethylphosphoramide 
HPLC   high performance liquid chromatography 
HRMS   high resolution mass spectrometry 
i   iso (branched) 
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INT   intermediate 
IR   infrared spectroscopy 
J   coupling constant 
KHMDS   potassium hexamethyldisilazide 
L   liter 
l.l.s.   longest linear sequence 
LDA   lithium diisopropylamide 
LiHMDS  lithium hexamethyldisilazide 
M   molar 
m   multiplet 
Me   methyl 
Mes   mesityl 
mg   milligram 
min   minute 
mL   milliliter 
MOM   methoxymethyl 
m.p.   melting point 
ms   milisecond 
Ms   methanesulfonyl 
MS   mass spectrometry 
MS   molecular sieves 
MTBE   t-methyl ether 
μg   microgram 
μL   microliter 
n   normal (linear) 
N   normal (mol/kg) 
NaHMDS  sodium hexamethyldisilazide 
NCS   N-chloro succinimide 
n.d.   not determined 
NHC   N-heterocyclic carbine 
NME   N-methylephedrine 
NMI   N-methylimidazole 
NMO   N-methylmorpholine-N-oxide 
NMR   nuclear magnetic resonance 
4-NO2-Bz  4-nitrobenzoyl 
NOE   nuclear Overhauser effect 
NOESY   nuclear Overhauser effect spectroscopy 
Ph   phenyl 
PIDA   phenyliodonium diacetate 
pin   pinacol 
PG   protecting group 
PMB   para-methoxybenzyl 
ppm   parts per million 
PPTS   pyridinium-para-toluenesulfonate 
Pr   propyl 
PTSA   p-toluenesulfonic acid 
Py   pyridine 
q   quartet 
quant   quantitative 
R   arbitrary organic substituent 
r.r.   regioisomeric ratio 
rac   racemic 
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RCAM   ring closing alkyne metathesis 
RCM   ring closing (olefin) metathesis 
rt   room temperature 
s   singlet 
s.m.   starting material 
sat.   saturated 
t   triplet 
TBAF   tetra-n-ammonium flouride 
TBS   dimethyl-t-silyl 
TC   thiophene-2-carboxylate 
TDMPP   tris-(2,6-dimethoxyphenyl)phosphine 
TEMPO   (2,2,6,6-tetramethyl-piperidin-1-yl)oxyl 
TES   triethylsilyl 
Tf   trifluoromethanesulfonyl 
TFA   trifluoroacetic acid 
THF   tetrahydrofurane 
TIPS   tri-iso-propylsilyl 
TLC   thin layer chromatography 
TMS   trimethylsilyl 
Tol   ortho-tolyl 
TPPO   triphenylphosphine oxide 
TS   transition state 
Ts   toluenesulfonyl 
UV   ultraviolet 
(S,SFC)-WalPhos (S)-1-{(SFC)-2-[2-(diphenylphosphino)-phenyl]-ferrocenyl}-ethylbis-[3,5-bis-
(trifluoromethyl)-phenyl]phosphine 
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7 Appendix 
7.1 Crystallographic Data 
Compound 68 
 
Identification code (intern) 9052 
Empirical formula  C14H17NO6 
Color  colorless 
Formula weight  295.28 g · mol–1  
Temperature  100 K 
Wavelength  1.54178 Å 
Crystal system  triclinic 
Space group  P 1, (no. 2)  
Unit cell dimensions a = 5.9280(5) Å α = 78.427(3)°. 
 b = 7.3798(6) Å β = 84.323(3)°. 
 c = 16.2463(13) Å γ = 86.923(4)°. 
Volume 692.45(10) Å3 
Z 2 
Density (calcd) 1.416 Mg · m–3 
Absorption coefficient 0.944 mm–1 
F(000) 312 e 
Crystal size 0.17 × 0.15 × 0.05 mm3 
θ range for data collection 2.788 to 67.699°. 
Index ranges –6 ≤ h ≤ 7, –8 ≤ k ≤ 8, –19 ≤ l ≤ 19 
Reflections collected 29024 
Independent reflections 2417 [Rint = 0.0443] 
Reflections with I > 2σ(I) 2128 
Completeness to θ = 67.679° 96.4%  
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Absorption correction Gaussian 
Max. and min. transmission 0.95709 and 0.88038 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2417 / 0 / 194 
Goodness-of-fit on F2 1.052 
Final R indices [I > 2σ(I)] R1 = 0.0384 wR
2 = 0.1046 
R indices (all data) R
1
 = 0.0441 wR2 = 0.1094 
Extinction coefficient 0 
Largest diff. peak and hole 0.196 and –0.291 e · Å–3 
 
7.2 Calibration of HPLC-MS for RCAM 
In order to obtain quantitative results during analytical HPLC-MS reaction monitoring, the device was 
calibrated as follows. Two independent stock solutions (1.57 mg and 2.36 mg) of the starting material 
92 in HPLC-grade MeCN (392 μL and 500 μL) were prepared and dilution series performed 
(Table 7.1). After recording the respective HPLC chromatograms (two for each concentration), the 
concentrations (c in mg/mL) were plotted against the averaged area points (Figure 7.1). A straight 
calibration line was obtained, which can be used to determine the quantity of starting material in the 
HPLC trace of attempted RCAM reactions. To this end, the area points determined from a certain 
measurement can be inserted into the linear equation and the corresponding mass approximated via 
the concentration.  
Table 7.1. Data acquired for enyne-yne 92. 
Entry c [mg/mL] Area Points (× 1000) Area Points (× 1000) Ø Area Points (× 1000) 
1 4.00 5067.96 5067.96 5067.96 
2 2.00 2832.76 2676.90 2754.83 
3 1.00 1338.63 1338.97 1338.80 
4 0.50 874.49 767.48 820.98 
5 0.25 316.14 318.02 317.08 
6 0.125 153.01 159.05 156.03 
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Figure 7.1. Straight calibration line for 92. 
The same procedure was carried out for the desired product 93b in order to obtain the amount of 
product formed in the RCAM reaction (Table 7.2, Figure 7.2). Two independent stock solutions 
(1.19 mg and 1.36 mg) of the product 93b in HPLC-grade MeCN (297 μL and 500 μL) were prepared 
and dilution series performed as described above. 
Table 7.2. Data acquired for cyclic enyne 93b. 
Entry c [mg/mL] Area Points (× 1000) Area Points (× 1000) Ø Area Points (× 1000) 
1 2.80 4195.12 4195.12 4195.12 
2 1.40 2097.30 2088.91 2093.10 
3 0.70 1057.20 1043.43 1050.31 
4 0.35 504.22 509.18 506.70 
5 0.18 262.01 267.24 264.63 
6 0.09 134.73 118.60 126.67 
 
 
Figure 7.2. Straight calibration line for 93b. 
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